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Abstract 
The ability to prevent vertical transmission of HIV (where HIV is transmitted 
from mother to (unborn) baby in utero, at birth or through breastfeeding) is 
generally considered to be the most successful achievement of HIV 
biomedicine and care. Indeed if appropriate care and biomedical technologies 
are available, transmission rates can be reduced to less than 1%. However, 
there has been very little qualitative research investigating the contingencies 
and requirements of specialist HIV antenatal care in resource rich settings.  
 
Adopting theoretical insights from Science and Technology studies (STS) and 
anthropology within a broader sociological frame, this research explores the 
challenges of HIV and the successful prevention of vertical transmission in a 
specialist antenatal clinic which arguably has access to the most advanced 
care and biomedical technologies.  
 
In doing so, the thesis investigates the way in which the identity of a particular 
illness — specifically HIV — is maintained in social, clinical and technical 
domains. Moreover, it explores the requirements of successful specialist HIV 
antenatal care from the perspective of both practitioner and patient, and it 
considers how the interests of patients, (unborn) babies and health 
professionals are reconciled, if at all, within the clinic.  
 
The description of specialist HIV and antenatal care provided in this study 
draws on empirical research conducted in an HIV specialist antenatal clinic 
housed within an acute National Health Services hospital in London, UK. The 
research makes a practical contribution to knowledge about specialist HIV 
antenatal care through theoretically informed reflections on some of the 
requirements and contingencies of providing and participating in specialist 
antenatal HIV care in London. Moreover, the research offers an analysis of 
the clinic that interrogates the relations between social dynamics, (bio)medical 
practice and technological interventions. In this way, the research also 
contributes to the social scientific HIV field by explicating how social 
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understandings of HIV and pregnancy are intimately entangled with 
(bio)medical practice, technological intervention, and what I have called an 
“HIV diaspora”.  
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Chapter	One:	Setting	the	Stage	—	Preventing	Vertical	Transmission	of	
HIV	in	London	
 
[I]f we are to understand the challenge of HIV (the human 
immunodeficiency virus), we must understand our field of inquiry 
(Rosengarten, 2009, p. 4). 
This thesis explores the challenges of HIV and how the prevention of vertical 
transmission1 of HIV and care for HIV-positive pregnant women is achieved in 
one of the UK’s most prominent specialist HIV antenatal clinics. The purpose 
of such an inquiry is to contribute to understandings of successful care from 
the perspective of those receiving and those providing it. In this research, I 
observed and participated in the events that took place in one of the UK’s 
most prominent and busy HIV specialist antenatal clinics for nine-months 
(2008-2009). The clinic was the perfect location to examine the way in which 
care for HIV-positive pregnant women takes place and how vertical 
transmission of HIV is prevented. This chapter will help situate the inquiry and 
broader context in which the research unfolded by providing an overview of 
some of the challenges of HIV as they exist outside of the clinic. The overview 
provided in this chapter is not meant to be a comprehensive outline of the 
history of HIV/AIDS, the prevention of vertical transmission or of the literature 
pertaining to the pandemic. Rather, my intention here is to situate the case 
study, outline the requirements of preventing vertical transmission of HIV, 
provide cursory information about the scale of the problem of HIV, and 
introduce the clinic wherein this research took place.  
 
The chapter is structured as follows: it begins by providing an outline of the 
global HIV situation as well as a discussion of the requirements of the 
prevention of vertical transmission of HIV. This has been included to make 
clear that there is a stark global divide between geographical locations where 
people have access to technologies that have managed to turn HIV into a 
                                                
1 Vertical transmission of HIV is also known as mother-to-child transmission (MTCT). 
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chronic condition and areas where HIV is a precursor to death. The divide is 
central to the findings of the thesis and to my concluding argument. In the 
next sub-section, I give an epidemiological overview of the history of the 
prevention of vertical transmission of HIV in the UK. This is followed by an 
outline of the guidelines and actual care practices for the prevention of vertical 
transmission of HIV in the UK as well as statistical information about the HIV 
epidemic in the UK (with a focus on HIV-positive women — in particular, HIV-
positive women in London). The chapter will then provide a preliminary 
ethnographic description of the clinic and an explanation from the perspective 
of the healthcare practitioners of the process women go through to become 
patients there. I conclude with a chapter breakdown of the literature review, 
methodology and empirical research.  
	
The	global	HIV	pandemic:	Preventing	vertical	transmission	of	HIV	
 
UNAIDS estimates that in 2012 there were 35.3 (32.2-38.8) million people 
living with HIV (UNAIDS, 2013, p. 4) and that approximately 25 million (23.5-
26.6 million) of them live in sub-Saharan Africa (UNAIDS, 2013, p. 3). 
Moreover, in the same year (2012) only 9.7 million people living with HIV had 
access to antiretroviral therapy in low- and middle-income countries (UNAIDS 
2013, p. 1).  
 
Towards the end of the twentieth century, the use of a combination of 
antiretroviral drugs (here on referred to as ARVs) drastically altered the 
course of the HIV pandemic (Anderson and Doyal, 2004; Detels et al., 1998, 
p. 1497; Dieffenbach and Fauci, 2009; Kaplan et al., 2009; Palella et al., 
1998, p. 853), changing the prognosis of an HIV-positive person from almost 
certain death to a life with a chronic illness (Carlsson-Lalloo et al., 2016; 
Siegel and Lekas, 2002, pp. S69-S70; Persson, 2013, p. 1067; van Sighem et 
al., 2010). 
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The prevention of vertical transmission of HIV-12 is generally considered to be 
one of the most successful achievements in the use of ARVs (Taylor, et al., 
2012, p. 97). According to the Centers for Disease Control and Prevention 
(CDC), if a pregnant woman’s HIV is diagnosed during or prior to her 
becoming pregnant and appropriate care and interventions are available and 
breastfeeding is avoided, the HIV transmission rate could be reduced to less 
than 1% (CDC, 2012, p. 1; Townsend et al., 2008, p. 937). The use of ARVs 
to prevent vertical transmission of HIV is synonymous with (using) treatment 
as prevention. Therefore, this entire thesis addresses treatment as 
prevention3 as it pertains to the prevention of vertical transmission and the 
specific work that is carried out in the specialist HIV antenatal clinic. In what 
follows I will offer a brief description of efforts to prevent vertical transmission 
in the UK.  
	
The	history	of	the	prevention	of	vertical	transmission	in	the	UK	
 
Tests that were able to detect antibodies to both HIV-1 and HIV-2 became 
available in the mid-1980s (Nicoll et al., 2000, p. 1). In the UK, antenatal HIV 
                                                
2 An explanation of HIV-1 and HIV-2 will follow.  
3 Treatment as prevention is perhaps most commonly associated with efforts to prevent 
transmission of HIV between adults. In regards to this, a report was published in 2008 which 
had a monumental impact on the HIV biomedical and social science field (Persson, 2010). 
The report is usually referred to as the “Swiss Consensus Statement”, and was published by 
the Swiss federal Commission for HIV/AIDS (Wilson et al., 2008). The statement claims that 
HIV-positive people who are receiving effective Antiretroviral Therapy (ART) — and 
consequently have an undetectable viral load — and are without STIs are sexually non-
infectious (Wilson et al., 2008; Vernazza et al., 2008). Thus, the study claimed that treatment 
could prevent HIV infection between adults in serodiscordant sexual relationships. Hence, the 
Swiss statement directly pertained to HIV-positive adults who were in sexual relationships 
with HIV-negative people. In other words, the Swiss statement concerned the transmission of 
HIV through sexual contact between adults and not through vertical transmission.  
 
The significance of the Swiss statements’ is that it partially proved that treatment could be 
used as an effective HIV prevention method. Therefore, the statement can be seen to mark a 
different approach to HIV. This new approach uses treatment as prevention (TasP). The 
treatments that are perhaps most commonly associated with treatment as prevention are: 
pre-exposure prophylaxis (PrEP) which utilises a combination of different ARVs to protect 
HIV-negative adults from HIV; pre-exposure prophylaxis (PrEP) should be taken by the HIV-
negative adults prior to exposure to HIV (McCormack et al., 2015). Moreover, it was deemed 
advisable to give post-exposure prophylaxis (PEP) (which is a combination of ARVs) to 
people after they had possibly been exposed to HIV (Henderson and Gerberding, 1989). 
Clearly, neither of these prevention methods would pertain to efforts to prevent vertical 
transmission of HIV.  
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testing was first offered to pregnant women in 1985 (Duffy et al., 1998, p. 
270). Following this, surveys began in 1988 in selected regions of England in 
order to establish the prevalence of HIV-1 infection amongst people assumed 
to be heterosexual (Ades et al., 1991, p. 1562; Nicoll et al., 1998, p. 254; 
Nicoll et al., 2000, p. 1;Taylor et al., 2012, p. 97). Anonymous unlinked 
residual blood samples from babies born in the regions included in the survey 
were tested for antibodies to HIV-1 (Ades et al., 1991, p. 1562; Brown et al., 
2004, p. 160; Nicoll et al., 1998, p. 254; Taylor et al., 2012, p. 97). 
Consequently, each HIV-positive baby detected by the survey also revealed 
two HIV-positive adults.  
 
Between 1988-1996, an analysis of the data collected by the national surveys 
showed that black African women and women with a history of injecting drug 
use were at most risk of HIV-1 infections (Nicoll et al., 1998, p. 257). Similarly, 
De Cock and Low wrote that African women in the UK had a higher 
seroprevalence than other women in the UK (1997, p. 1747). Moreover, 
London was discovered to be the city with the highest number of women who 
were HIV-positive and pregnant (Nicoll et al., 1998, p. 257). Based on this, 
Nicoll and colleagues argued that it was justifiable to create policies that 
would improve the HIV services available to black African women (1998, p. 
256).  
 
Since 1992, it has been the policy in the UK to offer every pregnant woman a 
confidential and voluntary antenatal HIV test in areas where the maternal HIV 
prevalence is high; elsewhere women who are at increased risk of being or 
becoming HIV-positive are also offered the test (Mercey et al., 1996, p. 1129; 
Nicoll et al, 1998, p. 253). However, as Mercey and colleagues point out, 
selective antenatal HIV testing has failed to detect the vast majority of cases 
(1996, p. 1129).  
 
Thus, in the late 1990s HIV healthcare providers and epidemiologists voiced 
significant concern about the state of antenatal HIV care and screening 
practices in the UK (Tookey et al., 1998; MacDonagh et al., 1996; De Cock 
and Johnson, 1998; Nicoll et al., 1998). Much of the debate was highly critical 
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of the low rates of HIV detection in the UK and supportive of a move towards 
“universal access” to HIV testing during pregnancy, which was generally 
thought to be a crucial step towards normalising HIV testing during pregnancy 
(De Cock and Johnson, 1998; Mercey, 1998; Tookey et al., 1998). 
Normalising HIV testing during pregnancy was considered by many 
researchers to be vital in order to make testing more acceptable to pregnant 
women and their care providers (De Cock and Johnson 1998, p. 290; Mercey, 
1998, p. 241). According to these researchers, normalisation would happen 
by making the test available to all pregnant women during their initial booking 
visit and as part of the package of tests already offered to all pregnant women 
(De Cock and Johnson 1998, p. 290; Mercey, 1998, p. 241).  
 
However, there was also much deliberation about whether or not selective or 
universal HIV antenatal testing would be more (cost) effective (Gibb et al., 
1998, p. 261). Selective testing would target women from known risk groups, 
that is Black African women and women who were known to be or to have 
been injecting drug users (Tookey et al., 1998, p. 135). Conversely, universal 
testing would target all pregnant women within a defined region (1998, p. 
135.). Some of the primary concerns voiced about selective testing were that 
care practitioners might be reluctant to choose only certain groups of women 
for HIV testing during pregnancy out of fear of being perceived as 
discriminating against and stigmatising them (Gibb et al., 1998, p. 261). Thus, 
Duffy and colleagues argued that despite the fact that antenatal HIV testing 
was first offered to pregnant women in the UK in the mid-1980s, midwives and 
obstetricians were still disinclined to discuss HIV testing with their patients 
(Duffy et al., 1998, p. 270; Mercey, 1998, p. 242). Hence, whether or not a 
pregnant woman was offered an HIV test depended on which hospital she 
attended and the particular care provider she met with (Conaty et al., 2005; 
Duffy et al., 1998; Gibb et al., 1998; Jones et al., 1998; Nicoll et al., 1998, p. 
253; MacDonagh et al., 1996; Sadler et al., 2006; Tookey et al., 1998). 
Consequently, Mercey argued that the UK lagged behind other countries 
when it came to providing pregnant women access to HIV testing (1998, p. 
242). Moreover, Mercey argued that this was particularly reprehensible 
because since 1990 the UK had been adept at assessing the amount of 
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babies who are at risk of infection but had not attempted to reduce the risk 
these babies were under (1998, p. 242.). Finally, universal testing was 
ultimately considered to be the most cost effective and also the most able to 
detect HIV infection in women who were not identified as belonging to the 
known risk groups (Ades et al., 1999a, p. 271).  
 
Following this, in 1999 targets were set for the universal offer of an HIV test 
as part of antenatal care in England (Cliffe et al., 2001, p. 376; Townsend et 
al., 2006, p. 248). The targets were intended to obtain the national goal of 
reducing the amount of babies who acquired HIV through vertical 
transmission by 80% by the year 2002 (Adam, 1999, p. 2). An initial step in 
achieving these goals was a directive where all health authorities in England 
were asked to ensure that “all pregnant women [were] offered and 
recommended an HIV test as an integral part of their antenatal care” (Adam, 
1999, p. 2). A caveat was included for women who booked in while in labour 
or who were otherwise too late to receive antenatal care; these women would 
be offered a test postnatally (1999, p. 2). 
 
The new screening targets were thus implemented in the same year that Ades 
et al. observed that out of the over 300 HIV-positive women who gave birth in 
the UK every year, more than 75% of the women had not had their HIV 
infections diagnosed at the time they gave birth (1999b, p. 1230). 
Furthermore, Postma et al. commented on the fact that despite existing 
guidelines on antenatal screening, few women in the UK actually screened for 
HIV during pregnancy compared to countries with similar access to care and 
health technologies (1999, p. 1656). Importantly, however, when HIV was 
detected antenatally the medical and care interventions available in the UK 
where very successful and led to the reduction of vertical transmission of HIV 
and the decline of HIV related morbidity (Duong et al., 1999).  
 
By 2002, one-third of the English units that provided antenatal care reported a 
90%+ uptake of HIV antenatal testing (Townsend et al., 2006, p. 248). Since 
then, the rates of vertical transmission in the UK have been on a continuous 
decline since 2006 “reaching an all-time low of 5 per 1000 in 2010-2011” 
 16 
(Townsend et al., 2014, p. 1049). Moreover, the number of HIV-positive 
mothers in the UK who go on to have additional pregnancies is on the rise 
(French et al., 2012, p. 287). The effectiveness of the British guidelines for the 
care of HIV-positive pregnant women in preventing vertical transmission were 
confirmed by Townsend et al. (2008).  
 
In 2004, the Health Protection Agency noted that while HIV screening should 
be available to all pregnant women, those who were refugees and asylum 
seekers — and had recently arrived to the UK from high prevalence countries 
(as well as injection drug users and sex workers) — were at particularly high 
risk (The UK Collaborative Group for HIV and STI Surveillance, 2007, p. 47).4 
Furthermore, the Health Protection Agency found that in 2006 pregnant 
women from [born in] Sub-Saharan Africa had the highest HIV prevalence in 
the UK (2007, p. 90). Moreover, in the same year, the second highest HIV 
prevalence was amongst pregnant women who had been born in the 
Caribbean and Central America (2007, p. 90). Further to this, Tariq and 
colleagues found that in the UK, pregnant HIV-positive Black women of 
African ancestry or otherwise are more likely than white HIV-positive women 
to be late in booking their first antenatal appointment (2012a, p. 978). 
Problematically, evidence shows that late booking increases the risk of 
vertical transmission and adverse health outcomes for both mother and baby 
(2012a, p. 978). Therefore, while universal testing and antenatal HIV care 
have undoubtedly been overwhelmingly successful in the UK in preventing 
vertical transmission, certain groups of women are still more at risk.  
 
This disparity is especially apparent in London compared to the rest of the 
UK. Public Health England estimated that in 2011 the HIV prevalence 
amongst pregnant women in London was 3.5 per 1,000, whereas the 
prevalence in the rest of England was 2.2 per 1,000 (Aghaizu, 2013, p. 8). 
Overall, the prevalence was the highest amongst women originally from Sub-
Saharan Africa with 23 per 1,000 being HIV-positive (2013, p. 8; Taylor, 2012, 
p. 97). In comparison, UK-born pregnant women had a prevalence of 0.5 per 
                                                
4 Please note that the reference was authored by the UK Collaborative Group for HIV and STI 
Surveillance, but published by the Health Protection Agency.  
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1,000 (Aghaizu, 2013, p. 8). Further to this, the British HIV Association (here 
on referred to as BHIVA) reports that since 2000 approximately 10 cases of 
vertical transmission of HIV from women diagnosed with HIV prior to delivery 
are reported every year in the UK (Taylor, 2012, p. 97). Furthermore, every 
year approximately 20-30 children who were born in the UK to mothers who 
were not known to be HIV-positive at the time of the child’s birth are 
diagnosed with HIV (2012, p. 97).  
	
Encountering	the	HIV	specialist	antenatal	clinic	and	preventing	vertical	
transmission	of	HIV	
 
This research uses qualitative methods to explore an HIV antenatal specialist 
clinic. As mentioned above, I spent nine months in the clinic gathering data. In 
particular, I was interested in what makes everyday life and HIV positivity 
compatible, and the prevention of vertical transmission of HIV possible in the 
clinic. Moreover, I was interested in how the prevention of vertical 
transmission of HIV and care for HIV-positive pregnant women is done in 
clinics that had access to the most advanced biomedical resources, 
information and skilled medical practitioners. In what follows, I set out the 
empirical scene in which my study took place.  
 
The Department of Sexual Health (DOSH) at “London Hospital” in an inner 
city area of London is home to one of England's busiest HIV centres. The 
centre facilitates several satellite clinics, one of which is the HIV specialist 
antenatal clinic. It is a once-weekly open clinic for pregnant HIV-positive 
women in the local community and is held in the hospital’s antenatal 
department. Approximately 40-50 HIV-positive pregnant women receive care 
in the clinic every year. Other antenatal specialist clinics, such as a clinic for 
women with diabetes, may simultaneously convene in this space.  
 
DOSH has a multidisciplinary approach to HIV care. A group of health care 
professionals, some of whom specialise in HIV and some who are based at 
other hospitals in London (an HIV specialist pediatric nurse, and an HIV 
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specialist community nurse), will care for the clinic’s patients and/or their 
families.5 They are called the Multidisciplinary Team (here on referred to as 
MDT); a more detailed description of the team will be provided in Chapter 
Three. The core members of the team responsible for antenatal patients 
usually attended clinic meetings on a weekly basis: Ellen,6 an HIV specialist 
midwife, Sophia, an HIV specialist doctor, and an HIV consultant physician, 
known as either Anne or Marie.7 The patients would most often see both 
Sophia and Ellen on days that they visited the clinic; the specialist consultant 
physicians rarely stayed for patient consultations. Patients are regularly sent 
to other areas of the hospital to carry out different procedures such as filling 
out prescriptions, having blood taken, and sexually transmitted infection (STI) 
screenings. Ellen, the specialist midwife, was the only MDT member who 
exclusively cared for the HIV specialist antenatal clinic’s patients. Other 
members of the MDT periodically attend meetings depending on specific 
issues relating to a patient, such as foetal abnormalities, the presence of other 
children who might need testing, and obstetric interventions such as 
scheduled cesarean sections.  
 
The clinic convenes in the antenatal department in a purpose-built modern 
hospital building. It is accessed via the main entrance hall of the hospital 
beyond a waiting area, reception, café and convenience store. There, a large 
sign above the entrance to a corridor informs you that if you follow the 
coloured lines on the laminated floors of the hospital, you will be directed to 
the various wards beyond the main building. Upon entering the reception area 
of the clinic, the patient is required to register with the receptionist, receive her 
antenatal file which contains medical notes as they pertain to her antenatal 
care, and then sit down in the waiting room. The waiting room is light and airy 
with several rows of chairs. Two televisions are mounted on the walls. They 
play a reel of advertisements and public health alerts on a loop, extolling 
                                                
5 In fact, most of the members of the MDT were not actively involved in the patient’s care until 
she had had her final postnatal appointment at the specialist antenatal clinic and had her care 
transferred to other clinics.  
6 As will be discussed in Chapter Three, all of the research participants within this thesis have 
been given pseudonyms.  
7 Marie filled in for Anne during the autumn. Anne took charge of the clinic after the Christmas 
hiatus.  
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advice on issues such as how to care for one’s self and their babies, the best 
car seats to buy and breastfeeding techniques to employ. There is an 
occasional advertisement aimed at male viewers, assuring them of their 
usefulness and the importance of involvement in their partner’s pregnancy 
and their baby’s life. Posters are also plastered on the walls, giving advice 
and warnings: what and when to eat, not to smoke or drink, and so on.  
 
There is a general sense of urgency on the part of the employees of the clinic, 
expressed in their tone of voice, purposeful walk and the way they deftly guide 
patients through the various rooms and stages. The professionals’ efficiency 
is in stark contrast to the slow and awkward movements made by the 
pregnant women, as they slouch in their chairs, looking as if they have 
resigned themselves to an undetermined wait. Various healthcare providers 
from other clinics come in and out of the waiting room calling patients’ names, 
often mispronouncing them. They wait while the patients gather their 
belongings and follow them into the consultation rooms. Patients are 
occasionally greeted with a warm smile or a hug. At other times the 
employees tap their feet as they impatiently wait for the women to waddle 
over to them.  
	
Becoming	a	patient	
 
In the following section, I will use the practitioners’ description of the process 
to explain how women become patients in the clinic. It is worth mentioning 
that the description reflects on how the practitioners told me they plan a 
patient’s introduction to the clinic. In practice, as we see later, care is much 
more complicated than I am able to make allowances for here. These 
complications will be considered in the empirical chapters of this thesis.  
 
Practitioners working in the clinic are alerted to a patient’s existence via 
external sources such as DOSH, the virology department in another hospital 
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in London,8 GP offices, community midwives, and routine gynaeo-urinary 
(GU) screens. These sources provide the clinic with the initial test results, 
both for pregnancy and of HIV-positivity. However, a woman will only become 
a patient in the clinic if she intends to keep her pregnancy. In this way, some 
women might be known to be HIV-positive and pregnant, but they might never 
be cared for in the clinic because they choose to terminate their pregnancies.9 
If a patient is unaware of her HIV status, the HIV specialist midwife will recall 
the patient to communicate these results and accompany the patient to the 
DOSH for registration,10 and for baseline HIV blood tests, including a CD4 
count11 (indicates how well the immune system is working) and viral load 
tests12 (amount of virus in a blood sample) (AIDS.gov, 2015; Carter and 
Hughson, 2014; San Francisco AIDS Foundation, 1998). The two tests are 
the primary way in which disease progression is monitored. The results from 
the tests will also be used to decide upon an appropriate treatment regime: 
the patient’s medical and social background will also be assessed, as these 
might complicate the administration of certain treatments.  
 
To monitor and quantify the viral load there were several different commercial 
assays available within the National Health Services in the UK at the time of 
this study. The assays most commonly used to assess the London clinic’s 
samples are the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative 
test and the Abbott RealTime HIV-1 (ROCHE and ABBOTT for short)(de 
Ruiter et al., 2008, p, 465; Sloma, 2009).  
 
ROCHE and ABBOTT are sensitive to various strains of HIV. Essentially there 
are two types — HIV-1 and HIV-2 — and both have the same mode of 
transmission. However, HIV-2 tends to be harder to transmit than HIV-1 and it 
                                                
8 London Hospital does not have its own virology department. Therefore, as per contract 
between the two NHS trusts, in the first instance London Hospital sends their blood samples 
to a hospital in another health trust.  
9 A woman might also miscarry before she has become a patient.  
10 The HIV specialist midwife arranges these appointments outside of the weekly HIV 
specialist antenatal clinics.  
11 CD4 cells are white blood cells and are an essential part of the immune system. HIV 
usually infects CD4 cells which eventually leads to more copies of the virus being made. 
There is usually a decrease in the CD4 cell count when a person has HIV.  
12 Indicates the severity of a viral infection which is estimated by measuring the amount of 
“virus” (HIV RNA particles) in a blood sample.  
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is also thought to be relatively uncommon, especially outside West Africa 
(Heimer, 2007, p. 552). Moreover, there are several different strains of HIV-1. 
The most common of these is called group “M” and approximately 90% of 
HIV-1 infections are thought to belong to this group. Within this group there 
are at least nine genetically distinct subtypes, referred to as A, B, C, D, F, G, 
H, J and K. Furthermore, it is possible, although rare, for two different sub-
strains of the virus to meet in the cell of an infected person and mix their 
genetic material, consequently producing a new “hybrid” virus. The hybrid 
strains that “survive” and infect more than one person are referred to as 
circulating recombinant forms (CRFs). The various subtypes of HIV-1 have 
been allocated specific geographical locations where they are understood to 
be most prevalent (AVERT, 2014; Cohen et al., 2008, p. 1244). The excerpt 
below describes the global spread of these subtypes. 
 
· The HIV-1 subtypes and CRFs [circulating recombinant forms] are 
typically associated with certain geographical regions […] As studies 
have shown, individuals are increasingly presenting with sub-types not 
native to the country of diagnosis.…  
 
·   Subtype A and CRF A/G predominate in West and Central Africa, with 
subtype A possibly also causing much of the Russian epidemic. 
 
· Historically, subtype B has been the most common subtype/CRF in 
Europe, the Americas, Japan and Australia and is the predominant sub-
type found among MSM [men who have sex with men] infected in 
Europe. Although this remains the case, other subtypes are becoming 
more frequent and now account for at least 25 percent of new HIV 
infections in Europe. 
 
·   Subtype C is predominant in Southern and East Africa, India and 
Nepal. It has caused the world’s worst HIV epidemics and is responsible 
for around half of all infections. 
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·   Subtype D is generally limited to East and Central Africa. CRF A/E is 
prevalent in South-East Asia, but originated in Central Africa. Subtype F 
has been found in Central Africa, South America and Eastern Europe. 
Subtype G and CRF A/G have been observed in West and East Africa 
and Central Europe. 
 
  ·   Subtype H has only been found in Central Africa; J only in Central 
America; and K only in the Democratic Republic of Congo and 
Cameroon (AVERT, 2014). 
The significance of the above is that at the time of this study, some of the 
older commercial assays were still in use within the NHS and might falsely 
indicate that an individual with “divergent subtypes” has a low or undetectable 
viral load (de Ruiter et al., 2008, p. 465). BHIVA recommends re-testing with 
another assay if there are discrepancies in a patient’s clinical status, viral load 
and CD4 count (2008, p. 465). However, not all discrepancies are necessarily 
assay or subtype related; according to the BHIVA, “[a]lthough rare, some 
untreated individuals may have an undetectable viral load in conjunction with 
low CD4 cell counts” (de Ruiter et al., 2008, p. 465). Accordingly, the ROCHE 
assay occasionally under-quantifies the viral loads of the clinic’s patients, 
making the patient seem healthier than she actually is. ABBOTT is therefore 
the MDT’s ideal assay, as it is more sensitive and is consequently in higher 
demand.  
 
Moreover, the manner through which a woman’s HIV is managed during 
pregnancy varies depending on a number of factors such as whether or not 
she conceived while taking Highly Active Antiretroviral Therapy (here on 
referred to as HAART), or if she started taking it during pregnancy, if she has 
other infections or illnesses such as Tuberculosis (here on referred to as TB) 
or Sexually Transmitted Infections (STIs), if she is or becomes resistant to any 
of the drugs commonly used, if her viral load fails to be suppressed, and so on 
and so forth (Taylor, et al., 2012, p 101). The practitioners will decide upon an 
appropriate regime based on the patient’s particular medical history as well as 
her lifestyle and wishes. In accordance with official guidelines, for their own 
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health the MDT would like all of their patients to start taking ARVs at twenty-
four week’s gestation if they have not already begun to do so, as in the case 
of women who knew their status prior to conception, and women who 
commenced treatment earlier in pregnancy (2012, p. 108).13  
 
The possibility of a (unborn) baby becoming infected with HIV through vertical 
transmission is related to a pregnant woman’s viral load; essentially, the 
higher it is, the greater the risk. Hence, the patient’s viral load and CD4 count 
is monitored throughout her pregnancy to ensure the effectiveness of her 
treatment regime. A successful regime would ensure that her viral load is 
undetectable by the time she is ready to give birth.14 The regime involves 
administering a Therapeutic Drug Monitoring test (TDM) two weeks after the 
patient starts taking ARVs. The test evidences the amount of drug (ARVs) in 
the patient’s blood. If the test results show that the patient does not have the 
expected amount of drug in her body, this alerts the team to the fact that 
something is wrong. The patient may not be taking the prescribed doses in 
the right way at the right times, or the drugs may not be working properly in 
her body on the virus.  
 
The frequency of the patient’s appointments in the clinic depends on the 
gestation of her pregnancy and her mental and physical health. If necessary, 
the MDT will offer further support according to the women’s individual needs 
throughout the entire pregnancy, as well as her birth experience and any 
issues that arise postnatally. At around twenty-four to thirty weeks’ gestation, 
the HIV specialist midwife, as part of the MDT, decides upon a birth plan in 
consultation with the patient. A copy of the birth plan is given to the patient to 
put in her antenatal notes and a copy is given to the labour ward. The birth 
plan is a crucial stand-in for the MDT, if they are absent at the birth. The plan 
provides detailed instructions on how to manage the patient’s HIV during and 
after labour along with initial care for the baby. 
 
                                                
13 If no interventions are made, the risk of vertical transmission of HIV is estimated to be 
between 25% to 40% (Newell, 1998).  
14 The meaning of an undetectable viral load will be considered further in Chapter Four.  
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Women with an undetectable viral load are usually encouraged to have a 
vaginal birth. If the mother has a vaginal delivery, she will present herself at 
the labour ward at the onset of her labour. She will inform staff that she is a 
patient of the HIV specialist midwife. This will alert them to her serological 
(HIV) status. They will then consult her birth plan and follow the guidelines 
that the specialist midwife has set out. If it has been decided that the patient 
will have a caesarean section, she will be admitted to hospital the day before 
the scheduled surgery. The HIV specialist midwife will admit her and make 
sure that any necessary medication is administered and that she is fully aware 
of what will happen over the whole delivery process. The next day, the 
surgery is performed and the patient is presented with her baby. Ideally, the 
HIV specialist midwife should be present throughout and an MDT obstetrician 
should perform the surgery. In the case of both vaginal deliveries and 
caesarean sections, staff will ensure that all confidentiality agreements laid 
out in the birth plan are met in order to avoid disclosure of the patients’ HIV 
status to unwitting witnesses at the birth, such as partners that have yet to be 
informed of the patient’s HIV-positivity. After the birth, the mother will recover 
from the procedure in the maternity ward. The length of her stay in hospital 
will depend on her relative health and speed of recovery. A healthcare 
professional will make a few home visits during the first few weeks of the 
baby’s life, and at six weeks the new mother will come in for her last 
appointment with the HIV specialist antenatal team. After this, the mother will 
receive all of her HIV care at the DOSH and her baby will be cared for in the 
paediatric ward at the London Hospital.  
 
The neonatal management of infants born to HIV-positive women varies 
depending on the status of the mother, e.g. when the mother started taking 
HAART, and her viral load (Taylor, et al., 2012, p. 128). Infants born to HIV-
positive mothers are tested with either HIV Deoxyribonucleic acid (DNA) the 
polymerase chain reaction (PCR) or HIV RNA tests at the following times: at 
some point during their first forty-eight hours before being discharged from 
hospital, at six weeks of age, and at twelve weeks. Additional testing is 
advised for infants who are at increased risk of transmission, for example, if 
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the mother has been known to breastfeed (2012, p. 132).15 In situations 
where transmission risk is considered to be low, because of the mother’s 
supressed viral load, the preferred treatment for the infant would be 
Zidovudine monotherapy (one drug), administered twice a day for four weeks 
(2012, p. 128). If the infant is not (and has never been) breastfed, and all of 
the tests have been negative at twelve weeks, BHIVA advises that the parents 
are told that the baby is HIV-negative (2012, p. 132). Still, at eighteen months 
the toddler will be tested for the last time to ensure that it has not 
seroconverted, meaning that it has not become HIV-positive (Taylor, et al., 
2012, p. 132).  
 
The description of the HIV specialist clinic above is derived from the 
observations I made while in the clinic — stories the practitioners told me and 
the clinical guidelines that informed the care provided to the patients. It is an 
account that focuses on the various technical diagnostic tools used by the 
MDT for the benefit of the clinic and its patients. Therefore, it is an account of 
the clinic that mostly avoids recounting the messiness that care in practice 
always entails. As mentioned previously, these stories will be saved for later 
chapters. Here I would like to make clear that the clinic is able to provide the 
most advanced care, biomedical technologies and medicines for HIV-positive 
pregnant women. In this clinic the prevention of vertical transmission is the 
norm. Analysing a clinic in such a prominent position allows for an 
investigation into a clinical environment wherein the care provided is not 
restricted because of lack of resources. In other words, whatever the 
challenge(s) of HIV may have been in the clinic, lack of resources did not 
feature as a primary concern. Thus, by choosing a location wherein resources 
were (comparatively) abundant, I was able to explore the challenge(s) of HIV 
in an environment that was best-equipped to negotiate and contend with 
them.  
                                                
15 In accordance with national guidelines since 2001, HIV-positive women in the UK have 
been advised to entirely avoid breastfeeding (Hawkins et al., 2005; Lyall et al., 2001; Taylor et 
al., 2012).  
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Structure	of	the	thesis	
 
In Chapter Two, I will discuss a diverse set of literatures to create a theoretical 
framework able to explore the processes and socio-political complexities 
involved in HIV and prevention of vertical transmission of HIV in the London 
clinic. The chapter begins by reviewing qualitative studies that consider the 
problem of HIV in the UK, specifically as it pertains to vertical transmission 
and pregnant HIV-positive women originally from Sub-Saharan Africa. This 
initial section of the chapter will also reflect upon social scientific literatures 
that consider the HIV/AIDS epidemic in order to explore significant themes 
evident in the UK based studies.  I will then outline the work of Didier Fassin 
and show how his contribution enables consideration of the effects that 
geopolitical concerns and scientific developments may have on the resources 
available to people living with HIV and the experience of being HIV-positive 
and pregnant. Moreover, arguments made by both Marsha Rosengarten and 
Nancy Scheper-Hughes will be considered in this chapter and re-threaded 
throughout the rest of the thesis. Following this, I will discuss how the work of 
Science and Technology Studies (STS) scholars, Annemarie Mol in particular, 
may assist in making sense of the challenges associated with providing care 
to HIV-positive pregnant women and attempting to prevent vertical 
transmission. I will demonstrate throughout how the various literatures assist 
my arguments in each subsequent chapter.  
 
Influenced by the methodological approach used by Annemarie Mol (and in 
collaboration with John Law), Chapter Three will show how my extension of 
their contributions and the methods chosen for this project assists in the 
exploration of the requirements of good HIV specialist antenatal care. Further 
to this, the chapter will provide a description of the methods and my 
methodological approach to conduct this study. Moreover, consideration will 
be paid to the emotive concerns that arose for me during the research 
process.  
 
Chapter Four will examine the limitations and particularities of some of the 
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biomedical technologies that the practitioners in the clinic use to inform their 
practice. I will argue that the technologies in question have the potential to 
mirror issues related to the global HIV pandemic. This discussion will help 
clarify the complex and varied work that the practitioners engage in to provide 
their patients with care. Additionally, the chapter will argue that the 
practitioners’ care efforts are directed at the patient and her offspring in 
accordance with how the practitioner imagines them to have the potential to 
become in the future. Consequently, the chapter will begin to detail the 
components and requirements of the provision of good care in the clinic and 
describe the patients, postnatal women and babies, who are the (potential) 
beneficiaries of care.  
 
This exploration will continue throughout Chapters Five and Six from different 
vantage points. Each of these perspectives will assist in clarifying what care in 
the clinic constitutes and what is at stake for practitioners and patients in its 
provision. Recurring themes in each chapter will be the significance and 
implication(s) of a patient’s immigration status and country of origin. The final 
chapter will reflect upon the arguments made in this thesis and consider how 
they might benefit efforts to care for HIV-positive pregnant women.  
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Chapter	Two:	Framing	the	Challenge	of	HIV	in	the	Specialist	Antenatal	
Clinic	
 
As mentioned in the previous chapter, the stated aim of this thesis is to 
investigate the challenges of HIV and successful care in an HIV specialist 
antenatal clinic. My intention is to make a practical contribution to knowledge 
about specialist HIV antenatal care in London by offering theoretically 
informed reflections on some of the contingencies of providing and receiving 
care. To begin this investigation, this chapter poses the question: what is the 
problem of HIV (during the antenatal period) in places wherein access to 
biomedical technologies and specialist care is not (comparatively) restricted?  
 
In order to explore this question, this thesis will investigate what HIV is in the 
specialist clinic, both as it is “[achieved] as a seemingly stable object”, and as 
it is experienced by the patients and practitioners (Rosengarten, 2009, p. 28). 
Hence, it is necessary for me to set up a framework that is able to contend 
with a multitude of things, or what Mike Michael and Marsha Rosengarten 
have called “an intricate assemblage of multiple phenomena” (2013, p. 37), 
without privileging any of the various components involved. Accordingly, in 
what follows I provide a review of literatures that pertain to Black (African) 
HIV-positive pregnant women in the UK and the provision of antenatal care to 
them. Key themes and areas of concern evident in these studies will then be 
explored in relation to literatures that have diverse theoretical approaches.  
 
The chapter is structured as follows: it begins by examining the scarce 
qualitative studies that consider HIV and pregnancy amongst Black and Black 
African women in the UK. My intention is to discover how these studies 
conceive of the problems of HIV in UK antenatal clinics. Aided by social 
scientific studies that concern the HIV/AIDS pandemic, I will discuss several 
issues that emerged within these UK based studies. After this, the chapter will 
introduce three different sets of theoretical literatures that address the areas 
of concern outlined in the UK based studies. Moreover, I will make clear 
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throughout the chapter how these various theories and literatures will be used 
in subsequent chapters.  
 
Below is a brief description of the three different areas of concern and a 
cursory description of the literature that will be used to explore them:  
 
1) The UK based studies find that something about the patient’s diasporic 
positionality makes it difficult for them to fully engage with the interventions 
and care on offer in the UK. To explore this, I will consider anthropological 
literatures that help to further investigate the significance of the patients’ 
location within a diaspora. This section will provide a way of considering the 
consequences of a patients’ movement between different geographical 
spaces.  
 
2) Moreover, the UK based studies draw attention to the fact that patients’ 
experience and understanding of HIV biomedical interventions and 
technologies may be drastically different from their medical practitioners, 
which could lead to problems in the clinic. In order to investigate this theme, I 
will discuss literature that explores the way in which a specific disease can be 
done differently.  
 
3) Finally, the studies highlight the significance of the care that patients 
receive and the relationships established between practitioner and patient. 
Thus, the chapter will end by discussing literature that considers the 
importance of the care on offer in the clinic.  
	
Qualitative	studies	pertaining	to	HIV	specialist	antenatal	care	and	Black	African	
women	in	the	UK 
 
As discussed in the previous chapter, Black African women (and women of 
other black backgrounds) are disproportionately affected by HIV in the UK, 
particularly in London (Nicoll, et al., 1998; Gibb et al., 1998). Therefore, I will 
explore qualitative studies that concern their particular circumstances. 
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However, there are very few UK based qualitative studies that consider issues 
related to HIV-positivity, pregnancy and/or motherhood (Tariq, 2013, pp. 48-
49). Additionally, even fewer specifically concern the experiences of Black 
and/or African pregnant women living with HIV in the UK.16  
 
In 2012, Shema Tariq and colleagues sited two UK based qualitative studies 
that considered HIV and pregnancy and included women originally from 
Africa,17 both of which were unpublished and had small sample sizes (2012b, 
p. 2).18 Moreover, in 2013 Tariq identified only seven UK based qualitative 
studies that considered HIV-positivity and pregnancy and/or maternity (2013, 
p. 49).19 Furthermore, only five of these studies cited by Tariq explored 
antenatal care and HIV-positivity (2013, pp. 49-50).20  
 
In addition to the articles cited by Tariq, she has, to the best of my knowledge, 
been involved in most of the significant published articles21 which used a 
qualitative methodology and concerned Black (African) HIV-positive pregnant 
women living in the UK (Dhairyawan et al., 2012; Tariq et al., 2012b; Tariq et 
al., 2014; Tariq et al., 2016).22 Because these studies all use the data and 
findings from Tariq’s unpublished PhD thesis,23 the primary focus in the 
                                                
16 There have, however, been more notable qualitative studies that consider pregnancy and 
other aspects of being a woman living with HIV in resource rich settings such as: Keegan et 
al, 2005: Jarman et al., 2005; Psaros et al., 2012; Richter et al., 2002; Sanders, 2008, 2009; 
Siegel et al., 2006; Giles et al., 2009; Gurevich et al., 2007; Kelly et al., 2012).  
17 Additional studies consider the experiences of HIV-positive pregnant women in the UK, 
although the participants were all white and from the UK/Europe (Kelly et al., 2012; Wilson, 
2007).  
18 One of these studies is an unpublished MA Thesis (Carter, 2009) and the other was 
presented at a conference (Naftalin et al., 2010).  
19 In her thesis, Tariq cites six articles, but she lists seven in total. I believe the discrepancy is 
because Kelly et al. wrote two articles, which Tariq cites, but she has only “counted” one of 
them (Tariq, 2013, pp. 49-50). In addition to the articles listed in the footnote bellow Tariq 
cites the following articles here: Doyal and Anderson, 2005; Wilson, 2007.  
20 Tariq cites the following articles: Carter, 2009; Kelly et al., 2012, 2013; Naftalin et al., 2010; 
Treisman et al., 2014. Please note that Tariq cites the article by Treisman et al., as having 
been published in 2013 (Tariq, 2013, p. 50).  
21 However, there are other qualitative articles that have been published — some of these will 
be discussed in this chapter.  
22 This was the first qualitative paper to investigate the experiences that women living with 
HIV had with infant feeding in a “high-income setting” (Tariq, 2016, p. 5). The paper examines 
the way in which African women living with HIV in the UK make decisions about infant feeding 
(2016).  
23 Moreover, quantitative data from this same study was used to analyse the effects of two 
different “combinations of ARVs commonly used in ‘resource rich settings’” (Tariq et al., 
2011a); for a study that used epidemiological data pertaining to the use of ART and HIV-
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following will be to provide more information about her thesis. After this, I will 
explore prevalent themes apparent in the studies mentioned above. 
 
As an HIV specialist physician who worked as an HIV doctor at Homerton 
University Hospital24 prior to and during the research period (Tariq, 2013, p. 
85), Shema Tariq explored in her PhD thesis how African pregnant and 
postnatal women living with HIV in the UK engage with HIV services and 
interventions during the antenatal period and postnatally (2013, p. 14). Tariq 
used a mixed methodology to explore her primary research question (2013, p. 
14)25 which was “how do African women living with HIV in the UK engage with 
HIV services and intervention during and after pregnancy (Tariq, 2013, p. 
14)?” The study was comprised of epidemiological data amassed during 2000 
and 2010 by the UK’s and Ireland’s National Study of HIV in Pregnancy and 
Childhood (NSHPC),26 pertaining to about 12,000 pregnancies. This involved 
interviews with pregnant African women living with HIV receiving care in HIV 
specialist antenatal clinics in London, healthcare professionals, voluntary 
sector workers and members of a Pentecostal church. Moreover, 
ethnographic data was collected in an HIV charity, a Pentecostal church and 
three HIV specialist antenatal clinics in London (Tariq et al., 2012b, p. 1; 
Tariq, 2013, pp. 14, 83-84, 86-90). 27  
                                                                                                                                      
positive women’s maternal viral load at the delivery of their second babies (French et al., 
2014); and for a study that investigated the association between “detectable maternal viral 
load at delivery and MTCT in pregnancies in women with HIV born in Sub-Saharan Africa” 
(Tariq et al., 2011b). Moreover, epidemiological data from the same study was used to 
investigate the association between the ethnicity of HIV-positive pregnant women and late 
antenatal booking (Tariq, et al., 2012a).  
24 Tariq does not provide Homerton University Hospital with a pseudonym in her thesis. 
Please see: Parisaei et al., (2007) for an article that compares the deliveries of HIV-positive 
women and women from the general population that give birth at Homerton University 
Hospital.  
25 For a discussion on the benefits of using this methodological approach when exploring HIV 
and pregnancy amongst African women living with HIV in the UK please see: Tariq and 
Woodman, (2010).  
26 The NSHPC is a surveillance program that has been collecting data in the UK and Ireland 
since 1986, on pregnant women and women who give birth and have been diagnosed with 
HIV (Tariq, 2013, p. 60). For more information about the NSHPC, please see: 
http://www.ucl.ac.uk/silva/nshpc. 
 
27 Many of the clinical consultations that Tariq observed were her “own” (2013).  
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Tariq’s findings were overwhelmingly optimistic (2013, p. 300). Indeed she 
concluded that practically all HIV-positive pregnant women in the UK take 
ART during pregnancy and “achieve virological suppression” by the time they 
are ready to give birth (2013, p. 294). Moreover, vertical transmission of HIV 
was incredibly unusual in the UK and most women engaged with HIV services 
after having been pregnant (2013, p. 294.). However, Tariq sites the following 
issues as being of concern: patients’ experiences with “poor care” within other 
areas of the NHS, patients’ negative experiences with interventions, and 
patients finding it difficult to refrain from breastfeeding (2013, pp. 294-295). 
Moreover, she found that Black (African) women living with HIV generally 
booked in for antenatal care later than white HIV-positive women (Tariq et al., 
2012a, p. 978; Tariq, 2013, p. 294). In what follows, I will describe four of the 
themes that emerged in the studies cited above.  
	
Something	about	the	patient’s	location	within	a	diaspora	disrupting	care	 
 
The studies mentioned above find that there is something about the patient’s 
life and/or cultural, political, and social positionality outside of the clinic which 
may disrupt care (Tariq et al., 2012a, p. 978; Dhairyawan et al., 2013, p. 2; 
Tariq, 2013, pp. 201, 267-268; Tariq et al., 2014, p. 59). In other words, when 
care fails (according to these studies), the fault lies with the social and not the 
biomedical. Subsequently, Tariq contributes the success of care as being the 
result of the patients’ engagement with care and (bio) medical technologies 
(2013, p. 300). Moreover, she argues that the complicated issues patients 
experienced (and which subsequently led them to reject care) were closely 
linked to their position within an “African diaspora” (Tariq, 2013, p. 300). She 
uses the concept to refer to “the contemporary global migrations of various 
African communities who retain relationships with their homelands and an 
ethnonational identification whether it is Yoruba, Nigerian or African” (2013, p. 
34). Moreover, she argues that African diasporic HIV-positive women in the 
UK 
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exist within a global healthscape where biomedicine is highly visible and 
popular. Seeking medical care for pregnancy and HIV was therefore not 
culturally alien. However, their vantage point within diaspora gave them 
an acute sense of disjunctures within the healthscape as it manifests in 
the UK and in Sub-Saharan Africa. For some women, the knowledge 
that they could access services and interventions that may not be readily 
available in their home countries served as a motivating force to engage 
with HIV care (Tariq, 2013, p. 285).  
In this way, Tariq ultimately found that “a complex constellation of cultural and 
structural factors including stigma and lack of UK citizenship rights emerged” 
as the most significant hindrance for women thus positioned to engage with 
care (2013, p. 14).  
 
The UK based qualitative studies make a similar argument regarding a school 
of HIV social scientific research that labels various inequalities and social 
norms as being the key drivers that make an individual vulnerable to HIV, and 
are thus the driving force of the HIV pandemic (i.e. structural drivers) 
(Auerbach et al., 2011).28 What’s concerning is that approaches which 
promote the significance of structural drivers have a tendency to view the 
social as being separate from (bio)medical practice “where sociality becomes 
the sphere of power dynamics that fuel the epidemic” (van der Zaag and 
McKnight, 2016: forthcoming). Instead the literatures that are critical of this 
approach do not position the social as being separate from the biomedical, 
rather they engage with the effects of the biomedical and biomedical 
interventions (Persson, 2013; Race, 2001; Rosengarten, 2009; van der Zaag 
and McKnight, 2016: forthcoming). Some of the arguments made in these 
literatures will be considered later in this chapter.  
                                                
28 It is important to point out, however, that the UK based studies position structural factors as 
being the reason why HIV-positive black African women have difficulty engaging in care — 
rather than using the concept of structural drivers to consider a group’s vulnerability to HIV.  
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Problems	with	prevention	technologies	 
The studies above argued that prevention technologies such as replacement 
feeding29 had multiple meanings and consequences for the women who 
engaged with them. Indeed, Treisman and colleagues report that the twelve 
African HIV-positive women they interviewed claimed that not being able to 
breastfeed was the most upsetting aspect of being an HIV-positive mother 
(2014, p. 145). The authors suggest that the women felt this way because 
breastfeeding was central to their “cultural identity as mothers” (2014, p. 145). 
Moreover, the studies found that breastfeeding was culturally significant for 
Black African HIV-positive women and the women felt that being a “good 
mother” was connected to breastfeeding her baby (Tariq, 2013, p. 275; Tariq 
et al., 2016, p. 1; Treisman et al., 2014, p. 145). Additionally, within the 
women’s communities, replacement feeding “signif[ied] their HIV status” 
(Tariq et al., 2016, p. 1) and women from African communities where 
breastfeeding is “culturally normative” indicated they would find it particularly 
difficult not to breastfeed (2016, p. 1). Further to this, within the women’s 
communities “the bottle-fed infant therefore functioned as a visible surrogate 
marker for an HIV-positive status” (2016, p. 3).  
Influenced by the discussion above, I will reflect upon the ways HIV-positive 
women may safely mother their children and how this varies between different 
geographical locations. As I show in Chapter Six, this is because some HIV-
positive women are advised to breastfeed their infants while others are 
encouraged to replacement feed them (WHO, 2010, p. 45; Dunn et al., 
1992). Accordingly, it will become clear that living as an HIV-positive person 
who adheres to official advice may be entirely different in various 
geographical locations. The differences I am referring to here pertain to the 
requirements and effects of HIV (biomedical) interventions and prevention 
technologies on offer to people living with HIV in those locations.  
 
                                                
29 Replacement feeding refers to the process of replacing breast milk with some other 
foodstuff (McAndrew et al., 2012). In Chapter Six I will elaborate on the definition and 
requirements of replacement feeding and explain how I have come to think of it as a 
technology.  
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Therefore, what matters are the various technologies, (bio) medicines and 
care that are on offer and the socio-historical and economic contexts and 
positions of people living with HIV in a particular geographical location. 
Additionally, however, what is or is not on offer, and the socio-historical and 
economic contexts and positions of people living with HIV in other 
geographical locations, also matters. For example, as Tariq et al. have 
argued, an HIV-positive mother in the UK who is strongly advised not to 
breastfeed may find it more difficult to adhere to her care practitioners’ advice 
because she knows that HIV-positive mothers elsewhere are advised to 
breastfeed their babies (Dunn et al., 1992; Tariq, 2013, p. 275; WHO, 2010, 
p. 45). 
	
The	infallibility	of	biomedicine	and	biomedical	technologies	 
 
Moreover, the UK based qualitative studies position the care and (bio) 
medical technologies on offer in specialist HIV antenatal clinics as having the 
ability to prevent vertical transmission, if patients engage appropriately with 
them. This stance is not surprising, especially considering the following 
statement by the CDC:30 “[w]hen HIV is diagnosed before or during 
pregnancy, perinatal transmission can be reduced to less than 1% if 
appropriate medical treatment is given, the virus becomes undetectable, and 
breastfeeding is avoided” (CDC, 2012, p. 1). 
 
The role HIV-positive women play in prevention efforts are mentioned by the 
CDC only in relation to “prevention challenges” (2012, p. 2). They cite the 
following issues as being significant prevention challenges: “[s]ubstance 
abuse […], [s]ocioeconomic issues […], [l]ack of awareness that pre-chewing 
of food for infants is a transmission risk [...], and limited access to safe 
conception methods and services (for HIV-serodiscordant heterosexual 
couples)” (2012, p.2).31 Thus, like Tariq, the CDC position the successful 
                                                
30 The CDC is describing care in a resource rich location. 
31 The CDC is of course describing a situation specific to the USA. However, I cite the CDC 
here to draw out that the prevention challenges they mention are positioned as coming from 
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prevention of vertical transmission as having to do with HIV-positive pregnant 
women engaging with and accepting the care, medicines and technologies on 
offer appropriately (2013, p. 300).32 ((Bio) medical) interventions33 are thus 
situated as the solution to the problem of vertical transmission, if only HIV-
positive women are able to access and appropriately accept them. 
 
I understand the CDC’s description of prevention challenges and the 
significance of biomedical medicines to be indicative of a concern expressed 
by many social scientific researchers over the pre-eminence bestowed upon 
biomedicine as the solution to the problem of HIV (Coates et al., 2008; 
Persson, 2013; Walby, 1996).34 In relation to this, Nguyen and colleagues 
consider the conflicts between a desire to posit biomedical developments as 
the solution to HIV and one that is more able to embrace social issues 
(2011).35 They argue that the idea that HIV is a medical problem that should 
best be dealt with using biomedical technologies is problematic (2011, p. 291) 
because  
in the rush to paradigm shift, game-change, roll-out and scale-up yet a 
new set of acronyms and standardized interventions, local 
epidemiological, political, and socio-historical context is once again 
being ignored, surely only to resurface later as “culture” once much-
heralded interventions fail to deliver. Holding out for a magic bullet — 
unlikely to ever come — diminishes interest in the hard, messy work 
required to enable social change and address the social inequalities and 
structural violence that drive this epidemic. Biomedical interventions are 
unlikely to live up to their promise if social determinants of access to 
                                                                                                                                      
the women and/or their socioeconomic position. Moreover, in 2010 the BHIVA/CHIVA 
guidelines writing group made a similar statement in relation to care in the UK (2010, p. 1).  
32 However, Tariq makes it clear that successful care extends beyond the prevention of 
vertical transmission. Nonetheless, social issues connected to the patients are positioned as 
standing in the way of prevention.  
33 The interventions would offer the mothers ways of feeding infants that did not involve 
breastfeeding.  
34 It is important to mention that these researchers are not specifically concerned with the 
problem of vertical transmission of HIV.  
35 Taken from: ‘Remedicalizing an epidemic: from HIV treatment as prevention to HIV 
treatment is prevention’ 
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prevention and treatment are not addressed (Nguyen et al., 2011, p. 
292). 
A focus on biomedical solutions becomes even more worrisome when 
considering the limited evidence that biomedical prevention is effective in 
“real-life conditions” (de Wit et al., 2011, p. 381). Thus, de Wit and colleagues 
bring up the important point that biomedical prevention efforts depend on the 
way in which people and their communities behave (2011, p. 381). Further to 
this, they remark that “[t]hese behaviors are shaped and constrained by the 
social, cultural, political and economic contexts that affect the vulnerability of 
individuals and communities” (2011, p. 381).  
 
Referencing Flowers, Persson adds that “part of the attraction of the 
biomedical solution to the pandemic is that its apparent universality and 
simplicity can bypass the messy complexities of people’s lives” (2013, p. 
1068). Like this, and for Flowers, the global HIV pandemic is fuelled by social, 
political and financial inequalities (2010, p. 2). Even so, Flowers argues that 
psychosocial and sociocultural understandings of living with HIV are 
becoming rejected and overlooked in preference for biomedical solutions that 
appear to be more straightforward (2010, p. 2).36 Here it is important to 
consider that the authors of the UK based qualitative studies would be in more 
or less agreement with the arguments discussed above. Indeed the UK 
studies’ intention is precisely to gain a better understanding and draw 
attention to the significance of the “messy complexities of people’s lives” 
(Persson, 2013, p. 1068). Equally, however, is the fact that these studies 
acknowledge that there is an apparent biomedical solution to the problem of 
vertical transmission of HIV (CDC, 2012). Therefore, the stance taken by the 
UK based studies is to explore what is it about the “messy complexities of 
people’s lives” that makes them not able to accept the care and biomedical 
technologies that promise a solution to the problem (of the vertical 
transmission) of HIV (Persson, 2013, p. 1068). Thus, while the figures the 
                                                
36 However, here it is important to mention that none of the social scientific studies mentioned 
here are specifically considering HIV in relation to vertical transmission in resource rich 
settings.  
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CDC (2012) present are clearly astounding, I argue that “the complexities [the 
prevention of vertical transmission are] embedded in and brings forth go 
beyond the scope of biomedicine” (van der Zaag and McKnight, 2016: 
forthcoming). Some of these complexities will be explored in the next section.  
	
The	consequences	of	care	failures	and	the	emotive	experience	of	providing	care		
 
Another important issue I would like to highlight in Tariq’s research is the 
emotive investment specialist practitioners make in order to provide their 
patients with care. Moreover, I will draw attention to the care failures that may 
be eclipsed by the UK antenatal clinics’ success at preventing vertical 
transmission. In order to do this, I will relay Tariq’s motivation to commence a 
PhD (Tariq, 2013, pp. 16-17). Her incentive for the study stemmed from her 
experiences as a medic working with HIV-positive pregnant women (2013, p. 
16). Tariq and her colleagues felt that women living with HIV from Western 
Africa were singularly resistant to HIV care (2013, p. 170).  
 
Tariq recounts an experience she had several years previously with a patient 
from Sierra Leone — Pauline — and cites her as the catalyst for her research 
(2013, pp. 16-17). She explains that Pauline had rejected specialist HIV 
antenatal care entirely and suffered a miscarriage as a direct consequence 
(2013, p. 17). Pauline said that the HIV specialist midwife had cursed her with 
HIV and thus caused the miscarriage (2013, p. 17). However, with 
tremendous effort, Tariq and her colleagues were able to entice Pauline to 
engage with care during her subsequent pregnancy, and she gave birth to a 
baby born free of HIV (2013, p. 17). However, after the baby’s birth, Pauline 
ceased to engage with HIV services for her own health (2013, p. 17). Finally, 
after years without receiving any care for her HIV, Pauline came into hospital 
with advanced HIV infection and was diagnosed with kidney failure (2013, p. 
18). Nevertheless, as she was fearful that members of her church would see 
her attending HIV services, she refused any treatment and discharged herself 
from the hospital (2013, p. 18). Tariq explains that Pauline’s story was by no 
means unique (2013, p. 18) but her story did, however, remind Tariq that “HIV 
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pregnancy is embedded within a complex matrix of biomedical, social and 
cultural factors that are often poorly understood” (2013, p. 18).  
 
Here I would like to emphasise that if we were to assess the care provided in 
the specialist clinic in relation to the serological status of babies born to 
mothers who received their care there, Pauline’s’ trajectory through the clinic 
would have been a success. After all, Pauline gave birth to a baby born free of 
HIV (Tariq, 2013, pp. 17-18). Thus, if we only consider certain aspects of her 
story, it could be viewed as further confirmation that specialist care and 
biomedical technologies are undoubtedly successful at preventing vertical 
transmission when patients engage with them. However, the baby born free of 
HIV was not the only person that was being cared for (or about) by the 
practitioners (and presumably Pauline) in the clinic. Instead, the baby that 
Pauline miscarried mattered to them, as did Pauline, her child, and her sexual 
partner(s). All of these peoples’ wellbeing, deaths and/or possible deaths are 
part of and potentially eclipsed by one instance of the successful prevention of 
vertical transmission. By this I mean that specialist antenatal clinics may be 
(outwardly) assessed in relation to the prevention of vertical transmission of 
HIV, and not in relation to interrupted pregnancies (i.e. miscarriages and/or 
still births), patients’ and practitioners’ feelings or the future health of former 
patients. In other words, the unquestionable success of using treatment and 
care to prevent vertical transmission of HIV may belie the failures, deaths, 
struggles and suffering experienced by the patient, her family and medical 
practitioners. Therefore, Tariqs’ experience with Pauline makes it clear that a 
baby’s serological status is not the only thing that matters.  
 
The discussion above brings to mind an argument made by Nancy Scheper-
Hughes about the significance of “public records” in her book, “Death Without 
Weeping: The Violence of Everyday life in Brazil” (1993, p. 292). Scheper-
Hughes’ (1993) ethnography is relegated to two Brazilian towns in order to 
explore the effects extreme poverty has on maternity. In the course of that 
work, she makes the following observation in regards to the status of the 
information that becomes recorded in public records:  
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Public records […] are obviously not “neutral” documents. They are not 
in any sense “pure” sources of data. […] public records, count only 
certain things, not others. They count some things better than others 
[…]. They reveal a society’s particular system of classification. So they 
are not so much mirrors of reality as they are filters […] (Scheper-
Hughes, 1993, p. 292).  
Thus the CDC’s report like the “public record[s]” presents a filtered version of 
reality (1993, p. 292). In other words, the reality presented by the CDC 
(2012)(i.e. 99% success rate at preventing vertical transmission of HIV), filters 
away the failures and the emotive experiences and consequences of 
providing care described by Tariq.37  
 
Further to this, Tariq’s concern for Pauline is related to the often-mentioned 
fact that very little was actually known about Black (African) HIV-positive 
women in the UK’s experiences with antenatal care (Tariq, 2013, p. 201; Tariq 
et al., 2014, p. 59). The studies suggest that a problematic consequence of 
this is that the patients may have entirely different ways of understanding HIV 
and the requirements of care than do the medical practitioners. In other 
words, while the information the patient receives from the practitioners is of 
course not the only information that she would necessarily have access to, it 
is, however, the information that the practitioners would like to inform her 
behaviour. Although this does not mean that the practitioners’ information 
does necessarily dictate or influence the patients’ behaviour. However, and 
importantly, any other information or source of information that the patient 
might refer to (or be suspected of believing in) is positioned as potentially 
problematic, and therefore always suspect. Thus, the exact reasons why 
                                                
37 Moreover, I argue that the practitioners may also function as filters. Thus, they sift through 
data (i.e. peer reviewed articles, official guidelines pertaining to the care and treatment of 
antenatal HIV, personal experiences of providing care and so on) and select the material they 
deem most appropriate to their patient cohorts’ medical needs and the patients’ (perceived) 
capacity to take on board information. Further to this, in this context a filter could be (part of) a 
technology; for example, when entering a term into a search engine the specific requirements 
and boundaries of that search engine will delineate the responses that are generated. 
Consequently, the responses generated would not necessarily reflect the available 
information related to the search term on the Internet or elsewhere. I will return to the concept 
of a filter in Chapter Four, where I use it to discuss viral load assays.  
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Pauline responded to care in the way that she did were not known by Tariq 
and this was a problem for her (2013).  
 
Moreover, for Tariq, Pauline’s time in the clinic also represents a failed 
opportunity to enhance her in the future. She argues that this is because 
specialist HIV antenatal care’s additional significance is that it provides 
practitioners with an opportunity to entice women to participate in long-term 
care (2013, p. 201). Additionally, she contends, it is possible that “experiences 
of clinical services during pregnancy are likely to influence how women 
access care and manage their HIV later in pregnancy and in the longer term” 
(2013, p. 201). In other words, specialist HIV antenatal care’s purpose 
extends beyond the prevention of vertical transmission and attempts to 
enhance the patient (as she has the potential to be) in the future. However, 
Tariq argues that the specialist team’s ability to ensure that their care fulfils its 
“promise” may be ruined by medical professionals in other fields (in her 
example specifically, maternity services) (Tariq, 2013, p. 294; Tariq et al., 
2014, p. 59).  
 
In this way, assessing the success of antenatal care based on whether or not 
HIV is transmitted to babies born to HIV-positive mothers fails to grasp the 
requirements and consequences of care for everyone involved. Thus, Tariq 
concludes her thesis by stating that her quantitative findings show that things 
are not too bad (2013, p. 294). Contrariwise, I argue that Tariq’s story about 
Pauline illustrates how the findings she is referencing overshadows the fact 
that in the clinic the problem of HIV is not contained within the 
mother/pregnant woman and her bab(ies)’ bodies. Consequently, the problem 
of HIV in the clinic cannot be resolved through biomedical interventions even 
if they can promise futures less affected by HIV. Instead, the problem of HIV 
in the clinic, as Tariq describes it, has the potential to extend beyond the 
possible transmission of HIV between mother and baby — to encompass and 
affect imagined futures and the feelings of both practitioner and patients and 
everyone else (potentially) involved.  
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And while Tariq et al. would undoubtedly agree with what I have written 
above, HIV specialist practitioners would also contend that biomedicine does 
offer a solution to the problem of HIV in the context of vertical transmission. 
This is because, for them, biomedical technologies and care are understood 
as having the ability to intervene into the “real” of the patient’s virus, as the 
practitioners imagine it to exist in the patient’s body prior to the technological 
interventions that display HIV (Rosengarten 2009; McKnight and van der 
Zaag 2015; van der Zaag and McKnight, 2016: forthcoming). However, while 
the practitioners would say that this is true, they would, as became clear 
above, also contend that the “problem of HIV” in the context of vertical 
transmission goes beyond whether or not the virus is transferred from mother 
to baby. The rest of the chapter will consider three broader themes that have 
emerged in the UK based studies in relation to theoretical literatures.  
	
How	can	we	think	about	the	significance	of	geographical	place	and	movement	
between	places?	 
 
Thus far, it has become apparent that geographical place and origin matters, 
even if the exact ways in which they come to matter are obscure. Hence, 
while HIV is undoubtedly a global issue, the consequences are clearly 
different depending on where the person living with the virus is and comes 
from. Therefore, in addition to questioning the relationship between 
biomedical and social scientific descriptions of HIV, attention should be paid 
to how geographical locations would impact on these renditions and the way 
in which geographical space and the movement between spaces may impact 
on social aspects of HIV.  
 
The idea of movement is especially pertinent to my work as I am looking at a 
clinical space in London that caters primarily to women who have moved and 
travelled tremendous distances. Following this, I question how we should 
begin to think about and clarify the significance of place and space, the effects 
of the movement of people between spaces, and the significance of the 
previous spaces that they occupied. In order to do this, I will begin to include 
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literatures that are more anthropological in their approach and methods. This 
is because, as Rayna Rapp has argued, anthropology is best at “show[ing] in 
lush empirical detail how national context, religious institutions and traditions, 
family formations, and cultural familiarity or distance really count in the making 
of scientific contexts” (2006, p. 420). And while my approach shares many 
components with ethnographic approaches, it is not a fully-fledged 
ethnography as it is understood within traditional anthropology (Hammersley 
and Atkinson, 1995). Instead, my research takes a qualitative approach that 
includes elements of observation, alongside the use of interviews.38 
 
Flowers and colleagues remark on the way the expense or unavailability of 
HIV treatments in some countries means that an HIV diagnosis in those 
locations is tantamount to a “prognosis of death” (2006, p. 110). Furthermore, 
they argue that even in geographical locations where treatments and care are 
available, the meaning of an HIV diagnosis is variable (2006, p. 118). This is 
because of the risk of deportation that many HIV-positive people constantly 
live with and the complications that may arise from living with a chronic long 
term illness (2006, p. 118). These observations are important as they ask us 
to pay attention to the ways in which the circumstances of people living with 
HIV in the same geographical locations can vary drastically depending on, in 
their example, how resources and privileges (permanent residency and 
citizenship) are allocated or denied.  
 
Furthermore, Heimer makes important points about the significance of 
geographical location and the import of paying heed to the specific 
circumstances that have made HIV/AIDS in sub-Saharan Africa different from 
HIV/AIDS in, for example, the United States of America (2007, p. 551). 
According to Heimer, it is primarily the social aspects of the disease that make 
it worse in Sub-Saharan Africa. Specifically, she writes that  
 
[t]o be desperately poor, and HIV positive is very different from being 
comfortably well-off and HIV positive; to live in a country with a double-
                                                
38 I will expand upon my research methods in Chapter Three.  
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digit prevalence rate is much riskier than to live in one where fewer 
people are infected; to depend for life-saving drugs on foreign 
philanthropy makes access to treatment more precarious than it is in 
developed countries with imperfect) social welfare programs (Heimer, 
2007, p. 552).  
Her arguments are significant and I will extend them in this thesis by showing 
how inequalities experienced by people in specific geographical locations do 
not necessarily disappear if the people in question move to a different 
location. The point here is that the local cannot be easily separated from the 
global. People do not necessarily stay in the same geographic location. 
Moreover, there is constant movement between locations of information and 
(bio) medical technologies. Also, the implication of the various components 
connected to the pandemic in the various locations they might (temporarily) 
inhabit may change and be affected by their new environments.  
 
I have found some of Didier Fassin’s work useful when trying to think through 
these issues. Fassin’s (2007, 2013) argument has precisely been to think of 
HIV and AIDS on a more geopolitical level, and, in the course of that work, he 
uses certain concepts that may be useful for understanding some of the 
apparent issues about the way these geopolitical questions seem to appear 
and disappear in the HIV social scientific literature as well as in the HIV 
specialist antenatal clinic. 
 
For Fassin, AIDS in South Africa epitomises the nexus wherein the 
experience of life and the body in its entire social, political, historical and 
physical manifestations converge (2007, 2013). He considers the condition of 
“life embedded in the economic and social reality” as well as the experience of 
“life lived both individually and collectively” (2007, p. 226). Moreover, Fassin 
seeks to elucidate the “experience of the body” as it is embedded in the social 
contexts in which happenings occur, as well as the historical trajectories that 
have enabled them to emerge (2007, p. 226). He argues that an individual’s 
experiences in the world “preserves the mark of the past, the past one lived 
oneself as well as the past experienced by the group to which one belongs” 
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(2007, p. 226). Although Fassin does not say this directly, an underlying idea 
behind this is that the person that he is concerned with is embedded within a 
particular location and subject to the possibilities ascribed to their bodies 
within that location.39  
 
In the case of South Africa, for instance, the experiences of black South 
Africans living with HIV are directly related to the historical effects of 
apartheid. Moreover, Fassin argues that it is essential that an “AIDS patient’s 
experiences in South Africa cannot and must not be considered foreign to 
‘us’” (2007, p. XV). In line with Flowers et al.’s previous argument (2006, p. 
110), Fassin advocates for thinking of our shared humanity as not so much a 
matter of culture, but rather one that involves looking at historical facts that 
have led us to a position where we have different experiences and different 
“things” happen to our bodies as a result of differences in access to 
resources.  
 
Applying Fassin’s arguments to the NHS specialist antenatal clinic means 
attention must be paid to the experiences of the clinic’s patients, and the 
contexts in which things happen to them. However, because the majority of 
patients have moved tremendous distances and are thus incorporated into a 
geopolitical framework, these happenings are diasporic in nature. Hence, 
what life is, as it is embedded in economic and social realities, may vary and 
be affected by the fact that these realities have changed for the person in 
question. After all, the patients cared for in the HIV specialist antenatal clinic 
in London have often been subjected to multiple economic and social realities. 
Which leads me to pose the following questions: “what is the experience of 
the body when it is pregnant and what are the contexts in which things occur 
to the pregnant body?” Moreover, “how do we think about the historical 
                                                
39 These sentiments are echoed by Farmer (2004) who argues for the importance of informed 
historical and political knowledge when trying to make sense of AIDS epidemics in the 
postcolonial world, and Ridge and colleagues (2007) who remark upon the stark difference 
between access to HIV resources and information between white gay men and non-white 
HIV-positive people in the UK. Moreover, Crane argues for the significance of considering 
and understanding the effects of poverty and marginality when conducting AIDS research 
(2002).  
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trajectories that have enabled these things to occur?” The answers to all of 
these questions are bound to be multiple, and the way in which the answers 
might interact is undoubtedly complex.  
 
While Fassin’s analysis touches on geopolitical concerns, his framework is 
tied to a specific geographic location and is what he has accordingly termed a 
“vertical ethnography” (Fassin, 2013, p. 120; Hansen, et al., 2013, p. 117). 
Fassin uses the term to describe ethnographies that study a given society on 
“several levels” or “places” (2013, p. 120). He claims that vertical 
ethnographies uncover a multitude of perspectives within the given society 
(2013, p. 120). Moreover, Fassin argues that one of the strengths of a vertical 
ethnography is in the level of detail a researcher is able to amass regarding 
their location of interest (2013, p. 120). An underlying assumption in his 
definition of a vertical ethnography is that the “levels” or “places” (2013, p. 
120) wherein the society under scrutiny moves, will remain confined within a 
country’s borders. In this way, Fassin freely moved around South Africa 
collecting data. He did not, for example, limit his enquiry to one township or 
province; neither did he follow his research participants as some of them 
moved outside of South Africa. The way Fassin collected data within South 
Africa becomes remarkable when thought of in relation to his description of 
horizontal ethnographies. Fassin contrasts vertical ethnographies with 
horizontal ones which he argues have a “geographical extension”, and are 
(although he does not say so directly), therefore not equipped to “reveal a 
diversity of perspectives” (2013, p. 120). He presents a study by Nancy 
Scheper-Hughes’ as an example of a horizontal ethnography and thus her 
study is used to exemplify the limitations of this kind of ethnography (Fassin, 
2013, p. 120).40 
 
While respectfully acknowledging Fassin’s contributions to my thesis, I take 
issue with his critique of Scheper-Hughes’s work and the way he distinguishes 
between horizontal and vertical ethnographies. My concern is threefold: firstly, 
Fassin’s arguments in regards to the superiority of a vertical ethnography 
                                                
40 The article in question is called “Parts unknown: Undercover ethnography of the organs-
trafficking underworld” (2004). 
 47 
presuppose that ethnographers will be more fruitful if they place a 
geographical limit on their area of enquiry. By default, Fassin is thus 
proposing a country as an appropriate field of enquiry. This is problematic 
especially when considered in relation to the following statement he makes in 
regard to a reviewer’s critique of his book When Bodies Remember 
Experiences and Politics of AIDS in South Africa (Fassin, 2007): 
I contend that one should not have to choose between the sufferers or 
their relatives and the activists or the sociologists, the private worlds of 
patients and the public scenes of politics and science: it is in the 
confrontation of these critical social spaces and those who inhabit them 
that a deeper understanding of the larger picture becomes possible 
(Fassin. 2013, p. 121.). 
Here I question whether or not it would be possible to adhere to Fassin’s 
contention if the ethnographer discovered that some or all of the actors 
named above (i.e. sufferers, their relatives, sociologists, private worlds of 
patients, public scenes of politics and science) were connected to or part of 
places outside of South Africa (2013, p. 121).41 Fassin’s argument implies that 
if the ethnographer were to follow them outside of the boundaries of a country 
and consequently engage in a horizontal ethnography, the ethnographer’s 
ability to capture a diversity of perspectives would be inhibited. Therefore, 
Fassin’s promotion of a vertical ethnography is problematic because it 
imposes restrictions on how far the ethnographer should go in tracing what 
matters and how bodies come to matter. Thus, while Scheper-Hughes writes 
that her ethnographic method was to “follow the bodies” (2004, p. 32), Fassin 
is suggesting that it would have been more fruitful had she stopped as soon 
as the bodies appeared to cross borders.  
Secondly, Fassin’s suggestion that his study is relegated to South Africa is in 
fact misleading. Thus, while most of his research participants and the 
locations he conducts fieldwork in are undoubtedly South African, their 
circumstances and the conditions unto which they exist are entirely connected 
to places outside of the country. As Fassin points out himself, the HIV 
                                                
41 For example, a sociologist could simultaneously be in South Africa conducting fieldwork 
while also being part of a research institution in Europe.  
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epidemic in South Africa, for example, is connected to the HIV epidemic in 
other countries (2007, p. 75).  
 
Finally, Fassin’s critique of horizontal ethnographies risks diminishing his own 
vertical ethnographies’ value. This is because Fassin is suggesting that 
smaller geographical areas by default garner richer data and more in-depth 
enquiry. If this were true, why stop at the borders of a country? Why not be 
more specific, more local? Why not investigate a township, or an area within a 
township, a house, or a bedroom? Further to this, does a geographical 
extension to an ethnography always pertain to countries? If it does, would this 
make research on the migration patterns of, for example, South Africans 
between neighbouring countries less ethnographically rich than a study that 
considered the migration of South Africans within South Africa? Who decides 
if the unit of analysis is too large or too small to produce evocative and 
meaningful data? Moreover, I question the usefulness of positioning vertical or 
horizontal ethnographies as being better or worse than the other. Surely, any 
ethnography, or research for that matter, should be assessed in relation to 
what it finally accomplishes and not the boundaries of the location wherein it 
took place?  
 
Further to this, my research would not fall neatly into either of Fassin’s 
categories. Therefore, while my unit of analysis was small, both in terms of its 
physical space and also in terms of the amount of people that regularly 
frequented it, the patients in the clinic were so unmistakably and intrinsically 
connected to geographical locations which were far away from the clinical 
space, that I could not ignore this. In this way, it is the moments when there 
appears to be a conflation between local and global, privilege and 
disadvantage, that I became interested in investigating further. Thus, the 
inequalities have to do with more than just differences in the availability of 
certain biomedical technologies and care options within or between different 
geographical locations. Rather, the differences have to do with the way in 
which certain groups of people will have better care than other groups of 
people, wherever they are (Flowers et al., 2006, p. 119). In what follows, I will 
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introduce the concept of an HIV diaspora and explain how I would like the 
term to be understood and used.  
	
HIV	Diaspora	
 
One of the persistent hesitations in this thesis is this broader picture: the 
inequalities that exist between the HIV-positive pregnant women cared for in 
the specialist antenatal clinic in London and HIV-positive women elsewhere. 
These geopolitical concerns have been an abiding anxiety and question of 
mine, although they are not obviously articulated in this way in the space of 
the NHS specialist HIV antenatal clinic.42 As mentioned previously, in this 
thesis I am concerned with a clinic located in a country where HIV is a chronic 
illness. However, the clinic caters mainly to people originally from locations 
wherein HIV-positivity would signal a life-limiting condition. Thus, my empirical 
material deals with people that have moved through different geographical 
spaces and (political) economies. In this way, it became clear to me that 
despite the clinic’s location and its associated privileges, its patients’ 
movement through (and experience with) multiple geographical locations 
transformed the clinical space into a geopolitical one; traces of these issues 
take shape in the interactions between the healthcare providers, the patients 
and myself. 
 
The majority of the clinic’s patients were thus immigrants, and while some of 
them had become British and/or had permanent residency in the UK, they 
were (as will be explored in later chapters) all indelibly and intricately 
connected to their countries of origin. Moreover, the connections were always 
significantly affected and amplified by (various issues related to) HIV and the 
meaning, consequences and effects of the virus in their countries of origin and 
                                                
42 However, it is important to mention again that an awareness of the significance of past 
geographical locations is readily acknowledged amongst the HIV practitioners. Thus, Erwin 
and Peters (1999) argue for the importance of taking the particular concerns of Black Africans 
living with HIV in the UK into consideration, if care efforts are to be improved for this patient 
group. And Doyal and Anderson (2005) provide an evocative assessment of the experiences 
of HIV-positive African women living in London, which highlights the importance of the 
women’s culture, religion and communities. Moreover, and as discussed previously, Tariq 
sites the significance of an African diaspora (2013).  
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in the UK. Following this, I wanted to find a term that would both allude to the 
experience of geographical movement (of individuals and groups) between 
locations wherein HIV and death are coupled to locations wherein they are 
not. Therefore, I have chosen to speak of an HIV diaspora and the women 
who are enveloped within the diaspora, to refer to this phenomenon. I will 
subsequently demonstrate throughout this thesis how the diasporic HIV-
positive women involved in this research are connected to and affected by the 
vicissitudes of HIV in multiple geographical locations.  
Moreover, my attraction to the concept of diaspora is tied to the term’s 
unequivocal connection to postcolonial studies where it is consequently 
explicitly and unapologetically about power, location, race, (post)colonialism 
and gender (Clifford, 1994, pp. 313-314). In regards specifically to gender, 
Clifford makes the interesting observation that for women, the experience of 
diaspora may both reinforce and also weaken “gender subordination” (1994, 
p. 314). Additionally, by using the term diaspora, I invoke the three core 
elements that Brubaker argues are often considered integral components of a 
diaspora (2005, p. 5): namely, “dispersion in space”, “orientation to a 
‘homeland’” and finally, “boundary-maintenance” (Brubaker, 2005, p. 5; 
Clifford, 1994, p. 305; Safran, 1991, p. 83; Tölölyan, 1996, p. 14).  
However, I acknowledge that my use of the term does not neatly fall within its 
traditional meaning or common usage (Clifford, 1994, p. 306). Thus, I argue 
that the HIV-positive pregnant women involved in this study were incorporated 
within an HIV diaspora. Hence, what they have in common is that they moved 
(or had been moved) across geographical spaces, and they are all in some 
way still connected to a homeland. It could be that they have left behind 
children or that the experiences they had in their homeland were so deeply 
affecting that they will be forever emotionally connected to their previous 
location. Finally, in regards to boundary maintenance, the HIV-positive women 
involved in this study occupy an interesting position. Within diaspora studies 
the act of boundary maintenance is usually understood of as pertaining to 
either various kinds of self-segregation and/or forms of social exclusion 
(Brubaker, 2005, p. 6). And while this may also apply to women incorporated 
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within the HIV diaspora, in their case, boundary maintenance likewise pertains 
to their HIV, or rather, the methods that are used by health care practitioners, 
the women and their families and communities to come to know, detect and 
contend with their virus. Accordingly, in Chapter Four, I will explore the ways 
in which viral load assays are implicated in the maintenance of an HIV 
diaspora. In Chapter Five I will provide several examples of how a patient’s 
diasporic position may disrupt the provision of care in the clinic. And finally, 
Chapter Six will consider how various methods of feeding infants have 
particular significance for women within the HIV diaspora.  
In relation to the above, these chapters will consider who/m might benefit from 
various HIV interventions and will include an assessment of the way in which 
some HIV interventions may simultaneously appear to promise futures less 
affected by HIV, while also providing futures affected by other kinds of HIV. As 
I will discuss in Chapter Six, replacement feeding assures prevention of HIV 
transmission through breast milk, but it may also reveal the mother’s HIV and 
thus expose the infant to the stigmatising effects of HIV/AIDS despite the fact 
that the infant has been born free of the virus. Consequently, I will argue that 
babies born to HIV-positive mothers may be marked by the stigma of 
HIV/AIDS that is enacted within the infant’s family (van der Zaag and 
McKnight, 2016; forthcoming). This discussion will also make clear that the 
(imagined) benefits of any intervention or technology should be considered in 
relation to the intervention’s possible adverse effects on the lives of people 
affected by HIV.  
Henceforward, it will become clear in these chapters that various technologies 
and people are involved in the act of maintaining HIV diaspora boundaries. 
Consequently, it will become apparent that there is a disconnection between 
the real of HIV (as it may or may not be inside a person’s body) and its 
stigmatising effects on the bodies of HIV-positive and HIV-negative people. 
Again, I use the concept of “the real” to refer to the way in which the virus is 
imagined by the practitioners to exist in a host’s body prior to the 
technological interventions that display HIV (Rosengarten, 2009; McKnight 
and van der Zaag, 2015, pp. 135-136).  
 52 
However, the UK based qualitative studies discussed earlier drew attention to 
the fact that the women living with HIV might have significantly different ways 
of understanding HIV (and associated intervention and technologies) than 
their clinic care providers. Therefore, in what follows I will explore the question 
of “what is HIV” within the clinic. I have found the work of Annemarie Mol 
useful when trying to investigate this question. This is because one of Mol’s 
primary concerns has been to discover what a (specific) disease is within a 
clinical environment.  
	
Doing	HIV	in	the	clinic	 
 
Up until this point, it has become clear that I am concerned with a disease, 
with pregnancy, practices of care, and with the unequal access to biomedical 
technologies which is apparent within the HIV/AIDS pandemic. Moreover, the 
discussion of the UK based qualitative literature above made it clear that very 
little is known about Black (African) HIV-positive pregnant women’s 
experiences with care or their understanding of HIV. Following this, I have 
found the work of Annemarie Mol to be useful for understanding what HIV is 
for practitioner and patient, as well as how its identity is maintained within the 
clinic and the requirements of the care that are provided to HIV-positive 
pregnant women. More specifically, The Body Multiple: Ontology in Medical 
Practice (2002), and The Logic of Care: Health and the Problem of Patient 
Choice (2008) are particularly valuable when thinking about HIV and 
pregnancy. Her other book, The Body Multiple: Ontology in Medical Practice, 
is an “ethnography of disease” (Mol, 2002, p. 151) written from the 
perspective of medical practitioners and the technologies, methods and 
methodologies they use. What is of particular relevance for me is how Mol 
(2002) questions what a disease is within a clinical environment, and thus, 
she provides me with the tools to do the same. Before I expand upon her 
work, I will briefly discuss some of the theoretical ideas that inform her 
thinking.  
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While Mol’s approach comes from a version of STS, it is important to consider 
what John Law and others have argued — namely that there is no unified field 
that we could call STS (Law, 2008). Instead STS consists of multiple, 
sometimes competing, theoretical impetuses.43 However, Beynon-Jones 
points out that much of STS’s theory shares a united analytical incentive 
which consists of “the de-centring of human agency and the 
acknowledgement of the live-liness of the nonhuman world” (Beynon-Jones, 
2013, p. 107).  
 
Similarly, one of STS’s primary contributions to my way of thinking about HIV 
and the clinic is the argument that both science and technology are entirely 
social and active processes (Latour and Woolgar, 1986; Berg and Akrich 
2004, p. 2) which are not natural in and of themselves. Following this 
proposition it becomes clear that there is not, nor will there ever be, a 
scientific or technological method in existence that is able to “interpret” nature 
and produce knowledge thereby to uncover an elemental truth about the world 
(Berg and Akrich, 2004, p. 3). This position, Berg and Akrich argue, enables 
STS to completely refuse to make any hypothesis about the nature of the 
objects it studies (Berg and Akrich, 2004). On the contrary, it considers 
“nature” as an empirical question (Berg and Akrich, 2004). By this, they mean 
that because STS does not fundamentally believe that there is a particular 
way of knowing a truth about an object and it does not assume a pre-existing 
truth prior to what is produced by interactions within a particular network 
(Akrich and Pasveer, 2004, p. 65), it is therefore only possible to investigate 
the ways in which the object comes to be known and enacted (Berg and 
Akrich, 2004, p. 3).  
The version of STS that I am concerned with here involves an approach in 
which no kind of body is positioned above the other. Neither the body, as it is 
experienced by an HIV-positive pregnant patient, as it is understood by health 
care practitioners, or as it is seen through various biomedical technologies, is 
prioritised over others. Rather, this tenet of STS tries to follow the 
complexities of all of these bodies by “describing how each one is specifically 
                                                
43 When I refer to STS, it is with the caveat that I am not speaking about all versions of STS.  
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connected to a set of practices, material devices and rhetorical genres which 
include modalities defining the way it relates to other bodies” (Berg and 
Akrich, 2004, p. 3). Following this, the significance of the location wherein 
empirical material is gathered becomes clear. This is evident if we consider 
the different circumstances that would inscribe an HIV-positive pregnant 
woman in a location where HIV and death have been decoupled (see 
Rosengarten 2009, p. 3), versus an HIV-positive pregnant woman in a 
location where HIV is an inevitable precursor to death. It becomes clear that 
what the body of the HIV-positive person is (and may become) in these 
diverse locations may be entirely different. Further to this, the effects of any 
particular rendition of the body would presumably be different depending on 
who is asked about it. By this I mean that the experience of being a patient in 
the antenatal clinic versus the experience of being a medic caring for that 
patient would ostensibly be different. Further to this, the perspectives of 
patient and practitioner would be different from a biomedical, and/or 
assessment technologies’ rendition of the body, or parts of the body. In other 
words, the various ways that HIV is done in different geographical locations 
and from different perspectives enable different and “ontologically multiple” 
kinds of bodies affected by HIV (Mol, 2002).  
 
Indeed, for Mol, it is the actions taken by the medical practitioners that are of 
theoretical interest (2002, p. 152). She argues that her ethnography’s concern 
with the specificities of medicine “is its force but also constitutes its limits” 
(2002, p. 26). She distills atherosclerosis the disease (as it is evidenced by 
and through medical practice) from the experience of being a person 
diagnosed with atherosclerosis.  
  
It is possible to say that in practices objects are enacted. This suggests 
that activities take place- but leaves the actors vague. It also suggests 
that in the act, and only then and there, something is - being enacted. 
[…] Thus, an ethnographer/praxiographer out to investigate diseases 
never isolates these from the practices in which they are, what one may 
call enacted. She stubbornly takes notice of the techniques that make 
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things visible, audible, tangible, knowable. She may talk bodies — but 
she never forgets about microscopes (2002, pp. 32-33) (Emphasis in 
original).  
Moreover, Mol argues that the object does not pre-exist its own enactment. Or 
in other words, objects are real only if they are part of practice. By her 
definition, the object is “a reality enacted” (2002, p. 44). As a result of disease 
being enacted in practice, she argues that it is possible for the same disease 
to be done differently in different environments (2002, pp. 35-36; Law, 2009, 
p. 152). Mol claims that the differences depend on the varying requirements of 
the locations and the actors involved in the object’s enactment. In other 
words, the same object can therefore be entirely different. In relation to this, 
Beynon-Jones argues that Mol’s main argument is that “the real is relationally 
enacted in [socio-material] practices” and that “if those practices were to 
change the real would also be done differently” (Beynon-Jones, 2013, p. 107). 
Thus, as mentioned above, bodies are ontologically multiple (Mol, 2002, p. 
46), and so if the object is HIV, what HIV is, and the effects that it has, are 
particular to the environment wherein HIV is enacted.  
 
Here it is important to stress that Mol would not say that HIV becomes a 
material reality only if and when it is enacted. For example, a person with 
undiagnosed HIV will still be subject to the progression of the disease, 
although the pathologies experienced may be attributed to some other 
malady.  
 
Mol’s exposition opens up the possibility of considering what the effects of 
multiple objects may be on, for example, antenatal HIV prevention methods, 
both within the space of the clinic and external to it. In other words, what 
antenatal HIV interventions constitute might vary depending on what HIV is 
within the environment wherein the interventions take place. Following this, 
HIV-positive pregnant women and their unborn babies would be significantly 
affected by the way HIV is enacted within the space where they receive their 
care. According to Mol, the variations in the discernment, reading and 
interpretation of the virus correspond to what are effectively multiple viruses 
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— that is, different ontological accounts which would each have 
corresponding ways of being acted upon, and enacted by the practitioners 
and their patients. In other words, a patient’s body and disease may be done 
differently. Furthermore, her arguments suggest that a patient’s virus would 
not pre-exist its enactment through practice.  
 
While Mol’s approach has been hugely influential, it is not without its 
detractors. One of the main criticisms directed towards her work is that it fails 
to adequately acknowledge the researcher’s role through the act of 
conducting research (writing and theorising) and how it is an integral part of 
the “intervention” that is being observed (Gad and Bruun Jensen, 2010). 
However, I will provide my own critique of the Body Multiple later in this 
chapter and in relation to her other book, The Logic of Care (2008).  
	
HIV	and	pregnancy:	things	are	getting	more	complicated	
 
Successful HIV care depends on a patient’s compliance to care, for the 
reason that the patient must participate in care for it to work. The patient must, 
for example, come to her appointments and take ART, concede to various 
interventions such as having a caesarean section and she must answer 
questions the practitioner deems to be significant. Therefore, after the initial 
diagnosis of HIV-positivity and confirmation of pregnancy, the requirements of 
successfully preventing vertical transmission concern the particular care on 
offer, i.e., the logic of care in the clinic, which in this instance require that the 
practitioners must encourage the patient to speak about her life and of her 
experience of the care she is receiving. These narratives are considered 
crucial to the prevention effort. This is because the practitioners know that the 
patient’s feelings and experiences may disrupt care; for example, a patient 
who hates coming to the clinic may be less likely to regularly attend her 
appointments and a patient who believes that prayer alone may cure HIV 
might not conform to the practitioners’ plans for her care (Doyal and 
Anderson, 2005, p. 1736). Thus, the practitioners know that patients who are 
experiencing difficulties in their lives outside of the clinic will find adhering to 
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treatment regimes more onerous (Tariq, 2013, Doyal and Anderson, 2005; 
van der Zaag and McKnight, 2017: forthcoming). Further to this, the patient’s 
narrative would assist the practitioners in determining how to work with 
patients who are resistant to care. The practitioners would have different 
approaches depending on, for example, if the patient’s reluctance (was 
thought by the practitioners) to concern her religious beliefs, depression, 
psychosis, lack of family support, and so on. Importantly, the practitioners 
would need the patient to speak about her life in order to establish what 
influenced her hesitancy.  
 
Consequently, while HIV can be done (in the way that Mol writes of doing 
disease), without the perspective of the HIV-positive patient it cannot be 
treated and vertical transmission cannot be prevented without the patient’s 
participation. Following this, an ethnography of HIV and pregnancy requires 
that the ethnographer also consider the perspective of the patient, being that it 
is an inherent and crucial part of care and prevention. As can be seen in the 
quote below, Mol makes an allowance for this; that is, the inevitable 
complications that follow if an ethnographer expands her scope of interest to 
include multiple objects.  
If one begins to study the interferences between the enactments of two 
or three multiple objects (such as atherosclerosis and sex difference), 
then the complexities start to grow exponentially — though these are 
complexities to be investigated elsewhere, for this is the point where this 
study stops. It has done what it set out to do. A single/multiple disease 
has been described as a part of the practises in which it is enacted (Mol, 
2002, p. 151)(Emphasis in original).  
Encouraged by Mol’s invitation to investigate these complexities elsewhere, 
this study seeks to explore some of them. A first step in doing this is to think 
about the kind of woman that presents herself (or is presented to) for 
diagnosis in an HIV specialist antenatal clinic in London and the kind of care 
she requires. To begin, the primary goal of the specialist antenatal clinic is to 
manage the pregnant and postnatal patients’ HIV and health, while 
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simultaneously preventing vertical transmission. Moreover, while the unborn 
baby is not legally a patient in its own right, and is therefore not a subject of 
care, the future baby’s health is of primary concern.44  
 
Accordingly, the practices in which the practitioners in the clinic engage are 
intrinsically concerned with the issue of time as it relates to their patient’s 
pregnancy. By this I mean that they must consider the patient, as she is when 
she first presents herself in the clinic and as they expect and/or hope she will 
become throughout her pregnancy and postnatally. Therefore, in addition to 
their own, and their patient’s expectations and desires for her unborn bab[ies], 
they must take into consideration the subjectivity and health of the 
baby/babies (that will hopefully be) born to their patient, especially so in cases 
where vertical transmission is considered to be particularly difficult to prevent.  
 
Moreover, I argue that the combination of HIV and pregnancy (as perceived 
by the practitioners) require that they consider the feelings they think their 
patient and their offspring may have in the future when making decisions 
about care in the present. This is particularly significant because it alludes to 
some of the complexities that may occur in the specialist clinic if a pregnant 
patient resists or refuses the practitioners’ desired care plan. From the 
practitioners’ point of view, a patient’s refusal to comply with their care plan 
may make it impossible for the patient and her (unborn) baby to achieve what 
they imagine is their potential in the future. In other words, a patient’s 
noncompliance may endanger the patient’s and her (unborn) baby’s future. 
Thus, while the pregnant patient is legally autonomous and has the right to 
concede to or refuse care, her unborn baby is not and cannot. Consequently, I 
argue in later chapters that the practitioners advocate in the present on behalf 
of the (unborn) baby and the mother as they imagine them having the 
potential to become in the future. It is the unborn baby’s promise of a future 
free from HIV, and the practitioners assumption that the postnatal patient will 
be happy that prevention occurred, that changes the way the pregnant 
                                                
44 Vora (2013) makes a similar argument in relation to assisted reproductive technologies in 
India.  
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patient’s autonomy is conceived of and dealt with in the clinic, prior to the 
baby’s birth.  
 
In regards to this, Mol explains that a vascular surgeon in one of her hospitals 
of interest makes an assessment as to whether or not invasive treatment may 
be appropriate based on his patient’s specific circumstances at that moment 
in time (2002, p. 72). Inversely, I argue that the practitioners in the HIV 
specialist antenatal clinic base their care decisions on the patient as she is 
now and on how they hope she and her baby will become in the future. 
Hence, they are consulting with a real present-time patient, with her future 
self, and with her future baby, as they imagine them to have the potential to 
become if care is successful.  
 
In other words, the practitioners are charged with the task of trying to 
envisage and contend with the future, i.e., with the patient and her offspring 
as they may or may not become, as a result of the biomedical innovations and 
care the present-time patient engages with or rejects. It will become clear in 
my empirical chapters that the future patient, or rather, the future patient and 
her HIV — (negative or positive) future baby — play a significant role in the 
care made available to the “present-time pregnant patient”, as do ideas about 
the kind of behaviour good (becoming) mothers ought to engage in. Although 
it is not spoken of in this way in the clinic, I will illustrate in chapters Four and 
Five how the practitioners explore and anticipate the possibilities of the 
biomedical technologies and care on offer in the clinic in relation to their 
patient’s (real and imagined) behaviour. The patient’s (real and imagined) 
behaviour becomes accessible to the practitioners through their interpretation 
of the patient’s behaviour and narrative. 
 
Many of Mol’s arguments are useful to me in that they ask us to question how 
an object comes into being within an environment and to investigate how the 
object is maintained, negotiated and coordinated within that space. In this 
way, informed by my experiences in the clinic and my understanding of the 
requirements of HIV, pregnancy, the clinic and its patients, I intend to further 
Mol’s arguments in this thesis. Moreover, I will question what significance the 
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care on offer in the clinic has for the patients. These are all concerns that will 
be investigated throughout this thesis in relation to what the patients and 
practitioners told me mattered to them. To assist this, the next section will 
concern Mol’s articulations on the logics of care that she argues might be 
available to patients.  
	
The	logic(s)	of	caring	for	the	imagined	patient 
 
In The Logic of Care, Annemarie Mol questions the implications of the 
apparent shift within healthcare that attempts to “increase the possibilities for 
patient choice” (2008, p. xiii). She challenges the widespread assumption that 
“care” is a “soft form of force”, and claims that within the healthcare field “good 
care” as an ideal suffers from the elevated position of patient choice (2008, p. 
xxi).45 Mol contends that although the ideal of patient choice appears to be an 
attractive alternative to care, it is not often able to fulfil its promise of improved 
care. She explains that this is because the tenets that inform patient choice — 
or rather the rational that informs (in her words) the “logic of choice” — 
reduces the care on offer (be it a technological device or emotion such as 
kindness) to a rigidly bounded product that may be chosen or not (2008, p. 
18). Conversely, Mol argues that within the “logic of care”, care does not have 
defined boundaries and is thus “an interactive, open-ended process that may 
be shaped and reshaped depending on its results” (2008, p. 20). According to 
Mol, this capability is more conducive to the unpredictability of diseased 
bodies. In relation to this she writes:  
even though care is result-oriented, it is not necessarily bad when 
“health” and a “good-life” remain out of reach. Some diseases can never 
be cured, some problems keep on shifting. Even if good care strives 
after good results, the quality of care cannot be deduced from its results. 
Instead, what characterises good care is a calm, persistent but forgiving 
effort to improve the situation of a patient, or to keep it from deteriorating 
(2008, p. 20).  
                                                
45 In this thesis I will write about caring care, which I define as good care in practice and 
which retains the ideal of good care, as Mol has defined the concept. 
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Following this, she contends that the two logics are often incompatible and 
“good care” as an ideal suffers not only from the elevated position of “patient 
choice” (2008, p. 1) but also because “patient choice” “alters daily practices in 
ways that do not necessarily fit well with the intricacies of our diseases” (2008, 
p. 2). Accordingly, practices that are intended to encourage the expansion of 
the ideal of patient choice conversely “erode existing practices that were 
established to ensure ‘good care’” (2008, p. 1).  
 
Mol uses a personal example to illustrate the differences between the logic of 
care and the logic of choice. She describes a situation where she decided, on 
advice, to undergo an amniocentesis in order to establish the viability of a 
pregnancy (2008, p. xi). In response to the concern she expresses about the 
procedure, the nurse in charge tells her “it is your choice” — the insinuation 
being that Mol would be responsible if the outcome were negative and she 
lost her pregnancy (2008, p. xi). The implication is that Mol should weigh up 
the pros and cons of the procedure and make her own decision about whether 
or not to proceed with it. Mol argues that she is thus empowered by having 
the ability to choose while simultaneously being isolated (2008, p. xi.). Hence, 
she contends, the boundaries of the product on offer do not include, for 
example, a kinder, more supportive interaction with the practitioner (2008, p. 
xi). Here, it is important to clarify that the product on offer consists of both the 
amniocentesis and the nurse and her care. Following this, Mol gives 
examples of what the nurse might have said that would have been conducive 
to a logic of care, rather than one of choice.  
She might have touched me in a kind way. And she might have used the 
moment to encourage me to behave […] But instead she illustrates 
beautifully how mobilising the logic of choice can lead to poor care. It 
can shift the weight of everything that goes wrong onto the shoulders of 
the patient-chooser (2008, p. xi). 
Here I would like to consider the act of weighing up the pros and cons of the 
procedure in relation to the Body Multiple (2002). Would Mol’s feelings about 
the procedure have been heard if she had been one of the patient participants 
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in that study? Mol was concerned because the procedure carried a (small) 
risk of having a spontaneous abortion (Mol, 2008, p. xi). Mol’s concern over 
the procedure happened prior to the amniocentesis becoming enacted in 
practice. Moreover, Mol’s thoughts (i.e. the possibility of having a baby with 
Down Syndrome, her “healthy child”, and the already challenging demands of 
balancing parental and work responsibilities) were integral to her decision to 
have the procedure (2008, p. xi). Thus, they informed her behaviour in the 
clinic, while still remaining unarticulated in the clinic.46 Instead Mol’s unspoken 
thought processes are only heard long after the procedure was enacted in 
practice because Mol chose to write about them in a book. In line with my 
argument, Mol explains that had the nurse behaved in a way that reflected a 
logic of care, the nurse would have been attuned to the fact that a patient 
might have an internal conflict prior to engaging in a medical procedure. In 
other words, the nurse would have been aware of the significance of the 
patient’s unspoken feelings, even if those feelings do not ultimately get in the 
way of the practitioner’s plan for care. Accordingly, the nurse would address 
the concern Mol did not articulate. To do this the nurse would have needed to 
anticipate a patient’s trepidation and behave empathetically even if a patient 
does not show signs of or voice unease.  
To reiterate, Mol’s thoughts were part of the enactment of the amniocentesis 
— that is, her thoughts were enacted in practice. This is because her thoughts 
took place prior to the amniocentesis being enacted in practice. However, 
while Mol’s unspoken thoughts were enacted in practice they are only 
distinguishable to us because she chose to write about them long after the 
procedure took place. Her thoughts would not have been apparent to us if we 
had been the nurse or an ethnographer observing or taking part in the 
                                                
46 Prior to the procedure being enacted in practice Mol makes the following statement to the 
nurse: “I hope it all goes okay” (2008, p. xi). Thus, she does voice concern before the 
procedure took place. However, my point is that her statement does not indicate what her 
exact fears were (i.e. spontaneous abortion vs. giving birth to a baby with Down’s Syndrome 
and the effects this might have on her child and work). Thus Mol’s statement to the nurse did 
not reflect the reasons why she was uneasy, or her concern over the effects the procedure 
and/or an unhealthy baby might have on her child and work.  
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procedure (as Mol has described the role of an ethnographer in The Body 
Multiple (2002).  
Thus, Mol’s internal debate is only heard long after the procedure, even 
though it ostensibly took place because she had this internal debate. 
Therefore, while Mol’s thoughts — about her child, her work, and the effects 
that a baby with Down Syndrome might have on her already challenging work-
life balance — were integral to her decision to go ahead with the procedure, 
her thoughts would not have been evident to Mol the ethnographer/author if 
she had been a patient participant in that study. Rather, within that study a 
patient’s thoughts are overlooked if they were unspoken at the time when the 
procedure (being observed by the researcher) was enacted in practice. 
Conversely, within The Logic of Care (2008) Mol posits a patient’s internal 
conversation as being crucial to the way in which she has chosen to describe 
the differences between a logic of care versus a logic of choice (2008, p. xi).  
To reiterate: patients’ unspoken feelings about a medical procedure (or 
anything else) would not become apparent in the Body Multiple (2002), but 
these feelings are, according to Mol, integral to good care.47 Moreover, 
patients’ unspoken thoughts about a medical procedure may, according to 
Mol’s narrative, become hugely significant in the future. In her case, the 
feelings she had about the amniocentesis prior to its enactment in practice 
become integral to her arguments in the Logic of Care. It is possible, however, 
that another patient might not respond to her concern in way that is so 
productive.  
Nonetheless, a patient’s unspoken feelings about a medical procedure or care 
clearly have the potential to matter in unpredictable ways in the future. By this 
I mean that the unspoken has potential to matter in the future in ways that 
could not be anticipated in the present. For example, the nurse caring for Mol 
                                                
47 I am not suggesting that Mol is saying that a patient’s thoughts are not important. Instead, 
Mol’s argument that reality is enacted in practice entails that the patient’s thoughts would be 
part of whatever became enacted in practice, although, as I have argued, these thoughts 
would not necessarily become apparent to the practitioners or the researcher.  
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could not have predicted that she would have been mentioned in a book 
written by her in the future, even though Mol’s feelings, which later informed 
the book, were part of what became enacted in practice. Thus, the unspoken 
may be enacted in the future in ways that bear no obvious relation to their 
enactment in the past or present. I will consider these arguments further in 
Chapter Five when I discuss the way the practitioners fear that a patient’s 
past experience with health care may influence her behaviour in the present 
and future.  
 
Accordingly, in Chapter Five I will argue that the practitioners believe that a 
patient’s feelings about her experiences with care in the past have the 
potential to influence the patient’s engagement with care in the future. A 
patient who, from the perspective of the practitioners, behaved as an ideal 
patient (i.e. accepting of all interventions and forthcoming with information the 
practitioners required) may, if she falls pregnant again, rebel completely 
against the practitioners’ desired plan of care. According to the practitioners, 
the impetus of her rebellion could be unarticulated feelings that she has in the 
present about HIV or the care that was provided to her in the past. 
Encouraging the patient to speak about the things the practitioners feel may 
be relevant to her care (in the present and future) is the only way that they 
feel they can prevent these potentially disastrous imagined futures from 
becoming enacted in practice.  
 
Returning to The Logic of Care (2008), the variable in Mol’s example is the 
nurse and her behaviour, not the patient’s person or positionality. However, 
both of the logics that Mol is describing become much more complex and 
problematic to envisage in practice, if the patient is the variable. We may 
consider Mol’s ideas further by questioning whether patients with temporary or 
conditional access to advanced biomedical technologies and care would be 
situated differently from patients who have no access or patients who have 
unfettered access. Following this approach, the effects of different kinds of 
patients’ incorporation into any logic might vary significantly. Consequently, 
and in relation to my work, the positionality of the patient outside of the clinic 
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as she is located prior to being incorporated into either “a logic of care” or “a 
logic of choice”, should be considered (Mol, 2008).  
 
Underlying Mol’s argument is the proposition that patient choice will not bring 
about desired improvements in healthcare and that the introduction of patient 
choice will not ultimately make space for patients. She claims that it would be 
advisable to try and “improve care on its own terms” without provoking it by 
“dreaming of choice” (2008, pp. 2, 73). Instead, her aim is to “articulate the 
specificities of good care so that we may talk about it” in order to protect it, for, 
as she argues, good care is under threat (2008, p. 2).  
 
Furthermore, Mol writes that initially choice is perceived as being good 
because it “offers individuals autonomy” and promotes equality (2008, p. 74). 
However, beyond this initial perception, at the point at which patients may be 
expected to make life and death decisions, in their choice of treatment options 
for example, it becomes clear that the logic of choice avoids providing 
guidance, since the patient is expected to “attach their own value to just about 
everything” (2008, p. 74). However, Mol contends that such autonomy does 
not truly exist, and any choice that the patients make at this point is not in fact 
their own (2008, pp. 74-75).  
 
The idea of choice is further complicated for Mol because the facts — on 
which care decisions are based — are not factual, but rather intertwined with 
values (2008, p. 74). Consequently, she contends that informing a patient that 
they have a particular pathology is an interactive and negotiated process that 
is inherently imbued with values. Accordingly, for Mol, the process of 
disclosure of a pathology is a negotiation between healthcare provider and 
patient (2008, pp. 11, 18, 20). Furthermore, she writes that within the case of 
diabetes, the fact that there are no facts has to do with the complications and 
the complexities of the disease itself (2008, p. 45), meaning that the idea that 
there is something called a “normal blood sugar level” and then conversely an 
abnormal one is not a fact; rather, she suggests, it is much more complex 
(2008, pp. 45-46). This assertion enables me to consider the circumstances 
through which truths about HIV and pregnancy are produced and negotiated 
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within the power relations of the antenatal clinic. For example, the presence of 
HIV during pregnancy may entirely alter accepted truths about gestational 
health. Therefore, it can be seen that the common sense knowledge that it is 
potentially detrimental to take toxic drugs while pregnant changes if the 
pregnant woman is HIV-positive and it becomes a statement where toxic 
drugs are vital to the future baby’s health. These truths are not necessarily 
easy to assimilate into practice.  
 
In this way, the choice that Mol was given by the nurse regarding whether or 
not she was to have an amniocentesis could not be provided in the specialist 
antenatal clinic if the procedure was considered by the practitioners to be 
potentially detrimental to the patient’s future health or the future health of her 
unborn baby. For example, in relation to care in the specialist clinic, the option 
of not taking ART during pregnancy is not presented to HIV-positive pregnant 
patients as a viable choice for them.48 Of course, this does not mean that the 
patient is not able to choose to refrain from taking ART. Rather, I suggest that 
this choice would not be accepted or respected by the practitioners as if it 
were made by a fully autonomous individual who was capable of making 
informed decisions about her care.49 Importantly, I am not suggesting that the 
practitioners would force a patient to take ART, rather, my intention is to make 
clear that a patient’s choice not to take ART would not end the practitioners’ 
efforts to convince her to take them.  
 
Following this, choice as a viable activity that the patient is encouraged to 
engage in has its limits — or rather, I argue it ceases to exist after the patient 
has chosen to be a patient in the specialist antenatal clinic, if and when she 
behaves in a way that is considered to be detrimental to her health and/or the 
health of her unborn baby. In other words, after her formal induction into the 
clinic, the assumption is that the patient has acquiesced to participate in a 
process that will provide her and her unborn baby with the best possible care, 
                                                
48 Another example: pregnant HIV-positive women are not offered the choice of having a 
home birth or a hospital birth. This is because a home birth is considered to be too risky and 
not conducive to the requirements of the prevention of vertical transmission.  
49 It must be mentioned that Mol contends that within a “logic of choice”, the patient’s ability to 
choose functions in the same way. In other words, there is no real choice as such. 
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ensuring the prevention of vertical transmission and optimal outcome for their 
health. Participating in this process requires a certain kind of behaviour on her 
part, the particulars of which are constantly up for negotiation, but ultimately it 
is the practitioners that determine what that behaviour ought to be. Therefore, 
the practitioners have carefully assessed the potential consequences of any 
choice that is presented to the patients in the clinic to ensure that the potential 
effects of those choices would not impede the practitioners’ ultimate goal.  
 
Returning to Mol’s logics, she argues that within the logic of care there is only 
a single normative layer and that “the crucial moral act is not making value 
judgements, but engaging in practical activities” (2008, p. 75). Accordingly, 
within the logic of care, “doing good” is good, and making life “better” is 
desirable (2008, p. 75). However, Mol importantly contends that the 
particularities and meaning of [doing] “good”, “better” and “worse” and what 
constitutes and enables a “better life”, are not predetermined, prior to 
enactment and/or practice; rather, they “form part of [practice]” (2008, pp. 75-
76). Making decisions about what constitutes a better life is, Mol suggests, a 
collective decision, established through negotiations with the relevant actors 
in all its complexity (2008, p. 76).  
 
It is here that I would like to further Mol’s argument by contending that the 
relevant actors that take part in the negotiations mentioned above include the 
practitioners’ imagined future patients — both the mother as she will be 
postnatally, if vertical transmission is prevented and she has a healthy baby, 
and the baby born free of HIV. These are the ideal patients that are kept in 
mind when dealing with resistant (and sometimes hostile) pregnant patients. 
As mentioned above, the fact that the pregnant patient has chosen to 
continue with her pregnancy illustrates that her future self (as the practitioners 
imagine her to be if vertical transmission is prevented) would be glad that she 
participated in a process that ensured the prevention of vertical transmission. 
In other words, the patient that is consulted about care choices is not limited 
to the present time patient.  
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Mol advocates the need to reposition “choice” as a “defining face of human 
life” (2008, p. 73) to one wherein it will be viewed simply as an “activity” that 
may or may not be good to engage in, depending on the particularities of the 
situation within which it arose (2008, p. 73). Following this move, she argues 
site-specific questions would need to be posed such as “where and when to 
organise situations of choice where and when other configurations might be 
more appropriate” (2008, p. 73).  
 
Mol’s arguments are valuable when addressing concerns related to the 
particularities of the space of the antenatal clinic: for instance, what are the 
factors that would dictate the type of configurations into which bodies would 
be organised within the antenatal clinic? However, her argument is less useful 
when trying to approach or make sense of things that are not articulated in the 
clinic prior to becoming enacted in practice. In other words, Mol’s assertions 
do not elucidate the extent to which the configurations apparent in the 
antenatal clinic may be (or are) affected by forces and/or variables that remain 
unarticulated.  
 
To conclude this session, Mol’s propositions are useful when considering the 
intricacies inherent in both pregnancy and HIV. In this regard I suggest that 
her thesis allows for an investigation into the complexities of pathologies and 
certain conditions, and the medicalisation of bodies, as they appear within the 
clinic. In other words, Mol’s arguments are useful to the investigation of 
circumstances that are enacted in the clinic and the logics of care that inform 
care practices in the clinic. However, the practitioners’ focus on the wellbeing 
of the future patient and her hopefully HIV-negative baby changes the idea of 
the present-time patient’s autonomy in relation to her ability to make decisions 
or to be offered choices in regards to her care.  
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Conclusion	
 
The ability to successfully prevent vertical transmission of HIV in resource rich 
locations is an unquestionable achievement. However, this chapter has 
clarified that while the problem of HIV in relation to vertical transmission can 
be resolved in the clinic through the use of biomedical technologies and care, 
the problem of HIV is not limited to the transference of the virus between 
mother and baby. Thus, this chapter has outlined theoretical insights that I will 
use in the subsequent chapters in order to further explore the contingencies of 
HIV in the clinic.  
 
Based on the literatures discussed in this chapter, I have taken the idea that 
within the space of the HIV specialist antenatal clinic, different kinds of issues 
emerge from the practices that are connected to, amongst other things, 
different locales, technologies and understandings of HIV. It is in relation to 
these concerns that Fassin is useful in that he emphasises the importance of 
investigating how traces of these geopolitical dynamics are articulated and 
negotiated in the clinic. However, these issues extend to other aspects of the 
clinic such as the technologies that it depends on, and it is here that the work 
of Annemarie Mol is of particular assistance. Consequently, by using Mol I 
argue that the technologies used in the clinic participate in the construction of 
certain kinds of HIVs as well. Moreover, these problems follow the patients 
into the clinic and trickle through every aspect of the events that take place 
within it. In response to this, later chapters will question the way bodies are 
identified as belonging to geographical locations that are imbued with 
significance, regardless of the current location of the bodies in question.  
 
At the onset of this thesis, I contend that the space of the antenatal clinic is 
the subject of analysis. Following this, it is clear that I will explore a space 
which encompasses domains, which are simultaneously social, and 
biomedical. My position is that what HIV is (discovered to be) within the clinic 
and the areas that the patients and practitioners within in it negotiate, will 
depend entirely on who or what is asked to provide an account of HIV. 
Moreover, all of the accounts provided will have been filtered, and in this way, 
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they do not represent a comprehensive account of the problem of HIV. 
Further to these ideas, the next chapter will discuss the methods used to 
conduct this study and consider the experience of conducting research in a 
highly emotive environment.  
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Chapter	Three:	Methodological	Negotiations	and	Emotive	Perspectives	
This chapter will outline the methodological issues which were explored in 
order to conduct this study. The project devises a research methodology 
attentive to practices drawn from science and technology studies (STS). 
Therefore, the discussion will be positioned within debates prevalent in some 
versions of STS that consider the enactment of disease and provision of care, 
as well as social scientific and anthropological discussions that reflect upon 
the significance of intimacy and the experience of doing research. Moreover, 
the chapter will consider the decisions made in regards to choosing research 
participants, along with the process of collecting and analysing data. 
Furthermore, the chapter will reflect upon some of the ethical constraints and 
shortcomings of the study.  
	
Uncovering	the	specificities	of	HIV	and	pregnancy	through	practice	
 
In “Embodied Action, Enacted Bodies: the Example of Hypoglycaemia” 
(2004), Mol and Law argue the idea that diseases, in particular 
hypoglycaemia, are enacted in practice, as is the body (affected by disease). 
In this article, they explore the practices that take part in the enactment of a 
disease in order to investigate the question of “what is a body” (Mol and Law, 
2004, pp. 43, 45). In other words, they use ethnographic methods to describe 
how bodies and diseases are done through practice. They state: “[as] part of 
our daily practices, we also do (our) bodies. In practice we enact them” (2004, 
p. 45). Following this, Mol and Law provide an ethnographic description of 
hypoglycaemia (2004, pp. 46, 49) through their investigations of clinical 
presentations, trials and epidemiological overviews (2004, pp. 46, 49) and by 
asking people with hypoglycaemia what it is, how they attempt to “intervene 
into it”, “counter act it”, avoid it and attempt “not to know it” (2004, p. 49).  
 
Mol and Law speak to health care providers about hypoglycaemia (2004, p. 
47) and in this way get a feel for how practitioners see this condition, as well 
as what is required of their patients in addition to an “appropriate 
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engagement” with relevant technologies (2004, p. 47). Thus, they report that a 
nurse speaks about the significance of a patient’s “self-awareness”; patients 
who are self-aware are, according to this professional, able to live more 
“flexible lives” (2004, p. 47). Moreover, they observe hypoglycaemia where it 
is “beneath the skin”, located within text books — where it is situated as a 
consequence of various “treatment practices” and is thus found  
in hospitals, information leaflets and people’s homes. It is in the daily 
lives of people who suffer from diabetes mellitus. In daily life 
hypoglycaemia is something that may occur, happen, be done (Mol and 
law, 2004, p. 46). 
Consequently, they received a multitude of answers from various respondents 
to their question of “what is hypoglycaemia” (2004, p. 50)? Their next question 
was what the answers implied “for the body” (2004, p. 50). In response to this 
question they write  
The answer is, two things. First, as they enact hypoglycaemia, bodies do 
a lot of things: they act. And second, while it is measuring, feeling, 
countering, avoiding and producing hypoglycaemia the body is being 
enacted, too. But no, it is more complicated still. For acting and being 
enacted go together. Thus we may ask: while it is acting, what is a body 
made to be (2004, p. 50)? (Emphasis in original) 
In order to answer this question, they use stories from the lives of people 
affected by the disease to illustrate what acting and enacting do. Accordingly, 
they explore the way the technologies that patients are meant to use interact 
with their lives, and the way in which people are required to reorganise their 
lives in order to fit into the requirements of the technology. To illustrate their 
point, Mol and Law provide details of the difficulties affected people thus face 
as a result of other obligations that they have. For example, they describe 
how a manual labourer finds it difficult to prick his finger to test his blood 
during his workday because he cannot access clean water to wash his hands 
(2004, p. 50). 
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From this they discuss the way some of the technologies people are required 
to engage with attempt or encourage them “to stop whatever they are doing in 
order to feel their bodies from inside”, thus “[training] inner sensitivity” (2004, 
p. 48). Importantly, Mol and Law also consider how various methods of caring 
for people with hypoglycaemia may have different ways of enacting the body 
of the person with the disease, as well as different effects on the patient’s life, 
and the way she lives her life (2004, p. 55). The next section will reflect on 
another text by Mol that is explicitly concerned with the logics of care.  
	
Finding	good	care	
 
In The Logic of Care, Mol analyses the practices involved in living with and 
treating diabetes which promote “good care” (2008). Mol is able to speak 
about this concept because her methodological approach enabled her to 
establish what “good care” is in practice. In other words, the methods that Mol 
used to conduct her study, as well as the way she treated the data she 
collected, allowed her to uncover it. Hence, Mol writes that she worked with 
her empirical material similar to the way a chemist handles “mixed liquids”, 
since a chemist would “distil it in order to separate out” various components 
(2008, p. 10). 
 
Accordingly, Mol spent time in clinics collecting data in numerous ways to 
observe care practices. The materials that she thus distils have been 
gathered in different ways from multiple sources (2008, pp. 8-9). In other 
words, she sifted through her data in order to establish what “good care” is. 
Her intention was to amass “snapshot stories about the treatment of, and life 
with, diabetes inside and outside of the hospital” (2008, p. 2). Fieldwork was 
conducted in an ethnographic mode; she attended patient consultations, and 
analysed lay and professional texts on diabetes in books, journals and 
websites. Furthermore, she conducted interviews with practitioners and 
patients.  
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For Mol, fieldwork is necessary in order to articulate the logics that she argues 
are embedded within practices (2008, p. 8). This is because the rationality of 
the practices she is interested in, i.e. the logic of these practices, may be 
“[implicitly]: embedded in practices, habits and machines” (2008, p. 8). 
Moreover, the logic of these practices may not be “obvious to the people 
involved” in the practices or even “verbally available to them” (2008, p. 8). 
Consequently, according to Mol, it is only through the process of immersing 
oneself in the field and observing practice that the researcher is able fully to 
appreciate the logic(s) that determine the way in which practice is enacted 
within a particular environment. Furthermore, her approach embraces the idea 
that the final product, as she presents it, is intentionally selective. This is 
significant to this study as will be discussed later in this chapter.  
 
Influenced by Mol and Law, I am interested in investigating the practices that 
take place in the enactment of both HIV and pregnancy in the clinic. In a 
similar way, this exploration helped me understand what a body is in the clinic 
(Mol and Law, 2004, pp. 43, 45). Thus, like Mol and Law, I use ethnographic 
methods to describe how HIV-positive pregnant and postnatal bodies are 
done through practice (2004, p. 45).  
 
More specifically, Mol and Law’s approach persuaded me to ask the 
practitioners in the clinic about what they felt HIV and pregnancy were for 
them and for their patients, and what they felt an “appropriate engagement” 
with relevant technologies was for their patients in order to prevent vertical 
transmission of HIV (Mol and Law, 2004, p. 47). Furthermore, Mol and Law’s 
approach encouraged me to observe HIV and pregnancy as they were 
situated as a consequence of various “treatment practices” (2004, p. 46). 
Moreover, I took from them the idea that various methods of caring for HIV-
positive pregnant women could have different ways of enacting the HIV-
positive woman’s body and her (unborn) baby’s body, and thus also have 
different effects on both of their lives (2004, p. 55). 
The methodological contribution that The Logic of Care (2008) makes to this 
thesis concerns the way Mol conducted her fieldwork and treated the data she 
collected. Thus, from Mol I take the methods she used in order to separate 
 75 
out “good care” from “messy practices” (Mol, 2008, p. 10). While many of 
Mol’s and Law’s arguments are directly relevant to this study, our thinking 
departs from each other in a few ways, which I will discuss below.  
	
Intervening	into	both	HIV	and	pregnancy		
 
The idea of intervening into a disease and/or counteracting it, and attempting 
to know or not know a disease, are particularly interesting in relation to HIV 
and pregnancy. This is especially considering that many women may enact a 
combination of these responses. An extreme example of this could be HIV-
positive pregnant women who may not want to know HIV but yet still have a 
healthy pregnancy, or who may want to counteract HIV but not in any way 
intervene into their pregnancy. Here it is important to consider that many HIV-
positive people do not experience significant symptoms of their HIV prior to 
taking ARVs, which can have serious and sustained unwanted effects 
(Rosengarten, 2009, p. 4). Therefore, in relation to HIV, in some 
circumstances it may be more appropriate to describe the patient’s desire to 
intervene into the disease as being a desire to intervene into the “unwanted 
effects” of the medication she is taking.  
 
Furthermore, the concept of inner sensitivity (Mol and Law, 2004, p. 48) 
discussed above is noteworthy in relation to the HIV specialist clinic when 
considering the fact that it is both HIV and pregnancy that are being cared for 
in the clinic. As mentioned elsewhere in this thesis, certain symptoms such as 
vomiting could be considered normal symptoms of a healthy pregnancy, or 
they could allude to the possibility that a patient may be experiencing 
unwanted effects of ARVs. Accordingly, the implications of inner sensitivity 
may vary drastically depending on what a patient and/or practitioner decides 
is the cause of the patient’s symptoms. Later in the thesis, I will show that 
these contradictory positions may have substantial implications for care.  
Likewise, Mol’s ethnographic method and her preoccupation with practice do 
not specifically encourage consideration of the feelings and thoughts of 
researchers. Nor does her approach prompt a focus on the emotive 
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relationships that may develop between researcher and research participants. 
However, on entering the field it became abundantly clear to me that my 
thoughts and feelings about the research process and the research 
participants significantly influenced the way I conducted myself in the clinic, 
and how I made decisions about how to write about the clinic. Therefore, I 
found the work of Clifford Geertz (2001), Julia O’Connell-Davidson (2008), 
and Fraser and Puwar’s discussion of O’Connell-Davidson’s work particularly 
useful when trying to make sense of the intimacy that arose between the 
research participants and myself and the experience of conducting research 
in a clinic with vulnerable patients. A description of their contribution will be 
discussed below in relation to analysing and disseminating research and the 
emotive experience of being in the field.  
	
The	experience	of	doing	research		
 
In “Thinking as a Moral Act: Ethical Dimensions of Anthropological Fieldwork 
in the New States”, Clifford Geertz argues that the significance of the social 
sciences is that their theories and methods are derived from the social world, 
thus they are produced by the people who live in the same social worlds to 
which these “methods apply and theories pertain” (2001, p. 22). Following 
this, Geertz argues that thinking (about the social worlds the researcher 
inhabits) is a social act (2001, p. 21). In other words, for Geertz, “thought is 
conduct and is to be morally judged as such” (2001, p. 21). This argument, he 
writes, brings “thinking out into the public world where ethical judgement can 
get at it” (2001, p. 21).  
 
Geertz contends that “the moral quality of the experience of working social 
scientists, the ethical life they lead while pursuing their inquiries […] should be 
a central aspect of modern consciousness” (2001, p. 22). To use Mol’s 
vernacular to stress this point, Geertz would argue that thinking is enacted in 
practice. However, as I touched upon in the previous chapter, thoughts and 
feelings only become heard if they are articulated in some way. So, thinking is 
a moral act that is intrinsically connected to the lived experience of being in 
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and becoming with the field. However, despite the relevance of these 
processes, Geertz contends that “the moral quality of the experience of 
working social scientists, the ethical life they lead while pursuing their 
inquiries, is virtually never discussed except in the most general terms” (2001, 
p. 22). These arguments resonate with me, and so, like Geertz, I will discuss 
some of the ethical dimensions of my time in the clinic in an attempt to offer 
up my thought processes for ethical judgement.  
 
As mentioned above, the emotive experience of being in the clinic became 
increasingly important to me while I was conducting fieldwork. Furthermore, 
my feelings have intensified since leaving the clinic through the process of 
further analysing the collected data and writing it up. In a similar way, 
O’Connell Davidson reflects upon the relationship she developed with a 
research subject in her article, “If no means no, does yes mean yes? 
Consenting to research intimacies” (2008). Here O’Connell Davidson asks 
whether or not the intimacy that may arise between a researcher and her 
research subjects is ethical just because the researcher has obtained 
informed consent from the research participant (2008, p. 49). Further to this, 
and because of the kind of relationship she developed and eventually lost with 
her research participant “Desiree”, O’Connell Davidson questions the extent 
to which it is possible for a research participant to fully “consent to being 
objectified through the research process” (2008, pp. 50-51). What I take from 
O’Connell Davidson’s article is the significance of the relationship she 
established with her research participant to the production of data. In 
response, I will consider how my relationships to my research participants 
influenced the empirical material I collected. Moreover, I will discuss how 
O’Connell Davidson’s decisions about what she finally chose to write about in 
regards to Desiree (and what she omitted from dissemination) impacted upon 
the way I decided not to include certain themes in this thesis.  
 
In “Introduction: Intimacy in Research”, Mariam Fraser and Nirmal Puwar 
consider O’Connell Davidson’s article and the manner in which intimacy is 
produced during the process of doing research (2008, p. 1). Fraser and Puwar 
contend that despite the fact that “sensory, emotional and affective relations” 
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are an integral part of the research process, they are often made to be 
invisible and are not adequately considered in discussions about methods and 
methodology, or in researchers’ discussions of the experience of doing 
research (2008, p. 1). They argue that the reasons for this invisibility has to do 
with (amongst other things) the generally accepted standards of academic 
practice and the way in which researchers grapple with “relations between 
scholarly research and personal relationships across time, and between 
scholarly research and, for example, creativity, fiction, or sensationalism” 
(2008, p. 1). The invisibility of the affective dimensions of the process of doing 
research is particularly problematic, they contend, because intimacy informs 
the production of knowledge, power relations and the way researchers 
grapple with ethical problems (2008, p. 1). In other words, by not directly 
attending to the affective dimensions of their research, researchers are 
neglecting to discuss issues that are fundamental to all aspects of their work. 
 
Moreover, they argue that researchers generally wish to describe their 
research methods as if they are distinct from their emotions (2008, p. 4). 
Following this, Fraser and Puwar write that the researchers’ experience in the 
field as an “embodied being” is consequently absent from academic discourse 
(2008, pp. 9-10). However, they argue that trying to fill in these absences 
brings forth new concerns — which are exemplified in O’Connell Davidson’s 
article — in that the boundaries between the role of researcher and friend or 
confidant are blurred during the process of data collection and dissemination 
(2008, pp. 9-10). Therefore, Fraser and Puwar write that a consequence of 
the intimacy established between researcher and her research subjects may 
be that “[the] dissemination of primary data to a wider public can be plagued 
by a sense of betrayal and disloyalty” (2008, p. 10). Taking my feelings of 
unease at the prospect of disseminating this research seriously, I have 
chosen to provide details of my emotive response to being in the clinic, to the 
people that I met in the clinic, and to the way in which our relationships 
developed.50  
                                                
50 Treating my emotions in this way reflects Reger’s (2001) position in “Emotions, Objectivity 
and Voice: An Analysis of a ‘Failed’ Participant Observation”, in which she argues that 
researchers must treat their emotions as data. 
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Description	of	method	
 
Moreover, this study’s methodology was influenced by grounded theory 
(Glaser and Strauss, 1968; Corbin and, Strauss 1990; Charmaz, 1990; 2006; 
2008a; 2008b; Glaser and Holton, 2004; Mason, 1996). I was attracted to the 
openness of grounded theory; it did not appear to have unnecessarily strict 
boundaries but was instead open to be augmented. As Charmaz writes in 
regard to this, “[g]rounded theory has evolved into a constellation of methods 
rather than an orthodox unitary approach” (Charmaz, 2008a, p. 161) (see 
Glaser and Holton, 2004, paragraph 7). I was drawn to the way in which 
grounded theory requests that a researcher asks questions about what is 
happening in the field and “[w]hat (theoretical category or theory) are these 
data a study of” (Charmaz, 2008a, p. 161). Additionally, this approach 
appealed to me because I did not want to enter the clinic with a pre-existing 
checklist of phenomena to be observed (Charmaz, 1990, p. 1162). Instead, I 
wanted theoretical categories to emerge from and be grounded in the data 
(Charmaz, 1990, p. 1162; 2007, p. 82; a2008, p. 163). In this way, Mason 
writes that grounded theorising is an instance where both theory, as well as 
explanation, comes from the emerging analysis that is enabled through 
“constant comparative methods” (1996, p. 142). Grounded theory encouraged 
me to closely examine the clinic, to evaluate what emerged in the clinic, and 
to connect the empirical world I was part of “to theoretical possibilities” 
(Charmaz., 2008a, p. 161).  
 
However, I did have concerns with grounded theory. My reservations about 
this approach had to do with what it purports to tell us about the worlds 
studied. Charmaz has argued that “by starting with data from the lived 
experience of the research participants, the researcher can, from the 
beginning, attend to how they construct their worlds” (1990, p. 1162). 
Nevertheless, I was (and am) part of the worlds that I research (Horsburgh, 
2003, p. 308). Therefore, I am a part of all aspects of this study: the data 
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collected from the research participants as it concerns their lived experience 
and the way in which I imagine that they construct their worlds. Thus, while 
the participants of this study lived a reality without me, I was not able to 
access that reality without making myself part of it. Instead, I am suggesting 
that my approach is indicative of a less sharply distinguished relation between 
researcher and her research object or participant. In this way, my concerns 
with the approach advocated by grounded theory have to do with claims about 
what the process may tell us about the world. I do not have concerns about 
the process itself. In other words, the tools grounded theory provides are good 
tools, so I used them. The next section will describe how I gained access to 
the clinic.  
	
Approaching	the	clinic	
 
When I conceived of this research project, I had two hospitals in mind as 
possible sites to conduct my study. Out of all the London hospitals, two had 
the busiest HIV specialist antenatal care facilities. I emailed HIV specialist 
practitioners in both places and quickly received courteous responses. 
However, my contact at the first hospital assured me that his clinic did not 
care for a significant number of HIV-positive pregnant women. He suggested 
that the London Hospital would be a better site for me. Moreover, “Anne”,51 an 
HIV specialist consultant physician and my contact at the London Hospital, 
was very enthusiastic about my project and her clinic cared for more HIV-
positive pregnant women than any other hospital in London. Prior to gaining 
ethical approval from the NHS, I visited the hospital on many occasions in 
order to meet with various practitioners to discuss my research.52 The first 
visit to the hospital took place in November 2007.  
 
Influenced by Mol’s approach to ethnography, I commenced fieldwork in the 
clinic with an interest in discovering and understanding what was happening 
                                                
51 All of the participants have been assigned pseudonyms. A more detailed description of my 
relationship with Anne will follow.  
52 I will expand upon my initial experiences with the clinic and practitioners later in this 
chapter.  
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there. Similar to Mol, a number of different data-gathering techniques were 
employed for this study in order to observe practice and care in the clinic: 
participant observations, unstructured in-depth qualitative interviews, and 
informal conversations. While the methods I used to conduct this study are 
undoubtedly ethnographic, I did not adhere to the approach taken by a more 
traditional anthropological ethnography. Thus, I did not observe the daily lives 
of my informants for an extended period of time (Hammersely and Atkinson, 
1995, p. 1; Walsh, 2004, p. 226). Nor, like what Fassin states in reference to 
his ethnographic work, did I assume that it was possible for me to provide an 
all-inclusive description of my informants or the clinic (2007, p. xxi). Instead, 
and in line with the way Charmaz has defined ethnography, my approach was 
oriented towards remaining open to the events that took place in the clinic and 
to the people that frequented it (2006, p. 21).  
 
Therefore, upon entering the field my initial question was “what is going on 
here”? I often felt silly when asking basic questions like this but they were 
essential for forming a better understanding of the events that occurred in the 
clinic, rather than relying only on observation (Charmaz, 2006, p. 22). A 
follow-on question I asked was “what is ‘here’”? In other words, what is this 
space I am trying to investigate? Who are the participants in this space? 
Where have they come from and how do they negotiate the space and their 
inclusion into it? Are the events that take place “here” confined to this space 
(whatever it is)?53  
Consequently, the organisation of the specialist clinic, both physically and 
logistically, was of interest to me. Where are the patient’s medical notes 
stored and moved around within the hospital? What happens in the 
consultation rooms, waiting room and other spaces in the clinic? Who is in 
charge of these spaces, if anyone? How do the HIV specialist clinic’s patients’ 
interact with patients and care-providers and administrators from other 
clinics? How do the HIV specialist care providers interact with other medics 
                                                
53 These questions were prompted by the structure of the clinic and the temporary nature of 
the space. Further to this, the question of what “here” was more complicated to explore 
because while the clinic sessions took place once a week, the care that was provided by the 
practitioners was not limited to the session. For example, the HIV specialist midwife would 
keep in contact and meet with patients outside of the clinic sessions.  
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and administrative staff? As I will expand upon later, these questions helped 
me develop further questions and eventually theoretical categories that then 
assisted me in directing subsequent data collection and analysis (Charmaz, 
2006, p. 25).  
 
Further to this, I was particularly interested in tracing HIV, pregnancy, 
(unborn) babies, patients, and technologies used in the management of HIV. 
As I began to spend more time in the clinic, collecting and analysing data,54 
my list expanded to include “good” (becoming) mothers, resistance and 
compliance to care, the patients’ religion and family. Moreover, I was attuned 
to the way in which the practitioners and patients connected to the clinic did 
(or did not do) “HIV”, “pregnancy” and “HIV-positive pregnant bodies”. For 
example, attention was paid to the way HIV (positivity), pregnancy, and 
maternity were spoken (or not spoken) about, (apparently) understood, 
approached and discussed by the research participants, as well as the 
expectations they had of themselves and each other, and how these were 
expressed, fulfilled or left unsatisfied. Likewise, the way in which relationships 
between participants developed and were maintained, negotiated and 
severed was of interest to me. Hence, I was especially attentive to the 
research participant’s opinions of the clinic, as well as to each other and to the 
people connected to them. My ethnographic approach has retained Mol’s 
interest in discovering what a body is (within a specific environment), how 
disease is done there, and what the logics of care are that enable and 
promote “good care” within that space.  
	
Ethical	approval		
 
Ethical approval to conduct this study was granted by the NHS Research 
Ethics Committee (REC), the Research and Development office (R&D) at the 
London Hospital, as well as the Research Ethics Committee (REC) at 
Goldsmiths, University of London. The process of gaining ethical approval 
from the NHS REC is lengthy and complex and initially involves filling out an 
                                                
54 A more detailed description of how data was collected and analysed will follow.  
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online form with questions that are meant to assess the ethicality of the 
proposed project. Once the form is complete, the applicant submits it and thus 
begins a multifaceted journey, the intention of which is finally to gain 
clearance to commence fieldwork.  
 
While the entire process of gaining ethical approval from the NHS REC could 
very well be the subject of a thesis in its own right, I will only provide a 
flowchart in an appendix to this thesis detailing some of the steps that were 
taken in order to gain approval. Not mentioned in the flow chart, however, are 
all of the additional requirements that may or may not be necessary, 
depending on the researcher. For example, I was asked to redo many of my 
childhood vaccinations,55 as I could not produce medical records that 
confirmed that I had had them, and my childhood was spent abroad.  
 
In contrast, the process of gaining ethical approval from Goldsmiths was 
straightforward. I met with the head of the Goldsmiths REC, although this was 
not a part of the requirement to gain approval. We had an enjoyable informal 
chat about research ethics. After this, I filled out a short form and submitted it 
via email to the REC. Shortly thereafter, I received notice that my project had 
been approved.  
 
  
                                                
55 In fact, the vaccinations were a requirement of the London Hospitals’ “honorary contract”, 
which was needed in order to fulfill the requirements of the Research and Development office 
at the London Hospital.  
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Consenting	processes	and	gatekeeping		
 
As mentioned above, my initial access to the clinic was negotiated with the 
help of Anne, one of the clinic’s consultant physicians. Thus, Anne was the 
initial gatekeeper (Walsh, 2004, p. 229). Anne and I had extensive 
discussions about how my project should be introduced to both patients and 
practitioners. In accordance to the way I described the procedure in my NHS 
REC application, Anne dictated that practitioners would be in charge of 
informing patients about the project, recruiting patients for interviews and 
seeking verbal consent to have me attend consultations. Moreover, I would be 
responsible for seeking verbal consent from members of the MDT to attend 
meetings and otherwise spend time with them. The procedures for gaining 
verbal consent, outlined above are in accordance with Ali and Kelly’s advice 
for contending with situations where it would be difficult to gain informed 
written consent (Ali and Kelly, 2004, p. 121). It would have been very 
challenging indeed to ask and expect each and every participant in the 
various MDT meetings to delay the meeting so that they could all sign a 
consent form. Moreover, before gaining approval to commence the project 
Anne requested that I meet with several senior and/or influential members of 
the MDT to gain their support.56 Further to this, Anne invited me to an MDT 
meeting so that I could inform the team about my project and request their 
participation.  
 
After receiving approval from the hospital’s R&D department to commence the 
project, Anne introduced me to Sophia, an HIV specialist doctor who was 
preparing to take over the clinic from the clinics’ previous HIV doctor.57 After 
this, Anne left the hospital for a six-month long research leave. Thus, Sophia 
took on the responsibility of informing patients about my project and recruiting 
patient participants. Ellen also helped me establish connections to other 
members of the MDT. For example Laura, an HIV paediatric nurse, told me 
                                                
56 I will not expand upon these meetings or explain who they were with. This is because they 
took place prior to me having received R&D approval to commence the study.  
57 Consultant physicians and HIV doctors would normally be placed in the clinic for a six-
month period, although Sophia stayed longer than this. I will not expand upon the reasons for 
her extended stay.  
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that she had only agreed to be interviewed after Ellen had made it clear that 
she approved of me.  
 
Ellen and Sophia were responsible for informing patients about my project 
and they always negotiated with the patient and received their initial verbal 
consent to participate. I never witnessed these exchanges. However, Sophia 
told me that she would normally give verbal information to patients about the 
project while making the written information available. Then, during their next 
visit to the clinic, Sophia or Ellen would ask the patient if I could observe their 
consultation. The patients gave Sophia or Ellen verbal consent to allow me to 
observe each and every consultation that I attended.58 As a point of contrast, 
Mol describes the way in which a practitioner sought out patient consent to 
participate in her study:  
The surgeon walks to the door and calls in the next patient. They shake 
hands. The doctor points at my presence and says that I’m there to learn 
something. He sits on a chair behind his desk. The patient, a woman in 
her eighties, takes a chair at the other side of the desk, clutching her 
handbag on her lap (Mol, 2002, p. 21). 
Mol continues to provide a verbatim rendition of the consultation (2002, p. 21). 
It is worthwhile to mention that it is of course possible that the patient had 
received more information about the study, but if this were true, Mol does not 
write about it. What Mol’s case makes clear is that the onus of informing a 
patient about a project lay with the patient’s healthcare provider. In my 
situation, I did not feel that I was in a position where I could dictate to the 
health care professionals how I wanted them to negotiate consent, or inform 
patients of my project.  
 
Returning to my study, Sophia asked some of the women who had consented 
to let me observe their consultations if I could interview them. If they agreed 
she would give them my contact information. Sophia and I decided that she 
                                                
58 According to Ali and Kelly (2004), giving verbal information to potential research 
participants about a study is in accordance with the parameters for ethical research practice 
provided by the Declaration of Helsinki. 
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would only approach patients for interviews if Sophia deemed them to be 
relatively low risk patients — meaning that the patients were known to adhere 
to their medical treatment and that they were not currently experiencing acute 
social issues.  
 
Thus, during each clinic session I asked one of the members of the MDT who 
met with patients (Sophia, Ellen or Marie) if I could attend their consultations. 
Verbal consent was given,59 after which the practitioners would negotiate 
consent for me to attend consultations from their patients, as described 
above. Research participants were only asked to sign a consent form if and 
when they had agreed to be interviewed by me. The way in which potential 
research participants were informed of the project and the way in which 
consent to participate was negotiated was in accordance with the description 
of the process that I provided in my NHS REC form.  
	
Participant	observation	in	the	clinic	
 
After meeting all of the requirements to conduct this project,60 I ended up 
spending nine months in the clinic doing fieldwork, from July 2008 until March 
2009. During this time I attended twenty-nine specialist antenatal clinic 
sessions, which were all of the sessions held during this period, and I 
observed consultations held by all of the health practitioners who saw the 
clinic’s patients during my time there.61 
 
All in all, I regularly attended the consultations of twenty-one different 
patients.62 A total of forty-eight different women were discussed by the 
practitioners, thirty of these women attended appointments at the clinic while I 
was there, and the rest were either anticipated patients, or former patients. 
                                                
59 None of the practitioners ever denied my request.  
60 These requirements concern the process of gaining ethical approval to conduct a research 
project within the NHS.  
61 Sophia, Ellen and Marie.  
62 Of these 21 women, I had to sit in the waiting room during one of Eleanor’s consultations 
because Sophia and Ellen were on high alert for an extremely volatile patient (Field Notes, 27 
August, 2008). 
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For example, Patient Number 47”63 who miscarried before Ellen was able to 
register her as a patient, or Patient Number 28”, who was pregnant but not 
HIV-positive; however, she was in contact with the clinic because her 
husband (a patient at DOSH), was HIV-positive, and they had told the MDT 
that using condoms compromised their religious beliefs. Connected to each of 
these women were their families, who were also discussed and who 
occasionally attended consultations.  
 
Out of these thirty patients, four were born in the UK and were mixed race 
(either white British and Black Caribbean, or white British and Black African), 
while the rest of the women were Black African and from countries in Sub-
Saharan Africa.64 The clinic’s patients’ ages ranged from their early twenties 
to mid-thirties, with most of them being in their twenties.65 A French interpreter 
attended one of the patients during a consultation — otherwise all of the 
consultations were conducted in English — although many of the women 
whose consultations I attended apparently had only a perfunctory grasp of the 
language. Moreover, many of the patients in the clinic were either illiterate or 
had limited reading and writing abilities.  
 
There were nine patients whose consultations I never sat in on, although I 
would nonetheless hear about these women during the practitioners’ 
meetings. Of these women, six were never asked if I could meet them. They 
were, for various reasons, deemed by the practitioners to be too volatile 
and/or had already expressed a dislike for being introduced to new 
practitioners. For example, Patient Number 1” told Sophia that she was 
reluctant to speak to people about HIV. Consequently, the practitioners would 
try and avoid introducing her to new people. The three remaining women who 
                                                
63 Later in this chapter, I explain the way in which I “named” research participants and the 
people they spoke to me about.  
64 One of the women that I interviewed was from the Caribbean; however, she was not a 
patient in the clinic during my fieldwork.  
65 Theodora was nineteen when she first became a patient; she had a birthday during her 
time in the clinic.  
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had been asked if I could sit in on their consultations declined, also for diverse 
reasons.66 
 
The data for this study was collected in numerous locations: consultations 
between patients and practitioners (Sophia, Marie and Ellen), informal chats 
between the practitioners and myself, MDT meetings, interviews with patients 
in the antenatal clinic, and at the DOSH. Additionally, I helped out at a 
community outreach session organised by Sophia on behalf of DOSH, 
interviewed practitioners in the antenatal clinic, at the DOSH and in the 
midwives’ offices and at two other London hospitals where I interviewed two 
other members of the MDT,67 and at the homes of several patients.68 
Moreover, I spent time at the paediatric ward at the London Hospital where I 
met another member of the MDT but did not interview her, and at the 
maternity ward visiting postnatal patients and their babies. I accompanied 
patients to the “blood clinic” to have their blood drawn, and spent time with 
patients in other areas of the hospital.  
	
Interviews		
 
Five health practitioners were interviewed for this project: Ellen, the HIV 
specialist midwife, Sophia, an HIV specialist doctor, Anne, a consultant 
physician, Laura, a HIV specialist paediatric nurse and Leslie, an HIV 
specialist community nurse. Second interviews were held with Ellen and 
Sophia. As mentioned previously, Ellen was the only health professional in the 
clinic that cared exclusively for the clinic’s patients. Three of the practitioners 
interviewed were white British, while Sophia and Laura were black women of 
African descent, one UK born, and one from South Africa. The interviews 
lasted for about one hour. All of the interviews were recorded with a 
Dictaphone with the interviewee’s consent and later transcribed by me.  
                                                
66 Patient Number 25” said “no” without giving Sophia a reason. Patient Number 14” said no 
because she was contending with her husband’s infidelity.  
67 An HIV specialist community nurse and an HIV specialist pediatric nurse. Both nurses 
where members of the MDT but they were based at other London hospitals.  
68 I visited Celine, Elisabeth and Eleanor.  
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While the number of health practitioners who regularly interacted with the 
clinic’s patients in the clinic was very small (Ellen and Sophia), seventy-five 
professionals overall were either discussed and/or present in the hospital, or 
in some way connected to the patients and/or MDT during my time there. 
These professionals include support staff within the NHS, such as members 
of the hospital’s legal team, employees at various NGOs, and social workers 
and health professionals at other NHS trusts. 
 
During the course of this project, I interviewed nine patients, and held second 
interviews with three of them, as well as a third interview with one woman. All 
of the patients interviewed received a small monetary compensation for their 
time and expenses. The first interviews with patients took place in a 
consultation room in the antenatal clinic, and the second interviews took place 
in a consultation room in the DOSH — except for four interviews with three 
women which took place in their homes at their request. Interviews conducted 
at the hospital lasted about an hour as I was not able to secure rooms for 
longer periods. The interviews held at patients’ homes lasted between 2-3 
hours.69 The increased length of time was always at the patient’s initiative. All 
of the interviews were recorded onto a Dictaphone and transcribed by me. 
The patients were given the participant information sheet and consent form, 
which I read aloud.70 
 
Two patients declined to be interviewed when asked by Sophia. One of the 
women did not offer her reasons and the other said that her husband would 
not let her (Field Notes, 17 December, 2008, p. 5; 18 February, 2009, p. 10). 
He was worried that taking part would be too upsetting for her (Field Notes, 17 
December, 2008, p. 5). Another patient, Patient Number 31”, agreed to an 
interview but I was not able to schedule an appointment with her (Field Notes, 
11 February, 2009, p. 7). Finally, one other woman agreed to be interviewed 
but I ended our meeting before she signed a consent form. 
 
                                                
69 The last interview with a former patient took place in May 2009.  
70 The practitioners were given the same forms but I did not offer to read them aloud.  
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All of the women whom I interviewed (and were asked if they would be 
interested in being interviewed) had come to know me several weeks before 
the interviews took place — exceptions were Evelina and Theodora. Evelina 
was a postnatal patient whom Sophia thought would be an excellent person 
for me to interview because of her talkative nature and compelling 
background. I interviewed Theodora during her first week as a patient of the 
clinic. However, I developed a relationship with her after our initial interview. 
Furthermore, I had numerous phone conversations with a few of the patients 
whom I had interviewed and grown close to.71 These interactions continued 
sporadically for well over a year after I had left the clinic. In addition to 
chatting about their lives, I did some advocacy work on behalf of three of the 
patients I interviewed;72 that is, I phoned solicitors, organised clothing 
donations, attempted to locate support groups and find information on tenancy 
rights and obligations.  
 
The last of these conversations took place approximately a year and a half 
after I left the clinic.73 At this time, I had stopped phoning the former patients 
and only heard from them when they called or texted me. I stopped phoning 
patients after having a few uncomfortable interactions: one when Alegra 
answered her mobile and pretended that I was someone else. I could hear 
several people around her and was worried that she felt the need to lie about 
speaking to me. I asked her to call me whenever she wanted to, but she never 
did.  
	
Field	notes		
 
Field Notes were written while Sophia waited for patients to arrive, while I was 
in the waiting room, and during all of the MDT meetings. I would only refrain 
from taking notes in the presence of the practitioners when we were having 
more intimate and informal chats. In order to contend with the medical terms 
                                                
71 The patients whom I stayed in contact with after leaving the clinic were Celine, Elisabeth, 
Alegra and Evelina. These conversations do not form part of my research data.  
72 Eleanor, Alegra and Evelina.  
73 When Elisabeth phoned to let me know she was pregnant again.  
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used by the practitioners, I developed shorthand and would often have to ask 
Sophia or Ellen for clarification during our informal chats, as the practitioners 
would use abbreviations when speaking to each other. Fearing what might 
happen if I lost a notebook, and in order to keep track of all the practitioners 
and patients, I substituted their names with a prefix of either patient (P) or 
health professional (HP) and a unique number. For the sake of clarity and 
readability, I subsequently replaced these codes with pseudonyms when 
writing the thesis. However, pseudonyms have only been given to research 
participants who gave either verbal or written consent to participate in this 
project. Instead, when I write about the research participants’ accounts of 
people in their lives, I refer to them either by a prefix and their unique number 
(i.e. Patient Number 1), or by a term that identifies their relationship to the 
research participant (i.e. “the research participant’s husband” or “the research 
participant’s former patient”). This will make it easier to distinguish between 
research participants and the people the research participants spoke to me 
about.74  
 
Following this, I would record myself onto a Dictaphone, reading the notes I 
had taken during the clinic. The written notes were thus supplemented with 
my recorded observations which were more nuanced and would focus on all 
of the details that I had not had time to record in written form, but which were 
still fresh in my mind. I transcribed the recordings onto a word processor and 
they thus constitute my Field Notes. This process allowed me to provide a 
more meticulous and affect-laden depiction of my experiences and 
observations. Moreover, the process of recording myself speaking about the 
day’s clinic was remarkably therapeutic. Here it is important to stress that 
while I was only an observer in the clinic, the act of witnessing so much 
anguish and hearing so many stories of atrocious acts of violence, death, 
destitution and hopelessness was upsetting. Speaking about the things that I 
had witnessed and heard was therefore an outlet for pent-up emotion, as well 
as being a method of data collection.  
                                                
74 As discussed above, all research participants gave written and/or verbal consent to 
participate in this research project.  
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Data	analysis	
 
I began analysing and coding data as soon as I had transcribed and imported 
into NVivo the notes I had recorded and written during and after the first clinic 
session I attended (Corbin and Strauss, 1990, p. 419; Seale, 2004, p. 243-
244; Charmaz, 2006, p. 82).75 Moreover, I wrote down questions that arose 
for me during this process and posed them to relevant people during the next 
clinic session. I continued to analyse data throughout the data collection 
period. This approach is in accordance with guidance provided by Glaser and 
Strauss (1968; Montgomery, 2010 p. 74). 
 
When coding the data I decided to code by incident-to-incident, rather than, 
for example, line-by-line. Several things motivated this decision. First, the fact 
that the data I was initially analysing were my field notes meant that they were 
already in my own words (See Charmaz 2006, p. 53, for a discussion on why 
field notes are often better suited for coding “incident-by-incident”). Secondly, 
this method of coding was more conducive to the structure of each clinic 
session and the different areas I collected data in during the day. While each 
and every clinic session I attended offered unique experiences, my time in the 
sessions would usually be structured accordingly:  
  
1. Waiting for Ellen, the HIV specialist midwife, in the antenatal clinics 
waiting room.  
2. Chatting with Ellen in a consultation room while we waited for the other 
practitioner(s) to arrive.  
3. Observing the MDT meeting. Three practitioners would usually attend.  
4. Chatting with Sophia, an HIV specialist doctor, in her consultation room 
while we waited for patients to arrive.  
5. Observing and often participating in patient consultations or waiting in 
the waiting room during consultations.  
                                                
75 This was the first clinic session I attended after having received my research contract from 
the hospital’s R&D office. As mentioned above, I had in fact attended clinic sessions prior to 
gaining ethical clearance in order to introduce myself to the MDT and discuss my research 
proposal. These meetings do not form part of the data used in this thesis.  
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6. Moment 4 and 5 would be repeated throughout the day, depending on 
how many patients would show up to the clinic.  
7. Participating in a “debrief” meeting between Sophia and Ellen after the 
last patient left.  
 
Various incidents within these moments were readily identifiable. For 
example, the practitioners would always recap and discuss the patients who 
were expected to attend the day’s clinic session. This would include her most 
recent biomedical interventions, tests, treatment plan and her social wellbeing 
during the morning meeting. It would not have been useful to code this data 
word-by-word or line-by-line as the data only made sense within the context of 
the meeting (Charmaz, 2006, p. 50).  
	
Theoretical	sampling	
 
Here I will describe how coding during this initial phase allowed me to begin to 
develop one of the most significant theoretical categories in this thesis. During 
initial coding I was struck by the import the practitioners in the clinic placed on 
finding out a patient’s immigration status. Moreover, during consultations and 
interviews the patients would inevitably bring up issues that related to either 
their immigration status or their country of origin. Following this, issues related 
to a patient’s immigration status permeated all of the data that I collected in 
each of the primary moments of data collection I listed above. Consequently, 
during data analysis I created the following codes in NVivo for “establishing 
immigration status”, “worrying about ‘home’ and ‘staying in the UK’”. The 
significance of these initial codes became apparent as I collected and 
analysed more data.  
 
It soon became clear to me that there were other noteworthy codes 
fundamentally connected to the two codes mentioned above. Some of these 
related codes were “left behind family”, “partners’ immigration status”, “access 
to benefits”, and “relationship to family and/or community”. Further analysis 
emerged through the process of recording memos, collecting more data, 
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comparing data with data, and then comparing the data with the codes I 
created (Charmaz, 2006 p. 42). Then, while engaging in focused coding I 
tested “establishing immigration status” against more data (Charmaz, 2006, p. 
42). The importance of the code held fast as did its connections to the other 
codes mentioned above. Eventually this process led me to create the 
theoretical code “diasporic issues” (Charmaz, 2006, p. 45, 63). This term 
signalled a theoretical direction that emerged from my data collection and 
analysis, and later, led to the theoretical concept of an “HIV diaspora”, 
discussed extensively in this thesis.  
 
As a testament to the effectiveness of using grounded theory to analyse the 
data I collected, it is worthwhile to mention another code that I developed. 
This code was initially called “not wanting to be pregnant”. As more data was 
collected and analysed, this initial code developed into a theoretical one: “lack 
of bodily autonomy”. Data that pertained to this theoretical category 
concerned patients who had expressed a deep and often persistent 
unhappiness with being pregnant, and being or becoming mothers. Within this 
category, pregnancy and maternity were constructed as unfortunate and 
unavoidable biological consequences of being a woman. I mention this code 
because prior to commencing fieldwork, I had, perhaps naively, not 
anticipated that the patients in the clinic might not want to become mothers.  
 
Furthermore, when patients first began to express unhappiness with 
becoming mothers to me, I had hoped that these feelings might have to do 
with a concern over the unborn babies’ wellbeing. Consequently, I had 
anticipated that these sentiments would disappear if and when the babies 
were safely delivered. This did not always happen, however. Therefore, if I 
had applied preconceived codes or categories to the data, and refrained from 
constantly interrogating my own assumptions, it is quite possible that these 
issues would not have become apparent to me (Charmaz, 2006, p. 46). So, 
the way in which the theoretical category “lack of bodily autonomy” developed 
is symptomatic of what Charmaz says grounded theory encourages: namely, 
early and continual “analytic thinking [that] keep researchers interacting with 
their data and nascent analyses” (2008a, p. 156).  
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Memo	writing	
 
A crucial aspect of both the collection and analysis of data was the process of 
recording memos. I commenced memo writing as soon as I began the initial 
analysis and coding of data. Because of the writing difficulties I have due to 
dyslexia, I would record my memos on a Dictaphone while I was coding and 
analysing the data and then transcribe the recorded memos into NVivo. Like 
many other severely dyslexic persons, I would not have been able to capture 
my thoughts if I had tried to write them down directly. The process of memo 
recording and writing was fundamental to my ability to begin to develop 
focused codes, to think about the data, and the experience of being in the 
clinic. Moreover, keeping memos helped inform the direction I took when 
gathering additional data (Charmaz, 2006, p. 72). Also, recording and then 
transcribing memos added an additional step and another technology to the 
process of data analysis. The added step was introduced through the 
requirements of the technology. In this way, I would almost always augment 
and add to my recorded memos while I was listening to and transcribing them. 
Consequently, the memos as they were in NVivo, represent my thoughts over 
a period of time. Although there was some overlap, the memos I took were 
divided according to the following categories: 
 
• Memos pertaining to the practitioners (what they said, how they 
interacted with each other and with me)  
• Memos pertaining to the patients (what they said, how they interacted 
with me or other people present during our interactions, i.e. children 
and patients’ partners)  
• Memos pertaining to interactions between patients, practitioners and 
myself 
• Memos pertaining to my thoughts about being in the field: the emotive 
dimensions of collecting data and interacting with research participants  
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NVivo	
 
All of the data collected for this project was analysed with the help of NVivo 
and to a lesser extent, Inspiration, which is a visual software program 
designed for people with dyslexia. The decision to use NVivo was motivated 
by the research training all first-year MPhil/PhD students had received in the 
Sociology Department at Goldsmiths, University of London. The program was 
available to me and seemed fairly straightforward when managing large 
amounts of data. In relation to this, Welsh argues that social scientists are 
often not able to make an informed choice when selecting which software 
package to use to manage their data because they lack the necessary 
expertise (2002, p. S2). Welsh’s observations are relevant to my research and 
it is important to state that the training I had received in NVivo persuaded me 
to use the program as a tool to manage data and influenced my decision to 
adopt a grounded theory methodology. However, as Welsh contends, it is 
possible to use NVivo without also using grounded theory (2002, p. S2). 
While Inspiration was not created as a tool for qualitative research, it proved 
to be valuable in that the program allows data to be organised into more 
organic two-dimensional structures. Data was entered into the programme 
after it had been coded and then assessed in NVivo and placed into “mind 
maps”. These maps enable the user to visualise and manipulate data in a 
manner that is more compatible with the way in which many people with 
dyslexia, myself included, process information. Following this, I used 
Inspiration to create visual maps of the empirical material I had collected and 
analysed. The maps make sense to me in a way that a text-based software 
program could not.  
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Afterthoughts		
The grounded theory goal of generating theoretical analyses that fit 
empirical reality requires researchers to gain an intimate familiarity with 
this empirical world. Researchers cannot assess how well their analyses 
fit their data unless they have gained intimate familiarity with the studied 
phenomenon (Charmaz, 2008a, p. 162). (Emphasis added) 
Fulfilling Charmaz’s prescription would apparently require that both the 
researcher and the empirical world are static with clear boundaries. Instead, 
my impression of the antenatal clinic is that it is more akin to a sand dune in 
that it may retain a similar form, but it is never the same. Likewise, I have 
changed over the years and my relationship with the empirical world as I have 
captured it (as it was years ago) is consequently very different now. I argue 
that Charmaz’s statement allows for differences between researchers but it 
does not directly engage with the differences in the same researcher over 
time, or with her changing relationship to her empirical material.  
 
I was concerned about this issue. However, accounting for this problematic 
happened unintentionally because I interrupted my PhD studies for several 
years. When returning to the doctorate after this long break, I re-read the 
collected empirical material. Time away from the research along with changes 
that occurred in my life — most significantly, I had become a mother and had 
had personal experience with antenatal care in the UK (although not specialist 
HIV antenatal care) — meant that my interpretation and relationship to many 
aspects of the data had changed. An example of this is the way that I viewed 
breastfeeding. Many of the patients I had interviewed spoke extensively about 
breastfeeding. Consequently, I spent a lot of time exploring these issues with 
the patients. While I empathised with the patients’ sadness over not 
breastfeeding at the time, I started to view the issues of breastfeeding in a 
much more emotive and visceral way because of my own experience of 
having a baby. Thus, re-reading all of the breastfeeding data I had collected 
and analysed left a different impression on me than it had done previously. Of 
course, what I have described here is a revised reading of the end product. In 
this sense, I was viewing a static empirical world, a world which was the same 
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as I had left it. It was my reading of that world that had changed because I 
had altered. So, re-assessing the data confirmed to me that while the 
theoretical categories I had created after the initial analysis stood fast, my 
emotive relationship to the data had not.  
What I have described above reflects an argument made by Crapanzano. He 
writes that there is a tendency, or even a compulsion, to attribute the reality 
that has been negotiated between ethnographer and subject to the subject 
(1980, p. x), when in fact, the researcher is always changing in relation to, and 
as a result of, the subject(s) of her research and vice versa. In this way, the 
realities that are negotiated through the ethnographic encounter are 
negotiations between ethnographer and subject. Further to this, I suggest that 
these negotiations may continue even after the researcher leaves the field. 
The next section will consider some of the ethical constraints and dimensions 
of this study.  
	
Ethical	Considerations	and	the	Studies’	Shortcomings:	Who	said	what	about	whom	
and	can	I	use	what	they	said?	
 
Here I will directly address the question of whether it is ethical to include what 
the research participants said about people who had not given (verbal or 
written consent) to participate in this study. Any researcher who interviews 
health care practitioners about anything that concerns their vocation will 
undoubtedly hear stories about other health care practitioners and the 
practitioners’ patients. Indeed the weekly structure of the clinic sessions — by 
this I mean the fact that the practitioners met and discussed patients before 
they arrived — meant that I from the very first day I attended a clinic session, I 
heard about people who had not given verbal or written consent to participate 
in the study.  
 
Further to this is the fact that even when the practitioners spoke about 
patients or practitioners who had given consent to participate in the study, I 
would hear things about them that the person in question might not know 
were being discussed. For example, the practitioners sometimes spoke to me 
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about the difficulties they experienced working with a particular member of 
staff or about how badly behaved a patient’s children were. In other words, 
the research participants told me many things about other participants that 
pointed to the fact that they each had different ways of experiencing and 
speaking about events that they both took part in.  
 
Any researcher who interviews patients about their lives may very well hear 
stories about health care practitioners, the patients’ family members, their 
sexual partners and children. In fact, the main thing that both patients and 
practitioners discussed with me were their relationships and interactions with 
other people. Of course this is not surprising considering that people are 
inevitably connected to other people. So, anything a person may say about 
their life will undoubtedly reveal information about those connections and the 
people to whom they involve. Consequently, I would constantly hear intimate 
details about people who had not consented to participate in my project. While 
what I have written above is unsurprising, the question remains as to whether 
or not it is ethical for a researcher to include stories about people who have 
not consented to participate in a study. I will address this question firstly by 
considering what these stories are, and then by what the implications might 
be of not including or seeking out these stories.  
 
The qualitative interviews that I conducted with research participants 
produced an account of the interviewee’s opinions (Byrne, 2004, p. 182). 
Moreover, the interview data was produced as a result of an interaction 
between the research participant and me (Mason, 1996, p. 36; Byrne, 2004, 
p. 181). Therefore, when research participants spoke to me about other 
people in their lives, I understood these stories to be accounts of their 
experience (Byrne, 2004, p. 182). To use Marsha Rosengarten’s terminology 
to further clarify my point,76 the stories interviewees tell about other people or 
events are “[approximations] achieved through […] selective and reiterative 
practices. There [was] no stable” (Rosengarten, 2009, p. 28) third person or 
event that the interviewee is able to provide an objective description of. Mol 
                                                
76 Rosengarten (2009) does not make this argument in relation to interviews.  
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describes the interviews she and her research assistants conducted in a 
similar way (2002). Thus, when Mol discusses Mr. Gerritsen’s story she 
contends that his narrative uncovers something about “his feelings, his sense 
making, and his self-irony” (2002, p. 14), even though he spoke almost 
exclusively about his daughter and her new flat (2002, p. 13-14).  
 
Consequently, in later chapters when I discuss events and people that the 
research participants told me about during interviews (and/or while I was in 
the clinic), they are not stable representations of a third party or of events that 
have taken place. Instead, they are my interpretation of an interaction that I 
had with a research participant. In other words, I describe my interpretation of 
my interaction with a research participant, during which they told me an 
interpretation of an experience they had (Charmaz, 2006, p. 25-26). 
Accordingly, Charmaz writes:  
An interview is contextual and negotiated […] the result is a 
construction-or reconstruction-of a reality. Interview stories do not 
reproduce prior realities. Rather these stories provide accounts from 
particular points of view that serve specific purposes […] an interview 
reflects what interviewers and participants bring to the interview, 
impressions during it, and the relationship constructed through it 
(Charmaz, 2006, p. 27). 
When describing the interviews I held with both practitioners and patients, it is 
important to mention the significance of the time I spent in the clinic in terms 
of shaping my questions and the dynamics between the interviewee and 
myself. The relationships that I developed with the interviewee before 
interviewing them undoubtedly helped me to explore very sensitive topics 
such as experiences with sexual and domestic violence. Moreover, and 
importantly, in the interviews I would often ask questions that encouraged the 
interviewee to reflect and expand upon topics that had been mentioned during 
consultations that I had taken part in (Charmaz, 2006, pp. 25-26). 
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What would be the implication for scholarship if it was unethical for a 
researcher to consider stories about people who were not research 
participants? In other words, how would a researcher go about investigating 
domestic violence if she was required to get the consent of both partners in 
the relationship being described by a victim of domestic violence? How would 
a researcher be able to explore practices of care from the perspective of 
health care practitioners or patients if she was required to track down and 
obtain the consent of any person mentioned? For example, would Mol have 
been required to gain the consent of the patient whose severed leg she 
discusses (2002, pp. 29-31), or the dead woman’s next of kin described by a 
pathologist she interviewed (2002, pp. 45-46)?  
 
As will become clear in later chapters, like Mol, I discuss the patient’s 
partners, family members, children and acquaintances (none of whom agreed 
to participate in this project, or knew about it, as far as I am aware) and 
provide details of their behaviour, some of which is undoubtedly criminal 
and/or morally reprehensible. Moreover, I discuss the practitioners’ stories 
about patients and other professionals who did not consent to participate in 
this project. Importantly, all of the discussions in the following chapters that 
consider these stories were collected from research participants who 
consented to participate in this study and the stories concern their lives, their 
truths, their version of events, as I have collected, interpreted, analysed and 
disseminated them.  
	
Keeping	my	“researcher	hat”	on	
 
As I spent more time in the field the line between researcher and friend 
became less clear. For example, on two occasions I was asked if I wanted to 
attend the scheduled caesarean sections of patients. However, after 
discussing the possibility of doing this with one of my supervisors, I decided to 
decline the offers.77 It is important to clarify why I was asked if I wanted to 
                                                
77 I would regularly speak to my supervisors about issues that arose for me while in the field. 
Speaking to them about how best to conduct myself while in the clinic thus functioned as a 
kind of contingency plan for me.  
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attend the first operation. The pregnant woman in question had a young child 
who needed to be cared for while she was in hospital. The patient only had 
one friend who could either attend the surgery as her birth partner or care for 
her older child while the patient was in hospital. The possibility of my being 
the birth partner was brought up as a way of solving her problem. Thus, my 
role would have been that of a guest and supporter of the patient, not as a 
researcher. The concern was that I would have, in that situation, occupied the 
role of both friend and researcher and that this dual positionality might be 
intensely emotional and also ethically problematic. How could I stay in the role 
of researcher (i.e. “keeping my researcher’s hat on”) whilst witnessing and 
participating in what would undoubtedly be awesome events involving women 
I cared about? Moreover, how would it be ethical for me to attend the birth as 
a researcher when I had been invited as a friend? Walsh writes of the 
dilemma a participant observer may face in the following way:  
The problem is that [the activities the participant observer engages in] 
carries the danger of reactivity and of going native through identification 
with the subjects of study, unless the intimacy created in social 
interaction is restrained by attempts to maintain the role of stranger on 
the part of the observer (Walsh, 2004, pp. 229-230). 
Following this, it can be seen that while the methods that I used and the 
specific circumstances of the patients in the clinic elicited intimate and intense 
relationships and interactions, my prior commitment to be a sociologist and to 
produce a PhD thesis, and remain a “stranger”, delineated the extent and 
nature of my engagement with the patients in the clinic. While this may seem 
counter-intuitive and in opposition to the amassing of compelling data, it 
reflects the concerns outlined by Fraser and Puwar (2008) in relation to “If no 
means no, does yes mean yes? Consenting to research intimacies”.78 They 
further write that this topic serves as a reminder 
 of the continued relevance of established research dilemmas: how are 
“boundaries”, between researcher and researched, proximity and 
distance, to be maintained? Where do the power relations lie? Is it an 
                                                
78 The article in question was written by O’Connell Davidson.  
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ethics of research, or of friendship, that requires negotiating here (2008, 
p. 9)? 
The possibility of attending the surgeries required me to assess the 
confronting nature of the request, and in this way, think deeply about what it 
would mean for me to take part, and how witnessing a birth may affect my 
relationship to the women in question and the clinic in general. Accordingly, I 
concluded that the scheduled C-sections would have been instances where it 
would have been difficult for me to maintain the boundaries between myself, 
as a researcher, and the women, as the researched. This is because I felt that 
the intimacy levels of being a birth partner would consequently make these 
boundaries difficult to maintain.  
 
Moreover, the request(s) required me to think about the kind of access I was 
able to secure to the women’s lives as a result of their apparent isolation. Had 
the patients had less need to confide in someone, most likely I would not have 
been able to have as much access to intimate details and events. I mention 
these concerns as a way of illustrating how, although often difficult, I 
attempted to act as an ethically conscientious researcher. However, the 
decision not to attend the surgeries meant I did not act in the way I would 
have, had I behaved as a friend to the patients. Had I acted as a true friend 
and consented to be a birth partner, I would never have considered the event 
to be a research opportunity.  
 
The observations above were made possible by the passage of time and the 
distance I now have from those events. Admittedly, while I was in the middle 
of conducting fieldwork, the boundaries between being a researcher and 
being a friend (or perhaps it would be more accurate to describe my role as 
an emotive witness) were often blurred. How could they not be when 
confronted with the immediacy of many of the patients’ needs? This could be 
thought of within O’Connell Davidson’s terminology: in this way, my reluctance 
to describe myself as a friend to the patients I grew close to stems from the 
way my role as a researcher in the clinic and our respective positionalities 
outside of the clinic influenced the power relations between us.  
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According to O’Connell Davidson’s perspective, what significantly never 
changed in regard to my relationship to the clinic’s patients was the fact that 
they were always in tremendously precarious positions while I was not, and 
importantly, my research benefited from their insecurity. Hence, while both 
patients and practitioners were participants in this project, their fundamentally 
different positionalities within and outside of the clinic are reflected in every 
aspect of this thesis. Moreover, these differences (and my response to them) 
influenced what I chose to research and include in the dissemination of this 
project and what I left out and/or did not investigate. O’Connell Davidson 
considers similar concerns in regard to her friendship with her research 
subject:  
The tension between the friendship and the research was most 
pronounced in relation to questions about what could and could not be 
treated as “research data”. Often, the knowledge I acquired as a friend 
was significant for various aspects of the analysis of prostitution that I 
was developing, but I felt it would be a betrayal of our friendship to 
record and publish it, and so I did not (2008, p. 54).  
It is important to stress that I never developed the level of intimacy with the 
participants in this project that O’Connell Davidson did in hers. Nonetheless, 
her articulations feel relevant to me. Ellen, Sophia and I developed 
relationships wherein we discussed intimate details about our lives: issues we 
had had with our parents, schools we had attended, relationships to partners 
and friends, and, although the starting point had been HIV, pregnancy and the 
clinic — over the course of my time in the clinic I came to care about them 
and their lives outside of the hospital. I would argue that it was almost taken 
for granted that these discussions were not part of my research, or rather, that 
I was trusted to know when they could be and when they could not.  
 
In response to this, I relegated the practitioners’ intimate details about their 
lives to the periphery of this research. The practitioners are consequently less 
exposed than the patients whose intimate narratives are at the heart of this 
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study. Therefore, in this thesis the practitioners’ commitment to providing 
good care is discussed in regards to the practice that they engage in and not 
in relation to their motivations. It is important to point this out because, while I 
am keen to respect the health care providers’ trust in me, respecting that also 
entails conveying their steadfast dedication to bettering the life chances of 
people affected by HIV. This is complicated to do without providing a more 
intimate portrayal of them, which would detail their political and personal 
motivations for working within the field of HIV medicine, and the remarkable 
personal sacrifices many of them had to make in order to provide the level of 
care they felt their patients required.  
 
Moreover, I was, as mentioned previously, influenced by the way in which Mol 
distilled “good care” from “messy practice” (2008, p.10). Attending to health 
practitioners’ life stories and sentiments do not feature in her rendition of good 
care. Consequently, and in accordance with Mol’s approach, the practitioners’ 
intimate stories about their lives have been filtered out of my final rendition of 
care in the specialist clinic. However, inversely from Mol, the intimate 
experience of being in the field and the intimacy I developed with the 
participants has not been siphoned away. Rather, these experiences and 
relationships were a central component in the collection of data for this 
project. In the next section I will discuss how certain things about me seemed 
to matter in various ways to the research participants.  
	
Concerns	with	my	relationship	to	patients	
 
Here I will consider some of my concerns about my interactions and 
relationships with patient participants. A difficult situation arose for me when I 
was at Celine’s flat interviewing her for the second time. Her mother was with 
her when I arrived and Celine introduced me to her as a doctor from the 
London Hospital. When we were alone, Celine assured me that she knew I 
was not medically trained; however, she said it was better if her mother 
thought I was a (medical) doctor.  
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This proved extremely awkward after the interview when we were all playing 
with Celine’s baby and her mother asked me a few specific questions about 
HIV transmission. I knew the answers to her questions but I worried about the 
fact that she thought I was a medical professional with expert knowledge on 
the matter. In response, I mumbled that I was a sociologist and that I was not 
qualified to answer her questions. Celine’s mother’s English was quite poor 
and I felt as if I had only managed to evade “outing” Celine’s lie because of 
this. This exchange led me to decline an invitation to attend Celine’s baby’s 
naming ceremony. I was worried that Celine would expect me to lie to her 
friends and family about my identity and our relationship. Celine never phoned 
me again after I declined the invitation.  
 
The encounter with Celine and her mother left me disconcerted. In hindsight I 
see that declining the invitation may have betrayed Celine’s expectations of 
our relationship. These expectations may have arisen as a result of the 
intimate access she had given me to her life during her pregnancy. Declining 
the invitation might have confirmed to Celine that I did not place her life or 
needs in the same regard as my own (Geertz, 2001, p. 36). In this way, I have 
come to see that I did not offer a fair exchange for the things she let me hear 
and witness. In other words, while the second postnatal interview with Celine 
was the last time I needed her actively to participate in my research, this 
meeting might not have satisfied her expectations of me. Upon reflection I see 
that she might have stopped phoning me because I had betrayed an 
unspoken relationship both of us had previously been invested in maintaining 
(Geertz, 2001, p. 34). While I will never know what her expectations were, I 
believe that they had to do with the status I could have lent to her and her 
family had I agreed to act as a medically trained doctor who participated in her 
social events. Moreover, I believe that she wanted her mother to feel 
reassured that she was receiving such personal attention from a real doctor. 
 
In Doing Ethnography, David Walsh makes note of the responsibility the 
researcher has towards the informers of the text and the need to close 
relationships appropriately with them (2004, p. 227). In regard to this, the way 
in which my relationships ended with the women was disconcerting. My 
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attempt to protect Celine led me to possibly offend her by rejecting the 
invitation. Moreover, being thus cut off and out of people’s lives in which I had 
hitherto been so intimately involved, was upsetting. Nor could I resolve basic 
questions about their lives and wellbeing such as: was vertical transmission of 
HIV prevented? Did she finally leave her abusive partner, get deported; is she 
still alive? These concerns extended to all of the patients mentioned in the 
clinic while I was conducting fieldwork.79 
 
The nature of care in the clinic and the legalities regarding access to medical 
notes meant that I could not expect to receive information about women once 
they ceased to be patients in the clinic. Following this, once a patient had her 
final appointment I would not hear about her again (unless she was 
mentioned for some reason by the practitioners). The full implication of being 
thus cut off from her narrative only became clear to me when I left the field 
and came to the realisation that I had been cut off from forty-eight women 
whose wellbeing I had been (to varying degrees) invested in. Therefore, while 
I take Walsh’s advice seriously, it is difficult to know what an appropriate end 
to our relationships would have been.  
	
Attending	to	patients’	and	practitioners’	perception	of	me	
 
Another important aspect to my experience of doing research in the clinic was 
the way certain things about me — such as the colour of my skin, my accent, 
and my perceived nationality — seemed to be significant in specific ways to 
the patients in the clinic as well as to the practitioners. Therefore, in this 
section I will consider the way in which I “read” the patients’ and practitioners’ 
perception of me and discuss its significance to my time in the clinic. Brian 
Fay argues in Contemporary Philosophy of Social Science that the 
relationship between researchers and their subjects is not only perspectival 
but is also positional, meaning that the respective behaviour of both, 
ethnographer and subject, partially depends on their relative positions in 
regards to each other and on their mutual recognitions of each other’s 
                                                
79 The practitioners in the clinic may also become similarly “cut off” from patients.  
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positions (1996, p. 45). In what follows, I will describe a few instances wherein 
both the patients’ and the practitioners’ “reading of my positionality” seemed 
to become apparent and in this way discuss the reflexive nature of this project 
(see Hammersley, et al. (1983, p. 14); O’Connell Davidson (2008, p. 57)).  
 
During one of our meetings80 and prior to the commencement of my fieldwork, 
Anne, a consultant physician in the clinic, pondered on the effect my ethnicity 
and nationality might have on the patients. She explained that in her 
experience many HIV-positive patients of Black African descent preferred to 
speak to white professionals. However, she also said that it might be possible 
for me to gain some kind of insider knowledge because of my ethnicity and 
nationality: being black but a different kind of black.  
 
Moreover, Sophia and I often discussed the status and effects of our 
“blackness” in the clinic and the way many patients expressed a reluctance to 
meet black (care) professionals.81 However, and importantly, both Sophia and 
I felt these patients’ concerns stemmed from the fear that we might know 
them or members of their communities outside of the clinic. Once it was 
confirmed that we moved in different social circles, the reluctance of meeting 
us was no longer present. In this way, the colour of our skin functioned as an 
alert to the fact that they might know us outside of the clinic, while in my case 
my accent often dispelled these concerns.  
 
Indeed, all of the patients that I interviewed broached the subject as well, 
usually to speak of my perceived “American-ness” as being one of the 
reasons why they eventually felt comfortable with me, despite my being black. 
Furthermore, Sophia told me that patients would often ask her where I was 
from, prior to consenting to having me attend their appointments. Below is an 
extract from my Field Notes that concerns the questions some patients asked 
Sophia about me. The patient in question had seen me in the waiting room 
and knew that I was the person Sophia was referring to when she asked the 
patient if I could sit in on her appointment:  
                                                
80 This meeting took place after I had received ethical approval to commence the study.  
81 Sophia is British of Black African descent.  
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Sophia said that the last patient had asked if I was from here: “is she 
from London”; as soon as Sophia had told her that I was from the US 
and Sweden she was ok to have me sit in.82 Sophia said that she felt 
that my accent worked to my benefit; people did not “read” me as being 
from “here” (Field Notes, 6 August, 2008, p. 14).83 
Not mentioned in the notes above is the crucial fact that I was not read as a 
black woman from here, i.e., a Black woman of either African or Caribbean 
decent. It is here that the work of Fassin becomes particularly useful. As 
discussed previously, Fassin argues that it is important to consider the way in 
which the subjects of our research are inscribed within various historical 
trajectories, although he does not in the same way consider the significance 
of the historical trajectories the researcher is inscribed within. It is, however, 
useful to do precisely this in order to fully appreciate the way judgements 
about people are made. It is, as Abu-Lughod, referencing Dwyer, points out: 
anthropologists are not outsiders to the societies they study. Rather they are 
in constant “historical and social relation” to them (1989, p. 276). Accordingly, 
for many of the patients it seemed as if my “American-ness” alleviated the 
concerns that had arisen from my “blackness”.  
	
Shortcomings	in	the	study	
 
When planning what to disseminate in this thesis, I have been concerned 
about the fact that the practitioners in the clinic would be able to identify each 
other. Thus, honouring the agreement I made — to allow Anne to read 
everything I write that uses the data I collected in the clinic, prior to 
publication, and to make anything I might publish available to the MDT— has 
led me to be very careful about how I discuss the practitioners in the clinic.  
 
Moreover, the identities of the practitioners in the clinic are not fully protected 
despite providing pseudonyms to all of the research participants. Anyone 
reading this text could easily figure out which hospital I was based at. This is 
                                                
82 None of the patients ever remarked on the fact that I am also Swedish.  
83 I speak English with a North American accent.  
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because the description of the specialist clinic that I provide makes it easily 
identifiable amongst other HIV specialist antenatal clinics in the UK. Thus it is 
ostensibly possible to deduce the names of the practitioners mentioned in this 
thesis. It is important to mention that true anonymity within the context of 
doing HIV research within the NHS in the UK (and especially London) would 
be difficult to achieve because of the relative “smallness” of the HIV medical 
field and the fact that HIV specialists within various NHS trusts in London 
often have professional relationships with one another.  
 
Hence, anyone working with HIV within the NHS in London would 
undoubtedly know all of the HIV specialists at any particular trust. These 
concerns were brought up on several occasions while I was in the clinic. Ellen 
made jokes about how she and the other professionals would read through 
my published thesis and try to figure out who said what. So, I could argue that 
the practitioners were aware of the risks they took when agreeing to partake 
in this research. Moreover, I could interpret Ellen’s joke as acceptance of this 
fact. However, this does not feel right. Instead, I made the decision not to 
include explicitly personal information that the practitioners disclosed to me 
during my time in the clinic. Moreover, I have chosen not to discuss issues 
related to the practitioners’ relationships and interactions with each other. In 
this way, I hope that they will all feel that while I cannot entirely protect their 
anonymity, I have not disclosed information that in any way compromises their 
relationships to each other or their positionality within the clinic. Editing out the 
practitioners in this way is thus, as mentioned before, a necessary limitation to 
this thesis.  
 
These restrictions were implemented after the fieldwork and initial analysis of 
the data was finished. Therefore, concern over the practitioners’ opinions did 
not in any way interfere with the collection or analysis of data. Rather, their 
opinions (as I imagine them) have come to matter to me when deciding what 
to write about in this thesis. In other words, data was collected and analysed 
freely, but I do not feel that I have the same freedom when choosing how to 
disseminate my findings.  
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For example, one of the important theoretical categories that developed 
through my data collection and analysis related to the organisational structure 
of the clinic. In regards to this, I was interested in the way information about 
patients was collected, discussed and shared. Consequently, I investigated 
amongst other things, how notes were kept (or not), and how they were 
shared between different clinics (or not). Another theoretical category that 
emerged concerned the power dynamics between the practitioners in the 
clinic. I became interested in the way different health care providers spoke 
about and interacted with each other. However, on reflection, I have decided 
not to include these topics. This is because the benefits of including such a 
discussion did not outweigh the risks for my research participants (Ali and 
Kelly, 2004, p. 125). The exclusion of any deeper analysis of the practitioners’ 
activities is a necessary and unavoidable shortcoming in this study. Omitting 
this analysis points to the fact that researchers are not autonomous, nor is the 
research that they produce.  
	
Conclusion		
 
In this chapter I have outlined some of the methodological issues that I dealt 
with while studying HIV and pregnancy in the clinic. While the previous 
chapter explored, amongst other things, the way Annemarie Mol’s theoretical 
contributions influenced the framing of this thesis (that is, I draw on her 
arguments which state that bodies are ontologically multiple, that conditions 
emerge out of practices as well as the notion of “good care”), in this chapter, I 
have considered instead Mol’s and Mol’s and Law’s methodological 
approaches and the ways they are consistent with their theoretical arguments 
— as well as their approach’s influence on the methods used to conduct this 
project. Their approach influenced my methodology and enabled me to 
discover how HIV and pregnancy were enacted in practice in the clinic.  
 
Moreover, in this chapter, I have considered Julia O’Connell Davidson’s 
discussion on the significance of a researcher’s emotive connection to her 
research participants. O’Connell Davidson’s argument allowed me to reflect 
 112 
upon the way it felt to be in the clinic and conduct a research project in a 
highly emotional environment with participants who were often vulnerable. 
Thus, in this chapter I have shown how her work influenced my attempts to 
behave as an ethically sensitive researcher.  
 
Further to this, I have discussed how my methodological approach has been 
influenced by Clifford Geertz’s argument that (a researcher’s) thoughts should 
be visible so that their ethicality can be assessed (2001, p. 21). In this chapter 
and in the rest of the thesis, both Geertz’s and O’Connell Davidson’s 
arguments have consequently encouraged me to include my thoughts and 
feelings about the research process and my relationships to participants. 
Moreover, this chapter has considered some of ethical concerns and 
shortcomings of the study.  
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Chapter	Four:	Biomedical	Possibilities	and	Complications	
 
There is a real capacity to cock up substantially, and it puts a different 
spin on how you approach it (Interview with Anne, a consultant 
physician, 11 March, 2009, p. 12). 
Having successfully decoupled HIV from death, ART and appropriate care 
have made the prevention of vertical transmission the norm in the UK. 
However, in this chapter I will show that the practitioners are now placed in a 
position where a false move on their part may cause their patients and their 
(unborn) baby irrevocable harm. I will argue that this fact is a constant burden 
for the practitioners. Moreover, negotiating this burden, which in this chapter 
is evidenced as the unwanted (imagined) possibilities of the biomedical 
technologies and medicines on offer to the practitioners and their patients, is 
an essential part of the care that they provide. Thus, this chapter will show 
that the practitioners’ dependence on technologies that are vital to the 
successful prevention of vertical transmission of HIV may simultaneously 
complicate their ability to care for their patients. In other words, it is assumed 
that the practitioners are able to rely on the technologies to produce the “right” 
results, when in fact they know from practice that the technologies are not 
necessarily reliable. It will become clear in this chapter that what is ultimately 
at stake for the practitioners in the clinic is the future health of the postnatal 
mother and her baby. In this way, the chapter will explore what happens when 
the practitioners care for the patient as she is now — taking into consideration 
the patient as they hope she will become.  
 
The approach taken in this chapter is drawn from Annemarie Mol’s argument 
(discussed in Chapter Two) namely in that thinking about the way an illness is 
done enables reflection on how the illness’s identity within a particular 
environment is tenuous, variable and in need of continued and sustained 
maintenance (2002, p. 23). I have also drawn from Mol’s and Mol and Law’s 
approach to fieldwork, discussed in Chapter Three, and taken inspiration from 
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Mol (2008) who has encouraged me to explore the notion of good care in the 
clinic.  
 
Influenced by Mol and Law, I have analysed the practitioner’s behaviour so 
that I could ascertain what the practitioners felt was required of their patients 
in order for the MDT to prevent vertical transmission of HIV (2004, p. 47). 
Moreover, I was interested in understanding what the practitioners felt their 
patients needed to do in order to “[appropriately engage]” with relevant 
technologies (2004, p. 47). To this end, I will discuss some of the “treatment 
practices” the practitioners used to discover what HIV was (2004, p. 46). And 
while Mol and Law were interested in exploring the effects various methods of 
caring for people with a disease (hypoglycemia) had on the diseased body 
and how the patient lived her life (Mol and Law, 2004, p. 55), I am interested 
in exploring the effects various methods of caring had on the practitioners and 
their understanding of the care they provided for their patients. Moreover, I am 
interested in investigating what the practitioners felt their various methods of 
care had on their patients’ bodies and lives.  
 
The chapter is organised as follows: the first section is about how some of the 
technologies the practitioners depend on to inform their care are suspected as 
misrepresenting HIV. This section will argue that the technologies’ unreliability 
is directly related to the clinic’s patients’ position within the HIV diaspora. The 
chapter will then consider the notion of a filter as discussed by Nancy 
Scheper-Hughes (1993) and argue that some of the technologies used in the 
clinic tell us more about our beliefs than they do about a patient’s HIV. After 
this I will consider what Marsha Rosengarten (2009) would call the 
“generative capacity” of some of the technologies used in the clinic. Finally, I 
will discuss some of the problems with the idea of patient choice and argue 
that choice as an activity as encouraged in the clinic has its limitations 
because of the practitioners’ concerns with the patient and her baby’s future. 
 
The empirical material in the chapter is based on my observations of patient 
consultations, MDT meetings, and discussions and interviews with 
practitioners (specifically Anne, a consultant physician and Ellen the HIV 
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specialist midwife). As mentioned in the previous chapter, all research 
participants who gave either written or verbal consent to take part in this 
project have been provided with pseudonyms.  
	
Contending	with	specific	technologies’	inbuilt	knowledge	of	HIV-	filtering	
information:	Misreading	foreign	viruses 
 
In the antenatal clinic, the viral load assay reads HIV inside a pregnant 
woman’s body by measuring the amount of virus (HIV Ribonucleic acid (RNA) 
particles) in her blood. During my time in the clinic it became clear to me that 
the practitioners were concerned that the assays produced inaccurate 
interpretations of their patients’ virus, which might adversely interfere with 
their clinical practice. This is significant because assessing a patient’s blood 
on an assay is a vital first step in caring for her and her unborn baby.84 
Essentially, the patient’s blood is turned from biological material into 
information that is sent back to the clinic — information which is now out of 
date. For example, the amount of virus that was in the patients’ blood sample 
might not correspond to the amount of virus currently in her blood and it is 
then used by the practitioners to help them create a treatment plan for the 
patient. The intention is that the information will assist the team in altering the 
virus’s course in the patient’s body by preventing it from multiplying and from 
ultimately being transmitted to her (unborn) baby. There are, however, many 
things that can complicate this initial task.  
 
Several of the practitioners explained to me that they suspected the results 
from certain viral load assays had provided them with inaccurate information. 
Indeed, on numerous occasions the suspicion that the viral load results they 
received for patients were in fact inaccurate was confirmed. They clarified that 
the ROCHE assay occasionally under-quantifies the viral loads of their 
patients, making them seem healthier than they actually are (de Ruiter et al., 
                                                
84 For a more detailed discussion on viral load assays, please refer to Chapter One.  
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2008, p. 465). ABBOTT is therefore the practitioners’ preferred assay, as they 
believe it is more sensitive to their patients’ viruses. 85 
 
Thus, if a particular blood sample is processed through one viral load assay 
rather than another, the viral load may not be accurately quantified. In other 
words, the technology has been made to be able to distinguish between what 
are considered to be foreign and native forms of the virus.86 If incorporated 
into practice, this inaccurate reading of a patient’s virus could complicate the 
patient’s care and potentially increase the risk of vertical transmission of HIV. 
Therefore, while the process of assessing a patient’s viral load might initially 
appear to be simply about acquiring and coordinating information, it is also 
about different understandings of HIV and how these are built into the 
technologies available to the clinic. A similar argument has been made by 
Flowers and colleagues who contend that a positive HIV antibody test has the 
ability to generate identities in addition to confirming the presence of a virus 
(2006, p. 120).  
 
The problems outlined above could be thought of in relation to how Didier 
Fassin (2007) discusses the significance of place, space and movement. 
Fassin makes the suggestion that people are embedded within particular 
locations and limited to the possibilities accorded to their bodies within that 
location.87 Consequently, viral load assays built to be sensitive to subtypes 
that are considered more common in the northern hemisphere serve to 
“exclude” people from the southern hemisphere (who have an “unrecognised” 
subtype of the virus) and who have managed to change geographical 
locations. To reiterate, the geographical division between people with access 
to advanced life-enhancing biomedical technologies and those that do not 
have access can be maintained, even when the geographical discrepancies 
                                                
85 The practitioners within the antenatal clinic were reluctantly dependent on an inter-NHS 
trust outsourcing of their patients’ blood as the London Hospital did not have its own full time 
virologist. In the first instance the London Hospital sent blood samples to a virology team 
within a different NHS Trust in the city. For a further discussion of viral load assays please 
see Chapter One.  
86 Please see Chapter One for a discussion on the way various sub-types of HIV-1 have been 
allocated specific geographical locations where they are understood to be most prevalent 
(Heimer, 2007).  
87 Please see Chapter Two.  
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are dissipated. To put it more succinctly, when people who would normally not 
have access to advanced biomedical technologies (because of the 
geographical and/or political location or trajectory they are inscribed within) 
relocate themselves and inhabit the position of people with unrestrained 
access, the way the technologies have been made might still impede any 
benefit.  
 
Therefore an HIV-positive person’s original geographic location, or rather the 
location in which she acquired her infection (assuming she had with the 
subtype thought to be prevalent there) could, in this instance, delineate her 
inclusion and extent of her participation in various processes of care available 
in the clinic. In other words, fully partaking in and benefiting from the different 
technologies and interventions available in a particular geographical location 
may require more than simply having access. From this follows the fact that 
people living with HIV within the same location may not experience the same 
transformative possibilities promised by the availability of advanced HIV 
detection and assessment technologies (Flowers et al., 2006, p. 118). The 
implications of this are that inequalities between different geographical 
locations are, in my example, maintained even when geographical distance is 
no longer an issue. Hence, even when patients who are incorporated within 
the HIV diaspora are offered the same access to particular kinds of 
biomedicines and technologies, their ability to be enhanced by these 
inventions may be curtailed by the way in which the technologies have been 
built to not detect certain kinds of differences that the clinic needs them to do 
— in this instance, different subtypes of HIV. Consequently, the technologies 
in question make and maintain other kinds of differences such as access to 
treatment, locations and futures less affected by HIV, or in the case of babies 
born to HIV-positive mothers, futures free from HIV. 
 
An additional complication in this scenario is how the practitioners felt patients 
may respond to their viral load results. It is important to clarify that I will not 
provide an exploration of the actions or motivations of a patient in what 
follows. Instead, my discussion of Patient Number One (drawn from 
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conversations with practitioners and from here on referred to as P1)88 should 
be read as an exploration of the practitioners’ understanding of a patient they 
encountered in the clinic. While P1 and I had many friendly interactions with 
each other in the waiting room, I never interviewed her or observed her 
consultations.  
 
P1 was in the second trimester of her fifth pregnancy and had recently been 
informed that she was HIV-positive. Observing her behaviour in the clinic, the 
practitioners explained that they were not convinced that P1 believed their 
diagnosis. In regards to this, P1 told one of the practitioners that she was 
under a spiritual curse and that in order to overcome it, she would have to 
“trust in God” and avoid any mention of HIV. P1 explained to Sophia, a 
practitioner, that speaking of HIV in her presence invoked the Devil and 
affirmed the curse (Field Notes, 4 February, 2009, pp. 3-4).  
 
Consequently, P1 often refused to be introduced to new members of the 
clinical team or allow them to be involved in her care. Moreover, she would 
not attend any appointments if they were held at the DOSH because an evil 
spirit lived there. Her non-compliance severely complicated the care that the 
practitioners wanted to provide her with. Furthermore, they were concerned 
that she would eventually abscond entirely from their supervision. In order to 
prevent this from happening, the practitioners decided to reorganise their 
clinical practice to accommodate her. They allowed P1 to dictate where and 
when her care would take place and which practitioners she would see.  
 
The practitioners were very cautious with her throughout her pregnancy, 
spending a lot of time trying to figure out how best to negotiate her conditions 
with their agenda. During a meeting, Sophia expressed that the incorrect viral 
load results were particularly problematic when dealing with a patient like P1, 
who was, according to Sophia, under the impression that she had been 
healed from HIV based on her results from the ROCHE assay. Sophia said 
that explaining to a patient why it looked as if they were HIV-positive on some 
                                                
88 P1 was from the Congo. 
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machines while not on others was very difficult (Field Notes, 4 February, 
2009, pp. 3-4). 
 
On a very practical basis the requirements of HIV and pregnancy (as they are 
perceived by the practitioners) necessitate that when making decisions about 
the patients’ care in the present the practitioners should consider the feelings 
they think their patients and their (potential) offspring may have in the future. 
This is particularly significant because it alludes to some of the complexities 
that may occur in the specialist clinic if a pregnant patient resists or refuses 
the practitioners’ desired care plan. Thus, practitioners in an HIV specialist 
antenatal clinic would base their care decisions on the patient as she is now 
and on what they hope she and her baby might become in the future. In a 
more abstract sense, they are consulting with a real present time patient, with 
her future self, and with her future baby, as the practitioner imagines them to 
potentially become if care is successful. Imagining and thus considering the 
future in this way is an important aspect of the care that the practitioners 
attempt to provide their patients with.  
 
Moreover and in this context, the viral load assays’ ability to produce 
information about HIV has the potential to cause problems in the clinic on 
several levels. As with the example of P1, what the practitioners fear is that 
she will interpret the technologies’ inadequacies as a sign of having been 
cured of HIV. However, it is important to point out that the technologies’ 
capacity to generate information about HIV is not always considered to be 
bad; for example, in situations where the practitioners never question the viral 
load count or when they deem it is correct and vertical transmission is 
prevented and mother and baby are well at the final postnatal appointment, 
the technology could be thought of as having the potential to generate positive 
effects. This is because the technology provided crucial information that the 
practitioners then used to inform all aspects of the patient’s care and finally 
prevent vertical transmission, thereby securing the relative wellbeing of their 
patient(s). Thus, it can be seen that when all goes well, the exactitudes and 
possible merits of the multiple components involved in the patient’s care are 
not necessarily analysed and assessed individually. This might only be done 
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when things go badly or are suspected of potentially going badly. However, 
and importantly, the practitioners are well aware of this as will become clear 
later in this chapter.  
 
The viral load assays used by the antenatal clinic in the London Hospital were 
specifically attuned to assessing sub-types of HIV that were (and are) most 
common in white gay males in the UK. These assays pre-date the changing 
demographics of HIV in the UK that has seen black Africans, in particular 
black African women, as being disproportionately affected by HIV. 
Consequently, the technology includes histories of the pandemic, its 
movement through time from place to place and between bodies. Accordingly, 
P1’s case reflects an argument I made above, namely that the process of 
assessing a patient’s viral load may create different understandings of HIV. In 
other words, despite having more or less uncontested access to the most 
advanced biomedical technologies, medicines and information, the 
practitioners constantly labour with the knowledge that these technologies 
may in fact obscure what they are ostensibly meant to divulge, manage and 
access. Moreover, the practitioners contend with this knowledge while 
negotiating the different understandings patients have of their bodies and the 
status of their HIV infection.  
	
Compensating	for	unreliable	technologies		
 
In Chapter Two I introduced the concept of a filter and argued that the 
practitioners function as filters within the clinic. Here, we can see that there is 
a further complication, namely that the information the practitioners — as 
themselves filters — have access to may also be filtered. The issues 
discussed above are evocative of Nancy Scheper-Hughes’ (1993) work, 
insofar as the discussion above illustrates how certain knowledges of the 
patient’s body could potentially remain entirely hidden unless they are actively 
“sought out”. Accordingly, the technologies available to the clinic are “not 
neutral” nor do they produce “pure sources of data” (1993, p. 292). Rather, 
the technologies like the “public records” discussed by Scheper-Hughes 
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“reveal a society’s particular system of classification. They are not so much 
mirrors of reality as they are filters” (1993, p. 292). This is meaningful and I 
argue that one of the crucial tasks the practitioners adopt is the constant 
anticipation of and supplementation for potentially “hidden” information. Using 
Scheper-Hughes’ language further to clarify this point, the practitioners place 
tremendous significance on the information that the “filters”89 have made (or 
are suspected of having made) (nearly) inaccessible by sifting it out and 
away.  
 
Moreover, the inaccurate reading of a patient’s virus, discussed above, points 
to a crucial problem that stems from the healthcare practitioners’ and, indeed, 
the “HIV biomedical field’s” reliance on biomedical technologies. Thus, while 
the practitioners have located the virus as being in a patient’s body, the 
actions they carry out on the virus, its movement through time and space, 
within and outside of the host’s body, together with the technologies used to 
identify it within each of these contexts, always places its identity (by this I 
mean, for example, the viruses genotype and the severity of the infection) 
under question, according to the practitioners. Following this, in order to 
provide care to the patients within the clinic, the practitioners must anticipate 
the varying interpretations of these technologies and prepare ways of 
contending with them. Anne, a clinician in the clinic, expands on this during an 
interview:  
We have turned the viral load tests and the genotype tests into a holy 
grail of fact and they’re not that factual. They are constructions, 
particularly the resistance tests; they’re constructions of ideas about 
what resistance might be; they’re being worked out in past time; they’re 
out of date before you start looking at them for viruses that are 
geographically distinct from ours. We have something that we invest a 
certainty in and we model our thoughts and we marshal our clinical 
actions against a level of certainty which then proves to be wrong; it 
                                                
89 In this particular instantiation the filters in question are the viral load assays.  
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undermines what you thought you were doing (Interview with Anne, a 
consultant physician, 11 March, 2009, pp. 10-11)! 
The variations in the discernment, reading and interpretation of the virus 
correspond therefore to what would effectually be multiple versions of the 
virus which could each have corresponding ways of being thought about and 
enacted by the practitioners and their patients. In other words, the intangibility 
of the virus is potentially increased and perpetuated as a consequence of the 
way it is done by the viral load assays.  
 
These issues are further complicated by the fact that not all of the 
practitioners that care for the clinic’s patients will necessarily have access to 
the same viral load results. This complication became apparent to me during 
clinic one day when Ellen expressed her concern over the accessibility of her 
patient’s results. She explained that a patient’s initial results were zero; 
however, this proved to be inaccurate when her blood was retested on a 
different assay90 (Field Notes, 18 February, 2009, p. 7). Ellen’s fear was that 
the patient might be cared for as if she was an HIV-positive pregnant patient 
with an undetectable viral load91 when her viral load was in fact detectable, 
thus potentially jeopardising her life and the future life of her unborn baby. 
Therefore, from the practitioner’s perspective, the multiplicity that is created 
as a result of the different assays and their results can “remain” in the hospital 
and have effects even after the MDT have discredited the initial assay’s 
results. Moreover, it can be seen that inaccurate viral load results are 
imagined by the MDT to have the potential to intercede into clinical practice in 
the future, in the sense that the practitioners fear that at any point in time they 
will discover that their procedures and practices in the past were in fact 
detrimental to the future health of their patients. In other words, the 
                                                
90 Please see Chapter One for a discussion of the significance of the different viral load 
assays used to assess the clinic’s patients’ blood.  
91 As mentioned previously this means that the amount of copies of virus per millilitre of 
plasma is below the lower limit of detection on the particular test assay being used. It is 
important to note that different assays have different lower limits. Thus, a sample may be 
undetectable on one assay but not on another (de Ruiter et al., 2008).  
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practitioners’ concern about the various technologies that they use does not 
necessarily change their practice — but it does make them feel unsure about 
their practice — and their ability to ensure futures less affected by HIV for 
mother and baby. Thus, the practitioners can never feel entirely confident that 
the care they provide (and/or provided) their patients with was in fact good 
care, despite their best intentions and efforts.  
 
Problematically, from the practitioners’ point of view, by the time the 
practitioners would discover that they had in fact used bad information to 
inform their practice it might be too late to rectify the mistake. In this way, the 
inaccurate viral load results would become part of the way in which HIV was 
enacted in practice. Consequently, I suggest that the possibility of this 
happening in the future is feared by the healthcare practitioners. This fear in 
combination with their mistrust of some of the (biomedical) technologies 
available to the clinic causes a constant foreboding. Here it can be seen that 
the work the practitioners do involves anticipating events and entities that 
have not (and may never) become enacted in practice.  
	
Dealing	with	the	generative	capacity	of	biomedical	technologies:	Displaying	HIV	
 
Here I will further explore how practitioners in the clinic contend with the 
knowledge that the biomedical technologies they rely on have a generative 
capacity.92 The practitioners are actively aware that HIV as it is displayed in 
the clinic is not, as Rosengarten has argued, “unaffected by technologies 
involved in [its] representation” (2009, p. 24). However, and importantly, I will 
argue that according to the practitioners, this happens because they believe 
the technologies available to them are inadequate to the task. Furthermore, 
they believe that better technologies might not have this effect on HIV. 
Accurately assessing a patient’s HIV is thus, for the practitioners, a matter of 
acquiring and coordinating various components that are able to display HIV as 
they imagine it is in a patient’s body, unaffected by the technologies currently 
                                                
92 See Rosengarten (2009): HIV interventions, Chapter Two. 
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involved in its representation. This section will demonstrate how this belief 
participates in the way in which the problem of “HIV” is framed, understood 
and potentially confronted; in other words, this belief delineates the 
practitioners’ efforts to combat HIV in the clinic. Moreover, this belief is the 
reason why the practitioners embrace a constant sense of unease in relation 
to their medical practice. 
 
The healthcare practitioners act on their patient’s virus even though the 
information they have about the virus is, as discussed previously, potentially 
out of date and highly suspect. However, immediate action is nonetheless 
required in order to prevent the virus from being transmitted to the unborn 
baby, and thus becoming what the practitioners fear it may become in the 
future (i.e. out of their control) if left untreated. Consequently, the practitioners 
suspect that the practices in which they engage in have the ability to facilitate 
the creation of “inaccurate” bodies and viruses. However, while practitioners 
may agree that they are implicated in what happens to the virus within the 
clinic, they also operate with a belief that there is a virus external to practice. 
In relation to this Rosengarten argues that  
the virus, as it appears, is an approximation achieved through highly 
sophisticated but nevertheless selective and reiterative practices. There 
is no stable object that we refer to as “HIV” or “the virus”. On the one 
hand, it is revealed by science as having altered over the course of the 
epidemic as a consequence of its movement and mixing with bodies and 
now, especially, with ARVs and associated observational technologies. 
On the other hand, though, there is a certain abstracting out of what is 
involved in this mixing — on the part of science — in order to achieve a 
seemingly stable object of study for intervention (Rosengarten, 2009, p. 
28)(Emphasis in original). 
Taking immediate action does not eliminate the feeling of trepidation that the 
practitioners struggle with. This is because taking action on a patient’s virus 
entails implementing a treatment regime that the practitioners know might 
alter their patient’s body in such a way that it will eventually be deemed 
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inappropriate, if the true identity of the virus is proven to be different from their 
present-time understanding of it. In order to stress this point, the practitioners 
view HIV technologies as potentially obscuring their access to the patient’s 
real virus (as they understand it to exist within her body but never observable 
or assessable in real-time). As discussed earlier, this is because the 
technologies are known to have the potential to facilitate the creation and 
endorsement of treatment regimes that will increase (or decrease) the 
likelihood of vertical transmission and mortality. In other words, the 
technologies are known to have the potential to irrevocably harm (or “heal”) 
the practitioners’ patient cohort.  
  
This brings to mind Rosengarten’s observation mentioned previously: that 
advanced biomedical medicines, specifically antiretroviral drugs (ARVs), have 
led to the decoupling of HIV and death (2009, p. 3). In regards to this, Anne 
explained that a consequence of the change in prognosis for HIV-positive 
people has been that practitioners now know that the care decisions they 
make could potentially cause harm to their patients and their (unborn) babies. 
For Anne, when death is no longer the inevitable outcome for an HIV-positive 
patient, the potential impact of all aspects of the care she might provide her 
patients becomes more significant. This is important and illustrates the 
practitioners’ tremendously difficult task of negotiating the porous line 
between attempts to provide care and inadvertently causing harm.  
The early days of the epidemic, when you were doing your best and 
actually the ability to do harm was relatively limited, it sounds very brutal, 
but now there is a real capacity to cock up substantially and it puts a 
different spin on how you approach it. If you get the treatment wrong at 
this point and you end up with an infected baby or you get the treatment 
wrong and the mother gets resistance,93 you’re dealing with something 
much more complicated and if you’re not up to speed, you know it’s a 
big deal. I think it’s changed things quite a lot (Interview with Anne, a 
consultant physician, 11 March, 2009, p. 12).  
                                                
93 Drug resistance refers to HIV’s ability to continue mutating and reproducing despite being 
exposed to Antiretroviral Therapy (WHO, 2014). 
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Anne’s articulations are important in regards to the notion of good care in the 
clinic and add another dimension to the decoupling of HIV and death, namely 
in terms of how the increased life chances of people living with HIV have 
drastically altered what is at stake in the provision of care.94 Consequently, 
the provision of good care now concerns the maintenance of (a good) life and 
not the management of (a decent) death. Moreover, what is shown is that the 
interventions that HIV is subjected to, both within the patient’s body (as it 
exists as a material object unobservable in real-time) and external to it (as it 
exists as a “seemingly stable object”) (Rosengarten, 2009, p. 28), together 
with the technologies used to identify it within each of these contexts, 
participate in the materialisation of HIV but they also place its identity (as the 
practitioners believe it to exist prior to its present time appearance) under 
constant question within the clinic. In other words, the practice and 
technologies that participate in the representation of HIV within the clinic are 
suspected, by the practitioners, of potentially displaying inaccurate renditions 
of the virus. Despite this, and as discussed above, these renditions may be 
incorporated into further clinical practice. 
 
Ellen spoke about the possibility of this happening in a meeting with Sophia 
and Anne, during which she discussed how the practitioners in the clinic 
tended to respond to viral load results from the ROCHE assay from patients 
on treatment, which stated that the patient’s viral load was undetectable. The 
following is an extract from my field notes and paraphrases Ellen’s 
articulations on the subject:  
If someone is on treatment, then we get eased into the belief that they 
are undetectable; but they might not be, we are being lulled into this 
sense of security with these patients. They might not be undetectable at 
all but we just expect them to be because we have these expectations 
that the medicines will work on their bodies in a certain way, but that 
might be a false expectation (Field Notes, 4 February, 2009, pp. 5-6)! 
                                                
94 Flowers (2010) considers some of the new uncertainties for people living with HIV that have 
been made possible because of their increased life changes. Persson (2013) discusses the 
impact these developments have on the lived experience of people living with HIV.  
 127 
Accordingly, if both the technology and the practitioners’ assumptions about a 
patient’s health are in “agreement” there is no other “system” that would 
“detect a fault”. Therefore, a technology’s negative generative effect would be 
allowed to fester. Hence, Ellen is expressing a fear of a reality that has not yet 
transpired. While the reality Ellen fears may never take place, her concern 
matters nonetheless because it influences the way practitioners use their 
imagination in combination with their knowledge and experience in order to 
anticipate future problems and consequently (attempt to) prevent them from 
ever occurring. Thus, the MDT’s mode of operation in the clinic is to embrace 
a constant sense of unease and suspicion towards the biomedical 
technologies on offer to them. Conversely, as will become clear in the next 
section of this chapter, they cannot allow their patients to have the same 
scepticism if and when they fear it might lead them to disengage or refuse 
care.  
 
Furthermore, many of the practitioners spoke with some nostalgia about the 
time prior to the introduction of certain technologies into the field. With regard 
to this, for example, Anne contends that clinicians’ over-reliance on 
biomedical technologies is something new and problematic.  
We worked out with patients what to do without that test. Then the 
technological stuff came along and moved HIV medicine into a different 
area and then you find that it’s not substantiated in fact, and it 
undermines all sorts of things that you thought you knew (Interview with 
Anne, a consultant physician, 11 March, 2009, p. 11)! 
Here, it can be seen that the practitioners have a new way of working which 
entails a dependence on technologies that were not available previously. 
These new technologies have generated different procedures and practices in 
the clinic. Furthermore, they have transformed the way in which the 
practitioners know and understand HIV, in that these technologies have 
changed what HIV is. Consequently, these technologies enabled the 
discovery of new entities that did not exist (as negotiable and identifiable 
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objects in the clinic) prior to the technologies’ introduction into the clinical 
environment.  
 
Here it is important to reiterate that the virus is understood by the healthcare 
practitioners to have a true identity, however inaccessible this identity appears 
to be. For the practitioners in the clinic the virus’ potential (future) effects on 
the body of the patient and her (unborn) baby evidences the virus’ reality. 
Hence, the practitioners would argue that there is a reality to which truth 
refers and that accessing this pure truth is a matter of making, having access 
to, and engaging, for example, better and more sensitive biomedical 
technologies. This belief is, as Rosengarten (2009) has argued, widely 
acknowledged to be true within the scientific community and it subsequently 
participates in the materialisation of HIV in the clinic. Thus, this belief plays a 
significant role in the way the problem of HIV is conceptualised and 
confronted both socially and biomedically within the clinic.  
 
On the basis of what I have described above, it seems that there is a worrying 
problematic at work. Although medicine sets out to achieve prevention, the 
very object to be prevented remains elusive. I suggest that it is within this 
problematic that the significance of the practitioners’ work becomes 
discernable in that they attempt to make it possible for their patients to be 
cared for, despite the shortcomings of the technologies available to them. The 
next section will further consider the care the practitioners provide.  
	
Problems	with	choice	
 
In this section I will contemplate how the practitioners perceive their patients’ 
resistance to care. I will argue that the healthcare practitioners allow for a 
certain amount of divergence from their overall plan of care, but that when 
pushed, they do have limits and these are imposed because of their concern 
for the unborn baby and the postnatal patient, as they imagine her to be and 
have the potential to become. Moreover, the significance of the idea of a good 
(becoming) mother will be considered in relation to the way in which non-
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compliant patients are understood by the practitioners. In order to do this, a 
brief description of Isabella’s time in the clinic will be provided below. This 
description has been extrapolated from my field notes. Isabella was often the 
topic of conversation during meetings between practitioners and she allowed 
me to observe her consultations with Sophia, although I never interviewed 
her.  
 
Isabella was in her twenties and of black British Caribbean descent. She had 
been diagnosed several years ago and received her HIV care at the DOSH. 
The practitioners described her as being a “long term non-progressor”95 and 
had never needed to take ARVs. Isabella had her first appointment with the 
antenatal clinic when she was fifteen weeks pregnant. The practitioners 
expressed concerns about her during their morning meeting on the day she 
was expected to attend clinic. There were three issues that caused them 
unease: first Isabella had strong religious beliefs, secondly she had expressed 
a desire to breastfeed, and finally, she had a child that had been conceived 
through rape (Field Notes, 30 July, 2008). This worried the practitioners as 
they felt that patients with this sort of history and intention often foreshadowed 
their resistance to the practitioners’ care, specifically as it pertained to medical 
interventions.  
 
The practitioners came to this conclusion by comparing Isabella’s information 
to their perception of similar cases, either medically, socially or both.96 This 
process is a standard procedure in the antenatal clinic. The points of similarity 
are then used in the clinic as a shorthand description of the kind of patient 
they feel they are contending with. Such shorthands or motifs could, for 
instance, be “Pentecostal Christian”, “believes in the power of prayer”, “West 
                                                
95 The term refers to HIV-positive patients whose HIV does not significantly multiply even 
when the HIV-positive person in question remains treatment naive — meaning that they do 
not take ART (Kumar, 2013).  
96 When first meeting a new patient the practitioners would try and establish her religious 
beliefs in order to assess whether or not they might interfere with the practitioners’ care plan. 
For example, some patients said that taking ARVs would show a lack of faith in God’s ability 
to heal them. 
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African” or “gave birth to a baby conceived through rape” and serve to alert 
the practitioners to problems they feel other patients in the same category 
generally have. However, it is important to note that the practitioners are well 
aware that a patient’s religious belief may also help her come to terms with 
her diagnosis (Anderson and Doyal, 2004, p. 95; Tariq, 2013). The motifs help 
to reveal the practitioners’ perception of the patient’s positionality outside of 
the clinic and how they consider it may potentially affect her behavior within it. 
Of particular concern to the practitioners is whether or not they believe the 
patient will take her medication without resistance and actively participate in 
consultations. Several of the practitioners told me that adherence to a 
treatment plan is less likely if the patient exhibits difficulty in coming to terms 
with her diagnosis and in coping with her life outside of the clinic.  
 
The progression and outcome of a patient’s virus and pregnancy are thus 
directly related to her acclimatisation to HIV antenatal care, according to the 
practitioners. Consequently, the practitioners believe that their patient’s 
course through the clinic can in some ways be discerned and its vicissitudes 
predicted by observing her present time behavior. They then utilise their 
judgments of these observations in conjunction with the HIV biomedical 
technologies available to them. This way of combining data gathered from 
medical technologies and the use of the practitioners’ interpretation of the 
patient’s behavior (as a tool to compensate for the perceived insufficiencies of 
the biomedical and HIV detection technologies available to them) was a highly 
sophisticated mode of operation in the clinic. The mode of operation 
subsequently participates in the “production” of the clinic’s HIV patients, as 
well as modes of intervention and care and their corresponding effects on and 
in their bodies. Furthermore, the apparent success of the practitioners’ mode 
of operation affirmed their approach and reifies all of their assumptions and 
ways of being, their objectivity, their existence and the validity of their 
interpretations, abstractions and presumptions.  
 
During the following weeks it became clear that the practitioners’ initial 
concerns were justified. Isabella told them when she was twenty weeks 
pregnant that she did not want to take any medication and that she wanted to 
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have a vaginal delivery. Isabella explained during a consultation that she 
could not understand how her baby could become infected with HIV. She 
wondered if she had the right to decide if she was to be medicated and to 
choose the mode of delivery. Sophia calmly explained to her the danger 
involved in not taking medication and having a vaginal birth. It is important to 
point out that the practitioners support a patient’s desire to have a vaginal 
delivery under most circumstances, assuming that the patient is on treatment 
and that her viral load results indicate that this would be a safe mode of 
delivery (de Ruiter et al., 2014, p. 67). Returning to the patient’s case, Sophia 
advised Isabella to consult with her family who were all aware of her status 
and to take a couple of weeks to think about the care on offer.  
Sophia asked [Isabella] why she doesn't want to take [ARVs]. Isabella 
said that she just has a feeling that the baby is going to be OK and 
everything will be OK and she just doesn’t want to do it. 
 
Sophia said that she did not want to negate her feelings and that she is 
all for supporting people and their feelings about their pregnancies but 
this is the information they had to go on. They started to throw 
percentages back and forth. Isabella had been healthy for a long time 
and had never gone on medication for her own sake; she was 
concerned that if she took something during pregnancy she would 
become sick. She kept on saying that Sophia couldn’t guarantee her that 
that won’t happen. Sophia said that she couldn’t guarantee her that she 
wouldn’t get sick but that if she didn’t take medication, it is such and 
such a percent risk that the baby would become positive. Isabella said 
that she had just been able to get around the fact that she wouldn’t be 
able to breastfeed and that that had been very, very hard for her. Now 
she felt that it was yet another thing that she might not be able to have a 
vaginal delivery and she might have to take medication (Field Notes, 3 
September, 2008, pp. 18-19).  
This was, up until that point, one of the most difficult consultations that I had 
sat in on. I felt uncomfortable and nervous throughout. Isabella expressed 
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such disdain and suspicion of the way in which the practitioners wanted to 
medicate her. Moreover, Isabella and Sophia both came across as genuine in 
their belief that their conflicting plans for Isabella’s unborn baby were the most 
appropriate. Isabella would take the statistical data that Sophia presented and 
interpret it differently from the way Sophia apparently intended it to be 
understood. Isabella argued that, based on the data Sophia provided her with, 
the risks involved with her taking medication and having a caesarean section 
did not outweigh the potential benefits of surgery and medication. After the 
patient left, Sophia told me that the practitioners had four weeks to convince 
Isabella to take medication, as they would want her to start at twenty-four 
weeks. She said that she had also been nervous and was worried about the 
way she had answered Isabella’s questions. It can be argued that Isabella 
was making informed decisions about her unborn baby’s health as well as her 
own. However, in this instance, Isabella’s behaviour was incompatible with 
Sophia’s plan for care.  
 
A few weeks later, Ellen told Sophia and me that Isabella had phoned in and 
said that she had decided that she would definitely not take any medication 
during her pregnancy. Ellen told her that it was the single most important thing 
she could do. Isabella had asked lots of questions about taking medication. 
Ellen assured her that it was OK to have questions, but that they needed to 
end at some point and she needed to start taking ARVs (Field Notes, 17 
September, 2008, p. 31).  
 
The way the practitioners dealt with Isabella’s desire to “choose” and inform 
herself of the options ostensibly available to her is indicative of the problems 
with a logic of choice, as has been defined by Annemarie Mol (2008). In this 
sense patient choice does not fit with the intricacies of HIV and pregnancy, at 
least not the way they are understood and dealt with by the practitioners in the 
clinic. Another related complication is that in Mol’s rendition of both the logic 
of care and the logic of choice, the patient that is cared for is assumed by 
default to believe that she is in need of the care on offer. Isabella’s response 
to care complicates this assumption. While it could be argued that she was 
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accepting of antenatal care, she was undoubtedly resistant to antenatal HIV 
care.  
While this way of caring for patients may appear paternalistic, this mode of 
operation is understood of as being necessary in the clinic. This is because, 
as mentioned previously, care efforts are directed towards the patient and her 
unborn babies’ future potential. So, if the practitioners begin to view the 
“present-time” patient’s behaviour as being potentially harmful to the patient 
and her babies’ future selves the practitioners must attempt to intervene. Ellen 
articulates these sentiments during our second interview:  
Although they’re foetuses and they’re growing it’s a baby to be, and that 
there’s two lives that we’re thinking about here, all the time, which is 
why, when a woman is perhaps in denial, or refusing treatment for 
whatever reason, I can’t let that go because we have another life on 
board that we know we can 99% prevent transmission to that baby, and 
that child is going to live with the consequences of this decision at this 
point. You can’t let that go, you have to keep working at it, you try other 
means, you can try and reach some sort of compromise about that baby. 
Obviously our emphasis is [the pregnant patient] and that’s how it’s seen 
in maternity, that the baby has no rights until the baby is born, but that’s 
kind of difficult as well, isn’t it? Because obviously baby does have 
rights. I’m still feeling about baby in utero that it’s growing and expanding 
and people who have early miscarriages often view those babies as a 
baby in its own right and it was not nothing, you know, it was very 
important, significant (Second interview with Ellen, the HIV specialist 
midwife, 18 March, 2009, pp. 12-13). 
Isabella’s case as I have described it here offers an empirical example of an 
argument I made in Chapter Two. Namely, that the patients in the specialist 
HIV antenatal clinic are presented with choices in regards to their care only if 
the practitioners imagine that all of the possible outcomes of those choices do 
not pose a significant risk to the patient and her babies’ future potential. 
Accordingly, patients in the clinic are only cared for as if they were 
autonomous individuals able to make informed decisions about their care if 
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their decisions appear to conform with the practitioners’ plan for care. If they 
do not, then the practitioners will take it upon themselves to try and ensure the 
patient’s future potential despite her present-time resistance. Here it is 
important to stress that I am not suggesting that the practitioners force their 
patients to behave. Rather, I argue that the practitioners put tremendous effort 
into persuading patients to want to (or at least act as if they want to) behave.97 
In other words, the pregnant HIV-positive mother is persuasively encouraged 
to accept certain interventions on behalf of the future health of herself and her 
future baby, as they have the potential to become postnatally. Patients who 
resist care are understood as not being able (for whatever reason) to have 
faith in the practitioners and their biomedical technologies’ ability to enact this 
vision of a future for mother and baby that is less affected by HIV.  
As such, the practitioners were in a position, as illustrated by Isabella’s case, 
where they have to camouflage the logic of care that informs their practice to 
make it look as if it is a “logic of choice”, when in fact all of the tenets that 
inform a logic of choice are fundamentally in opposition to the way 
practitioners deal with the intricacies of HIV and pregnancy. Thus, Isabella’s 
case illustrates the problematic nature of “choice” as a concept in the clinic. 
Accordingly, a logic of choice is not a viable option for the practitioners 
because the pregnant patient is not the only patient-chooser that the 
practitioners take into consideration. This is because the practitioners’ 
concern for the postnatal mother and the unborn baby’s future health made a 
logic of choice an impossibility within their clinic.  
 
Returning to Isabella’s time in the clinic, it became clear to me that the 
practitioners suspected she might not think that she was in need of HIV care 
at all (Field Notes, 8 October, 2008, pp. 7-9,10-11,13). Ellen said during clinic 
one day that she thought Isabella might have “issues with her thinking” and 
that the kind of behaviour she displayed usually had to do with fear or denial 
(Field Notes, 8 October, 2008, pp. 7-9,10-11,13). Ellen explained that it must 
be hard for Isabella, as the HIV team had always told her that she was “well” 
                                                
97 The next chapter will further expand on the way the practitioners care for their patients.  
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and “healthy” (Field Notes, 8 October, 2008, pp. 7-9,10-11,13). She 
suggested that Isabella’s resistance might stem from a fear of taking toxic 
drugs during pregnancy (Field Notes, 8 October, 2008, pp. 7-9,10-11,13). 
Sophia expressed similar sentiments. She told me during clinic that because 
she suspected that Isabella might not think she has HIV, Sophia could not 
“use the baby as motivation” to take ARVs, which is what she would normally 
do in a similar situation (Field Notes, 1 October, 2008, pp. 26-27). Hence, it 
can be seen that Isabella has to negotiate divergent bits of information which 
she has received from the health services. One is that she must take 
medication during pregnancy for the sake of her baby, and the other is that it 
is dangerous to take toxic drugs during pregnancy. Moreover, she must come 
to terms with the fact that while she was considered to be “well and healthy” 
before she became pregnant and subsequently did not ever need to take 
medication, the presence of an unborn baby in her body has suddenly made 
her body risky and in need of toxic drugs98 to control it. How to reconcile these 
conflicting statements? The practitioners are well aware of the problematic I 
have described above as is evident from the interview extract below:  
When they’re pregnant, you’ve got a very short space of time to give a 
result and then expect them to take on board all this treatment, which 
could involve toxic drugs, possibly caesareans, medications to baby, 
bottle feeding — all of that is the opposite of what you’re wanting when 
people are pregnant. You’re saying don’t take medicines, breast is best, 
you know, normal and natural and that’s what they want mostly from 
their cultures and it’s quite an adjustment and it’s a short time span so 
we have to work with where we are at (Second interview with Ellen, the 
HIV specialist midwife, 18 March 2009, p. 17).  
Here it can be seen that, while it is the crucial work of the practitioners to 
convince the patient to adopt their strategies for fighting the virus, they allow, 
nonetheless, for the patient to have a very different understanding of HIV and 
medicine as long as these understandings do not interfere with the patient’s 
                                                
98 Indeed medically sanctioned treatment breaks have been associated with increased 
morbidity and mortality (French et al., 2014).  
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adherence to the treatment plan. Although the virus exists within the patient’s 
body, the practitioners would normally use a language of collusion in which 
they imply that they are in league with the patient. However, a complete 
refusal to comply, as well as potentially being in denial of her HIV status, 
made it impossible for the practitioners to get Isabella on their side with them 
against the virus. 
 
As Isabella’s resistance persisted, the practitioners started to talk about being 
more assertive in their approach. However, the prevailing attitude amongst 
the practitioners was a desire to “work with her”. In this regard, they wanted to 
avoid mentioning that her baby would have a legal right to care once it was 
born, and that if she refused, the matter would become a child protection 
issue after the baby’s birth.  
Isabella’s appointment was very difficult [...] Sophia asked her if she had 
thought more about [taking medication]. Isabella was completely 
refusing Sophia would ask: “if you don’t want to talk about that, that’s 
fine, explain to me instead, how do you feel about a C-section?” The 
possibility would be explored and Sophia would say something like “you 
have to have an epidural”, and Isabella would say “no, I am not okay 
with that, I will not do this!’” Once Isabella asked what the blood of a 
person taking [ARVs] looks like Sophia answered that it looks exactly 
like the blood of a person who is not on [ARVs]. I get this feeling that 
they are not fully understanding what Isabella thinks of HIV and that is a 
huge problem, but Sophia drew pictures on a piece of scrap paper of 
blood and medicine; she drew a round circle and she described what the 
medicine would do and Isabella seemed really interested and she would 
say “now I understand, so this is what the medicine does, this is really 
interesting”, and then Sophia said “are you ok with this”? Isabella 
responded “this is really interesting, but I am not going to take it” (Field 
Notes, 8 October 2008, pp. 10-11)! 
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The practitioners were even more concerned during clinic the next week. 
Isabella had told them that she did not want the baby to be given any 
postnatal medication. The practitioners spoke more about getting a child 
protection order placed on the baby once it was born (Field Notes, 22 
October, 2008, p. 3). The following week Ellen told Sophia and me that she 
had heard from a midwife at another hospital that Isabella had registered as a 
new patient with them. Isabella did not disclose her HIV status to the hospital. 
Furthermore, she told the hospital’s antenatal practitioners that she did not 
want the team at London Hospital to know that she had “moved hospital”.99   
Marie [a consultant physician in the clinic] said that [Isabella] believes 
that her child is going to be negative and according to statistics, the 
chances are greater of her child being negative, even without her taking 
treatment, than are the chances of the child being positive. If she does 
end up having a negative baby and takes treatment she is going to think 
that it had nothing to do with treatment and that it was her God that 
protected her; if she does not take treatment and has a negative baby 
then she will think the same. Either way, her belief system is not going to 
be interfered with or changed and her belief system in and of itself would 
not necessarily make her a bad mother.  
 
Marie did not say this in a way that made me believe that she felt that 
she had to convince the others of this. It was more like she was trying to 
sort it out for herself, as if she needs to have a way of reconciling the 
idea of a good mother with a mother that does not take her pills nor 
wants her baby to have triple therapy (Field Notes, 5 November, 2008, 
pp. 10-11).  
                                                
99 Isabella informed her new midwife that she had been Ellen’s patient at London Hospital. 
Isabella’s new midwife contacted Ellen in order to organise the transfer of Isabella’s antenatal 
notes. This is standard practice if and when a pregnant patient moves hospital. However, 
Ellen had a professional relationship with the antenatal team at Isabella’s new hospital. 
Consequently, everyone in the new team knew that Ellen only cared for HIV-positive women. 
Thus, Isabella inadvertently disclosed her HIV status to her new care providers by revealing 
the name of her previous midwife. It is important to add that Ellen’s professional title (HIV 
specialist midwife) would have alerted Isabella’s new midwife to the fact that Isabella was 
HIV-positive, even if the new midwife had not known Ellen professionally. Ellen’s well-known 
presence within the NHS in London reflects the discussion in Chapter Three that considers 
the difficulties I have in ensuring the anonymity of the practitioners mentioned in this study.  
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What is particularly important about Marie’s observation is that it alludes to 
parallel logics and she recognises the generative effects of HIV interventions. 
Thus, available data and the patient’s “care outcome” would be used to 
confirm the validity of any particular rendition of HIV, although it is important to 
note that I do not think that Marie would view Isabella’s apparent 
understanding of HIV as having the same validity as her own. Furthermore, 
the extract illustrates that Marie does not think that Isabella’s behaviour 
necessarily makes her a “bad mother” (in this instance meaning someone 
who makes careless and random decisions about her baby’s health). It is 
important to note that none of the patients mentioned in the clinic were ever 
consistently constructed as being bad mothers. Rather, the practitioners spent 
a significant amount of time and energy trying to make sense of behaviour 
that was suspect in a way that still allowed the patient to be and or have the 
potential to become a “good mother”. In relation to this, I argue that contained 
within the promise of a future less affected by HIV for mother and baby, is, 
from the practitioner’s perspective, the present-time patient’s (who displays 
questionable maternal behaviour) final transformation into a good mother. In 
other words, the practitioners allow for the possibility that problematic 
behaviour displayed by present-time patients may dissipate in the future if the 
practitioners are able to successfully secure mothers’ and babies’ imagined 
potential.  
 
Moreover, I argue that the practitioners’ ability to envisage all patients having 
the capacity to become good mothers is vital to the provision of care in the 
clinic. This is because the practitioner’s ability and desire to provide the 
calibre of care that they feel their patients need requires that the practitioners 
care about their patients. In other words, the practitioners feel that successful 
care requires that they offer their patients the possibility to partake in an 
emotive and genuinely caring exchange with them. This kind of relationship 
would be more difficult for the practitioners to establish and maintain if the 
patient was reprehensible in the way a “bad mother” would be. This is 
significant and will be considered in more detail in Chapter Five wherein I 
further discuss the care the practitioners provide. 
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Returning to Isabella’s story, Ellen let us know a few weeks later that a 
meeting had been held concerning Isabella at her new hospital. Isabella had 
told the team that she wanted to breastfeed her baby. Ellen explained to us 
the different possibilities of what would happen to the baby once it was born. 
One option would be that Isabella would be asked to come into hospital and 
be supervised while giving the baby medication; another possibility would be 
to place the baby in temporary foster care during the time it needed to be 
medicated. Ellen said that this might be necessary, as they could not rely on 
Isabella to give the baby its medication voluntarily. Marie wondered why they 
would not automatically take the baby into care, as Isabella was insisting on 
breastfeeding. Ellen explained that a court case had decided that the “law 
could not stop a mother from breastfeeding”, therefore placing the baby in 
care on the sole basis that an HIV-positive mother was going to breastfeed 
was not an option (Field Notes, 26 November, 2008, pp. 9-11).100 Ellen told us 
about a midwife at yet another hospital who had several babies that were HIV-
negative. Ellen said they had had three tests done after they were born so 
they were definitely negative, but then the mothers breastfed them and they 
became positive (Field Notes, 26 November, 2008, pp. 9-11).  
During clinic the following week, Ellen relayed a phone conversation she had 
had with Isabella. Isabella had explained to Ellen that she has to “trust in 
God”, that everything will be fine and that bottle-feeding would show a lack of 
faith (Field Notes, 10 December, 2008, p. 2). Ellen had attended a child 
protection meeting at Isabella’s new hospital, during which a child protection 
plan had been devised. The plan was as follows: Isabella would have to stay 
in the maternity unit for five days, the baby would be put under a police 
protection order if she left. The hospital’s specialist midwife would be on call 
until the baby was born as Isabella had threatened to have an (unapproved) 
home birth. Isabella turned up at the hospital on the day of the meeting and 
agreed to take medication immediately, have a caesarean section and to 
replacement feed. However, she called the next day and said that she had 
changed her mind (Field Notes, 7 January, 2009, pp. 7-8).  
                                                
100 This stance is supported under article 8 in the European Convention on Human Rights 
(ECHR). The ECHR became part of UK Law through the Human Rights Act 1998 (BHIVA, 
CHIVA and BASHH, 2009, p. 10). 
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We found out that Isabella gave birth a few weeks later at the other hospital 
and had agreed to allow her baby to be medicated. Ellen said she was really a 
very complicated woman who had pushed all the boundaries (Field Notes, 21 
January, 2009, pp. 3-4). Sophia spoke to Isabella who told her that she now 
feels she should have listened to the practitioners at the London Hospital in 
the first place because the only result of her having gone to a different 
hospital is that more people know that she is HIV-positive, which is what she 
did not want. Ellen told me during our last interview that Isabella had left the 
country; this was the last I ever heard of her. Consequently, I do not know if 
vertical transmission of HIV was prevented or if she ever returned to London 
Hospital for her own HIV care. The issues I would like to draw out from 
Isabella’s time in the clinic are the expectations placed on patients regarding 
their provided care. Thus, the patient’s autonomy and consequently the 
patient’s ability to choose are superseded if and when a present-time patient’s 
behaviour may interfere with her and her babies’ future potential.  
 
Therefore, Isabella’s case makes clear that when making decisions about the 
patients’ care in the present, practically speaking the requirements of HIV and 
pregnancy (as perceived by the practitioners) necessitate that they consider 
the feelings they think their patients and (potential) offspring may have in the 
future. This is particularly significant because it alludes to some of the 
complexities that may occur in the specialist clinic if a pregnant patient resists 
or refuses the practitioners’ desired care plan. Consequently, practitioners in 
an HIV specialist antenatal clinic would base their care decisions on the 
patient as she is now and on what they hope she and her baby will become in 
the future. In a more abstract sense, they are consulting with a real present 
time patient, with her future self, and with her future baby as the practitioner 
imagines them to have the potential to become if care is successful. Imagining 
and thus considering the future in this way is an important aspect of the care 
that the practitioners attempt to provide their patients.  
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Conclusion 
 
This chapter explored what Mol would refer to as the practitioner’s logic as it 
was embedded in their practices (2008, p. 8). I have reflected on how the 
identity of HIV within the antenatal clinic depends on the practitioners’ 
continued and sustained maintenance (Mol, 2002, p. 23). Furthermore, I have 
explored how practitioners in the clinic viewed various actors’ (that are part of 
care in the clinic) ability to obstruct the practitioners’ desired care outcomes. 
Moreover, this chapter considered how the logic of care in the clinic required 
that the practitioners anticipate the way the patient’s body, virus and unborn 
baby will develop antenatally, in addition to constantly anticipating and 
working towards a specific future for both mother and baby. Also, I have 
illustrated how the practitioners constantly anticipate threats to the process 
that would enable mother and baby to fulfil their potential. These threats can 
come from any and all directions: the patients and the technologies that the 
practitioners depend on to inform their practice. In relation to this, I considered 
how the future patient always had the potential to be a good mother and that 
the practitioners see themselves as having the ability to help a mother 
become good in the future — if their care was successful.  
 
Additionally, I have explored the particulars of the way HIV interventions are 
dealt with in the clinic. I have considered how the healthcare professionals 
understand these interventions and how they believe their patients may 
contend with them. Moreover, I have illustrated how the healthcare 
practitioners have ways of contending with patients whose behaviour is 
understood as possibly threatening their future potential.  
 
The chapter considered the significance of the patient’s diasporic positionality 
as it related to some of the assessment technologies the clinic depended on. I 
argued that the successful prevention of vertical transmission of HIV in the 
clinic was related to the work practitioners do, and that this work was informed 
by the specificities of the logic of care in the clinic. Thus, the successful 
prevention of HIV as I described it depends on all the practitioners within the 
clinic working towards the same goal and being able to anticipate and 
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compensate for any disruptions. However, according to the practitioners in the 
clinic, issues related to their patients’ diasporic positionalities may complicate 
the care practitioners would like to provide.  
 
Moreover, throughout this chapter it has been made clear that the care 
practitioners provide their patients with is concerned with and involves both 
medical health expertise and biomedical technologies as well as 
encompassing the patients’ and her offsprings’ imagined potential. This 
chapter has begun to consider what this care attempts to achieve, what it 
entails, and what it requires of both practitioners and patient, from the 
practitioners’ perspective. It will become clear throughout the remaining 
empirical chapters that this form of care is imagined by the practitioners as 
having the potential to encompass their patients, as well as everyone that is 
and may become connected to their patients (as they are now and as they 
may become in the future).  
 
From the practitioners’ perspective, the provision of good care which is 
synonymous with caring care depends on their ability to compensate for any 
potentially harmful technologies.101 In other words, the successful provision of 
care in the clinic requires, according to the practitioners, a system that is able 
to substitute and, when needed, counteract, any or all of the biomedical 
technologies that do not do (or are suspected of not doing) HIV in a particular 
way. Subsequently, the prevention of vertical transmission of HIV concerns 
the particular care on offer, the attributes of the people who provide that care, 
and the way in which the biomedical technologies available to them are 
anticipated, interpreted and incorporated into the lives and bodies of their 
patients.  
 
Therefore, from the practitioners’ perspective, the unquestionable success of 
their clinic in preventing vertical transmission is related to their constant sense 
of unease, which in turn, motivated them to actively seek out certain 
knowledges of their patients’ bodies. This requires complex and rigorous 
                                                
101 For example, viral load assays.  
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negotiations with all of the various components within the clinic (and external 
to it), and is informed by the emotive approach to care that permeates and 
influences the practitioners’ practice.  
 
Providing good care thus requires that the practitioners make themselves 
available to have an emotive connection with their patients. Importantly here 
is the idea that the practitioners try to make it clear that they care, and that by 
caring they hope that they are able to make up for the shortcomings of the 
technologies on offer to them. The next chapter will further consider the way 
the practitioners told me they feel about the care they provide and the 
significance of the HIV diaspora.  
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Chapter	Five:	Providing	Care	within	the	HIV	Diaspora 
 
It shouldn’t be that if you’re in the developed world you’re fine but if 
you’re in Ghana, you’re not fine […] [B]eing an asylum seeker now is 
just, you know […] I don’t know how my patients survive (First interview 
with Sophia, the HIV specialist doctor, 30 September 2008, p. 14).  
This chapter will explore what constitutes good care from the practitioners’ 
perspective. I will do this by providing examples of things the practitioners 
believed had the potential to entirely disrupt what I will term the network of 
care. This chapter argues that issues related to the patients’ incorporation 
within the HIV diaspora pose a constant threat to the provision of care in the 
clinic from the health care practitioners’ perspective. Drawing on field notes, 
interviews with practitioners and an interview with a patient, I will explore 
several different areas of concern where the network was jeopardised. By 
exploring the events and circumstances that threaten clinical practice, this 
chapter will further investigate how the practitioners contend that the identity 
of HIV is maintained and how the prevention of vertical transmission of HIV is 
done in the clinic. Through this analysis I will consider the significance of the 
practitioners’ attempts to achieve their patients’ potential.  
 
The chapter will begin by considering Marilyn Strathern’s article “Cutting the 
Network” (1996). This discussion will clarify what I mean by a network and 
what the network may enable if it is not cut. The rest of the chapter will then 
describe instances when the network was either threatened or cut. 
Accordingly, I will consider how the practitioners conceive of and negotiate the 
possibility that the patient’s unspoken feelings about HIV may impede and 
complicate their ability to help secure the patient and her babies’ ultimate 
future selves. I will contemplate how the practitioners try to prevent certain 
events from taking place — events that the practitioners fear would be 
counterproductive to the future wellbeing of their patients and their offspring 
— if and when these events would become enacted. This discussion will 
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clarify the work that the practitioners do in the present in order to influence 
their patients (as the practitioners imagine them) in the future. Moreover, I will 
argue that the patient’s imagination becomes viewed as a result of the effects 
of their location within the HIV diaspora. 
 
In the clinic, a compromised relationship between practitioner and patient, 
regardless of what caused the conflict, is one of the most detrimental potential 
obstructions to the provision of care. In other words, I will argue that the 
provision of care is, from the perspective of the practitioners, entirely 
dependent on developing and maintaining certain kinds of relationships with 
their patients. At its best, the relationship should entice patients to have faith 
in the practitioners’ desire and ability to care for them. The analysis of the 
practitioners’ practices and of the issues and events that they feel are a 
potential threat to their practices will help me to uncover the logic of care, that 
is the rationality of the practice in which they engage (Mol, 2008, p. 8). The 
chapter will then consider the ways in which issues that stem from the 
patient’s immigration status may harmfully impact on the care that the 
practitioners would like to provide them with. After this, the chapter will 
discuss the threat that patients’ (suspected) past traumatic experiences may 
have on the network of care. Finally, I will consider an instance where the 
practitioners felt that a patient had been provided with bad care.  
	
Disrupting	the	provision	of	care	
 
In her influential article, “Cutting the Network”, Marilyn Strathern argues that 
for actor network theorists the concept of a network refers to the 
“heterogeneous elements that constitute […] an object or event, or string of 
circumstances, held together by social interactions” (Strathern, 1996, p. 521). 
She contends that in order to have analytical power a network must have a 
stopping point (1996, pp. 522-523). After all, she asserts, there are potentially 
never-ending amounts of networks within networks; where to draw the line 
(1996, p. 523)? In regards to this she writes:  
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a network is as long as its different elements can be enumerated. This 
presupposes a summation; that is, enumeration coming to rest in an 
identifiable object (the sum). In coming to rest, the network would be 
“cut” at a point, “stopped” from further extension. How might that be 
done (Strathern, 1996, p. 523)? 
For Strathern, a network is cut by a disruption: for example, a claim of 
“ownership” (1996, pp. 525-526, 531) which would separate those who belong 
in the network from those who do not (1996, p. 525). For example, she 
mentions that step-children may not appear in grandparents’ wills, drawing a 
line between those who inherit and those who do not. However, the events 
that cut or have the potential to cut a network may vary depending on the 
specificities of the network in question.  
 
Influenced by Strathern, I will use the concept of a network to refer to the 
conglomeration of components that would work and/or come together and 
facilitate the patient’s passage through the clinic, and the emergence of the 
imagined postnatal woman and her (hopefully) HIV-negative baby, as the 
practitioners envision they have the potential to become (1996, p. 520). The 
network that may enable this outcome is held together by and through the 
relations between the various actors within it (1996, p. 521). The provision of 
care requires that the network that facilitates care is not cut, as Strathern 
(1996) uses the term. Drawing on these ideas, in what follows I will illustrate 
how the practitioners believe that patients’ (beliefs about their) future 
expectations may have the potential to cut the network of care.  
	
Patients	fears	for	the	future,	preventing	an	imagined	future	
 
In this section I will consider the way in which practitioners manage a patient’s 
fears for her future. As I have discussed previously, the work the practitioners 
do in imagining a future for their patients, i.e. a future less affected by HIV, is 
fundamental to the care they provide in the clinic. However, I will show how 
the practitioners fear that their diasporic patients may disrupt their own care if 
the patients engage too deeply in the work of the imagination. In other words, 
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from the practitioners’ perspective, imagining a future for the patient is vital to 
the prevention of vertical transmission and their provision of postnatal care. 
But it is potentially detrimental to prevention and care efforts if their patients 
imagine it differently. In other words, patients must, according to the 
requirements of care, be encouraged to imagine their future but only as the 
practitioners would like them to. Thus, the practitioners believe that a patient 
who is too preoccupied with her and her baby’s future paradoxically risks 
cutting the network of care that would prevent vertical transmission and any 
forthcoming care. In what follows I will provide examples of how the 
practitioners encourage their patients not to think too deeply about the effects 
the HIV diaspora may have on their lives. 
 
The work that the health care providers do is partially about trying to get 
patients to not give in to the future possibilities that are in store for them. At 
the same time, the practitioners’ work in the present is always informed by the 
future imagined possibilities for the patient and her potentially HIV-negative 
baby. The practitioners are able to provide a significant amount of 
reassurance to their patients about their prospects in the present and near 
future. Accordingly, the practitioners are able to more or less guarantee that 
their patients will have HIV negative babies if the patients adhere to their care 
plans. In other words, patients must engage in care appropriately according to 
the practitioners (Gardner et al., 2011, p. 793). Beyond that, however, the 
practitioners are not able to give any assurances about their patient’s life 
prospects if the patient’s ability to stay in the UK is under question. To 
illustrate this argument I will describe my observation of a consultation 
between Yaema and Sophia. Although I never interviewed her, Yaema 
consented to my attendance at all of her consultations.  
 
Sophia was comforting a very upset patient. Yaema102 was having her final 
postnatal appointment and she was considered to be well and healthy and her 
baby, who was just over six weeks old, had recently received an HIV-negative 
                                                
102 Yaema was originally from Sierra Leone.  
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test result.103 During the consultation, Yaema broke down in tears. After some 
cajoling Sophia was able to establish that Yaema thought she would fall down 
dead at any moment. Sophia comforted Yaema in the following way:  
[Sophia said that] if they were having this conversation in Ghana104 then 
things would be very different because there are not the same medicines 
there. Sophia explained that if she spoke to a patient in Ghana and the 
patient said that they were afraid to die, she would say: “yes I 
understand that and I will do what I can for you now”. [But] because they 
were in the UK and they have all these medicines, she could tell the 
patient that you might be afraid of dying but that is not going to happen 
— “there is no reason why you and I should have a different life span” 
(Field notes, 24 Sept, 2008, p. 21). 
Later, I asked Sophia to expand on the analogy she had given Yaema:  
Ulla: With one of the patients you were speaking, when you spoke to her 
about HIV you were setting up location specific scenarios. You were 
saying, “in Ghana I would say this, and here I would say this”, how 
important do you think a patient’s previous experiences from a different 
location of HIV is to their understanding? 
 
Sophia: Oh, I think it’s immense because, I think that, your AIDS defining 
illnesses are you know, when I see someone with full AIDS defining 
illnesses, where you have got stigmata in your face, your mouth, your 
skin, everywhere; you’re emaciated; you know those are very harsh 
pictures to remember and then […] particularly, if you knew them pre-
HIV/AIDS, you would think “oh my goodness they were just like me and 
that’s how I’m going to end up, so just because I’m not like that now 
that’s how I could end up”! […] you can either be focused and say I will 
never let myself get to that point and I’m going to do everything I can, 
and I’m going to work with the doctors or whatever, or you can become 
                                                
103 Please see Chapter One for a discussion of the neonatal management of babies born to 
HIV-positive mothers.  
104 Sophia had worked as an HIV doctor in Ghana and would often use Ghana as a point of 
reference when discussing HIV care in Africa with patients.  
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apathetic and think that’s my destiny and what else am I going to do, 
and go on from there. And that’s a very simplistic view but it’s I think, I’m 
just trying to highlight the fact that it can really impact on where you go 
next and how you engage in services next. I think it’s the fear factor […] I 
think it’s important to say, “look, it’s there, but we can manage it and if 
we were in a different setting, your fears would be justifiable and so I’m 
not dismissing your fear but I am saying that we’ve got something 
different that we can offer, so that will not be inevitable”, and then, I think 
it’s quite a nice analogy for them (First interview with Sophia, the HIV 
specialist doctor, 30 September, 2008, p. 11-12). 
Sophia’s comment draws attention to the fact that the patient’s valid fear 
about the future may get in the way of her engaging in care in the present. In 
other words, while she may only have temporary access to biomedicines and 
care, fully benefiting from them while she does have access might be curtailed 
because she knows that her access is temporary. Consequently, the patient 
must be persuaded to think about her future prospects in a way that the 
practitioners believe is conducive to her care in the present. The practitioners 
know that their HIV diasporic patients, who are at a high risk of being removed 
from the UK, are probably realistic in questioning an imagined future “less 
affected by HIV”. So, there is a contradiction in this process: namely, that care 
depends on the practitioners encouraging patients away from thinking about 
futures the practitioners know are highly probable.  
 
Returning to Yaema’s consultation, Yaema seemed comforted by Sophia’s 
reassurance. However, underlying Sophia’s discussion about a patient’s life 
prospects depending on her geographical location was the fact that Yaema 
was living in the UK illegally. So, while Sophia was offering Yaema 
reassurance that her life was not in danger now, she was simultaneously 
acknowledging that Yaemas’ life would be in danger in the future. Important 
though is the fact that Yaema’s possible expulsion from the UK is an event 
that would take place (if it ever does) in the distant future. Thus, I would argue 
that Sophia was trying to encourage Yaema to take advantage of the life that 
is available to her now. In other words, Sophia was trying to persuade Yaema 
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from allowing her likely distant future to impede Yaema from benefiting from 
the care and biomedical technologies available to her in the present and in the 
near future. Care in the clinic is thus directed towards the near future patient 
— a future that does not extend beyond their access to care and 
biomedicines. That is, the successful provision of care requires that the 
patient works towards the practitioner’s vision of the near future, while the 
patient simultaneously refrains from imagining a potential but distant one. Put 
another way, the care that the practitioners provide depends on the patients 
not “cutting the network” that provides care, as a result of thinking too much 
and too negatively about their future prospects. 
 
Following this, I argue that for the practitioners, imagination (their own and 
their patients’) is an activity that becomes part of the real of HIV. Influencing 
the content and expanse of the imagination is therefore crucial. This reflects 
Rosengartens’ comment that: “imagination — as a mode of thought contrary 
to the presumptions of objective knowledge — is always present and inherent 
to what we take to be an external, unmediated ‘real’” (2009, p. 21). It is 
important to emphasise that, especially from the practitioner’s perspective, the 
fact that the imagination has this influence over what HIV may become does 
not in any way demote the status of “objective knowledge” about it. In other 
words, from their perspective, the imagination (their own and their patients) 
has a critical part to play in creating the HIV that is in a patient’s body (but 
cannot be known in real-time), but the HIV is nonetheless an “external, 
unmediated ‘real’” (2009, p. 21). 
 
Here I will make another argument in relation to the same empirical example. I 
contend that the practitioners use their ability to work with and within sadness 
as a tool that helps them direct the way their patients contend with their 
feelings and curtail their future imaginings. The following is an extract from my 
field notes which describes how Sophia and I interacted with Yaema and her 
baby during the consultation.  
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Sophia and I started to focus our attention on the baby, admiring her and 
talking about how lovely she was and how we couldn’t believe that she 
cried all night. Yaema said that her baby was [HIV-] negative, as she 
held her. Sophia said, “yes, see she is ok, she is beautiful, and she is 
lovely, you have to live for her and you will live for her and everything will 
be ok”. […] It was really sad. I felt an overwhelming desire to reassure 
[Yaema], comfort her — almost a physical reaction where you want to 
physically care for someone, and help them, but without being able to do 
that. 
  
Sophia wanted to examine [Yaema’s] chest. Yaema was holding her 
baby; she gestured towards me and I asked if I could hold the baby. 
Yaema looked happy and gave her to me. The baby was absolutely 
gorgeous. I think it meant a lot to her, the way that both Sophia and I 
admired her baby; I think that made Yaema feel more comfortable. 
Sophia reiterated that this is normal; a new mother doesn’t sleep and 
she has feelings of anxiety and being tired. I think she was attempting to 
normalise her experiences, to take them away from HIV and relate them 
to the experience of being a mother […] I felt very close to Yaema and I 
felt close to Sophia during the meeting. [The consultation] was very 
exhausting and I had to focus on not crying; I could tell that Sophia was 
as well. It was hard to see someone that upset (Field notes, 24 Sept, 
2008, p. 21-22).  
There is something very important (albeit subtle) that I would like to draw out 
of the extract above. My overwhelming emotion during the consultation was a 
desire to physically comfort Yaema, and because I felt that was not 
appropriate, I projected my need to comfort her onto her baby. Sophia, 
however, did not allow the emotionality of the consultation to stop her from 
providing Yaema with specialist HIV care. By this I mean that Sophia cleverly 
— and taking cues from Yaema herself — attempted to get Yaema to see the 
benefits of her current situation by directing the conversation towards her 
baby, and reiterating how it was born free of HIV, how beautiful it was and 
how normal it was to feel overwhelmed and sad when you are a new mother. 
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This way of negotiating Yaema’s sadness was not, I argue, a kneejerk 
response to someone crying; instead it was a crucial component of the care 
the practitioners provide their patients. Accordingly, providing care to patients 
located within the HIV diaspora requires that the practitioners are able to 
maintain the provision of care even when things are desperately sad and the 
patients’ future is bleak. Further to this, the provision of care requires that the 
practitioners use those sad moments as opportunities to direct the way their 
patients think about their lives and their futures. Consequently, incidents when 
patients opened up in this way were approached by the practitioners as 
tremendously advantageous opportunities in the clinic. The practitioners 
could, if they managed these situations appropriately, ensure that the patients 
felt cared for, able to articulate their fears and begin to think about their (near) 
futures differently.  
 
Potentially emotive situations are used as opportunities for the practitioners to 
convey their desire and ability to provide caring care (i.e. the provision of good 
care in practice) to their patients. Practitioners would even create such 
emotion. They would draw out key moments in the patient’s pregnancy and 
attempt to instigate an emotive discussion with the patient about it. For 
example, they would encourage patients to talk about the purchases they had 
made for their unborn baby, the unborn babies’ possible names, and the way 
it felt when the unborn baby moved inside of them, and so on. I argue that 
these discussions had the dual purpose of normalising the patient’s 
pregnancy and also of establishing caring relationships between patient and 
practitioner. So, I argue that in the specialist clinic any sign of a patient’s 
emotion is used by the practitioners as a possible point of entry to allow them 
to display that they cared about the patients.  
 
The provision of caring care in the clinic depends on the patients feeling cared 
for. Importantly, this does not mean that the patient needs to believe that the 
practitioners will be able to prevent vertical transmission of HIV, but rather, 
that the patient believes that the practitioners care about her and her (unborn) 
baby, above and beyond HIV. The responsibilities of “caring care” are thus not 
satisfied once it has been established that a baby has been born free of HIV 
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and the mother has had her last postnatal appointment. Instead, “caring care” 
is an ongoing process that concerns the patient’s future potential, and the 
potential of any babies and sexual partners she may have in the future.  
 
I felt closest to Ellen and Sophia during intense interactions with patients like 
the one described above. While I would usually feel overwhelmed during 
these distressing consultations, Sophia’s and Ellen’s professionalism never 
appeared to weaken in these situations. Thus, I argue that the dilemma I 
describe in Chapter Three in regards to my concern over possibly attending 
the caesarean sections would not present itself in the same way for the 
practitioners in the clinic. Rather, being able to feel deeply, and access, 
convey and feel an emotive connection with a person in a horribly difficult 
situation, while not losing sight of your responsibilities as a professional, i.e. 
your job to provide care, is part of the logic of care in the clinic. Indeed, 
according to the practitioners, being able to connect with patients on that level 
is a necessary skill for health care providers within the HIV diaspora.  
	
Immigration	status 
[M]any of [the patients in the clinic] have issues around just life really. 
Poverty, immigration status and having an HIV diagnosis where they’re 
going to need treatment could mean that they have to stay in the UK to 
get that treatment and to live, and therefore they’re restricted in what 
their future might be (First interview with Ellen, the HIV specialist 
midwife, 21 Aug 2008, p. 3). 
In the previous chapter, I argued that people living with HIV in the same 
geographical location might not experience the transformative opportunities 
promised by the availability of the care and technologies elsewhere. This 
argument was made in relation to the viral load assays used by the specialist 
clinic. Here, I will extend that argument by showing how the way various 
professionals interpret and subsequently follow bureaucratic guidelines and 
laws and “do their jobs” may obstruct the patient’s access to care. This 
argument will be made in relation to a patient named Verity. I will show how 
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practitioners connected to the clinic’s reactions to her immigration status 
disrupted her access to care in the clinic. Moreover, I will contend that Verity’s 
case evidences how global inequalities that pertain to unequal access to 
ARVs and specialist HIV care may be echoed in the clinic.  
 
Verity’s situation reflects the geopolitical concerns discussed in relation to 
Didier Fassin’s work in Chapter Two: namely, how people have different 
things happen to their bodies as a consequence of their varying access to 
resources. However, it is important to mention that Fassin makes this 
argument in relation to a global “west and the rest”, to use his terminology. 
Instead, I use his argument to consider the way in which location-specific 
inequalities may follow diasporic people as they move location. In this way, if 
we were to impose the empirical example I provide onto Fassins’ argument 
and use his terminology, then the inequalities he writes of follow “non-
western” peoples as they move to the “west” (2007).  
Despite their best efforts, the practitioners are not always able to care for 
women who come into contact with the clinic in the way they would like to, 
even if the woman herself acquiesces to and participates in HIV care 
“appropriately”. Failure to actualise their intended care plan in these instances 
is a result of the way the care provided is necessarily dependent on other 
actors that may sometimes be antagonistic to the practitioners’ concerns. It is 
these other actors that intercede into care (and may entirely obstruct the 
provision of care) in the clinic. It is important to stress that these obtrusive 
actors become involved in the network of care as a direct result of the 
patient’s position within the HIV diaspora. In the example discussed in this 
section, the patient’s immigration status in combination with her complex 
medical needs made her vulnerable to these actors. Moreover, in some 
circumstances, the purpose of these actors’ roles is precisely to thwart the 
provision of care to certain groups of people. While the preceding chapter 
considered the ways in which the provisions of care were complicated 
because of viral load assays, here this problem will be considered in relation 
to different empirical material and consequently further clarify the work that 
the practitioners do when attempting to provide their patients with care.  
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The following story, as I narrate it below, is taken from several weeks’ worth of 
field notes and an interview with Anne, a consultant physician whom I asked 
to explain her relations with Verity, the patient in this story. It is important to 
note that the information that the clinic gained about this patient was gathered 
over these weeks. In this way, I am providing a streamlined description of 
Verity’s time in the clinic and the conversations the practitioners had about 
her, whereas in reality the MDT painstakingly gathered much of the 
information about her over an extended period of time. Here it is significant to 
add that Verity only attended the specialist clinic on one occasion.105 Verity 
and her partner consented to my participation in Verity’s consultation. To my 
knowledge, none of the practitioners asked Verity if I could interview her, and 
no interview with her took place.  
 
During a briefing meeting in clinic one day, Marie, a consultant physician, told 
us about a new patient named Verity: she was 13 weeks pregnant and had 
come to the UK from a country in Sub-Saharan Africa a few months ago. She 
was on a visitor’s visa that was about to expire. Verity became very sick a few 
weeks back and was admitted to North London Hospital106 (NL Hospital). 
They diagnosed her with tuberculosis and discovered that she was pregnant 
and HIV-positive. She was subsequently transferred to the Central London 
Hospital (CL Hospital) because NL Hospital does not contend with TB and 
HIV co-infection (Field Notes, 17 December, 2008, pp. 4-5). During her time 
there, a doctor told Verity that her immigration status would not entitle her to 
secondary care107 which would encompass HIV care according to him. Thus, 
she would be able to receive tuberculosis therapy and immediate necessary 
obstetric care, with the bill to be paid at a later date (Interview with Anne, a 
                                                
105 Although I do not expand upon it here, another issue Verity’s case brings up is the 
tremendous amount of time the MDT would spend talking about patients. This becomes 
particularly noticeable in relation to Verity, considering that she only attended one clinic 
session. Despite this, her case was discussed in clinic for several months.  
106 I have chosen to provide pseudonyms of two hospitals mentioned in relation to Verity.  
107 Secondary care refers to planned or unplanned emergency care and/or surgery (West 
Middlesex University Hospital NHS Trust, 2014). HIV antenatal care is considered to be 
emergency care in the specialist clinic. So, Ellen felt that Verity’s HIV care should have been 
considered emergency care because Verity was pregnant. The care that the practitioners 
provide in the clinic is planned emergency care due to the combination of HIV and antenatal 
care. For example, patients have a care plan in place and have scheduled appointments for 
various procedures. Therefore, emergency care can be planned. 
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consultant physician, 11 March, 2009, p. 17). They were firm but kind in their 
rejection of her (Field Notes, 10 December, 2008, p. 3). All of the practitioners 
expressed their shock and disappointment that Verity had been refused HIV 
care. Ellen was dismayed and said that her HIV care ought to be considered 
emergency care because she was pregnant and it was a crisis108 (Field 
Notes, 10 December, 2008, p, 3). Verity came to clinic the following week with 
her partner, Jack, a white British man who had recently been diagnosed with 
HIV infection. Sophia and I met with them in the consultation room.  
 
The appointment was overwhelming. Verity looked extremely ill, scared and 
vulnerable, and she was remarkably skinny. Her skin looked lifeless, was an 
ashy greenish brown, and appeared to hang off her thin frame. Verity’s 
movements were also slow and laborious; her breathing was strained and she 
appeared to be in great discomfort throughout the consultation. I would never 
have suspected her of being pregnant. Verity and her partner seemed to be 
full of anticipation; they sat at the edge of their seats and listened attentively 
to everything Sophia said. They both asked lots of questions. Jack wanted to 
know if the clinic would really care for Verity. They appeared to breathe a sigh 
of relief when Sophia assured them that the MDT would help her. The couple 
looked noticeably reassured and started to thank Sophia over and over again. 
Sophia looked visibly touched by their heartfelt gratitude. The entire 
interaction was tremendously emotional. The following is an excerpt from my 
field notes:  
[Verity and Jack] did not seem angry, or they did not express their anger 
at this other hospital for refusing them care; they came across as just 
being grateful, and that almost upset me more. [The London hospital] did 
not have any information about this woman’s HIV, but the woman 
brought out some letters from the hospital and it turns out that her CD4 
count is very low and her viral load is high, and even if she was not 
pregnant, she should be on treatment for her own safety for her own 
health. And she has TB and she had pneumonia in 2004, and it hit me 
                                                
108 Free access to HIV care for anyone with HIV living in England, regardless of his or her 
immigration status became a legal fact in 2012 (Department of Health, 2012; The National 
Health Service (Charges to Overseas Visitors) Regulations, 2011). 
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that a doctor turned her away from treatment, knowing full well that that 
would probably mean that her child would be HIV-positive [and that she 
might die](Field Notes, 3 December, 2008, p. 9).  
Jack was very worried that their baby might have already been infected with 
HIV since Verity had not received any treatment. Sophia acknowledged his 
fear and explained that this might unfortunately be the case and that all they 
could do now was try and prevent the baby from becoming infected, if it had 
not already been. It is important to reiterate that this couple had spent several 
weeks desperately trying to find a hospital that would provide Verity with HIV 
care. They wanted their baby and they wanted it to have the best possible life 
chances.  
 
Sophia, Ellen and Marie decided that despite the fact that they would ideally 
want Verity to start taking ARVs as soon as possible they would have to wait 
until they received her “new results” the following week. The delay was 
necessary due to the incompatibility of some HIV medications with TB 
treatments. Another pressing concern was the fact that Verity would receive 
her care at different hospitals, which would be logistically challenging. Marie 
wanted Sophia to try and persuade Verity to choose to have both her HIV 
care and her TB care at the London Hospital because of the tremendous 
difficulties inherent in caring for both illnesses and her pregnancy (Field 
Notes, 3 December, 2008, pp. 1-2, 6, 8-11).  
 
I was overwhelmed by a sense of relief after Verity and Jack left — relief that 
Verity would now be cared for, that I knew all of the practitioners in the clinic 
would do their utmost to ensure that her baby had the best possible chances 
of being born free of HIV, and that she would finally receive skilled and 
compassionate care. I felt she was safe now, as safe as she could be in these 
circumstances. It is important to stress that I got the impression that the 
practitioners in the clinic also felt immensely happy that they were going to be 
able to help Verity and Jack. It was as if they were going to be able to rectify a 
horrible injustice that was taking place. The consultation felt hugely significant 
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and the practitioners’ dedication and ingenuity was humbling and elevating to 
witness. I felt proud of them and the work that they were doing.  
 
Ellen updated me on Verity’s progress during clinic the next week. Verity and 
her partner had been given a prescription for ART that would be compatible 
with her TB therapy. The following is an excerpt from my field notes:  
[Verity and Jack] had had a complete nightmare getting [her prescription] 
out of the pharmacy. They had waited around for hours and then could 
not get it, and then they had gone to two local community pharmacies 
that did not have it; and it had just been a long process and both Ellen 
and Marie were talking about how difficult things were with the 
pharmacies and how ridiculous communication was with patients. The 
pharmacy told [Verity and Jack] that they would give them a call as soon 
as the medication came in, and never called [them] and then Marie 
called the pharmacy and they actually did have the medicine there to 
begin with (Field Notes, 10 December, 2008, p. 3).  
Verity was discussed in clinic again the following week. Sophia had asked the 
London Hospital TB doctor if he would be willing to care for Verity; he had 
refused. It is important to mention that Verity did not reside within the 
hospital’s jurisdiction, meaning that Verity was not entitled to receive her 
medical care there. Consequently, her care would be split between the 
London Hospital and NL Hospital. In other words, Verity’s complex medical 
needs and her residency in a particular area of London all conspire to make it 
impossible for the MDT to care for her.  
 
The practitioners in the clinic often discussed the way in which circumstances 
directly connected to their patient’s position within the HIV diaspora 
significantly complicated the MDT’s ability to provide them with care. These 
sentiments are reflected in the extract from an interview with Anne, a 
consultant physician in the clinic.  
In this particular part of London, we have got a group of patients who are 
marginalised in every which way. In the early days of the epidemic when 
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you were dealing with people with a relatively rich constituency of British 
born men, there was a power there and people would listen; we are now 
dealing with what is a feminised epidemic and women are notoriously 
not listened to. Of a racial minority who are stigmatised and are 
marginalised and are not wanted, so it’s a discourse about migration, 
which is unpopular; to say to somebody, I’m looking after undocumented 
migrants with HIV in a disadvantaged bit of town, can you help? People 
go, ahem, well, I don’t know if we can, actually. So it is to do with where 
they are situated I think, politically, and being a migrant is a very difficult 
place because people don’t have any ownership for your problems 
(Interview with Anne, a consultant physician, 11 March, 2009, p. 2).  
A further complication that emerged was that Verity was discovered to be 
resistant to the preferred TB therapy; this irrevocably complicated her HIV 
care. Sophia said that if Verity had not had a partner who was fighting for her 
life it would never work (Field Notes, 17 December, 2008, pp. 4-5).  
Then they had a huge talk about the “rubbish” pharmacy; everyone was 
upset; Heather [a MDT paediatrician] said that we end up feeling all 
good about ourselves, but then there are all these other bureaucratic 
aspects. They were talking about how they can think that they are doing 
very good work with the patients but then they send the patients to other 
areas and the patients have really difficult times. Heather spoke a lot 
about that what they do really does not matter when the patients are 
then having to deal with the wider bureaucratic systems (Field Notes, 17 
December, 2008, pp. 4-5).  
Several weeks later, Verity was brought up in clinic again. Sophia told Anne 
that she had “gone to the CL Hospital” because she had been refused TB 
care at the London Hospital (Field Notes, 7 January, 2009, pp. 10-11). Later 
while we were alone, Sophia bemoaned the fact that there had been no 
consensus of care for Verity (Field Notes, 7 January, 2009, p. 11). After 
Verity’s transfer back to the CL Hospital, the practitioners at the London 
Hospital were no longer involved in her care; therefore I never heard anything 
more about her progress.  
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The ultimate consequence of Verity’s immigration status was that she is 
partially excluded from care. Thus, while she was in a geographical location 
wherein HIV and death have been de-coupled, she was not able to take full 
advantage of the care and biomedical technologies available in that location. 
For her, death and HIV were still associated. Further to this is the fact that 
upon its birth, Verity’s baby would be entitled to this care as well as UK 
citizenship; it would not, however, have the same chances of being HIV 
negative as other babies born to HIV-positive women with unquestionable 
access to free health care in the UK. Following this, and assuming Verity’s 
baby was born and survived, it would have been (if it was discovered to be 
HIV-positive) irrevocably disadvantaged because of the effects its mother’s 
immigration status had on it prior to its birth.  
 
The actors that prevented and complicated Verity’s access to care did not 
take her health or her unborn baby’s future health into consideration when 
they refused care. Rather, the refusal was directed towards her present-time 
body; the health of her future self and her potential future baby were not 
considered as they did not exist within this logic. Verity’s case makes clear 
that the network of care that would enable the prevention of vertical 
transmission may be interrupted by other networks; for example, that of the 
legal system (or rather certain practitioners’ interpretations of their legal 
obligations) which does not acknowledge or consider the significance of 
unborn babies’ future potential. So the needs, intentions and goals of one 
network may make it impossible for the network that would care for the clinic’s 
patients to work.  
	
Trauma 
 
In what follows I will argue that the practitioners worry their patient may 
disengage with care as a result of a past trauma. I will illustrate how 
practitioners may come to suspect a patient of being traumatised when the 
patient’s behaviour, in combination with what the practitioners know about 
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her, suggest that possibility. As will become clear, a patient may become 
labelled as being (potentially) traumatised if and when the practitioners cannot 
confirm that she is not. In other words, trauma may emerge as a threat to the 
network of care when its presence cannot be absolutely refuted. The danger 
that trauma poses to the network of care is that it makes it impossible for the 
practitioners to predict their patient’s behaviour. Thus, the practitioners fear 
the (future) effects of information that is not accessible to them because the 
traumatised patient cannot make that information available to them. In this 
way, the traumatised patient is, according to the practitioners, (potentially) 
immune to the effects of the caring care that the practitioners would provide 
her with. The practitioners thus see trauma as a barrier to the provision of 
care. In what follows I will describe Theodora’s time in the clinic which is 
based on my field notes and an interview. Theodora consented to let me 
observe all of her consultations with Sophia and I interviewed her once.  
 
Theodora was in her late teens and had come to the UK in 2002 from Angola; 
she was ten weeks pregnant and had just been informed that she was HIV-
positive. According to Theodora’s GP, the relationship with the father of her 
baby had broken down and there were significant social issues.109 The father 
was Theodora’s first sexual partner and she made it clear that she did not 
want to have the baby if he had infected her with HIV. Theodora did not have 
any direct contact with her partner who was either in prison or in a removal 
centre (the practitioners were not able to establish which one it was during my 
time in the clinic). Theodora had had a referral for a termination but had not 
gone through with the procedure. The information they had thus far on the 
patient concerned Ellen who explained that Theodora had been very reluctant 
to answer any questions about her family during her appointment booking.110 
Ellen asked Theodora if something had happened to her in Angola, and after 
being asked, Ellen said that she closed down completely.  
As the weeks went on, the healthcare practitioners’ concern over Theodora 
grew. They found it very difficult to get information about her background and 
                                                
109 Theodora had given the MDT permission to contact her GP.  
110 Ellen would usually have an initial appointment with new patients. She would attempt to 
gather as much information as possible on the patient during this meeting. These 
appointments would take place outside the normal HIV specialist clinic sessions.  
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her relationships outside the clinic. Their concern, I argue, was based on 
Theodora’s behaviour towards them — her reluctance to speak and otherwise 
engage with care (she refused to take a psychological assessment and would 
regularly refuse or delay various procedures), her age, their knowledge of her 
life and relationships with people in the UK, and the knowledge they had 
about the political situation in Angola in 2002. All of the information they had 
on Theodora in combination with her behaviour in the clinic led them to 
believe that she might be deeply traumatised by her experiences in Angola. 
The practitioners feared that Theodora might stop engaging in the care they 
were providing for her.  
 
Theodora agreed to be interviewed by me and to let me sit in on all of her 
consultations with Sophia; this surprised and pleased Sophia who hoped that 
her willingness to be interviewed might be a sign that she was starting to feel 
more comfortable opening up. However, her “cagey” behaviour persisted 
(Field Notes 18 February, 2009, p. 2).  
 
During her interview with me, Theodora explained that prior to her arrival in 
the UK she had lived in Angola with several other children and women whose 
husbands and fathers had been imprisoned. Theodora was unsure if the 
people she lived with were related to her and, if so, in what way. She now 
believed that the woman she thought was her mother was in fact her sister. 
However, she explained that she was not sure because, as she told me, 
“people lie for no particular reason” (Interview with Theodora, 14 February, 
2009, p. 11). When asked if she was still in contact with the woman she had 
thought was her mother, Theodora said the following:  
 
Ulla: Where does your sister live?  
Theodora: What sister?  
Ulla: You said the sister you thought was your mother before.  
Theodora: Oh, since the thing, I don’t know.  
Ulla: You don’t know?  
Theodora: I don’t know if she is alive, I have no idea  
(Interview with Theodora, 14 February 2009, p. 30). 
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Later in the interview I asked the following:  
 
Ulla: During the war did anything bad happen to you, or?  
[Theodora shakes her head no]  
Ulla: No?  
Theodora: Thank God, no. Just to my family. I don’t know what 
happened to them.  
Ulla: That’s hard; I can tell [she was shaking, trying not to cry]. Have 
you ever talked to anyone about that? Had anyone to talk to? 
Theodora: Just the Home Office when I came, they need to know, they 
said that they had to know, they ask a lot of questions. That’s it.  
Ulla: Would you like to speak to somebody about that? Maybe a 
therapist, or no? [She shakes her head no]. Maybe it could help to talk 
to somebody? No?  
Theodora: What are they going to do? Bring them back? They can’t!  
Ulla: No, but it might help you. No?  
Theodora: No, no, I’m good. I need to forget, not talk about it.  
(Interview with Theodora, 14 February, 2009, p. 12). 
 
Before I return to the issue of trauma, I would like to clarify here that the 
patients I interviewed had been informed (in the NHS REC participant 
information sheet) that they would be able to talk to a trained member of staff 
if they became upset during the interview.111 The interview extract above 
demonstrates how Theodora became upset and that I asked if she wanted to 
speak to a professional. I fulfilled my responsibilities towards Theodora in 
regards to the way I formulated the questions in the information sheet. 
However, I did not (and still do not) feel that my response to Theodora was 
enough.  
 
My discomfort related to a couple of different issues. Firstly, my uneasiness 
had to do with the fact that I felt I was asking too much of Theodora and that I 
                                                
111 I have chosen not to attach my “Participant Information Sheet” to this thesis as it reveals 
the name of the Hospital.  
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offered nothing worthwhile in exchange for her confidence. Secondly, I felt I 
was placed in a position where I had to determine if what she told me was 
likely to cause her to disengage with care at some point. How could I possibly 
predict her behaviour? Here it is important to state my “contingency plan”, 
mentioned in Chapter Three. After my interview with each patient I would 
make an assessment as to whether or not they had told me anything that I 
thought might warrant a break in confidence. In regards to Theodora, I 
eventually decided not to tell the practitioners what she had told me. This was 
because I determined that what she revealed to me was not significantly 
different from what the practitioners had already deduced about her past. I 
mention this not because I feel that I made the right decision, rather, I would 
like to draw attention to the fact that I (perhaps inadvertently) behaved in a 
way that was similar to the practitioners, in that I tried to anticipate the 
patient’s future behaviour based on her present-time self. This is interesting 
considering that it was never my intention to over-identify with the 
practitioners. Finally, my discomfort has to do with using Theodora’s, or for 
that matter, any of the patient’s I interviewed, narratives in this thesis. I am not 
suggesting that women in similar positions should not be research 
participants, but rather that the inclusion of their narratives (or narratives 
about them into a research project) is not as straightforward as I believed it 
could be when I began this project.  
 
Returning to a description of Theodora’s time in the clinic reveals how I 
emulated the practitioners in regards to Theodora’s behaviour and testimony. 
The practitioners were constantly trying to assess if Theodora’s taciturn 
behaviour might foreshadow her complete withdrawal from the clinic.  
When [Theodora] had her appointment, a lot of the conversation was 
about the fact that she is not eating and Sophia was trying to figure out if 
she was not eating because she didn’t have enough money to buy food, 
or if she was not eating because she just couldn’t eat, and she was 
feeling sick, and the patient was really difficult to get information from 
[…] Sophia is really concerned about [Theodora’s] mental health now; 
when she came back from the scan, [Theodora] said that they had told 
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her she is not growing enough, that the baby is on the small side, and 
Sophia was like, you know, this is what I mean, you have to eat, and 
during her appointment earlier Sophia asked her when the last time was 
that she had had a full meal and [Theodora] had said that it had been 
the previous week; she is not eating much at all, and she is very, very 
skinny (Field Notes, 18 February, 2009, pp. 10-11).  
To reiterate, Theodora’s behaviour in the clinic, in combination with what the 
practitioners knew about her background, led them to fear that the care they 
wanted to provide her with might be permanently disrupted because of her 
reactions to some sort of past trauma. Theodora’s reluctance to speak made it 
impossible for the practitioners to assess the validity of their fear. Thus, I 
argue that according to the practitioners the care that they provide always has 
the potential to be disrupted by the effects of a patient’s past atrocity. It is 
important to stress here that it was not only Theodora’s way of presenting 
herself in the clinic that concerned the practitioners. Rather, it was her 
presentation of self in combination with what the practitioners thought she 
might have experienced that led them to have concerns about her.  
In the absence of a more extensive personal history, the practitioners create a 
hypothetical past for the patient based on their knowledge and assumptions 
about the patient’s background (social, culture, religion, as well as political 
and historical context). In this way, the practitioners’ knowledge of the political 
situation in Angola in 2002 participates in the emergence of Theodora as a 
potentially traumatised patient. In other words, the traumatised patient 
emerges in the clinic because of a kind of silence on the part of the patient. 
The patient is understood by the practitioners to possess vital information; 
both information that pertains to her virus (as discussed in Chapter Four) and 
information that concerns her life and relationships outside of the clinic. The 
practitioners understand a potentially traumatised patient as being incapable 
of speaking openly, so she becomes unpredictable from the practitioners’ 
perspective. The trauma therefore threatens to disrupt the provision of care. 
The practitioners’ apprehension should be considered in relation to the 
discussion in Chapter Four that pertained to the viral load assays and the way 
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in which the practitioners are obliged to use information they suspect may be 
inaccurate. It became clear in that argument that the practitioners use 
technologies that they know might compromise the care they would like to 
provide. Accordingly, the assessment technologies, patients and other 
medical professionals are known to be capable of supplying the clinic’s 
practitioners with inaccurate and potentially damaging information on which 
the practitioners are obliged to base their practice. Here I make a similar 
argument with Theodora’s case: namely that the patient’s presentation of self 
in the clinic, most importantly her testimony, is used as a kind of technology 
that will ideally help the practitioners prevent vertical transmission. Therefore, 
from the practitioner’s perspective, a patient who does not provide a testimony 
and thus speak her trauma (if she is suspected of being traumatised) is 
potentially risky, in a way similar to a misreading viral load assay.  
However, I argue that there is a complication inherent to the practitioners’ 
approach, specifically in that those patients who are suspected of being 
traumatised will never fully be able to refute this suspicion. This is because a 
traumatised patient may be incapable of speaking her trauma. So, even when 
the patient speaks, her trauma is suspected of not having been fully spoken. 
Similar to the practitioners, when I mulled over everything Theodora had said 
during our interview, I determined that her assertion that nothing bad 
happened to her in Angola did not actually mean that nothing bad happened 
to her in Angola. Instead, I assumed that she could or would not tell me more. 
Thus, Theodora spoke and refuted a trauma, but in a sense I did not hear her.  
As discussed in Chapter Four, the practitioners’ knowledge that viral load 
assays have produced information that was later deemed inaccurate makes 
them feel apprehensive. In a similar way, patients who have been identified as 
being (potentially) traumatised will always make the practitioners uneasy. In 
other words, the patient will never be able to either refute the practitioners’ 
suspicions, or in any way assure the practitioners that they will be able to 
predict the implications of her trauma on her care in the present. Only when 
the failure or success of the practitioners’ efforts to prevent vertical 
transmission is established can the practitioners assess whether or not the 
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patient’s trauma had a negative impact on the care they provided. However, 
this assessment of the provision of past care is complicated because as 
mentioned previously, the effects of care are always subject to 
reinterpretation. In this way, we can begin to see the significance of the 
temporality of the care provided to patients within the HIV diaspora. I will 
explore the notion of temporality in more detail later. 
As mentioned before, from the practitioners’ perspective, they must have a 
level of trust in the patient’s presentation of self in order to provide care. In 
other words, the practitioners use the patient’s narrative to anticipate 
obstructions to the provision of care in the clinic. For example, if a patient 
revealed that she believed it was possible to prevent vertical transmission of 
HIV through prayer, the practitioners would then anticipate a particular kind of 
threat to care.112 Or, if the patient revealed that she was without recourse to 
public funds or any other means of support, the practitioners would be able to 
anticipate the consequences of this and enable them to initiate defences 
against these threats. But a patient who is suspected of not sharing potentially 
vital information, for whatever reason, makes it impossible for the practitioners 
to appropriately anticipate and contend with threats to their ability to provide 
care. This concerns the way the provision of care in the clinic requires that 
practitioners know the patient’s story and thus have access to the patient’s 
truth in so far as it may affect her time in the clinic. Thus, patients who are 
suspected of being traumatised and are consequently incapable of speaking 
their truths potentially threaten the network of care.  
To conclude this section, I will restate the discussion of Nancy Scheper-
Hughes’ (1993) work considered in Chapter Four. In that chapter I argued that 
certain knowledges of the patient’s body and life (that the practitioners deem 
to be relevant to her care) might remain hidden unless the practitioners 
actively seek them out. This argument was made in relation to viral load 
machines and how they were “not neutral”, nor did they produce “pure 
sources of data” (Scheper-Hughes, 1993, p. 292). Here I contend that the 
                                                
112 Indeed Fakoya et al. found that nearly one out of the three black African Christians that 
they surveyed from various denominations in the UK, believed that faith alone had the 
potential to “cure” HIV (Fakoya et al., 2012). 
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stories the clinic’s patients tell about their lives like the viral load assays and 
the “public records” discussed by Scheper-Hughes, “reveal a society’s 
particular system of classification. They are not so much mirrors of reality as 
they are filters” (1993, p. 292). The practitioners would view a patient’s 
presentation of self and the stories she would tell of her life during a 
consultation not as “mirrors” of the patient’s reality. Rather the practitioners 
would agree with Scheper-Hughes and contend that the patient’s presentation 
of self during consultations is a filtered version of her reality. This version may 
not contain information that the practitioners would deem vital to care. 
However, and importantly, the practitioners imagine that they are able to 
actively seek out information that has thus been filtered away. Their ability to 
do this however, is severely complicated if a patient is traumatised (van der 
Zaag and McKnight, 2017: forthcoming).  
	
Bad	care	
This section will be used to show what happens when the network of care is 
cut or when it was never established. This section will further clarify how care 
not only concerns just the present time patient, but also it has the potential to 
enhance or harm her future self, as well as future babies and partners. Cutting 
the network of care thus puts at risk the practitioners’ ability to care for all 
future patients as well. Moreover, I will illustrate how the MDT’s inability to 
fully protect, anticipate and compensate for the experiences their patients may 
have (and/or may have had) with professionals external to the clinic, may 
impede the MDT’s ability to provide good care.  
Ellen, the HIV specialist midwife, would often refer to a former patient113 who 
miscarried under particularly gruesome circumstances. I was given the 
impression that this patient’s experience in many ways exemplified Ellen’s 
concerns about some of the worst things that could happen as a result of the 
patient’s damaging interactions with professionals outside of the clinic. Ellen 
expanded on these anxieties during our first interview where she spoke about 
                                                
113 To the best of my knowledge I never met this patient. The narration that concerns her is 
based on conversations and interviews I had with Ellen.  
 169 
the patient in response to a question that asked if she ever felt anger towards 
other health care providers.  
I felt angry about a woman: she was on the [gynaecology] ward who had 
lost her baby, [had a] miscarriage. But the baby — the baby [was] 
delivered in parts and it [was] delivered over about a twenty-four hour 
period and she was in a side room and it was the night shift, and I think 
half the baby came out first; I mean it was a horrific delivery. And [staff 
on the ward114] wouldn’t go near her; there could be stigma about death, 
because it happens that people avoid women who have got dead 
babies. That can happen on the labour ward as well, that people don’t 
want to deal with those women. That can happen sometimes — a fear of 
death and the horribleness of that, and HIV as well. But you know she 
basically was left to go through that alone and then I picked her up again 
in the morning and that really, really angered me, makes me really, 
really angry (First Interview with Ellen, the HIV specialist midwife, 21 
August, 2008, p. 25). 
Later in the interview Ellen once again returned to this patient:  
Ulla: Does it ever hurt your feelings personally, if a patient rejects you? 
Ellen: I did find it — I had never had a patient reject me so fully as she 
did or when she actually lost her first baby and I popped in to say that 
I’m sorry to hear that this happened and I said that sometimes we don’t 
know why this would happen or what the cause is, and she said: “you 
are the cause”! It is quite difficult to be fully rejected; it is quite difficult 
because it’s nice to feel like you can help people, and actually, you do 
try and help them through and yet sometimes, I’m on a collision course 
with my information (First Interview with Ellen, the HIV specialist 
midwife, 21 August, 2008 p. 33). 
Here the problem with the patient’s rejection of Ellen extends beyond her 
desire to be liked: it is about how the patient’s negative experiences with 
professionals outside of the clinic may adversely impact on their opinion of the 
                                                
114 The staff in question were not members of the MDT.  
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clinic, the practitioners within it, and the care provided there. As a direct result 
of the poor care the patient experienced outside of the clinic, the practitioners’ 
ability to provide the patient with future care is jeopardised. While the patient’s 
miscarriage indicated the end of her pregnancy, it did not, from the 
practitioners’ perspective, end their intention to care for or about her. Rather, 
the provision of care would have continued assuming the patient would agree 
to be cared for. Here it is important to clarify that the future baby that I am 
referring to above is not limited to the unborn baby that died. Rather the future 
baby pertains to the potential of any and all future pregnancies and babies the 
patient may have. In addition, there are offspring that a patient may already 
have. This becomes clear in the following quotation from Ellen:  
What I do worry about is where there are women who have got children 
who are actually being cared for in Africa and we can’t do anything about 
that. We can suggest that they should get tested, but how do they do 
that? They’ve got to make a phone call to somebody who they would 
have to trust or tell […] the very, sort of sad situation would be that a 
child gets sick and dies as a result of the fact that we haven’t pushed for 
testing or thought to test (Second interview with Ellen, the HIV specialist 
midwife 18 March 2009, p. 9). 
 
The process of facilitating the emergence of the imagined relationship with a 
patient into the future is always a precarious undertaking from the 
practitioners’ perspective. However, the threats could have been minimised in 
the situation described above had the patient been provided with better, more 
caring care during her miscarriage — in other words, had she not been left so 
entirely alone to give birth to a disintegrated baby.  
 
Hence, while the practitioners in the clinic are part of a small specialist group 
that are able to provide well-honed, proficient and sympathetic care, their 
practice becomes implicated in the way the NHS (or any other (medical) care 
provider) as a whole provides or fails to provide good care. While the 
individual members of the MDT may share similar epistemological, 
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methodological and empathetic approaches to HIV and antenatal care, their 
patients may not judge the care they receive from the NHS according to each 
individual clinic in which they are cared for. Therefore, while the MDT devotes 
a significant amount of time trying to perfect their approach to patients (both 
medically and empathetically), they are nevertheless at risk of being 
indistinguishable from more hostile professionals in other parts of the NHS.  
The concerns I have described above are highly significant in the specialist 
clinic because of the practitioners’ preoccupation with the patient and her 
(unborn) baby’s potential. Unfavourable feelings about the care she is 
provided with is known to have the potential to negatively impact on her ability 
to accept care in the future. Indeed Tariq et al. make a similar observation that 
HIV-positive Black African women living in the UK with negative experiences 
with maternity services have the potential to influence their engagement with 
long-term care and their future decisions in regards to reproduction (2014, p. 
59).  
Thus, also at stake are all of the patient’s future babies and any sexual 
partners she may have. How the patient comes to terms with HIV and her 
HIV-positivity is known to have an effect on the way in which she will live her 
life as an HIV-positive person. Thus, according to the practitioners, whether or 
not she seeks out specialist (antenatal) HIV care in the future, discloses her 
HIV status to (potential) sexual partners, makes sure her children are tested, 
is connected to her experience with HIV (antenatal) care in the present. In 
other words, a bad experience of care in the present may lead to a woman 
becoming less likely to engage with care in the future. So, here I am arguing 
that pregnant HIV-positive women are cared for by the practitioners as if they 
exist within networks of people who are or may be (the practitioners imagine): 
alive, unborn, HIV- positive, HIV-negative, with a chance of being born free of 
HIV or not, in countries with access to ARVs and appropriate care or not, 
potential future patients in the clinic or the wider NHS or not. Importantly, the 
practitioners think about the effects their care may have on all of these 
hypothetical “people”, seeking to avoid bad care and to continually assess 
themselves in relation to their image of good care. In other words, the 
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practitioners imagine that the care they provide may directly impact on the 
health of an immeasurable number of people.  
This point enables me to extend the argument I made in the previous chapter 
in regards to patient autonomy. Concern for these future patients provides an 
example of how a logic of choice, as Mol (2008) has described it, is not 
conducive to the specificities of HIV antenatal care. As Mol argues, after the 
initial appeal of being offered a choice has worn off and reality sets in, it 
becomes clear that choice, in relation to specialist HIV antenatal care, does 
not offer the pregnant HIV-positive woman autonomy because she is not (nor 
will she be cared for as if she is) an autonomous individual (2008, p. 74). 
Rather, HIV-positive women with reproductive capabilities will always be 
potential future patients in the specialist antenatal clinic. Moreover, the 
wellbeing of their potential future offspring and any future sexual partners will 
always be relevant. Therefore, attached to the present-time patient is an un-
established amount of potential bodies and patients. The practitioners 
advocate for these eventual bodies and consequently, the present-time 
patient cannot be autonomous because she is not cared for as if her HIV was 
confined in her body. Instead, the present-time patient functions as a sort of 
ground zero in the clinic. By this I mean that an implication of her HIV-
positivity is that she is inevitably connected to other HIV-positive people who 
may or may not know their status. Moreover, her HIV-positivity and her 
reproductive capabilities means that other (HIV-positive or negative) bodies 
have the potential to emerge from her. Consequently, the practitioners are 
never finally able to assess the relative success or failure of the care they 
provide patients with.115  
	
 	
                                                
115 Instead the practitioners would view certain moments of care as either having failed or 
been successful. Thus, they would say that Patient X’s last course through the clinic was 
successful and this may remain true until something untoward happens in relation to her care, 
or her engagement with care in the future.  
 173 
Conclusion 
 
Pregnant HIV-positive patients are often asked and required to accept 
interventions in order to enhance their unborn babies’ chances of becoming 
HIV-negative and not specifically or necessarily for their own bodies’ benefit 
— for example, in the case of HIV-positive women who never needed to take 
ARVs prior to becoming pregnant. As discussed in Chapter Two, once a 
woman has chosen to become a patient of the clinic from the perspective of 
the practitioners, any further choices she makes during her pregnancy will be 
divided into two possible categories: 1) those choices that align with the 
practitioners’ understanding of behaviour that has the potential to facilitate the 
best possible outcomes for the imagined future postnatal patient and her 
baby, or 2) those that do not. In relation to this, Ellen expressed during an 
interview how she does not want the present time patient to get in the way of 
what she knows the imagined future patient and her (hopefully HIV-negative) 
baby have the potential to become.  
Because we have a baby on board too, and I would feel awful it’s quite 
hard when there is a positive baby, because you have such a sense of 
failure about that, because what we’ve got does work, and I’d hate — 
somebody because of their belief system or because of their emotion at 
the time — that they couldn’t do the right thing so that they ended up 
with a positive baby because you don’t want them to be in that position 
(First Interview with Ellen, the HIV specialist midwife, 21 August 2008, p. 
33). 
In order to achieve this end, it is apparent that the logic of care in the clinic 
requires that the practitioners engage in practical activities that they believe 
will make the lives of their patients better (Mol, 2008, p. 75). In this chapter, I 
have been emphasising that this logic of care is also a network of care and 
what has been demonstrated is that the practitioners imagine that there are 
numerous threats to this network. The way in which the practitioners 
anticipate and contend with these threats emphasises how they place a 
tremendous amount of importance on the relationships they are able to 
establish and maintain with patients. At best these relationships would enable 
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the practitioners to provide care despite constant threats to the network of 
care. Moreover, echoing and extending Mol’s contention that within the logic 
of care, the exactitudes of what a better life would entail “form part of 
[practice]” (2008, p. 75), I have highlighted that some of the relevant actors 
are not yet in existence, which leads to the practitioners advocating on behalf 
of only imagined potential actors. The practitioners’ desired outcome of this 
significant proposition is reflected in the extract below:  
What is nice about this job is that you get the relationship, [the women] 
pop by to see me with their babies or I see them at DOSH when they are 
about four years old or whatever. It’s rewarding if you can help 
somebody’s situation get better; there is a real joy in that so it’s not all 
doom and gloom. Some of them come along and they’re in their next 
pregnancy and I’ve known them from before and it can be quite fun (First 
Interview with Ellen, the HIV specialist midwife, 21 August, 2008, pp. 34-
35). 
Ellen’s articulations are important and illustrate how, from her perspective, it is 
the work that the practitioners do during a patient’s initial experience in the 
clinic that enable their subsequent pregnancies to be “enjoyable”. This mode 
of operation in the clinic is informed by the practitioners’ collective 
experiences with providing successful care to their patients. In other words, 
the practitioners know that they have the ability to provide good care and they 
know that the (future) patient and her (future) children will reap the benefits if 
she can be persuaded to acquiesce to it, and importantly, if no other actors (or 
other networks) interfere with the provision of care.  
This chapter has provided a series of key examples of events and situations 
that disrupted the provision of care in the clinic and has shown how the 
practitioners constantly try to anticipate and counteract these threats. First, 
the chapter showed that the network of care has to be established in relation 
to existent networks. The women patients are themselves in networks that 
extend beyond the clinic. Not least, most exist within a diasporic network. On 
the one hand, this threatens their care in the sense that the looming threat of 
deportation may affect their choices in the present. The chapter argued that 
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the clinic must care for the “near future” patient, and it negotiates — 
sometimes even creates — emotional scenarios in order to achieve that goal, 
even as the practitioners know they have no significant influence over the 
legal situation. On the other hand, living within an HIV diaspora may threaten 
the care the clinic aspires to if the patient has family members — including 
other children — still living overseas. Here, the practitioners feel they must 
“cut the network” themselves in relation to those members. 
 
Secondly, the chapter focused on the case of Verity where the unequal 
distribution of knowledge and specialisms across the NHS network meant that 
different understandings of the care available free of charge to a woman with 
her immigration status threatened to disallow access to the best care for her 
condition. This, coupled with restrictions arising from her residential location 
and exacerbated by her difficulties in accessing the correct drugs from the 
pharmacy, showed how the care provided in the clinic is threatened by other 
professionals within the NHS. Moreover, the case underscored that the 
network that the practitioners would wish to set up for such a case — that 
would include the baby’s care in the future — were not considered by other 
parts of the NHS. 
 
A third way in which the network of care is threatened was shown through the 
example of Theodora. Her case illustrated the idea that a patient who may be 
suffering from a traumatic experience in the past can cause worry on behalf of 
the practitioners who fear her trauma may prevent their ability to offer care. It 
was shown how the practitioners fear that a traumatised patient may 
involuntarily filter information away from the practitioners — information that 
may be vital to their provision of care.  
 
Fourthly, the network of care can be cut by other professionals lacking the 
same understanding or standards of care for HIV-positive mothers. This 
threatens the network of care not only by making the mothers upset or angry, 
but it also threatens the future network that the practitioners imagine is 
likewise within their remit of care. This section enabled me to argue that the 
practitioners also place the women patients within imagined future networks. 
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Additionally, this chapter has demonstrated that the practitioners’ ability and 
desire to provide good specialist HIV antenatal care is not enough to ensure 
the provision of care. This is hugely significant and alludes to the fact that 
being a patient of the clinic is not necessarily enough for the patients. In other 
words, the successful prevention of vertical transmission of HIV and the 
provision of good care is not enough to ensure that the clinic’s patients or her 
offspring will be able to decouple HIV from death. To reiterate the importance 
of this argument: the practitioners imagine the future patient and her offspring 
as they have the potential to become and they engage in caring practices that 
will ideally enable these figures to emerge. However, this entire process 
depends on the woman being able to accept care now and in the future. The 
ability to accept care in the future is a rare privilege that many of the clinic’s 
present-time patients know they will not have. The next chapter will consider, 
amongst other things, what it means to live with the knowledge that your life 
and your children’s lives are entirely dependent on your access to care.  
 
Thus, the discussion in this chapter has begun to outline an argument that will 
be furthered in Chapter Six: namely, that while the ability to prevent vertical 
transmission of HIV is an outstanding achievement, it is important to keep in 
mind that the (HIV-negative) babies of HIV-positive mothers are still at risk of 
morbidity and mortality as a consequence of their mothers’ serological status, 
if the mothers do not have continued access to life-sustaining care and ARVs. 
Consequently, from the patient’s perspective, the provision of good care and 
the prevention of vertical transmission of HIV is not enough to secure her life 
or the life of her baby.  
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Chapter	Six:	Uncertain	future(s)	
“Ulla: Do you think that you’ll tell116 your [child] when he’s older? 
 
Elisabeth: No, I think I’ll take it to my grave. 
 
Ulla: Are you worried that he would treat you differently? 
 
Elisabeth: No, I don’t think he would. But it’s just the fear, protecting him. 
Because I want to protect him. Because they will treat him differently, 
and I have seen it! At times, with some of the cousins, the way they will 
behave, and it’s because they know that I am, they figure: Oh maybe 
even the child? So stay clear of him, don’t move his stuff (First interview 
with Elisabeth, 17 December, 2008 p. 13)! 
 
It is just people from my own country; I think they have probably seen 
other people around that have [HIV]. So when they ask you they are just 
trying to snoop. They are just trying to dig deeper; they ask you what 
kind of birth did you have, was it a C-section or a normal birth? […] Once 
they know you had a C-section, and now you are bottle-feeding, they 
say now we know (Second interview with Elisabeth, 6 May, 2009 pp. 1-
2)! 
This chapter will consider the key fears and concerns expressed during 
interviews with the women attending the clinic. These fears and concerns 
reveal the complexities of the women’s negotiations of the care on offer in the 
UK. While the practitioners imagine the postnatal woman and her hopefully 
HIV-negative future baby in a certain way, and imagine their task in terms of 
facilitating that outcome through the biomedicines and technologies they are 
able to provide, the women are negotiating these within the context of other 
relations as they confront their future. These relations are not confined to the 
clinic but involve their partners, families and legal authorities. The way in 
                                                
116 That she is HIV-positive.  
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which the women imagine their futures (and the futures of their offspring) 
involve all these relations which are frequently tense especially where the 
women have precarious immigration status and where they believe levels of 
HIV acceptance in their “home” countries is low. Consequently, the women 
are not really able to make their decisions autonomously. The choices they 
make in relation to their own health have to be seen through the prism of 
these complex relations.  
 
This chapter will help clarify what is at stake for these women whose lives, 
children’s lives and general wellbeing are so entirely dependent on the care, 
biomedicines and technologies they are receiving. It becomes especially clear 
that being part of the HIV diaspora affects all aspects of their lives. Indeed, I 
will make an argument for the importance of considering the HIV diaspora as 
one of the most salient factors in assessing the circumstances of the patients 
in the clinic. This chapter will discuss these prominent fears or concerns in 
four sections: first, in regards to the shadow that fears about being deported 
casts over the women’s lives; secondly, the way in which replacement feeding 
— a cornerstone of HIV prevention — becomes problematic; thirdly, the 
challenges for those women who live with serodiscordant relationships, and 
finally the role that violence has played in the lives of the women.  
	
Imagining	a	future	or	imagining	death:	Fears	about	immigration	status	
 
In this section I will address some of the questions posed in Chapter Two: 
namely, how can we make sense of the significance of place and space and 
the effects of the movement of people between spaces, and the significance 
of the previous spaces that they occupied? These questions arose after it 
became clear to me that the majority of the clinic’s patients were highly aware 
that their HIV-positivity meant their lives would be considerably worse (if not 
impossible) if they were not able to remain in the UK.  
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In regards to this, all of the women who had a tenuous immigration117 status 
expressed their fear at some point of being “sent home”, which was for them 
synonymous with being sentenced to death. Accordingly, as mentioned 
before, women who felt themselves to be at risk of deportation realised that 
they would not have indefinite access to the kind of (biomedical) technologies 
and care available to them in the clinic and at the DOSH. Consequently, the 
way in which the women imagined their potential was intractably related to 
their ability to remain in a location wherein HIV and death have been 
decoupled. Moreover, it will become clear throughout this discussion that fear 
of deportation (in the future) has a significant effect on the way women come 
to terms with HIV-positivity and adapt to antenatal care and becoming a 
mother (Anderson and Doyal, 2004, p. 101).  
 
In other words, the women’s ability to imagine a future for themselves or a 
future-self was dictated by their immigration status. This is because women 
living with HIV who have an insecure claim to remain in the UK struggle with 
the knowledge that their lives and the lives of their (unborn) babies have two 
different possibilities that are entirely tied to location. Following this, while 
securing a baby’s HIV-negativity was a desirable achievement for the women 
I interviewed, a baby’s life would still be under threat because of the effects of 
its mother’s HIV status. If she is deported, the mother’s potential or eventual 
death would be the most extreme effect of HIV on the baby’s life. Thus, while 
the prevention of vertical transmission enables babies born to HIV-positive 
mothers to live free of HIV, it does not in and of itself protect the baby from the 
effects of the virus — the ultimate one being the death of both mother and 
child.  
 
Because she is aware of this precarious situation, an HIV-positive mother who 
is at risk of being removed from the UK simultaneously negotiates her own 
and her children’s future potential in two geographic locations. Following this, I 
argue that HIV-positive mothers in the clinic are tasked with the responsibility 
                                                
117 The practitioners in the clinic would categorise their patients as either having “secure 
immigration status” or “insecure status”. Insecure status could denote patients whose 
immigration status was unknown (by the practitioners) or if they were not in the UK legally 
and/or had not made themselves known to immigration services.  
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of participating in the prevention of vertical transmission as well as protecting 
their descendants from the negative effects of HIV even if prevention is 
successful. To reiterate and to stress the significance of this undertaking, 
women thus positioned need to contend with the fact that their offspring would 
be made more vulnerable if their HIV status was generally known, and if their 
progeny are suspected of also being infected. What is more, the women 
would also need to take into account the effects their own deaths would have 
on their children’s lives. What follows is a discussion of the way three women I 
interviewed (Eleanor, Alegra and Evelina) spoke about the importance of their 
geographical location.  
 
Eleanor had been raped by her brother-in-law and was frightened of being 
sent back to her country of origin in East Africa. She explained that she had 
seen what her life would be like as an HIV-positive person there. After 
witnessing her sister’s rapid physical deterioration and suffering, Eleanor 
began to suspect that the three of them were HIV-positive. Eleanor knew that 
a similar demise would befall her if she was forced to return to East Africa.  
I can’t go back home no matter what, honestly. If it means sleeping on 
the streets, I’ll sleep on the streets ‘cause I can’t go there; it’s like they 
are sending me to go and die […] it’s a matter of life and death. So I 
have to choose, if I’m going I have to choose, I’m going to die and I don’t 
want to die now (Second interview with Eleanor, 16 December, 2008, p. 
28)! 
Eleanor’s concern reflects Anderson’s and Doyal’s discussion of the way in 
which previous experiences with HIV may influence how people living with 
HIV come to terms with their diagnosis (2004, p. 96). Similarly, Alegra’s fears 
for the future were compounded by her immigration status. She explained that 
her ability to live and to imagine a future for herself was dependent on being 
able to stay in the UK. Her solicitor had made an application on her behalf for 
permanent residency, citing her medical status as the incentive. However, she 
had been told that the Home Office had rejected her case. I asked Alegra how 
this made her feel.  
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You living here illegally is not good! They can send you back to your 
country and what should happen to me? Just die! […] If they send me 
back I’m not going to live, but if I’m here I will live, I can work also, I can 
do everything people are doing here but not in Africa (Second Interview 
with Alegra, 21 April, 2009, p. 11). 
The conviction that their lives would end horribly and quickly if they were 
deported made it impossible for the women thus positioned to imagine an 
optimistic future for themselves or for their children. Being an HIV-positive 
mother in their countries of origin was for them synonymous with death and 
the abandonment of their children. In other words, the women are expressing 
what it means to know that your life is dependent on living in a location you 
have no legal right to remain in. In relation to this, Cooper and Bradshaw 
argue that fear of deportation may further damage pregnant asylum seekers 
in the UK in regards to their mental and physical health (2013, p. 1046). Thus, 
fear of the future has a real and immediate effect on the women’s lives in the 
present.  
 
Evelina expressed these sentiments during our interview where she explained 
how her diagnosis had ended her dream of making a better life for herself and 
her children. She was petrified of being deported. Evelina thought that if she 
were not HIV-positive, it would be very difficult, but just manageable, to 
support two children and herself in Jamaica; being HIV-positive made 
imagining a life there impossible for her. She did not know who would care for 
her children if she were to become sick or die. Evelina felt that HIV was 
tolerable now, only because she had the support of the practitioners at the 
DOSH and access to medication. She doubted that this would be available to 
her in Jamaica. HIV had taken away Evelina’s ability to envisage a favourable 
life. Moreover, her anxiety extended beyond the prevention of vertical 
transmission of HIV and was related to her ability to raise and support her 
children. What I would like to draw out of this argument is that the prevention 
of vertical transmission does not ensure a life for HIV-positive women or their 
HIV-negative babies. In other words, the successful prevention of vertical 
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transmission is not enough to prevent an infant from dying as a consequence 
of HIV. Evelina’s statements during our interview reflect these arguments.  
I don’t really think about life — things that are in the world, because 
you’re just going to go away and leave them. It’s just done me different. 
HIV just […] I don’t have any hopes or dreams. Sometimes I don’t really 
bother (Interview with Evelina, 8 December, 2008, p. 19). 
Moreover, Evelina was fearful of what people would think of her if she was 
forced to return and the effect that this would have on her and her children’s 
lives. She felt that people would be less inclined to help her if she needed it 
because they would consider her a person who had had an enviable 
opportunity but squandered it.  
They would think that I made a whore of myself […] They’d think I 
whored all over the place. That’s what they’d think [...] they have a thing 
like this if you went away […] you went somewhere where the money 
was given away so you should have come back with a lot of it (Interview 
with Evelina, 8 December, 2008, p. 20)! 
Evelina fears being excluded from a collective that would normally protect her 
and her children. Her rejection would result from the fact that people in her 
home country would think she had failed to take advantage of the privileges 
that she was assumed to have had temporary access to. Therefore, from 
Evelina’s perspective, failing to be appropriately enhanced by the resources 
thought to be available in a privileged geographical location — and even 
worse, becoming HIV-positive — would make any re-admittance and 
acceptance into her previous geographical location an impossibility. She is 
thus in limbo, as are her children. Consequently, she is unable to secure 
decent lives or futures for herself or her children in either location. Evelina’s 
feelings are reflected in Issiaka and colleagues’ (2001) argument which states 
that many women in African countries are dependent on family support 
networks to care for them if they should fall ill. Following this, they argue that 
HIV-positive women may not want to disclose their HIV status to members of 
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their family because caring for an infected person is considered to be “a 
negative investment” (2001, p. 126).  
As discussed in Chapter One, HIV-positive people in different geographical 
locations have varying access to ART. Following this, Evelina fears being 
expelled from a particular location wherein she can imagine a tolerable life as 
an HIV-positive mother. Another consequence of Evelina knowing that she 
could, at any time, be denied access to the UK is that she was never fully able 
to realise and fulfil her potential as an HIV-positive mother in a location 
wherein HIV is constructed as a manageable lifetime affliction. To clarify, 
Evelina’s narrative evidences her awareness of the multiple possibilities for 
what her life as an HIV-positive woman and mother might be. What is more, 
Evelina’s statements illustrate that she considers her immigration status to be 
one of the most crucial aspects that determines which of these possibilities 
will befall her.  
To reiterate, a consequence of this is that women thus positioned are never 
entirely able to take advantage of or be enhanced by resources that may be 
temporarily on offer to them. This is in part because they are not able to 
imagine their future selves (or their future offspring) as having sustained and 
uncontested access to life-sustaining and enhancing resources. Accordingly, 
an HIV-positive (pregnant) woman’s future self has two possibilities for what 
she and her children may become (if her immigration status is insecure and if 
she is at risk of being sent back to a country where ART and appropriate care 
is not readily available): that of being dead (sent “home”) or alive (in the UK).  
 
Here it is important to stress that being enhanced by biomedical technologies 
and care ostensibly on offer is not simply about the content or expanse of a 
patient’s imagination or her behaviour. Rather, I argue that the diasporic 
positionality of the women I interviewed placed all sorts of other restrictions 
and burdens on them, the most significant of which was that they were 
excluded from modes of protection (primarily legal and social protection) 
available to women who are not part of a diaspora. It is, I argue, the lived 
experience of what this exclusion entails that impinges on the women’s 
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expectations for the future. This, I contend, is particularly significant when 
thought of in relation to the levels of violence most of the women were 
subjected to on a regular basis.118 
 
Moreover, women thus positioned must constantly attempt to negotiate and 
coordinate between these contrasting locations and their differing 
expectations in them. As discussed in the previous chapter, Sophia summed 
up the essence of this when I asked her to expand upon a statement she had 
made to Yamea. Sophia had explained that the patient’s fear of dying would 
be appropriate if she were in Africa, but as long as she was able to remain in 
the UK, she could expect to live if she acquiesced to treatment (First interview 
with Sophia, the HIV specialist doctor, 30 September, 2008, p. 12). The point 
being that this fact indelibly complicates the women’s ability to fully immerse 
themselves in the technologies and care (temporarily) available to them. 
Moreover, as discussed in Chapter Four, even if a woman were to fully 
immerse herself in the technologies on offer, the technologies also have the 
ability to limit their potential enhancement.  
 
This is important, and I suggest it could have significant effects on the way in 
which women thus positioned adapt to motherhood as well as come to terms 
with their HIV diagnosis and use the HIV prevention and detection 
technologies available. These concerns are reminiscent of an observation 
made by Valle and Levy. They argue that the meaning that African American 
women in the USA place on their new diagnosis has an impact on the way 
they will come to accept or reject HIV care (Valle and Levy, 2008, p. 131). 
Although, for Evelina and other women similarly positioned, their diagnosis 
meant that the futures they had previously imagined were no longer possible. 
From the women’s perspective, an HIV diagnosis in combination with the risk 
                                                
118 Indeed all of the women that I interviewed were in, or had been in physically and/or 
emotionally violent relationships. Moreover, in a study based at an East London HIV clinic 
Dhairywan et al. (2013) found that one out of eight of the HIV-positive women they surveyed 
had experienced “intimate partner violence” during pregnancy.  
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of deportation meant the irrevocable end of their ability to be a good mother 
and secure an adequate future for their children and themselves.  
	
Replacement	feeding:	Prevention	or	detection	technology? 
Well, to be honest with you, I actually have issues with breastfeeding119 
because it’s really difficult when you know that this woman is positive 
and she’s been given that choice, but actually the choice is really more 
to do with what’s best for the child. So if they’re coming from an area [in 
South Africa] where there’s no clean water and they can’t clean, sterilise 
the bottles and all that, the chances [are] that the child is going to die of 
gastro-enteritis or some other problem much quicker than HIV, so in that 
way it makes sense that they breastfeed. But it is hard, isn’t it? Because 
you know that actually we are trying to reduce the risk and you are 
breastfeeding! (Interview with Laura, an HIV specialist paediatric nurse, 
29 January 2009, p. 19)! 
Breast milk is a transmission source of HIV.120 Therefore, HIV-positive 
mothers are able to avoid exposing their infants to HIV-contaminated breast 
milk if they replacement feed them, which the World Health Organisation 
(WHO) defines as “the process of feeding a child who is not receiving any 
breast milk with a diet that provides all the nutrients the child needs” (2010, p. 
45; Dunn et al., 1992). According to the WHO’s encompassing definition of 
replacement feeding, it is essentially any method of feeding using any 
substance aside from the infant’s mother’s breast milk. However, replacement 
feeding is not advised for all HIV-positive mothers. The WHO writes that this 
method is only advised for women who are able to fulfil the following criteria:  
Mothers known to be HIV-infected should only give commercial infant 
formula milk as a replacement feed to their HIV-uninfected infants or 
                                                
119 In addition to her work in London, Laura works with HIV-positive children in South Africa. 
During our interview she spoke about HIV care in South Africa and the fact that HIV-positive 
mothers are advised to breastfeed.  
120 According to the Nduati et al. (2000), if a mother is not on ART then the risk of vertical 
transmission of HIV through breast milk is about 16%. 
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infants who are of unknown HIV status, when specific conditions are 
met: 
a. safe water and sanitation are assured at the household level and in 
the community; and 
b. the mother, or other caregiver can reliably provide sufficient infant 
formula milk to support normal growth and development of the infant; 
and 
c. the mother or caregiver can prepare it cleanly and frequently enough 
so that it is safe and carries a low risk of diarrhoea and malnutrition; and 
d. the mother or caregiver can, in the first six months, exclusively give 
infant formula milk; and 
e. the family is supportive of this practice; and 
f. the mother or caregiver can access health care that offers 
comprehensive child health services (WHO, 2010, p. 37). 
National authorities in countries where women are generally not able to fulfil 
the requirements for safe replacement feeding are advised by the WHO to 
promote exclusive breastfeeding to HIV-positive women and their infants, for 
six months after birth (WHO, 2010; Goga et al., 2012). Thereafter women are 
counselled to introduce other foods while continuing to breastfeed for at least 
a further six months.121 In order to reduce the risk of infants becoming infected 
with HIV, women and/or their infants are advised to take ART throughout the 
breastfeeding period (WHO, 2010). This will reduce the risk of transmission of 
HIV to between 0%-6% (Tariq et al., 2016: Horvath et al., 2009: Siegfried et 
al., 2011).  
 
As this advice shows, replacement feeding is understood as providing HIV-
positive mothers with an alternative way to feed their infants non-
contaminated breast milk. Accordingly, replacement feeding is able to ensure 
health, if health is defined as the absence of HIV. However, replacement 
feeding is not able to guarantee health if health is defined as anything else, 
such as the absence of cholera, or typhoid, etcetera. Rather, in these 
                                                
121 For a discussion on the often conflicting advice on replacement feeding given to women in 
resource-poor settings please see: de Paoli et al., 2002 and Moland et al., 2010.  
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circumstances it can be seen to be the cause of these morbidities (Coovadia 
et al., 2007; IIiff et al., 2005). Thus, infants of mothers unable to fulfil the 
requirements for safe replacement feeding are at a more immediate risk of 
mortality from other illnesses such as diarrhoea, than they are of dying from 
an HIV-related illness.  
 
In this way, HIV prevention technologies can be assessed as health 
promoting technologies by a set of indicators (de Laet and Mol, 2000, pp. 231-
233). Replacement feeding’s health indicators concern HIV transmission 
through breast milk, but only for specific groups of HIV-positive mothers. For 
mothers not part of these groups, it would be more appropriate to speak of 
replacement feedings’ mortality indicators which concern malnutrition, 
waterborne bacteria and illnesses, etcetera. Hence, the process of comparing 
alternatives is a specific procedure that may have variable outcomes 
depending on any number of factors. However, in this example, access to 
certain resources (which is almost interchangeable with geographical location) 
is the most prominent influence. Here we see a clear geographical divide that 
has to do with access to resources between HIV-positive women who are able 
to secure their infants’ negative HIV status and lives by feeding them artificial 
milk, and women who are not.  
 
Replacement feeding is a technology122 that can in certain circumstances 
(which are almost entirely connected to geographical location) protect infants 
                                                
122 A note on replacement feeding as a “technology”: in this chapter I refer to replacement 
feeding as an HIV prevention technology. However, before I continue, I will clarify the way in 
which I have come to think of it in this way. For ease of expression, I use the phrase 
“replacement feeding” when it would be more accurate for me to write the “conglomeration of 
the various instruments that are used to facilitate replacement feeding”. These instruments 
could include spoons, cups, bottles, bottle sterilisers, kettles to boil water and so on. 
Importantly, however, is the fact that while what these instruments are and how they may be 
used can vary, the final product would always be the same: the final product being an object 
that is able to make and convey replacement milk into the mouth of a baby. Thus, 
“replacement feeding”, as I have defined it is a technology in a way similar to the bush pump, 
described by de Laet and Mol (2000). They write that the boundaries of the Zimbabwean 
bush pump are multiple and that each of the boundaries of the pump “define a limited set of 
configurations” (2000, p. 237). “They each, one might say, enact a different bush pump” 
(2000, pp. 237- 238). Thus, like de Laet and Mol, who refer to the bush pump as a fluid 
technology, I am thinking of replacement feeding as a “conglomeration of the various 
instruments that are used to facilitate replacement feeding”, i.e. are needed to get 
replacement milk into a baby. 
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from morbidity and mortality, while in other circumstances it cannot. 
Consequently, the meaning and effects of replacement feeding vary 
depending on the geographical location wherein it is used and on the original 
geographical location of the women who use it, as will become clear later in 
this chapter. Indeed, replacement feeding like the viral load assays discussed 
in Chapter Four is not a neutral technology (Scheper-Hughes 1993, p. 292). 
Instead, and restating the argument made previously, technologies “reveal a 
society’s particular system of classification” (1993, p. 292) and here I argue 
that they do even more than that since some of the technologies’ effects 
reveal global inequalities and their consequences.  
 
I argue that while replacement feeding may at first glance seem like the most 
straightforward HIV prevention technology on offer to HIV-positive mothers 
(who are located in geographical locations where it is advised), it is in fact a 
highly complex and contentious technology that also has the ability to harm 
women and their offspring. In other words, I will show that replacement 
feeding as an HIV prevention technology’s potential (to harm or help) is 
delimited by and connected to the particular circumstances and the (previous) 
geographical location of the women that engage with it, furthering the 
argument made previously that HIV and HIV (prevention) technologies have 
different meanings and effects for people who engage with them depending 
on their incorporation within the HIV diaspora. This also means that 
preventing HIV, and the morbidity and mortality associated with it, not only 
concerns access to biomedical technologies such as ART or appropriate care, 
but also to other conditions and circumstances that occur almost exclusively 
in specific geographic locations.  
 
In what follows, I will discuss two women’s problematic experiences with 
replacement feeding. I will argue that the difficulties they encountered are 
directly related to the way their families and communities used “replacement 
feeding” as an HIV detection device.123 Moreover, it will become clear that the 
technology is used in this way as a direct result of the meaning that it is 
                                                
123 Tariq et al. (2016) have made a similar argument as will be discussed below.  
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imbued with as a consequence of its position within the diaspora. To reiterate, 
the technology has a fluid meaning in that it is simultaneously an HIV 
prevention and a detection technology within specific diasporic 
communities.124 In part this is because HIV positivity is not the only, or 
necessarily the most immediate threat that they must protect their infants or 
themselves from. Here we see how the prevention of vertical transmission of 
HIV loses some of its significance when thought of in relation to the 
complexities inherent to living life as an HIV-positive mother.  
	
Eleanor	
I was on the bus, [the new-born] was crying. I tried everything. I gave her 
a dummy. So this [African] lady, she wanted me to give her milk. I had 
milk, but it was too hot […] so this lady says “the baby is crying too 
much, give her the breast, don’t be afraid of everyone; come sit here, 
give her the breast.” That’s what she was telling me, you know, “give her 
the breast, sit there, don’t be ashamed!” I looked at her and said, “no, 
she doesn’t want breast, I have given her food already”. One thing that 
lady kept saying to me, one thing I cannot understand, she kept on 
saying “my baby is crying” — I didn’t like it, I ended up insulting her. I 
told her I am the mom, I know best. Because she kept on insisting that I 
give the baby breast and that really just affected me and offended me 
[…] I had to get off at this stop where I was not getting off because 
people were looking at me (Third interview with Eleanor, 7 May, p 16)!  
Eleanor and I met during the first trimester of her second pregnancy. As I 
came to know her over the course of her pregnancy (and postnatally) I felt 
increasingly saddened by the mounting hopelessness she expressed over the 
way her life was turning out. It seemed to me that despite having the best 
intentions she encountered insurmountable difficulties any way she turned. 
Eleanor was young, lonely and beautiful and from what she told me about her 
life, it seemed to me that she would unquestionably trust men who presented 
                                                
124 By this I mean communities that are connected to geographical locations wherein HIV and 
death are not decoupled and locations where they are.  
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themselves to her in an authoritative manner. While some of these qualities 
might have been desirable for a young woman under different circumstances, 
I felt that they exposed Eleanor to the caprices of men that ultimately took 
advantage of her gullibility. Consequently, Eleanor was single, pregnant with 
her second baby, without recourse to public funds in her own right and had 
little hope of being able to legally remain in the UK.  
 
During our last postnatal interview, Eleanor told me that her mother, who lives 
in Africa, warned her never to reveal to anyone that she was not 
breastfeeding her baby. Eleanor’s mother explained that people in [their 
country of origin] would begin to suspect there was something “wrong with 
[her]”, if they knew the truth (Third interview with Eleanor, 7 May, 2009, pp. 
16-17). This conversation led Eleanor to believe that her mother suspected 
her of being HIV-positive, although she had never directly disclosed her status 
to her mother. Eleanor thought her mother had begun to suspect the truth 
after she had found out she was replacement feeding. In a similar way, Tariq 
et al. contend that within African diaspora communities in the UK, the “bottle-
fed infant” may become a “visible surrogate marker for an HIV-positive status” 
(2016, p. 3).125 Thus, Tariq argues that African HIV-positive mothers fear that 
their status will be revealed if it is known that they are not breastfeeding 
(Tariq, 2013, p. 270). Hence, in accordance with her mother’s advice, Eleanor 
came up with elaborate strategies to trick people into thinking that she was 
breastfeeding. Eleanor’s efforts to conceal HIV reflect Anderson’s and Doyal’s 
argument that HIV-positive women’s perceived need to keep their HIV-
positivity a secret often leads them to place major constraints on their social 
interactions (2004, p. 101-102).126 
 
Here it is important to state that not all women in the UK who abstain from 
breastfeeding would be suspected of being HIV-positive, considering that 
according to the most recent Infant Feeding Survey, only one in one hundred 
                                                
125 Eide et al., (2006) make a similar argument in relation to HIV-positive mothers in Sub-
Saharan Africa.  
126 As Tariq points (2013, p. 270) other researchers have shown that HIV-positive mothers 
often isolate themselves in an attempt to involuntarily disclose their HIV status (Blystad et al., 
2009, Cames et al., 2010; Desclaux et al., 2009; Nuwagaba-Biribonwoha et al., 2006).  
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mothers in the UK followed the NHS guidelines of exclusively breastfeeding 
their babies until six months of age (McAndrew et al., 2012, p. 4). In other 
words, the overwhelming majority of women in the UK replacement feed their 
babies. Therefore, my argument proposes that the meaning of replacement 
feeding in Eleanor’s situation is tied to her country of origin and the meaning 
replacement feeding has there. In other words, her mother’s concern was 
triggered by the fact that for her, breastfeeding was the ideal way to sustain 
an infant. Thus, I suggest that Eleanor felt that her mother had used the fact 
that she was not breastfeeding as a sign that she was HIV-positive.  
	
Elisabeth	
 
Elisabeth’s family and community voiced similar concerns although they did 
this in a way that was much more harmful to her. Elisabeth was a very well-
liked patient. The practitioners would talk enthusiastically about her on the 
days that she was expected to come in. A large part of Elisabeth’s popularity 
in the clinic stemmed from the fact that she would always bring her charming 
and precocious son with her. Elisabeth and I grew close during the course of 
her pregnancy and I subsequently gained insight into the incredibly hostile 
home environment she came from. Her dedication to her son and his sweet 
sympathetic nature became more poignant as she began to tell me about the 
threat of violence that both of them faced on a daily basis from her partner. In 
what follows, I have chosen to focus on one aspect of Elisabeth’s home 
environment that specifically concerns replacement feeding. However, it is 
important to point out that Elisabeth had told me that she and her son had 
suffered sustained and severe physical and emotional abuse at the hands of 
her husband and lived in constant fear of provoking him.  
 
Elisabeth’s extended family suspected her of being HIV-positive and she 
feared that they would try to ascertain if she was breastfeeding her baby, as 
well as find out if she had had a C-section. Elisabeth explained that her family 
would assume that she was HIV-positive if they found out that she was not 
breastfeeding and that she had not had a vaginal birth. Her concern is 
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reflected by Burns and colleagues who argue that in the UK, African migrants’ 
understanding regarding HIV is hugely influenced by their experiences with 
the virus in their home country (2007, pp. 104, 106). However, in Elisabeth’s 
case, it was her family’s understanding of HIV, and not her own, that had the 
most impact on her life.  
 
In regards to this, Elisabeth told me that her family and her partner’s family 
had swarmed around her every time she had been in hospital. After her older 
child was born and was a few weeks old, one of her relatives came to her 
house and accused her of having AIDS. Elisabeth felt that her family were 
trying to force her to admit that she was HIV-positive. She felt that they were 
not at all concerned about her or her child’s wellbeing; they simply wanted to 
upset her in order to see how she would react to their accusations. Elisabeth 
anticipated an intensification of the problems she experienced with her family 
after the birth of her second child. 
 
Aside from her husband, who was, as far as she knew, HIV-negative, 
Elisabeth had not disclosed her HIV status to anyone in her family, nor did 
she intend to. Based on what she had previously heard them say and do, she 
concluded that in order to protect her children, she must hide her status from 
them even though they suspected her of being positive. Despite not having 
concrete evidence of her or her son’s status, the persecution that Elisabeth 
and her son endured from their family was extreme and had a monumental 
impact on her wellbeing. She felt desperately lonely and fearful.  
 
Thus, Elisabeth’s child is penalised as being HIV-positive and marked by the 
stigma of AIDS that is enacted within the family, even though the child was 
born free of HIV. Hence, if a woman is confirmed to be or suspected of being 
HIV-positive, HIV will indelibly be connected to her (within her social relations) 
and to her offspring, even if her progeny are born free of the virus. In this way, 
HIV (as it is in the woman’s body unobservable in real-time) is not limited to 
the HIV-positive woman’s body, even if it is not physically transferred.  
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Elisabeth asked her husband not to tell anyone that she was not going to 
breastfeed. He ignored her request and told his parents. Elisabeth’s father-in-
law phoned her, yelling at her and questioning why she was not breastfeeding 
his grandchild. She feared that her husband had either told them about her 
HIV status or that they had figured it out. In this case, disclosure was not 
contained within a sexual relationship but spread to the larger family. As a 
result, the violence not only impacted on Elisabeth, but also her child.  
 
Disclosure is understood as something the HIV-positive person has control 
over — a truth of HIV that remains contained within the body of the one who 
discloses. However, this story shows that once HIV is spoken and put into 
discourse, it can be used by other people as a way of controlling or penalising 
the HIV-positive person and the people connected to her.127 Dodds and 
colleagues have made a similar observation in relation to African people living 
with HIV in the UK (2004, p. 22). They argue that HIV-positive people who are 
from the “Pan-African community” feared that if their HIV status became 
known to any individual from that group, the information might be spread 
further afield in the UK and “back home” (2004, p. 22). Returning to 
Elisabeth’s story, other acquaintances also harassed Elisabeth about not 
breastfeeding; she sometimes told them that she breastfed the baby at night. 
She thought that people from her own country pry in that way because they 
have seen other people go through similar things. Elisabeth believed that they 
wanted to verify if she was in fact HIV-positive. Many of the women Tariq 
interviewed expressed similar concerns (2013, p. 270). Accordingly Tariq 
argues that HIV-positive mothers fear that their HIV status will be revealed if it 
becomes known that they are not breastfeeding their infants (2013, p. 270).  
 
Moreover, she was often asked if she had a normal birth or not; Elisabeth 
tried to deflect those questions by asking why they would want to know. 
However, this strategy was not usually successful. Admitting to having had a 
                                                
127 For discussion on the tremendous influence stigma has on the lives of people living with 
HIV, please see Alubo, et al. (2002); Weston (2003); Anderson and Doyal (2004), Kalichman 
et al. (2004), Ostrom et al (2006), Mbugua (2007); Ridge, et al. (2007); Collins et al. (2008); 
Doyal (2009). However, my argument is that stigma is used by her acquaintances as a tool to 
control Elisabeth.  
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caesarean section and not breastfeeding would have been tantamount to a 
full disclosure of her HIV-positivity. Here it is important to stress that for 
Elisabeth, being associated with technologies that have the potential to assist 
in the prevention of vertical transmission simultaneously risks disclosing her 
status as HIV-positive. This is hugely significant for women thus positioned 
and I argue that this dilemma harks back to the argument made previously 
which concerned the way the prevention of vertical transmission is not enough 
to secure life for HIV-positive women or their children. Rather, Elisabeth and 
other women in similar positions may in fact risk their own and their children’s 
futures when attempting to prevent vertical transmission of HIV. 
 
According to Elisabeth, her husband was aware that she could not safely 
breastfeed their children and he did not directly oppose her replacement 
feeding their baby. However, he essentially created situations where Elisabeth 
would be confronted with their families’ and acquaintances’ hostile opposition 
to her feeding practices. Despite this, Elisabeth did not think that her 
associates were trying to persuade her to breastfeed her baby; rather she felt 
they were trying to force her to admit to being HIV-positive. I suggest that 
Elisabeth felt this way because the only reason why she was not 
breastfeeding her baby was because of the risk of HIV transmission. 
Therefore, Elisabeth associated replacement feeding entirely with HIV-
positivity and assumed that her family members would as well.128  
For both Eleanor and Elisabeth, replacement feeding was a signifier of their 
HIV positivity. In other words, and to use the language of Mol and de Laet, 
Eleanor and Elisabeth felt that replacement feeding and caesarean sections 
could be used by their communities as HIV detection devices (de Laet and 
Mol, 2000, p. 252). Elisabeth’s experiences as I have described them show 
that a technology’s fluidity is not necessarily entirely beneficial for all members 
of its user community. Indeed, Elisabeth’s narrative illustrates the complex 
ways a technology can simultaneously benefit and harm its users. 
                                                
128 As an interesting aside, Elisabeth’s husband was not suspected of being HIV-positive. 
Their child was stigmatised as being HIV-positive, yet the child was born free of HIV. 
However, her husband did not experience HIV stigma yet his sexual partner was known to be 
HIV-positive. So here we see another example of a disconnect between a mode of HIV 
transmission and its stigmatising effects. 
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Furthermore, her story shows that as “a device installed by the community” 
one of the “boundaries” of this aspect of its identity is firmly constructed 
around and generative of an antagonistic way of viewing HIV and HIV-positive 
mothers (de Laet and Mol, 2000, p. 252). Consequently, in this circumstance, 
and to continue to use de Laet’s and Mol’s terminology, replacement feeding 
as a fluid technology “contains”, as a “variant of its environment” (2000, p. 
252), both the ability to protect an infant from being exposed to HIV through 
its mother’s breast milk, and also the ability to disclose its mother’s HIV status 
and subject her and the infant to the censure of the mother’s family and 
community. Furthermore, while replacement feeding contains “variant[s] of its 
environment[s]” these are diasporic, if and when the women that engage with 
replacement feeding are also situated within the diaspora (de Laet and Mol, 
2000, p. 252).  
In order to further explore the implications of the arguments made above, I will 
now consider the way Laura, an HIV specialist paediatric nurse, explained 
during our interview the steps she would have to go through in order to 
procure replacement formula for her patients who were not in the UK legally. 
Laura told me that she would occasionally have to request financial 
assistance from Social Services for women who did not have the funds to buy 
replacement formula for their babies. However, for women who were in the 
UK illegally, accessing these funds was conditional. Similarly, Tariq and 
colleagues report that many of the African HIV-positive women living in the 
UK that they interviewed who were without recourse to public funds sited the 
burden of paying for replacement milk as being a substantial strain on already 
limited household finances (2016, p. 3).  
You can’t just say, well I’m illegal, I want milk! You know, you’re illegal, 
but we need to get them to get to a point where maybe they’re trying to 
be legal, so maybe in the meantime get them to get a solicitor; get them 
to start processing them and their immigration because the fact that they 
are processing and they are recognised, then at least, because children 
in this country have rights, any child born here, so I use that as an 
argument to say “actually, this child has a right to be HIV-negative, 
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because you know they need to get that chance” (Interview with Laura, 
an HIV specialist paediatric nurse, 29 January, 2009, p. 17).  
What I would like to draw out from the extract above is the complicated 
situation such HIV-positive women find themselves in. On the one hand, they 
need to procure replacement milk in order to ensure that their baby remained 
free of HIV, while on the other hand, exposing themselves to the Home Office 
(especially if they felt their chances of being granted leave to remain in the UK 
were slim) would pose a tremendous risk for them and their babies. Hence, 
not only do the effects of the technologies have the potential to harm the 
women while simultaneously preventing vertical transmission, but the process 
of gaining access to the technology may also cause harm. In other words, by 
making themselves known to the Home Office, the mothers would be 
exposing themselves to death if they were at risk of being deported to a 
country where HIV has not been decoupled from death. On the other hand, if 
they breastfeed their infant they risk exposing the baby to HIV. How to 
negotiate this predicament?  
 
Added to this is the fact that the rights the child would have as a result of 
being born in the UK would protect it from exposure to HIV through breast 
milk but not from having its life put in danger because of other harmful effects 
connected to its mother’s HIV-positivity.129 In other words, the rights that 
Laura says the child would have as a result of being born “here”, would 
ostensibly protect the child from certain effects of HIV for a period of time (the 
first six months of the child’s life during which it will exclusively consume 
replacement milk), but not after this. Moreover, as Verity’s case made clear in 
the previous chapter, the rights of the child do not (necessarily) have the 
ability to protect it prior to its birth. In that chapter, I argued that professionals 
who prevented and complicated Verity’s access to care did not take the health 
of her “future baby” into consideration because it did not exist within their 
logic. Following this, it becomes clear that protecting the (unborn) baby from 
(certain) effects of HIV is not necessarily a task that all of the people that 
                                                
129 Examples of different ways the effects of HIV may harm children and babies will be 
provided later in this chapter. 
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would be able to protect the (unborn) baby engage with.130 I will expand upon 
and clarify this argument later in this chapter.  
 
While the practitioners acknowledge the dilemma women thus positioned 
face, their immediate concern is with the prevention of vertical transmission. 
So, the practitioners know that they have the ability to facilitate the prevention 
of vertical transmission whereas their patient’s potential deportation is beyond 
their control. Surely, preventing vertical transmission is worth it even if the 
mother may be removed from the UK as a result?131 It is important to mention 
that I am not suggesting that the practitioners’ approach is wrong. Rather, my 
intention is to highlight that the technologies used to prevent vertical 
transmission have specific consequences for HIV-positive diasporic women. 
Moreover, I argue that the consequences are part of the technology, if and 
when women located within the HIV diaspora use the technology. In this way, 
my position is similar to the argument Rosengarten makes in relation to the 
“unwanted effects” of ARVs, mentioned previously (2009, pp. 18-19).  
 
While Rosengarten is specifically concerned with the unwanted effects ARVs 
have on the body of the person taking them, I extend her argument to 
encompass the unwanted effects replacement feeding may have on HIV-
positive women and their children’s lives and futures. Thus, I argue that we 
should think about these unwanted effects of replacement feeding as being 
part of what replacement feeding is for women located within the HIV 
diaspora. This would require a move away from the idea that it is the patient’s 
“culture” or family that would lead to the stigmatisation of replacement feeding 
and instead position the decoupling of HIV in some locations, but not in 
others, as being the real culprit (or source of the problem).  
 
                                                
130 I would like to stress that I am not arguing that the health of unborn babies should be taken 
into consideration. Rather, my point is to show that the practitioners in the clinic do take its 
health into consideration while others do not. 
131 Having said this, I do not wish to imply that women get deported because they were 
patients in the antenatal clinic. Rather, this sentence reflects a possible outcome of Laura’s 
statement.  
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Negotiating	the	burden	of	serodiscordance 
Couples with one person who is HIV-positive and one who is HIV-
negative are sometimes called “serodiscordant” or “mixed serostatus” 
[…]. “Serostatus” refers to whether someone has HIV infection or not 
(AIDS InfoNet, 2012).  
 
We’ve seen so many patients go through so many different things, so we 
can kind of, foresee what potential problems there are and you can kind 
of put them at ease saying “ok you may not have leave to remain in 
England but there’s other things that we can do, you know, it may be 
that you haven’t disclosed to your partner and while we don’t advocate 
that, we understand it” (First interview with Sophia, HIV specialist doctor 
30 September 2008, p. 2). 
 
We can’t force disclosure, but we do have a responsibility to help [the 
patient] do that to the husband, but then there could be dangers as well 
and those dangers can be very real for some […] we’ve got sort of a lot 
of evidence that domestic violence is an issue, with disclosure, so it’s a 
difficult path to tread and we also have got to think about the legal sides, 
because clearly there’ve been some court cases where people have 
gone to prison for not disclosing their status and having unprotected sex 
with their partner and we have to let people know that that is the case, 
and document that we’ve told them that, and then be seen to be working 
towards it (Second interview with Ellen, the HIV specialist midwife, 18 
March, 2009, p. 11). 
This thesis has previously considered the multiplicity of HIV in various 
contexts. Here I will add to this discussion by exploring the multiplicity of 
serodiscordance within the context of the lives of two of the women I 
interviewed. I will argue that women located within the HIV diaspora who 
disclose their HIV status to their sexual partner(s) do more than fulfil a legal 
and moral obligation.132 Instead, the practice of disclosure has the potential to 
                                                
132 In the UK, serodiscordance is understood as the responsibility of the person who is 
infected with HIV in a sexual relationship. This responsibility entails that if the person infected 
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forever subject HIV-positive women (who are incorporated in the HIV 
diaspora) and their children, to the consequences of HIV in multiple 
geographical locations. In other words, fulfilling a UK-specific requirement133 
to disclose means the women will (potentially) be subjected to effects of HIV 
from places outside of the country. In this way, I argue that the components of 
HIV that are disclosed is connected to (unknown) components elsewhere, 
outside of the UK, in places where HIV may be something very different than 
it is and has the potential to be. This in turn changes the effects of the patient 
and her partner’s serological status. Serodiscordance not only concerns the 
relationships between patients and their sexual partners. Instead 
serodiscordance concerns many more people who are, have been, or may be 
in the spaces wherein serodiscordance emerges.  
 
In the quotes above, serodiscordance emerges in multiple ways: in the clinic 
as an entity that must be negotiated by practitioner and patient alike; as an 
entity within relationships (both sexual, violent and supportive) between 
patient and practitioners and between patients and their sexual partners; as a 
temporal entity; as a legal entity; and as a diasporic entity. In what follows I 
will provide a description of my interviews with Alegra to begin to clarify the 
arguments made above.  
 
All the women that I interviewed who were or had been in serodiscordant 
relationships expressed to me how their partners made them feel tainted 
because of their status. What is more, their bodies were constructed as being 
an inherent threat to their partners’ bodies.  
	
 	
                                                                                                                                      
with HIV fails to disclose s/he can be accused of grievous bodily harm in the UK (Dodds et al., 
2005; Weait, 2007). The criminalisation of HIV transmission and its legal force is present in 
the clinic — made visible by the ethical-legal necessity for practitioners to encourage 
disclosure even though they know the effects of this may be violent to the women involved 
(Gielen et al., 1997, 2000; Kalichman et al., 2003).  
133 I am not suggesting that the act of disclosure is specific to the UK. Rather, what I mean is 
that disclosure in the London Hospital is part of a UK-specific requirement.  
 200 
Alegra	
 
I will begin with Alegra, the first woman that I interviewed for this project. The 
practitioners considered her to be a compliant patient because she appeared 
to concede to everything they suggested without question. However, Ellen the 
HIV specialist midwife did express some concern over her apparent docility. 
Ellen worried that Alegra’s compliance veiled issues that might obstruct her 
care or wellbeing in the future. These sentiments were apparently intensified 
when Ellen came into the room during our first interview and found Alegra 
sitting next to me crying inconsolably.134  
 
My connection with Alegra grew strong over the course of her pregnancy and 
antenatal period. The line between researcher and confidant often felt unclear 
to me as I became more involved in her life. What I found most difficult to 
contend with was how utterly and completely alone and exposed Alegra felt. 
Her distress was tangible and overwhelming. She was convinced that she 
would die a horrible death if and when she was deported and I could not 
contest the probability of this.  
 
Alegra did not have any experience with HIV prior to finding out that she was 
HIV-positive several years ago. This occurred when Alegra and her partner 
                                                
134 I reassured Ellen the following week that while Alegra had indeed opened up to me, she 
had not disclosed anything during our interview that I thought had the potential to adversely 
affect her engagement with care. It is important to add here that making these judgements 
about the information patients shared with me was one particularly stressful effect of the 
interviews I conducted and the relationships I established with the clinic’s patients. How could 
I possibly know what information might foreshadow the patient disengaging in care? How 
could I be sure that my behaviour during the interview would not have a negative impact on 
her relationship to the clinic? How could I remain in the role of a researcher (whatever that 
meant) when confronted with a woman who was so absolutely miserable? 
  
These are questions that I have not resolved in any satisfactory way. Rather, I learned to 
work with a constant feeling of unease while conducting this project. Further to this, my 
anxieties illustrate how, like the practitioners, I became concerned over the way my behaviour 
in the present might affect the women in the future. Moreover, I met with my PhD supervisors 
after this interview and before the following week’s clinic session. We discussed this interview 
extensively and they were given a transcription of the interview. I was very worried about 
making judgments regarding if and when I should break research participant confidentiality. 
My supervisors and I decided that I would refer to them in the first instance, if and when 
patients said things to me that concerned me. This way, they would help determine and 
negotiate whether or not I should break the patients’ confidence and alert the practitioners to 
something that the patients had told me. In this way, I came up with a sort of contingency 
plan.  
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had been trying to conceive a baby; they experienced difficulties and Alegra 
had been offered an HIV test. She was subsequently informed that she was 
positive. Devastated by the results, she told her husband and asked him to 
test as well. When his results came back negative, she asked him if they 
could separate. She felt that his reaction to her status was too much for her to 
bear. Had she been on her own, she thinks she would have been much better 
able to manage fluctuations in her health. However, he refused to leave, 
saying that he could not abandon her as she had no one else aside from him 
and he therefore had to stay with her. 
Sometimes I don’t even think that I am HIV-positive. I don’t mind. I go to 
school, I do everything all the people are doing. […] but for him he is 
really worried, you see. He knows that maybe I can die tomorrow (First 
interview with Alegra, 22 October, 2008, p. 7).  
The extract above explicates how many women diagnosed with illnesses are 
in a position where contending with their families’ opinion about their health is 
prioritised over their own. This is a consequence of their families’ reactions to 
their diagnosis having a substantial effect on their lives in a more immediate 
way than the illness itself. Alegra told me that she felt vulnerable being in a 
serodiscordant relationship. Consequently, she tried to reposition herself in 
the equation to make it impossible for her husband to claim that she placed 
him at risk. In regards to this, Alegra said that she no longer had sexual 
relations with her husband. Moreover, she had gone to great pains to 
separate all of their belongings. They did not share a bed, nor even linen or 
utensils. In fact the only thing that they did share was the toilet.  
 
Alegra explained that she was made to feel guilty over being HIV-positive 
despite the fact that her status was not tied to an act for which she thought 
she should have to feel culpable. She assured me that she was aware that 
she would be able to live with HIV (if she could stay in the UK), and that her 
baby would be able to be HIV-negative. However, she explained that her 
husband was not able to do the “things” that he would want to do with a 
partner because of her status. She felt that even if they were to use a 
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condom, he would eventually blame her (First interview with Alegra, 22 
October, 2008, p. 17).  
Because he is negative and maybe he have to do a lot of things with a 
woman who wasn’t HIV-positive and he can’t do that to me […] Maybe 
that’s why he worried, that’s why in the future maybe I can leave him 
(First interview with Alegra, 22 October, 2008, p. 17).  
Alegra stated her belief that her husband needed an HIV-negative wife. She 
was worried that he would take risks with her that would endanger his health 
and she therefore felt that it would be better if he could remarry an HIV-
negative woman. Accordingly, Alegra attempted to protect her husband from 
herself, and in so doing protect herself from her husband.  
 
Alegra expanded on this feeling of wanting to separate herself from her family; 
she said that the experience of being HIV-positive is in itself entirely isolating; 
even if her family did not want her to distance herself from them, she would. 
This is why she did not mind that her family lives so far away from her and 
that she did not have any contact with them. Here again is the idea reported 
by many women that separating oneself from loved ones is a reasonable way 
to protect them, and also, in this way, to pre-empt and contend with the 
(expected) future exclusion and violence. Additionally, being in a 
serodiscordant relationship enhances any inequalities and discord between 
the partners.  
	
Evelina	
 
These issues were also evident during my interview with Evelina. Sophia 
suggested that I interview her because she was very forthright about her 
circumstances. Evelina had recently given birth to her second baby and her 
care had, as was the norm, been transferred to the DOSH. She was the only 
woman that I interviewed and came to know whose pregnancy I did not follow 
in the specialist antenatal clinic. Despite this, Evelina was, as Sophia had 
predicted, very open with me about her life.  
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Evelina was still reeling from the heartbreak she had suffered as a 
consequence of finding out that she was HIV-positive. She had been infected 
by her previous partner, whom she had loved dearly and been in a long-term 
relationship with. She was almost certain that he had known that he was 
positive and had knowingly put her at risk. Therefore, Evelina ended what she 
considered to have been a near-perfect relationship and was consequently 
without a home or a means of support. She was living in the UK illegally and 
had been able to comfortably support herself and her young son (who was 
cared for by a relative in Jamaica) with the financial assistance of her ex-
partner. She explained that she had felt like a good mother for the duration of 
her relationship with her ex-partner. The life she had coveted before moving 
to the UK was within reach and she was in a stable relationship with a 
wonderful man.  
 
Without explicitly saying so, Evelina implied that her relationship with her 
current partner and the father of her new baby was dependent on her being 
sexually available to him. Following this, her living situation felt precarious and 
unsafe. However, she explained the most devastating repercussion of the end 
of her previous relationship was that she could no longer send money back 
home to support her son. Evelina had not felt able to tell him why she had 
ceased to be in contact and was plagued with worry that he would feel 
rejected, unloved and would be exposed to neglect.  
 
Evelina told me that her current partner was thought to be HIV-negative.135 
She felt the difficulties inherent in being in a serodiscordant relationship 
acutely. She believed that although all relationships have their problems, HIV 
became the focus of all conflicts when a couple was serodiscordant. Evelina 
said that her partner did not take responsibility for his own safety in protecting 
himself or getting tested. He left the responsibility of HIV up to Evelina, she 
said. This was tremendously stressful for her. They recently had a situation 
where they had sex and the condom they were using broke. Evelina felt 
                                                
135 Evelina did not know for sure if her current partner had ever been tested for HIV.  
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horrible about it, especially because she had been the one who had initiated 
having sex. Her partner became incensed with her and accused Evelina of 
trying to “destroy him” (Interview with Evelina, 8 December, 2008, p. 18). She 
felt that he blamed her for being HIV-positive. This was particularly distressing 
for Evelina because of the way she had become positive.  
 
During the interview it became evident that Evelina felt implicated by the 
derogatory views her partner expressed about HIV-positive people. 
Additionally, her partner’s inaction to care for himself made Evelina feel as if 
she was effectively placed in the position of potentially infecting him. From her 
perspective, she was forced to risk his life when they had sexual relations. 
Extricating herself from the relationship was not a viable option as Evelina and 
their baby were entirely dependent on his sporadic support. Moreover, his 
involvement with her was dependent on Evelina having a sexual relationship 
with him. For the women thus positioned, being financially dependent on men 
and having their bodies and HIV-positivity constructed in this way made living 
as an HIV-positive woman almost insufferable. It is important to stress that 
another crucial aspect of both Evelina’s and Alegra’s stories are that they 
were both without recourse to public funds and they felt themselves to be at 
constant risk of being deported.  
 
Returning to Evelina’s narrative, she did not act in the same way as Alegra in 
regard to separating herself from friends and family after being diagnosed. In 
this respect, Evelina told me that talking about being HIV-positive made her 
feel better about her status. Unfortunately, the people that Evelina had 
previously disclosed to had reacted badly, and warned her not to tell more 
people or to talk about it again. This upset Evelina and made her feel even 
lonelier. Moreover, her partner did not condone the fact that she occasionally 
went to a group for newly diagnosed people. He implied that only people that 
were in some way or another “abnormal” went to those groups. Evelina was 
devastated by his lack of support and wondered if she was in fact the only 
person like herself who was positive, meaning a heterosexual woman from 
the Caribbean (First interview with Evelina, 8 December, 2008 p. 25). She 
feared that her partner might be right and that there was something deviant 
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and tainted about her. She felt “soiled” and worried that people could sense 
that she was.  
 
Spending time with other people affected by HIV made her feel better about 
her lot. However, I suggest that her partner’s criticism of her involvement in 
HIV support groups alerted Evelina to the fact that there was a significant 
difference between her and the other participants who were, according to her, 
either white gay British men or black Africans. I will consider this in more 
detail after returning to Alegra’s narrative.  
 
Alegra’s desire to separate from her husband intensified after he returned 
from having his second HIV test. He told Alegra that a clinician at the London 
Hospital had warned him that he was at risk of becoming infected, simply by 
living with her. She believes that this was a lie; she assured me that she did 
not think that he was at risk, but she contended that her status personalised 
the possibility of her partner becoming infected. Therefore, in lieu of a 
permanent separation, Alegra decided to secede physically from him. 
Accordingly, they no longer slept in the same room, or shared utensils or any 
other household items. She explained that although many doctors contend 
that HIV cannot be transmitted through casual contact, completely extricating 
herself from her partner was the only way to absolutely protect him from 
becoming infected. Following this, Alegra was consequently protected from 
being accused of potentially infecting him.  
 
This is important, and is a recurring theme for many of the women I 
interviewed who were or had been in serodiscordant relationships. I suggest 
that women thus positioned feared infecting their partners, not only out of 
concern for the partner’s health, but also out of fear of retaliation and 
exploitation. Here it can be seen that a consequence of having a body that is 
considered to be risky is that women in these circumstances constantly have 
to anticipate being subjected to censure and violence. To reiterate, being thus 
positioned is especially difficult for women who are in some way or another 
dependent on men for support: all of the women that I interviewed were to 
varying degrees dependent on men and having sexual relationships with 
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them, especially those who had an insecure immigration status (and no 
access to public funds).  
 
Moreover, as discussed in Chapter Four, the way in which Alegra and Evelina 
negotiated their partners’ understanding of HIV and expectations on their 
behaviour relates to the work that the practitioners do when trying to pre-empt 
complications caused by patients who resist specialist antenatal care. In that 
chapter I illustrated how the practitioners reorganised some aspects of their 
practice in order to accommodate P1’s beliefs about HIV. Importantly, 
however, the practitioners did not compromise the care that they wanted to 
provide P1 with, as a result of the concessions to their plans for care. Alegra 
and Evelina do however make tremendous concessions in order to 
accommodate the serodiscordance that emerged in their relationships.  
 
The work that Alegra engaged in, in order to maintain a physical separation 
from her husband, does not mean that she believed that her husband was put 
at risk by sharing her utensils or bed linen. Rather, her concession to his 
understanding of HIV suggests that she recognised that it could have a 
negative impact on her if she did not. Further to this, from Allegra’s 
perspective, the husband that was at the focus of these negotiations was both 
her husband as he was now and as he would be if she were to die and he 
became the sole guardian of their baby. Following this, I argue that Allegra’s 
and Evelina’s behaviour in relation to their partners’ understanding of HIV was 
entirely dictated by concerns for their own and their children’s wellbeing, now 
and in the future.136 
 
While Alegra was convinced that her husband was not in any immediate risk 
of becoming infected, he was not persuaded. Consequently, in order to make 
life tolerable with him she chose to behave as if she did not have the 
knowledge she did about the virus’s modes of transmission. Her much more 
immediate concern was her husband’s perception of her serological status. 
Her actions reflected his perception of her HIV-positivity (or, rather her 
                                                
136 Please see Wilson (2007) for a discussion of the difficulties involved in being a mother with 
a chronic illness.  
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perception of his perception). To reiterate, this is because his behaviour could 
potentially have a much more immediate effect on her wellbeing. Following 
this, it can be seen that the version of serodiscordance that emerged within 
her relationship to her husband was intricately connected to out-dated 
understandings of HIV and its modes of transmission; the fear of violence; the 
fear of abandonment and the wellbeing of (unborn) babies. Moreover, all of 
these components of serodiscordance become more acute because Alegra 
felt that she was at risk of being deported. This aspect will arise again in the 
next section which will consider violence.  
	
Violence 
 
In this section I will illustrate how for women located within the HIV diaspora 
who have leave to remain in the UK and thus have the “freedom” to move 
from place to place, their diasporic positionality and temporality were not 
marked by “personal freedom”. Family ties delimited their freedoms forcefully. 
Indeed, these relationships were frequently laden with oppressive, even 
violent, gender dynamics to which HIV infection added a further complicated 
dimension. It will become clear that the patients I interviewed who are located 
within the HIV diaspora move through different geographical spaces and 
political economies. 
 
In what follows, I will consider the narratives of two of the women I 
interviewed: Asa and Kessie. However, it is important to point out that all of 
the women that I interviewed and the vast majority of women I came in 
contact with while conducting this project shared horrendous stories of abuse 
that they had been subjected to.137 A narration of the women’s experiences as 
told to me during our interviews, will be followed by a discussion of the ways I 
have attempted to make sense of their stories. Both Asa and Kessie were 
originally from countries in Sub-Saharan Africa and had permanent leave to 
remain in the UK.  
                                                
137 The stories were told to me by the women themselves and/or by the healthcare providers. 
However, as mentioned above this chapter is based on interviews I conducted with patients.  
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Asa	
 
Asa became HIV-positive and pregnant after being raped in London. The rape 
was arranged by Asa’s female cousin as a way of punishing her for a 
perceived transgression. Asa never criticised the use of rape as a mode of 
punishment; she did however stress that she was innocent of the 
transgressions she had been accused of. The accusations concerned Asa’s 
failure to appropriately help her cousin with a manual task. In other words, 
Asa had been charged with turning her back on a family member in need. Her 
description of the events left me with the impression that Asa felt that 
acquaintances of hers had been jealous of her apparent success in the UK. 
She implied that people assumed she had started to act “above her station” 
and that she was becoming too independent. Following this, I argue that the 
attack was used as a way of nullifying her perceived superiority. Further to 
this, I will suggest that the attack indebted Asa to her family and 
acquaintances.  
 
Asa believed her cousin knew that the man that carried out the rape was HIV-
positive. She explained to me that she now knows that plans for the rape were 
discussed amongst her acquaintances prior to the attack. Asa is aware of this 
because her partner knew that the rape was being organised; however, he 
had not known that Asa was the intended target of it until the day of the 
incident. He tried to contact Asa and warn her but he was too late. 
Accordingly, people close to Asa had sanctioned the rape and a woman had 
arranged it. Asa’s experiences demonstrate that organised rape as a form of 
punishment is a method of social control and as such, both men and women 
utilise and sanction it.  
 
It is important to stress that one of the things that I found most disturbing 
about the way Asa spoke to me about the attack was the fact that she 
appeared to accept that her partner had only tried to prevent it from 
happening after he found out that she was the intended target. In other words, 
she felt ingratiated to him because he had not left her, rather than being 
incensed that he would condone rape. This led me to conclude that she did 
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not think that his failure to try to prevent the rape of an unidentified woman 
was indefensible. Following this, it became difficult for me to reconcile my 
feelings for Asa’s partner with the way she spoke of him during the interview 
and her consultations. He was, according to her, a good, supportive man that 
she believed would become a decent father. She felt fortunate and grateful 
that he had chosen to stay with her and agreed to help raise her baby, despite 
the rape and her HIV-positivity.  
 
Asa went to the sexual health clinic at the London Hospital about a month 
after the incident, because she was feeling very ill. Shortly thereafter, she 
started to receive calls from the hospital, asking her to come back for an 
appointment. Asa was distressed and reluctant to comply with their requests. 
Her mother, who lived in Nigeria, finally convinced her to return to the clinic. 
Asa was told that she was HIV-positive. She was devastated and explained 
that she “was not herself” for some time afterwards. Asa disclosed to her 
mother who called her regularly and tried to support her, and to a few other 
family members, including her partner. He had been very sympathetic since 
the rape. She wanted to separate from him after finding out that she was both 
HIV-positive and pregnant; she wanted to keep the baby,138 but was worried 
about what he might do. Fortunately, she explained, her fears were 
unfounded and he was pleased that she was pregnant.  
 
Asa had seen the man that raped her several times since it happened. He had 
also phoned her and tried to apologise. After the incident she contemplated 
trying to kill him and then committing suicide. She confided in Sophia who 
convinced her to act differently and to report the rape to the police. Asa told 
her mother that she planned to report the incident but her mother persuaded 
her not to. Her mother explained that if Asa was able to live with the 
consequences of the assault she should leave it in the past. Asa was also 
concerned that if she were to report it, it would become generally known that 
she had been raped and that she was HIV-positive. Additionally, her mother 
                                                
138 Although it is important to state that Asa and one other woman I interviewed, Eleanor, did 
tell me during interviews that they had thought about the possibility of having a termination. 
Both women became pregnant after being raped by men in their acquaintance. In both cases, 
the women’s mothers convinced them not to take legal action.  
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pointed out that reporting the rape would make public what they both 
considered to be a private family issue. As I mentioned previously, this is 
significant and a recurring theme for the women I interviewed. Asa was asked 
to abandon her own desire for retribution for the sake of her family’s 
reputation.  
 
Further to this, Asa explained that the consequences of making the rape 
public would have been dire for her entire family; her HIV-positivity would 
have become known and her family’s internal struggles would have been 
exposed. All of these revelations would have had negative effects on her 
whole family including her child and her (unborn) baby. In regards to Asa’s 
mother’s request that she keep silent, Yankah argues that the monumental 
consequences of HIV/AIDS in Africa have made it an “unspeakable” event 
within “folk discourse” (2004, p. 183). Furthermore, I argue that Asa was 
placed in a position where she was made to feel gratitude towards (and be 
indebted to) people for accepting her despite her HIV-positivity and 
pregnancy. Moreover, anyone who knew about the rape and her HIV-positivity 
would have a means of extorting and influencing her behaviour in the future. 
Thus, the rape reaffirmed her family’s ability to influence her. Here it is 
significant to mention that the rape seemed to have brought Asa in closer 
relationship with her family and her partner. This was indeed the point of the 
rape: to cut her down to size, to return her to her “right” place within the 
gendered dynamics of both her partnership and her family. In a sense, the 
rape “brought her home”. 
	
Kessie 
 
There are similarities between Asa and the way Kessie became HIV-positive. 
Kessie was from a West African country. She moved away from home and 
became self-sufficient when she was still a child. Although Kessie did not say 
so directly, the stories she told me about her life left me with the impression 
that she had supported herself though sex-work. She met a white British man, 
whom she would later marry, when she was in her late teens. Shortly after the 
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relationship began he arranged for Kessie to get a visa and she arrived in 
London soon after. Kessie and her family were delighted; they happily let her 
move. Kessie explained that her family condoned the relationship because it 
enabled Kessie to negotiate a “better life” for herself and eventually for them:  
We were very poor. […] when you have many children like that; if a 
white man [turns up] in Africa, we see them as God so if someone like 
that turn up, it’s a blessing to the family so they can just release you. […] 
They were happy; we were all happy (Interview with Kessie, 28 January, 
2009, p. 4).  
Kessie’s husband started to drink heavily and abuse her shortly after she 
arrived in London. She was often forced to spend the night in phone booths 
and police stations, returning home in the early morning after he left for work. 
Kessie would leave again, before he came home. He was possessive and 
jealous, fearing that Kessie would leave him for someone closer to her age. 
Kessie confided in a few of her friends; they told her that this often happens 
and that it would not be out of the ordinary if he killed her. After being fully 
informed of the violence she was subjected to, her family advised her to leave 
him and come back home only if he stopped working. However, fearing for her 
life, Kessie eventually left her husband and moved back to Ghana where she 
lived for two years before he started to ask her to come back to London. He 
assured her that he would change and that her life with him would be better. 
She returned with him, and the abuse resumed.  
 
Kessie left him again and met the man who would become the father of her 
children. She became pregnant with her oldest child. Kessie told me she 
waited several months before she went to an antenatal appointment. She was 
given an HIV test and a few days later received a letter, asking her to come 
back to the clinic. She was told that she was HIV-positive. Her response was 
initially one of disbelief.  
 
Devastated and confused, Kessie called her previous partner, whom she 
referred to as her “white man” (Interview with Kessie, 28 January, 2009, p. 2). 
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On telling him that she was HIV-positive, she became suspicious of him when 
he did not sound surprised or upset. He advised her not to worry too much 
about it, informing her that now that she was in the UK legally, she would be 
taken care of and that many people were HIV-positive. Shortly thereafter he 
phoned Kessie and told her that he had just received a call from the hospital 
and they told him that he was HIV-positive as well. On hearing this, Kessie 
became apprehensive. She thought it improbable that he would receive his 
results over the phone and that this should happen on the same day she had 
been informed of hers. Kessie explained that she had been naïve; her 
gullibility prohibited her from trusting her suspicions. Her ex-partner eventually 
confessed that he had known that he was positive. The extent of his lie was 
confirmed when she began taking ART and recognised it as the same 
medication that he had been taking since she first met him. He told her that he 
had not known how to tell her he was HIV-positive; consequently he had 
turned to alcohol as a way of appeasing his guilt. He claimed that he had 
brought her to the UK because he felt guilty about having potentially infected 
her. After this came to light, Kessie explained that he has always helped her 
whenever she has been in need. She felt gratitude towards him for his support 
and she was also thankful that he did in fact enable her relocation to the UK.  
He didn’t leave me! The reason why I’m not so angry with him is that he 
didn’t abandon me in Africa; I would have been dead by now. But he 
brought me here and he stood beside me and he helped me and I thank 
God for that. Many, many girls like me have been abandoned like that 
and they are dead! Many of my friends in Africa that I know of are dead. 
And then I didn’t understand what was killing them, until now. So I tell 
God if, like he left me there, I would have been dead. But he was so kind 
with me because of my age, and the way he saw me; he just couldn’t 
leave me there, that’s why he brought me here and I think he has given 
me a second chance of living; [HIV] would have killed me, but he let me 
live. So I don’t get angry with him (Interview Kessie, 28 January, 2009, 
pp. 8-9).  
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Kessie is speaking of the complicated situation she is in; she is angry for 
having been lied to and infected, but she also recognises that things could 
have been worse for her. Her first husband’s continued interest in her is 
valuable to her and her family, although she cannot feel entirely comfortable 
with it nor can she disregard it. She was aware of her contradictory feelings 
towards him:  
Sometimes I get angry, but then I have to see it the other way, like he 
helped me. He gave me a second chance to live in life (Interview Kessie, 
28 January, 2009, p. 9).  
The decoupling of HIV and death are at stake for Kessie. In her lived reality as 
an HIV-positive woman Kessie negotiates what she thinks the effects of HIV 
would be if she were still in her country of origin. What that knowledge does 
for Kessie who is securely in the UK, is complicate her feelings of anger 
towards her first husband for knowingly exposing her to HIV. Thus, Kessie 
acknowledges that he took advantage of her while being simultaneously 
grateful that he extended his privilege (access to biomedical technologies and 
care through citizenship) onto her.  
 
I regularly heard stories like the ones above while I was in the clinic. Almost 
every patient cared for during my time there disclosed some kind of truly 
harrowing and complex events involving themselves and their close 
associates. The practitioners in the clinic would often hold the patient’s 
“culture” and/or religion responsible for her behaviour, although it is important 
to stress that none of the practitioners ever implied that violence was an 
inherent part of their culture or religion, or that of the women’s partners. 
Rather, the patient’s culture or religion would be used as an explanation for 
the patient’s confounding behaviour in response to the events they were 
subjected to. The women I interviewed seemed to view and respond to 
violence as if it was a normal part of life, rather than a state of exception. The 
work of Fassin can us help to think about the women’s experiences and 
choices in a way that does not position culture (whatever its meaning) or 
religious beliefs as a simplistic explanation of them. 
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As discussed in Chapter Two, Fassin stresses the importance of attuning to 
the social and historical contexts in which the “experience of the body” is 
embedded (2007, p. 226). Accordingly, Asa — and other women with similar 
histories and experiences — can be considered in a way that pays attention to 
the circumstances that have led them to be in a situation where these things 
happen to them as a result of their access to resources. However, here it 
becomes important once again to mention that while Asa was a member of an 
immigrant community, she also had permanent residency in the UK. 
Therefore, she would ostensibly be able to access the same resources as any 
woman legally residing in the UK would, but yet still she did not fully utilise the 
services available to her.  
 
Following this, I argue that for women originally from the “non-west” (to use 
Fassin’s language) who have been able to permanently establish themselves 
in the west, the fact that they are diasporic will always and indelibly have an 
effect on the way their lives are enhanced (as discussed earlier in relation to 
viral load assays) and how they utilise the resources on offer in their new 
locations. Moreover, the women are also intimately connected to other people 
whose wellbeing they are often invested in enriching. For example, and in 
Asa’s case, her oldest child had been left in her home country and was cared 
for by her extended family. In order to secure her child’s wellbeing, Asa was 
entirely invested in maintaining a good relationship with her family. In other 
words, her behaviour was always dictated by the requirements of her child, 
family and community. Thus Asa, and the other women in similar positions, 
were tasked with the responsibility of attempting to compensate for the social 
and historical contexts that dictated the way in which they and their left-behind 
families experienced their bodies (Fassin, 2007, p. 226). 
 
Thus, while Lindau et al. state that there is a relationship between women’s 
experience of sexual violence and feeling a lack of control over their sexuality 
(2006, p. 63), I suggest that Asa’s experiences with sexual violence evidences 
how feeling in control of any aspect of your body or sexuality is not a practice 
all women take part in. Rather, the interviews I conducted with HIV-positive 
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women and my time in the clinic left me with the impression that many of the 
patients I met viewed sex and pregnancy as something that happened to 
them because they were women. Choice, in regards to having sex, becoming 
pregnant, considering or having a termination, did not seem to be options for 
them. Following this, a sense of bodily autonomy as I had previously 
understood it to relate to the choices a woman (cared for in an NHS clinic) 
would be offered and be able to make did not seem like meaningful 
possibilities for most of the patients I met in the clinic.  
Thus Asa could not have acted as if she had bodily autonomy (assuming that 
bodily autonomy would have led her to make the rape public or alternatively, 
to go against her mother’s wishes and terminate the pregnancy) because she 
simply did not. As I have explained, as a consequence of her diasporic 
positionality, Asa simultaneously had to negotiate a middle ground between 
the requirements, possibilities and expectations available to her and her 
family in their multiple geographic locations. Following this, I argue that for 
women like Asa and Kessie, (ostensibly) benefiting from various services and 
institutions on offer in the UK to rape victims and victims of domestic abuse is 
complicated and diminished because their bodies are the sites onto which 
(their own, their families and communities’) expectations are placed. These 
expectations are acted out on these women’s bodies, and can be violent. But 
this violence does not necessarily break the relations between the women and 
their network of relations. In relation to this, Kessie explained that her first 
husband’s financial support maintained her extended family and enabled 
several of her family members to relocate to the UK. Given her first husband’s 
influence on her family’s wellbeing, how could she do anything but continue a 
relationship with him, on his terms? Moreover, within this context it “makes 
sense” that punishments would be extolled on members who attempt to leave 
or do not take appropriate care of the communities and families that they are 
in symbiotic relationships with.  
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Conclusion 
 
The women I interviewed had hoped that their relocation to the UK would be 
beneficial to themselves and their families. Often, women located within the 
diaspora were the sites onto which they and their families placed dreams of 
future prosperity. In other words, the move to the UK promised a reward for 
the self and the family. This reward would be obtainable in the future through 
sacrifice in the present. For the women I interviewed, the fantasy of this future 
ended as a result of their HIV diagnosis. Instead the women spoke of 
themselves as having changed from being full of potential to becoming 
liabilities for their children and family members (Kelly et al., 2012; Tariq, 2013; 
Wilson, 2007).  
 
Ultimately the women I interviewed felt that HIV would threaten them and their 
children, even if vertical transmission of HIV were prevented. Thus, HIV for 
the women I interviewed not only affects their present but also the way in 
which they imagine their futures and their children’s futures. Moreover, the 
women understood their geographical location to be the thing that ultimately 
determines their future possibilities. Thus I have argued that HIV-positivity has 
the ability to ruin a woman’s plans for the future, or even the belief that she 
has a future.  
 
Further to this, I made clear that for women thus located attempting to prevent 
vertical transmission of HIV could simultaneously put their lives and their 
children’s lives in danger. In this way, the unwanted effects of the 
technologies that the women engage with become part of what the technology 
is for women located within the HIV diaspora. I argued that this was true for 
women within the diaspora because they have to negotiate the meaning of 
HIV and the technologies used in its management and prevention, in multiple 
geographic locations.  
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Chapter	Seven		
You’ve got a woman that has come in, you want [her] to start treatment, 
she wants to pray, she doesn’t believe you she’s got [HIV] and the lab 
tells you her viral load is undetectable. You can spend a long time 
explaining what undetectable means, and then it’s wrong, and it’s not 
only wrong, it’s wrong by a couple of thousand times wrong, and you go 
back to the woman who has been to church, who has done a bit of 
praying and say: “actually the lab tests are wrong, and you’ve already 
got all those things we’ve talked about […] You are working with 
somebody who is in such a different place, that the meaning of the 
technology to that person is so important to get right” (Interview with 
Anne, a consultant physician, 11 March 2009, pp. 7-8)!  
The overarching purpose of this thesis was to explore the challenges of HIV 
and successful care in an HIV specialist antenatal clinic in a resource-rich 
setting. By providing theoretically informed reflections on the contingencies of 
both offering and receiving care in the clinic, my intention was to make a 
practical contribution to specialist HIV antenatal care by discovering what 
successful care required of both patient and practitioner. As mentioned 
previously, there is a dearth of UK-based qualitative research exploring the 
vicissitudes of receiving and providing antenatal HIV care. Thus, this thesis 
offers a unique insight into the experiences of under-researched groups,139 
and in this way makes an important contribution to sociological 
understandings of antenatal HIV care in the UK. Moreover, this thesis has 
explicated how the clinic’s success in preventing vertical transmission of HIV 
is entirely dependent on the work that each individual practitioner in the clinic 
provides, in addition to the biomedical technologies and medicines available 
in the clinic and the way the clinic’s patients adapt to and appropriate the care 
and technologies on offer.  
 
                                                
139 Here I am referring to both patient and practitioner.  
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In this final chapter, I will provide a summary of the research findings 
previously discussed in this thesis that are of practical use in the clinic and 
which contribute to sociological knowledge concerning HIV antenatal care in 
the UK. Moreover, the chapter will emphasise how this research has created 
new information about the requirements and contingencies of HIV specialist 
antenatal care. The chapter will then consider some of the limitations of this 
study and conclude by suggesting areas of future work.  
	
The	HIV	Diaspora	as	a	Tool	 
 
At the onset, this thesis illustrated how all of the events that took place in the 
clinic were intimately connected to places and spaces far away from there and 
to people who occupied or were imagined to occupy those spaces. In this 
way, the thesis argued that in order to begin to understand the problem of HIV 
as it became apparent in the clinic, attention must also be paid to the problem 
of HIV outside of the clinic and the UK.  
 
Accordingly, this thesis has explored how the HIV specialist antenatal clinic — 
and all of the patients cared for within it — are entangled with geographical 
spaces that have (or are imagined to have, by the patients and practitioners 
within the clinic) significantly different ways of approaching HIV than the clinic 
and the patients and practitioners within it. Thus, I have considered how we 
could begin to think about and explain the implication of place and space, the 
effects of the movement of people between spaces, and the significance of 
the previous spaces that they occupied. Hence, as a consequence of the fact 
that the majority of the clinic’s patients were from countries wherein HIV and 
death were not decoupled, HIV in the clinic was intricately part of what I have 
called an HIV diaspora.  
 
As mentioned before, I use this term to articulate the inequalities and 
differences between the effects HIV has on the lives of HIV-positive women in 
different geographical locations. In this way, I have argued that the diasporic 
HIV-positive women involved in this research were simultaneously connected 
to and affected by the vicissitudes of HIV in multiple geographical locations. In 
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other words, because the majority of the clinic’s patients were immigrants, 
and while some of them had become British and/or had permanent residency 
in the UK, they were all perpetually and intricately connected to their countries 
of origin. Moreover, these connections were always significantly affected and 
amplified by (various issues related to) the meanings, consequences and 
effects of HIV (as they were or were imagined by the women and practitioners 
to be) in their countries of origin and in the UK. Thus the concept of an HIV 
diaspora expanded upon Fassin’s argument (2007) that people are restricted 
by the specific possibilities accorded to them (and the groups they belong to) 
within a particular geographical location. Moreover, the concept of an HIV 
diaspora enables a way of assessing the experiences of women located 
within the diaspora that takes into consideration their complex positionality 
and the unequal global distribution of ART and advanced HIV care without 
reducing their experiences to issues related to their “culture” and/or (lack of) 
access to resources (Nguyen et al., 2011, p. 292). In connection with the 
above, the HIV diaspora is a valuable conceptual tool that may be used to 
better understand the contingencies of the experiences of being or caring for 
(an) HIV-positive (pregnant) mother whose current care location is different to 
where they came from (and wherein HIV and death may not be decoupled).  
 
Moreover, the concept of an HIV diaspora considers the diasporic significance 
and effects of (bio)medical technologies. This is important because, as I have 
made clear, the clinic’s patients and practitioners simultaneously contend with 
the meaning of the technologies on offer to them in the clinic, and in multiple 
geographical locations. This requires that patient and practitioner consider the 
possible future consequences of using technologies that promise the 
prevention of vertical transmission, but may also risk exposing women and 
their children to the stigmatising effects of HIV. Thus, for women living with 
HIV located within the HIV diaspora, biomedical technologies and prevention 
methods have specific meanings and effects for them and their relations 
because of their incorporation within the diaspora. Moreover, throughout the 
thesis I have argued that the HIV diaspora is maintained and its boundaries 
are policed by various technologies such as viral load assays, and by people.  
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Some of these complexities were explored in Chapter Four where I argued 
that various ways of understanding HIV may be built into the technologies that 
the clinic relies on to help prevent vertical transmission. In that chapter I made 
it clear that the process of assessing a patient’s viral load concerned the 
acquisition and coordination of information, as well as the way in which the 
practitioners (and their patients) negotiated the various technologies available 
to the clinic, and the different understandings of HIV that were built into and 
generated by the technologies. In connection to the above, I have further 
clarified that HIV-positivity is not a requirement in order to be included into the 
HIV diaspora. Rather, people connected to HIV-positive diasporic women also 
risked being affected by the diasporas’ stigmatising and violent 
consequences. I will return to this argument later in this chapter.  
 
Thus, Chapter Six considered the way replacement feeding functioned as a 
“fluid technology” within HIV diasporic communities (de Laet and Mol, 2000). 
In that chapter, it became clear that women located within the HIV diaspora 
who replacement-feed their infants may protect them from the real of HIV, 
while simultaneously exposing their offspring and themselves to HIV stigma 
and discrimination. Moreover, I argued that “HIV stigma” could be used as a 
tool to control women located within the HIV diaspora and reaffirm their 
position within their families and communities. Therefore, HIV stigma, or 
rather the threat of its stigmatising effects, was used as a tool to influence and 
control women located within the diaspora. Hence, the concept could be of 
considerable use to the clinic because the HIV diaspora permeated all 
aspects of care in the clinic. Further to this, the arguments made above are of 
practical use in the clinic because they encourage consideration of the 
multiple and fluid meanings various technologies may have to both 
practitioner and patient because of the HIV diaspora.  
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The	Requirements	of	Caring	Care	 
 
As discussed in Chapter Three, the fieldwork I conducted has enabled me to 
uncover the logics that were embedded within the practitioners’ in the clinic 
practices (Mol, 2008, p. 8). Thus, influenced by Mol and Law, I have explored 
some of the ways in which the clinic’s patients’ HIV was enacted as a result of 
how the practitioners in the clinic cared for them (Mol and Law, 2004, p. 55). 
And in doing this, I have investigated the way in which the identity of HIV was 
maintained in social, clinical and technical areas. Further to this, the thesis 
has considered what successful specialist HIV antenatal care requires of both 
practitioners and patient. Therefore, as explained in Chapter Three, like Mol 
and Law, I explored what HIV, within the context of pregnancy, was for 
patients and practitioners in the clinic and paid attention to the ways they 
“intervene[d] into it”, “counter act[ed] it”, and attempted “not to know it” (Mol 
and Law, 2004, p. 49). 
However, I have also argued that the lives of HIV-positive pregnant women 
are not only affected by the way in which their HIV was enacted in the clinic, 
but also by how HIV and the women were perceived and cared for or not, 
outside of the clinic in the present and future. Thus, this thesis has shown that 
the way patients and practitioners imagined the future mattered in the clinic. It 
is here that this thesis makes a contribution to STS approaches that consider 
enactment by clarifying the significance of a patient’s unarticulated feelings 
(Mol, 2008, p. xi). Accordingly, I have made an important distinction between 
what becomes articulated (and thus made visible to the ethnographer) and 
that which remains unspoken (at the time of observation), but has the 
potential to matter in the future.  
As I have argued, this is important in the clinic because the practitioners 
imagine that it is precisely that which they cannot detect (the patients’ 
unspoken feelings) that may entirely disrupt care. In other words, the 
provision of care from their perspective can be threatened in numerous ways, 
as described in Chapter Five. However, the practitioners are able to anticipate 
and attempt to contend with many of these threats because they are aware of 
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them. But they cannot anticipate the disruptions that a patient may cause 
unless she somehow “speaks”.  
 
Moreover, the description of HIV specialist antenatal care that I provided in 
this thesis has made it clear that the patient being “cared for” is not limited to 
the present-time pregnant patient but encompasses the “future-patient”, her 
(future) offspring and her (potential future) sexual partners as well. Therefore, 
from the practitioners’ perspective, the provision of good care, i.e. caring care, 
does not stop once the patient is discharged from the clinic, nor is care 
deemed successful after it has been confirmed that her baby was born free of 
HIV. Thus, importantly, the provision of caring care does not have the 
successful prevention of vertical transmission as its goal. Instead, the 
provision of caring care would extend beyond the patient’s virus (as it may or 
may not be transmitted to her baby) and encompass and (hopefully) affect the 
patient and everyone (that may become) connected to her future potential. 
Further to this, good care and thus the provision of caring care (from the 
perspective of the practitioners) entails that they attempt to ensure that the 
futures they imagine for HIV-positive women and their babies always continue 
to be possibilities.  
 
The significance of the temporal aspects of care become clear in what I have 
written above. Accordingly, as mentioned before, the practitioners’ care efforts 
in the clinic always concern the effects that the work that they do in the 
present may have in the future and in relation to any number of people. They 
do not simply try and prevent vertical transmission of HIV. The future potential 
pertains both to HIV (in its absence or presence) and also to behaviour. For 
example, the practitioners imagine that the provision of caring care could 
enable patients who had displayed questionable mothering skills to become 
“good mothers” in the future.  
 
To put it another way, the practitioners know from experience that they are 
able to do certain things in the present which will prevent vertical 
transmission, as well as influence bad mothers to become good and enhance 
their health. The things that stand in the way of ensuring these futures are the 
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current patient, her circumstances and the technologies, and sometimes other 
professionals that the antenatal clinic’s practitioners are required to work with. 
The practices that the HIV specialist practitioners engage with when they 
attempt to negotiate these obstacles is part of the caring care that they strive 
to provide. 
 
Throughout this thesis, I have argued that the successful prevention of vertical 
transmission of HIV requires that the practitioners also use their imagination 
to predict disruptions to their plans for care. Therefore, the practitioners do 
much more than facilitate the connection between patient and biomedicine 
and technologies. They are instead absolutely vital to prevention efforts. Here 
we see the significance of each practitioner’s moral, ethical and professional 
politics. Accordingly, while Geertz has argued for the importance of making 
the thought processes of researchers visible (2001), I contend that it is equally 
important for the ethical thought processes of medical practitioners caring for 
people affected by HIV to be made clear. The need for transparency became 
especially obvious in this thesis in relation to the discussions on the 
requirements of good care.  
 
In this way I argued that while good care was something that the practitioners 
strived to provide, it was not possible for them to establish if good care had 
actually been delivered. As discussed above, this was because the 
beneficiaries of good care were (from the practitioners’ perspective) people 
who had not yet come into being (as in they had not yet been conceived or 
born) or were otherwise unidentifiable to the practitioners (as in present-time 
patients’ (future) sexual partners). In this way, the practitioners did not 
assume that their patients were in monogamous sexual relationships, nor did 
they assume that a patient’s named sexual partner was necessarily the father 
of her (unborn) baby. The practitioners’ work of discovering these relations 
and assessing the (legal and moral) risk and responsibility that may be 
ascribed to them, became part of HIV and the provision of good care in the 
clinic” (van der Zaag and McKnight, 2016, forthcoming).  
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The	Consequences	of	the	Generative	Capacity	of	Biomedical	Technologies 
 
The discussion above clarified the fact that as soon as a patient discloses her 
HIV status, HIV will indelibly be connected to her (within her social relations) 
and her (unborn) baby, even if the baby is born free of the virus. In this way, 
the real of HIV (as it is imagined to exist prior to and independent from 
biomedical investigation and intervention, as well as the host’s body within its 
social environment: “[A] seemingly stable object” (Rosengarten, 2009, p. 28)), 
is not limited to the HIV-positive woman’s body even if it is not physically 
transmitted to another body (van der Zaag and McKnight, 2016: forthcoming). 
Subsequently, I have argued that the various technologies that were used to 
ensure the prevention of vertical transmission of HIV had the potential to 
expose the (former) patients and people connected to her, such as her 
offspring, to HIV. Following this, it becomes clear that from the patient’s 
perspective that the requirements and consequences of (successful) HIV 
antenatal care were at times hugely problematic.  
 
In relation to this, I argued in Chapter Six that replacement feeding may 
potentially expose HIV-positive women and their babies to HIV while 
simultaneously promising protection from the virus. While Mol and Law 
explored the multiple ways in which people with diseases interact with some 
of the technologies meant for their conditions and how people are required to 
reorganise their lives as a result of the requirements of the technologies 
(2004, p. 50). I further their argument by contending that it is not only the 
necessities of the technologies that are significant but also how the 
technologies in question are used as HIV detection mechanisms by members 
of the women’s communities, and the way in which the same technologies are 
also used as HIV prevention technologies in the clinic. Prevention 
technologies thus simultaneously promise lives less affected by HIV, while at 
the same time they risk exposing women and their families to other forms of 
HIV. Thus, there is a caveat attached to all the things that take the future into 
consideration (here specifically biomedical technologies that are used to 
prevent vertical transmission of HIV). The caveat is that what they mean or 
(can) do in the future is multiple. They can, for example, prevent HIV while 
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also exposing people to it; hence they can protect and also harm. Importantly, 
the harm that they can cause is specifically related to women who are located 
within the HIV diaspora.  
 
As mentioned above, I argued in Chapter Four that the logic of care in the 
clinic necessitated a system that was able to contend with and counteract 
anyone or anything that was suspected by the practitioners of possibly doing 
HIV in a way that they felt was counterproductive. However, I have also 
argued that the practitioners are aware that the technologies and practices 
that they are required to engage with may further distance them from the real 
of the virus. Moreover, they may also in fact make the practitioners change 
the real of the virus in a way that will later be discovered to have been 
counter-productive to their prevention efforts. I considered this in Chapter 
Four in relation to the viral loads assays used by the clinic.  
 
But here I would like to consider the discussion in relation to the practitioners’ 
feelings about the care they provide. The thesis has considered the way in 
which biomedicine and biomedical technologies’ ability to intervene into 
vertical transmission of HIV has changed what is at stake for the medical 
practitioners. In other words, the knowledge that a future free from, or less 
affected by HIV,140 is possible for both mother and child, transforms the import 
of the practitioners’ practice in the present. Of course, the complexities that I 
am describing are entirely related to the fact that it is now possible to cut the 
risk of vertical transmission of HIV to less than 1% (CDC, 2012, p. 1). Thus, 
the promise contained within the biomedical technologies on offer in the clinic 
may simultaneously enable lives less affected by HIV while also placing a 
tremendous burden on the practitioners. This is because now that the 
biomedical technologies are understood of as being (almost) infallible, each 
and every care decision made in regards to a patient is felt by the 
practitioners to be even more significant.  
 	
                                                
140 The mother will be less affected by HIV, if her baby is born free of HIV.  
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Patient	Autonomy	and	Future	Patients	 
 
Throughout the empirical chapters, I have explored whose interests are 
served by the care provided in the clinic and I have made it clear that the 
people who are the beneficiaries of care are the imagined future postnatal 
patients and their (hopefully) HIV-negative bab(ies). Thus, the practitioners do 
the work that they do in order to facilitate the emergence of an imagined 
postnatal woman and her baby, (hopefully) born free of HIV. Ultimately, this 
woman will have been so enhanced by the care that she was provided with 
during her pregnancy that she will be able to help the practitioners ensure that 
the virus contained in her body is never transmitted to other bodies in the 
future, be they sexual partners or her own future offspring. Hence, the care 
that the practitioners provide patients with is, as mentioned above, ideally 
meant to also benefit the lives of any number of people who may or may not 
yet exist or be known to the patient or practitioner.  
 
Thus, in connection to the above, and from the practitioners’ perspective the 
emergence of the imagined future patient and her baby born free of HIV 
depends on the care provided, and the biomedical technologies available to 
the clinic and to the patient’s behaviour. Importantly, the practitioners imagine, 
based on their experience, the necessity to anticipate possible technological 
malfunctioning in order to prevent disruptions to the emergence of the future 
patient and her baby. As I have argued, the practitioners feel that patients 
must be encouraged to imagine their futures. However, a problematic result is 
that what the patients imagine their future to be is understood by the 
practitioners to also potentially disrupt the provision of care; in other words, to 
cut the network of care in the clinic. Therefore, as discussed in Chapter Five, 
from the practitioners’ point of view, if the network of care is cut (Strathern, 
1996), any number of people (real or imagined) may be affected.  
 
In response to this, the practitioners attempt to sway the way in which the 
patient thinks about her future and the future of her offspring. An important 
consequence of this is that the present-time patient cannot be treated as if 
she were a fully autonomous patient who is adept at making informed 
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decisions about her care, if and when her desires (are thought to) contradict 
the practitioners’ plans for her care. Consequently, I argued that the most 
significant care decisions in the clinic are negotiated by the practitioners in 
consultation with a figure that they have imagined. This figure represents the 
way they envisage the patient and her unborn baby in the future, and the 
practitioners speak and act on behalf of these future bodies and subjectivities. 
Hence, the specialist care provided to HIV-positive pregnant women in the 
clinic is directed towards the near-future patient. Accordingly, good care in the 
clinic requires that the practitioners ensure that nothing adversely interferes in 
her (and her babies’) enactment, including the present-time pregnant patient.  
 
From the practitioners’ perspective, imagination is consequently part of what 
HIV may become in the clinic. As mentioned before, this supposition is in line 
with Rosengarten’s articulations on the status of the imagination (2009). She 
contends that imagination is always “present and inherent to what we take to 
be an external, unmediated “real”” (2009, p. 21). Importantly, however, is the 
fact that the practitioners would assert that while imagination may become 
part of HIV in the future, there is nonetheless an “external, unmediated ‘real’ 
of HIV” in the present, that is not understood (by the practitioners) as having 
been affected by imagination in the past or present (2009, p. 21). The concept 
of an imagined and/or future patient contributes to understandings of 
antenatal HIV care by acknowledging the role the practitioners’ imagination 
plays in prevention efforts. Moreover, it furthers Mol’s argument that the 
provision of good care does not (necessarily) entail offering patients choice in 
regards to their care (2008).  
 
Throughout the thesis, I have demonstrated how women incorporated within 
the HIV diaspora (especially those who are in the UK illegally) are dependent 
on their families and communities for support. Moreover, the practitioners 
view the patient’s lack of autonomy (as her autonomy pertains to her family 
and community) as being problematic and a potential threat to their ability to 
prevent vertical transmission of HIV. This is interesting when thought of in 
relation to the fact that the practitioners do not care for their patients as if they 
are autonomous. From their perspective, a patient’s autonomy is therefore not 
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desirable in and of itself. Instead, the value or usefulness of an autonomous 
individual (be they patient or practitioner) has to do with the things that the 
person might do with their freedom (here freedom pertains specifically to the 
ability to make particular decisions about medical care), and the effects those 
decisions may have on the individual and those connected to her in the future. 
This belief requires that someone is able to assess and imagine the possible 
outcomes of a patient’s behaviour. In the case of the clinic, the practitioners 
make these determinations.  
 
Moreover, while a patient may be treated like an autonomous patient during 
her time in the clinic, this autonomy could be revoked in the future at any time. 
In other words, autonomy is not a static state that an HIV-positive diasporic 
woman may or may not inhabit and have access to. Instead it is something 
that is constantly negotiated, potentially rescinded and/or granted. As a 
consequence, the previous chapters have shown that patients in the clinic 
were treated as if they were able to make autonomous decisions about their 
care if and when their decisions conformed with the practitioners’ plans. The 
practitioners’ rationale for these practices is the fact that the patient(s) to 
whom their care efforts are directed are the future postnatal woman and her 
baby. If these future patients are able to have the chance of being fully 
autonomous and also have lives less affected by HIV, the present-time patient 
cannot be allowed to get in the way of their emergence.  
	
Limitations	of	the	Study 
 
Some of the limitations of this research were discussed in Chapter Three. In 
addition to the concerns mentioned there it is important to state that the 
findings of this thesis should be considered with caution. In other words, 
assumptions should not be made about the experiences of African and black 
women living with HIV and their care providers in other locations based on my 
findings. Rather, it is probable that HIV-positive African women and HIV 
specialist practitioners in other areas of the UK might have very different 
experiences than the ones described here. Moreover, it is important to 
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mention that I only spent a short amount of time in the field. It is quite possible 
that had I spent more time in the clinic and further immersed myself in the 
field, as is common in a traditional anthropological study, I would have been 
able to provide a more encompassing analysis of HIV in the clinic. However, 
despite these limitations, I was able to produce intense and qualitatively 
valuable data due to the intimate relationships I established with research 
participants.   
	
Future	Work 
 
The work presented in this thesis highlights significant avenues for further 
research. One of the most pertinent is to further investigate the effects the HIV 
diaspora may have on both HIV-positive people and on people connected to 
them. This work could explore how the stigmatising effects of HIV emerge and 
are used within diasporic communities, and it could attend to the way in which 
the stigmatising effects of HIV may become disconnected from the material 
real of HIV. Here I am thinking in particular of the way the children of HIV-
positive mothers are subjected to HIV stigmas despite being born free of HIV. 
In relation to this, additional research could consider the ways engagement 
with various HIV prevention and/or detection technologies may also expose 
women living with HIV and people connected to them to HIV related violence 
and stigma.  
Another pertinent area of further research would be to explore in more detail 
the experiences of the HIV specialist practitioners. This work could include 
more clinics so that there is less of a risk of individual participants being 
identified. This would then allow for analysis into the way in which 
practitioners attempt to protect their patients from people and institutions that 
they feel may be harmful to their patients’ wellbeing. These were significant 
themes that emerged during my field work but I have chosen not to 
disseminate the findings in this thesis out of concern over not being able to 
protect the practitioners’ identities, as discussed in Chapter Three.  
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Final	Thoughts 
 
The lack of privilege granted to diasporic HIV-positive women has been a 
reoccurring theme throughout this thesis and within the HIV/AIDS pandemic. 
And, while there is a temporal component to the data in this thesis because it 
was collected years ago, the arguments I make are still highly relevant today. 
This becomes evident when we consider the difficulties in eliminating vertical 
transmission of HIV — an achievement that is technically possible (de Wit, et 
al., 2011, p. 385; UNAIDS, 2012, p. 43; van der Zaag and McKnight, 2016, 
forthcoming). 
 
While it is possible to reduce the risk of vertical transmission to less than 1% 
(and this is undoubtedly an incredible feat for biomedicine) this fact alone 
does not mean that women living with HIV or their children will not die as a 
direct result of HIV. This is unconscionable. But we knew this before I began 
this research. We knew that life, the ability to live free from certain 
diseases/afflictions, is a privilege that is intricately connected to geographical 
location. However, this thesis has drawn out how exclusion from privilege 
follows women as they move within the HIV diaspora.  
 
Further to this, this thesis has made it clear that proficient care and the 
prevention of vertical transmission of HIV should be considered in relation to 
the fact that it would not in and of itself assure women that they will be able to 
live with HIV and secure their children’s lives. In other words, I argue that 
there is a danger in singling out the possibility of reducing the HIV 
transmission risk to less than 1% — and hailing that a success — without also 
considering what might happen to the people involved after the intervention(s) 
take place. For instance, what are the life chances of diasporic mothers living 
with HIV and their children? In other words, the promise of any (bio)medical 
technology and/or intervention should be considered in relation to the 
circumstances and expectations, now and in the future, of the people who are 
meant to benefit from them.  
 
Thus, the provision of good care and the successful prevention of vertical 
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transmission of HIV is not enough for the clinic’s patients. Women living with 
HIV need more than this; they need to be able to live lives that are not 
constantly foreshadowed by death. They need to know that their future selves 
and their future children will have access to the care and biomedical 
technologies needed to sustain their lives. Further to this, women living with 
HIV need to be able to protect themselves and their loved ones from the 
stigmatising effects of HIV.  
 
Accordingly, this thesis has made it clear that women living with HIV who are 
incorporated into the HIV diaspora depend on their ability to stay in a place 
wherein ART and appropriate care are available and stave off the effects of 
HIV. This is not an easy task. In conclusion, the care provided in the clinic will 
always be under threat as long as ART, safe ways of replacement feeding, 
and proficient care are not universally available. To put it another way, good 
care in the clinic is threatened by the fact that HIV and death are only 
disassociated in certain global locations. Finally, it’s important to note that this 
thesis has made it clear that the care provided by the specialist practitioners 
attempts to counteract and anticipate the harmful effects of the HIV diaspora 
on their patients. This is important work. Making it easier for the practitioners 
in the clinic to provide care should therefore be of utmost urgency.  
  
 232 
Bibliography	
Abu-Lughod, L., 1989. Zones of Theory in the Anthropology of the Arab 
World. Annual Review of Anthropology, 18, pp. 267–306. 
Adam, S., 1999. Reducing mother to baby transmission of HIV (Health 
Service Circular No. HSC 1999/183). NHS Executive, London. [Online] 
Available at: 
<http://webarchive.nationalarchives.gov.uk/20060802113547/dh.gov.uk
/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digita
lasset/dh_4012128.p> [Accessed 18 November 2015].  
Ades, A.E., et al., 1991. Prevalence of maternal HIV-1 infection in Thames 
Regions: results from anonymous unlinked neonatal testing. The 
Lancet, 337(8757), pp.1562–1565.  
Ades, A.E., et al., 1999a. Selective versus universal antenatal HIV testing: 
epidemiological and implementational factors in policy choice. AIDS, 
13(2), pp. 271–278. 
Ades, A.E., et al., 1999b. Cost effectiveness analysis of antenatal HIV 
screening in United Kingdom. BMJ, 319(7219), pp. 1230–1234. 
Aghaizu, A., et al., 2013. HIV in the United Kingdom 2013 Report: data to end 
2012. November 2013. Public Health England, London. 
AIDS.gov, 2015. What is a CD4 count and why is it important? CD2 Count. 
[Online] Available at: <www.aids.gov/hiv-aids-basics/just-diagnosed-
with-hiv-aids/understand-your-test-results/cd4-count/> [Accessed 20 
November 2015]. 
AIDS InfoNet, 2012. Couples with mixed HIV status. [Online] The Body: The 
Complete HIV/AIDS Resource. Available at: 
<www.thebody.com/content/art55344.html?ic=4001> [Accessed 7 
March 2016]. 
Akrich, M., and Pasveer, B., 2004. Embodiment and Disembodiment in 
Childbirth Narratives. Body & Society, 10(2-3), pp. 63–84.  
Ali, S., and Kelly, M., 2004. Ethics and social research. In: Researching 
Society and Culture. London, Thousand Oaks and New Delhi: SAGE 
Publications. pp. 115–127. 
Alubo, O., et al., 2002. Acceptance and stigmatization of PLWA in Nigeria. 
AIDS CARE, 14(1), pp. 117–126. 
Anderson, J., and Doyal, L., 2004. Women from Africa living with HIV in 
London: A descriptive study. AIDS Care: Psychological and 
Sociomedical Aspects of AIDS/HIV, 16(1), pp. 95–105. 
Auerbach, J.D., Parkhurst, J.O., and Cáceres, C.F., 2011. Addressing social 
drivers of HIV/AIDS for the long-term response: Conceptual and 
methodological considerations. Global Public Health, 6(3), pp. S293–
S309.  
AVERT, 2014. HIV Strains: Types, Groups and Subtypes. [Online] Global 
Information and Advice on HIV & AIDS. Available at:  
<www.avert.org/hiv-types.html> [Accessed 24 November 2015].  
Berg, M., and Akrich, M., 2004. Introduction — Bodies on trial: Performances 
and politics in medicine and biology. Body & Society, 10(2-3), pp. 1–12.  
 233 
Beynon-Jones, S.M., 2013. “We view that as contraceptive failure”: Containing 
the “multiplicity” of contraception and abortion within Scottish 
reproductive healthcare. Social Science & Medicine, 80, pp. 105–112.  
BHIVA et al., 2009. “Don’t Forget the Children” — Guidance for HIV Testing of 
children with HIV-positive parents. [PDF] Available at: 
<www.bhiva.org/documents/Publications/DFTC.pdf> [Accessed 26 
November 2015].  
BHIVA/CHIVA, 2010. Infant feeding in the UK BHIVA/CHIVA Guidelines 
Writing Group. [PDF] Available at: 
<http://www.bhiva.org/documents/Guidelines/InfantFeeding/InfantFeed
Cons.pdf> [Accessed 11 March 2016].  
Blystad, A., and Moland, K.M., 2009. Technologies of hope? Motherhood, HIV 
and infant feeding in eastern Africa. Anthropology & Medicine, 16(2), 
pp. 105–118.  
Brown, A., et al., 2004. Recent trends in HIV and other STIs in the United 
Kingdom: data to the end of 2002. Sexually Transmitted Infections, 
80(3), pp. 159–166.  
Brubaker, R., 2005. The “diaspora” diaspora. Ethnic and Racial Studies, 
28(1), 1–19.  
Burns, F.M. et al., 2007. Why the(y) wait? Key informant understandings of 
factors contributing to late presentation and poor utilization of HIV 
health and social care services by African migrants in Britain. AIDS 
Care: Psychological and Socio-medical Aspects of AIDS/HIV, 18(4), 
pp. 398–403. 
Byrne, B., 2004. Qualitative interviewing. In: Researching Society and Culture. 
London, Thousand Oaks and New Delhi: SAGE Publications. pp. 179–
192. 
Cames, C., et al., 2010. Acceptability and feasibility of infant-feeding options: 
experiences of HIV-infected mothers in the World Health Organization 
Kesho Bora mother-to-child transmission prevention (PMTCT) trial in 
Burkina Faso. Maternal & Child Nutrition, 6(3), pp. 253–265.  
Carlsson-Lalloo, E., Rusner, M., Mellgren, Å., and Berg, M., 2016. Sexuality 
and Reproduction in HIV-Positive Women: A Meta-Synthesis. AIDS 
Patient Care and STDs, 30(2), pp. 56–69.  
Carter, M., and Hughson, G., 2014. CD4 cell counts. NAM Aidsmap. [Online] 
Available at: < http://www.aidsmap.com/CD4-cell-
counts/page/1044596/> [Accessed 20 November 2015]. 
Carter, N., 2009. The social impact of HIV in pregnancy. MSc. London School 
of Economics, London, UK. 
CDC, 2012. HIV among pregnant women, infants, and children in the United 
States (No. CS237006). [PDF] Centers for disease control and 
prevention (CDC). Available at: <www.cdc.gov/hiv/pdf/risk_WIC.pdf > 
[Accessed 19 November 2015].  
Charmaz, K., 1990. “Discovering” Chronic illness: using grounded theory. 
Social Science and Medicine, 30(11), pp. 1161–1172. 
Charmaz, K., 2006. Constructing Grounded Theory A Practical Guide 
Through Qualitative Analysis. London, Thousand Oaks and New Delhi: 
Sage Publications. 
 234 
Charmaz, K., 2008a. Grounded theory as an emergent method. In: S.N. 
Hesse-Biber, P. Leavy, eds. Handbook of Emergent Methods. New 
York: Guilford Press. pp. 155–172. 
Charmaz, K., 2008b. Grounded theory. In: J.A. Smith, ed. Qualitative 
Psychology: A Practical Guide to Research Methods. London, 
Thousand Oaks and New Delhi: SAGE Publications. pp. 81–110. 
Cliffe, S., Tookey, P.A., and Nicoll, A., 2001. Antenatal detection of HIV: 
national surveillance and unlinked anonymous survey. BMJ, 
323(7309), pp. 376–377.  
Clifford, J., 1994. Diasporas. Cultural Anthropology, 9(3), pp. 302–338. 
Coates, T.J., Richter, L., and Caceres, C., 2008. Behavioural strategies to 
reduce {HIV} transmission: how to make them work better. The Lancet, 
372(9639), pp. 669–684.  
Cohen, M.S., et al., 2008. The spread, treatment, and prevention of HIV-1: 
evolution of a global pandemic. The Journal of Clinical Investigation, 
118(4), pp. 1244–1254.  
Collins, P.Y., Unger, H., and von, Armbrister, A., 2008. Church ladies, good 
girls, and locas: Stigma and the intersection of gender, ethnicity, 
mental illness, and sexuality in relation to {HIV} risk. Social Science & 
Medicine, 67(3), pp. 389–397.  
Conaty, S.J., et al., 2005. Women who decline antenatal screening for HIV 
infection in the era of universal testing: results of an audit of uptake in 
three London hospitals. Journal of Public Health, 27(1), pp. 114–117.  
Cooper, M.H., Bradshaw, G., 2012. Meeting the health and social care needs 
of pregnant asylum seekers; midwifery students’ perspectives. Part 3: 
“The pregnant woman within the global context”; an inclusive model for 
midwifery education to address the needs of asylum seeking women in 
the UK. Nurse Education Today, 33(9), pp. 1045–1050.  
Coovadia, H.M., et al., 2007. Mother-to-child transmission of HIV-1 infection 
during exclusive breastfeeding in the first 6 months of life: an 
intervention cohort study. The Lancet, 369(9567), pp. 1107–1116.  
Corbin, J., and Strauss, A., 1990. Grounded theory research: Procedures, 
canons and evaluative criteria. Zeitschrift fur Soziologie, 19(6), 418–
427. 
Crane, J., Quirk, K., and van der Straten, A., 2002. “Come back when you’re 
dying:” the commodification of AIDS among California’s urban poor. 
Social Science & Medicine, 55(7), pp. 1115–1127.  
Crapanzano, V., 1980. Tuhami : Portrait of a Moroccan. Chicago and London: 
The University of Chicago Press. 
De Cock, K.M., and Johnson, A.M., 1998. From exceptionalism to 
normalisation: a reappraisal of attitudes and practice around HIV 
testing. BMJ, 316(7127), pp. 290–293.  
De Cock, K.M., and Low, N., 1997. HIV and AIDS, other sexually transmitted 
diseases, and tuberculosis in ethnic minorities in United Kingdom: Is 
surveillance serving its purpose? BMJ, 314(7096), pp.1747–1751.  
de Laet, M., and Mol, A., 2000. The Zimbabwe Bush Pump: Mechanics of a 
Fluid Technology. Social Studies of Science, 30(2), pp. 225–263.  
Department of Health, 2012. HIV treatment for overseas visitors: guidance for 
 235 
the NHS. [PDF] Department of Health, UK. Available at: 
<www.gov.uk/government/uploads/system/uploads/attachment_data/fil
e/212952/DH-Guidance-HIV-and-NHS-Charging-fORMATED.pdf> 
[Accessed 28 January 2016].  
de Paoli, M.M., Manongi, R., and Klepp, K.-I., 2002. Counsellors’ perspectives 
on antenatal HIV testing and infant feeding dilemmas facing women 
with HIV in Northern Tanzania. Reproductive Health Matters, 10(20), 
pp. 144–156. 
de Ruiter, A., et al., 2008. British HIV Association and Children’s HIV 
Association guidelines for the management of HIV infected pregnant 
women. HIV Medicine, 9, pp. 452–502.  
de Ruiter, A., et al., 2014. Guidelines for the management of HIV infection in 
pregnant women, web consultation draft, 2012 (2014 Interim review). 
HIV Medicine, 15(4), pp. 1–77. [Online] Available at: 
</www.bhiva.org/PregnantWomen2012.aspx> [Accessed 11 March 
2015].  
Desclaux, A., and Alfieri, C., 2009. Counseling and choosing between infant-
feeding options: Overall limits and local interpretations by health care 
providers and women living with {HIV} in resource-poor countries 
(Burkina Faso, Cambodia, Cameroon). Social Science & Medicine, 
69(6), pp. 821–829.  
Detels, R., Muñoz, A., McFarlane, G., et al., 1998. Effectiveness of potent 
antiretroviral therapy on time to AIDS and death in men with known HIV 
infection duration. JAMA, 280(17), pp. 1497–1503.  
de Wit,  J.B.F., Aggleton, P., Myers, T., and Crewe, M., 2011. The rapidly 
changing paradigm of HIV prevention: Time to strengthen social and 
behavioural approaches. Health Education Research, 26(3), pp. 381–
392.  
Dhairyawan, R., Tariq, S., Scourse, R., Coyne, K., 2013. Intimate partner 
violence in women living with HIV attending an inner city clinic in the 
UK: prevalence and associated factors. HIV Medicine, 14(5), pp. 303–
310. 
Dieffenbach C.W, and Fauci A.S, 2009. Universal voluntary testing and 
treatment for prevention of HIV transmission. JAMA, 301(22), pp. 
2380–2382.  
Dilmitis, S., et al., 2012. Language, identity and HIV: Why do we keep talking 
about the responsible and responsive use of language? Language 
matters. Journal of the International AIDS Society, 15, Supplement 2. 
Dodds, C., et al., 2004. Outsider status stigma and discrimination experienced 
by gay men and African people with HIV. [Online Research Report] 
London: Sigma Research. Available at: 
<http://www.sigmaresearch.org.uk/downloads/report04f.pdf> 
[Accessed 3 March 2016].  
Dodds, C., et al., 2005. Grievous harm? Use of the offences against the 
Person Act 1861 for sexual transmission of HIV. [Online Research 
Report] London: Sigma Research. Available at: 
<http://www.sigmaresearch.org.uk/files/report2005b.pdf> [Accessed 8 
March 2016]. 
 236 
Doyal, L., 2009. Challenges in researching life with HIV/AIDS: An 
intersectional analysis of black African migrants in London. Culture, 
Health & Sexuality, 11(2), pp. 173–188.  
Doyal, L., and Anderson, J., 2005. “My fear is to fall in love again...” How HIV 
positive African women survive in London. Social Science & Medicine, 
60(8), pp. 1729–1738.  
Duffy, T.A., et al., 1998. Antenatal HIV testing: Current problems, future 
solutions. Survey of uptake in one London hospital. BMJ, 316(7127), 
pp. 270–271. 
Dunn, D.T., Newell, M.L., Ades, A.E., and Peckham, C.S., 1992. Risk of 
human immunodeficiency virus type 1 transmission through 
breastfeeding. The Lancet, 340(8819), pp. 585–588.  
Duong, T., et al., 1999. Vertical transmission rates for HIV in the British Isles: 
Estimates based on surveillance data. BMJ, 319(7219), pp. 1227–
1229.  
Eide, M., et al., 2006. Social consequences of HIV-positive women’s 
participation in prevention of mother-to-child transmission programmes. 
Patient Education and Counseling, 60(2), pp. 146–151.  
Erwin, J., and Peters, B., 1999. Treatment issues for HIV+ Africans in London. 
Social Science & Medicine, 49(11), pp. 1519–1528.  
Fakoya, I., et al., 2012. Religion and HIV diagnosis among Africans living in 
London. HIV Medicine, 13(10), pp. 617–622.  
Farmer, P., 2004. An anthropology of structural violence. Current 
Anthropology, 45(3), pp. 305–325.  
Fassin, D., 2013. A case for critical ethnography: Rethinking the early years of 
the {AIDS} epidemic in South Africa. Social Science & Medicine, 99, 
pp. 119–126.  
Fassin, D., 2007. When bodies remember experiences and politics of AIDS in 
South Africa. California Series in Public Anthropology. Berkeley, Los 
Angeles & London: University of California Press. 
Fay, B., 1996. Contemporary philosophy of social science: A multicultural 
approach. Cambridge, MA: Wiley Blackwell.  
Flowers, P., 2010. HIV transitions: Consequences for self in an era of 
medicalization. In: M. Davis, C. Squire, eds., HIV Technologies in 
International Perspective. Basingstoke & New York: Palgrave 
Macmillan. pp. 109–125. 
Flowers, P., et al., 2006. Diagnosis and stigma and identity amongst HIV 
positive Black Africans living in the UK. Psychology & Health, 21(1), 
pp. 109–122.  
Fraser, M., and Puwar, N., 2008. Introduction: Intimacy in Research. History 
of the Human Sciences, 21(4), pp. 1–16.  
French, C.E., Cortina-Borja, M., Thorne, C., and Tookey, P.A., 2012. 
Incidence, patterns, and predictors of repeat pregnancies among HIV-
infected women in the United Kingdom and Ireland, 1990-2009. Journal 
of acquired immune deficiency syndromes (1999), 59(3), pp. 287–293.  
French, C.E., et al., 2014. Immunologic status and virologic outcomes in 
repeat pregnancies to HIV-positive women not on antiretroviral therapy 
at conception: a case for lifelong antiretroviral therapy? AIDS (London, 
 237 
England), 28(9), pp.1369–1372.  
Gad, C., and Bruun Jensen, C., 2010. On the Consequences of Post-ANT. 
Science, Technology & Human Values, 35(1), pp. 55–80. 
Gardner, E.M., et al., 2011. The spectrum of engagement in HIV care and its 
relevance to test-and-treat strategies for prevention of HIV infection. 
Clinical Infectious Diseases, 52(6), pp. 793–800.  
Geertz, C., 2001. Thinking as a moral act: Ethical dimensions of 
anthropological fieldwork in the New States. In: Available Light: 
Anthropological Reflections on Philosophical Topics. Princeton: 
Princeton University Press. 
Gibb, D.M., et al., 1998. Factors affecting uptake of antenatal HIV testing in 
London: Results of a multicentre study. BMJ, 316(7127), pp. 259–261. 
Gielen, A.C., McDonnell, K.A., Burke, J.G., and O’Campo, P., 2000. Women’s 
Lives after an HIV-Positive Diagnosis: Disclosure and Violence. 
Maternal and Child Health Journal, 4(2), pp. 111–120.  
Gielen, A.C., O’Campo, P., Faden, R.R., and Eke, A., 1997. Women’s 
disclosure of HIV status: Experiences of mistreatment and violence in 
an urban setting. Women & Health, 25(3), pp. 19–31.  
Giles, M.L., Helland, M.E., Lewina, S.R., and O’Brien, M.L., 2009. The “work” 
of women when considering and using interventions to reduce mother-
to-child transmission (MTCT) of HIV. AIDS Care, 21(10), pp. 1230–
1237.  
Glaser, B.G., and Strauss, A., 1968. The discovery of grounded theory: 
Strategies for qualitative research. London: Weidenfeld and Nicolson. 
Glaser, B.G., and Holton, J., 2004. Remodeling Grounded Theory. Qualitative 
Social Research, 5, 80 paragraphs. [Online] Available at: 
<www.qualitative-
research.net/index.php/fqs/article/view/607/1315Volume> [Accessed 
29 July 2015].  
Goga, A.E., et al., 2012. Infant feeding practices at routine PMTCT sites, 
South Africa: Results of a prospective observational study amongst HIV 
exposed and unexposed infants — birth to 9 months. International 
Breastfeeding Journal, 7(4), pp. 2–11.  
Gurevich, M., Mathieson, C.M., Bower, J., and Dhayanandhan, B., 2007. 
Disciplining bodies, desires and subjectivities: Sexuality and HIV-
positive women. Feminism & Psychology, 17(1), pp. 9–38.  
Hammersley, M., ed., 1983. The ethnography of schooling: Methodological 
issues. Driffield: Nafferton. 
Hammersley, M., and Atkinson, P., 1995. Ethnography: Principles in practice, 
2nd ed. London: Routledge. 
Hansen, H., Holmes, S., and Lindemann, D., 2013. Ethnography of health for 
social change: Impact on public perception and policy. Social Science 
& Medicine, 99, pp. 116–118.  
Hawkins, D., et al., On behalf of the BHIVA guidelines writing committee, 
2005. Guidelines for the management of HIV infection in pregnant 
women and the prevention of mother-to-child transmission of HIV. HIV 
Medicine, 6(S2), pp. 107–148.  
Heimer, C.A., 2007. Old inequalities, new disease: HIV/AIDS in Sub-Saharan 
 238 
Africa. Annual Review of Sociology, 33(1), pp. 551–577.  
Henderson, D.K., and Gerberding, J.L., 1989. Prophylactic Zidovudine after 
occupational exposure to the human immunodeficiency virus: An 
interim analysis. Journal of Infectious Diseases, 160(2), pp. 321–327.  
Horsburgh, D., 2003. Evaluation of qualitative research. Journal of Clinical 
Nursing, 12, pp. 307–312. 
Horvath, T., et al., 2009. Interventions for preventing late postnatal mother-to-
child transmission of HIV. Cochrane Database of Systematic Reviews 
Art. No: CD006734, pp. 1–36.  
Iliff, P.J., et al., the ZVITAMBO study group, 2005. Early exclusive 
breastfeeding reduces the risk of postnatal HIV-1 transmission and 
increases HIV-free survival. AIDS, 19(7), pp. 699-708. 
Issiaka, S., et al., 2001. Living with HIV: Women’s experience in Burkina 
Faso, West Africa. AIDS Care, 13(1), pp. 123–128.  
Jarman, M., Dr, S.W., and Lacey, G.D., 2005. Keeping safe, keeping 
connected: A qualitative study of HIV-positive women’s experiences of 
partner relationships. Psychology & Health, 20(4), pp. 533–551.  
Jones, S., Sadler, T., Low, N., Blott, M., and Welch, J., 1998. Does uptake of 
antenatal HIV testing depend on the individual midwife? Cross 
sectional study. BMJ, 316(7127), pp. 272–273.  
Kalichman, S.C. et al., 2003. Stress, social support, and HIV-Status disclosure 
to family and friends among HIV-Positive men and women. Journal of 
Behavioral Medicine, 26(4), pp. 315–332.  
Kalichman, S.C. et al., 2004. Traditional beliefs about the cause of AIDS and 
AIDS related stigma in South Africa. AIDS CARE, 16(5), pp. 572–580. 
Kaplan, J.E., et al., 2009. Guidelines for prevention and treatment of 
opportunistic infections in HIV-Infected adults and adolescents 
recommendations from CDC, the National Institutes of Health, and the 
HIV Medicine Association of the Infectious Diseases Society of 
America, [MMWR Recommendations and reports]. Centers for disease 
control and prevention (CDC), USA. Available at: 
<http://francais.cdc.gov/mmwr/preview/mmwrhtml/rr5804a1.htm> 
[Accessed 1 December 2015].  
Keegan, A., Lambert, S., and Petrak, J., 2005. Sex and relationships for HIV-
positive women since HAART: A Qualitative Study. AIDS Patient Care 
and STDs, 19(10), pp. 645–654. 
Kelly, C., Alderdice, F., Lohan, M., and Spence, D., 2012. Creating continuity 
out of the disruption of a diagnosis of HIV during pregnancy. Journal of 
Clinical Nursing, 21(11-12), pp. 1554–1562.  
Kelly, C., Alderdice, F., Lohan, M., Spence, D., 2013. Every pregnant woman 
needs a midwife — the experiences of HIV affected women in 
maternity care. Midwifery, 29(2), pp. 132–138.  
Kumar, P., 2013. Long term non-progressor (LTNP) HIV infection. The Indian 
Journal of Medical Research, 138(3), pp. 291–293. 
Latour, B., and Woolgar, S., 1986. Laboratory Life: The Construction of 
Scientific Facts. Princeton: Princeton University Press. 
Law, J., 2009. Actor Network Theory and Material Semiotics. In: B.S. Turner, 
ed., The New Blackwell Companion to Social Theory. Malden, Oxford, 
 239 
Chichester: Blackwell Publishing Ltd. pp. 141–158. 
Law, J., 2008. On sociology and STS. The Sociological Review, 56(4), pp. 
623–649.  
Legislation.gov.UK, 2014. The National Health Service (Charges to Overseas 
Visitors) Amendment Regulations 2012. [online] Available at: 
<Legislation.gov.uk> [accessed 4 June 2014]. 
Lindau, S.T., et al., 2006. Mothers on the margins: Implications for eradicating 
perinatal {HIV}. Social Science & Medicine, 62(1), pp. 59–69.  
Lyall, E., et al., 2001. Guidelines for the management of HIV infection in 
pregnant women and the prevention of mother-to-child transmission. 
HIV Medicine, 2(4), pp. 314–334.  
MacDonagh, S.E., et al., 1996. Descriptive survey of antenatal HIV testing in 
London: policy, uptake, and detection. BMJ, 313(7056), pp. 532–533.  
Mason, J., 1996. Qualitative researching. London: SAGE Publications. 
Mbugua, N., 2007. Factors inhibiting educated mothers in Kenya from giving 
meaningful sex-education to their daughters. Social Science & 
Medicine, 64(5), pp. 1079–1089.  
McAndrew, F., et al., 2012. Infant feeding survey 2010: Summary. Health and 
Social Care Information Centre, pp. 35. [Online] Available at: 
http://www.hscic.gov.uk/catalogue/PUB08694/ifs-uk-2010-sum.pdf 
[Accessed 3 December 2015].  
McCormack, S., et al., 2015. Pre-exposure prophylaxis to prevent the 
acquisition of HIV-1 infection (PROUD): effectiveness results from the 
pilot phase of a pragmatic open-label randomised trial. The Lancet, pp. 
1–8.  
McKnight, U., van der Zaag, A., 2015. When debility provides a future: 
preventing mother-to-child transmission of HIV. Feminist Review, 111, 
pp. 124–139.  
Mercey, D., 1998. Antenatal HIV testing. BMJ, 316(7127), pp. 241–242. 
Mercey, D., et al., 1996. Voluntary universal antenatal HIV testing. BJOG: An 
International Journal of Obstetrics & Gynaecology, 103(11), pp. 1129–
1133.  
Michael, M., and Rosengarten, M., 2013. Innovation and biomedicine ethics, 
evidence and expectation in HIV, health, technology and society. New 
York: Palgrave Macmillan. 
Mol, A., 2002. The Body Multiple: Ontology in Medical Practice, Science and 
Cultural Theory. Durham and London: Duke University Press. 
Mol, A., 2008. The Logic of Care, Health and the Problem of Patient Choice. 
London and New York: Routledge. 
Mol, A., Law, J., 2004. Embodied action, enacted bodies: The example of 
hypoglycaemia. Body & Society, 10(2-3), pp. 43–62.  
Moland, K.M., de Paoli, M.M., Sellen, D.W., van Esterik, P., Leshabari, S., 
Blystad, A., 2010. Breastfeeding and HIV: Experiences from a decade 
of prevention of postnatal HIV transmission in sub-Saharan Africa. 
International Breastfeeding Journal, 5(10), pp. 2–7. 
Montgomery, C.M., 2010. The co-production of gender and technology in HIV 
prevention research. Ph.D. London School of Hygiene Tropical 
Medicine, Department of Public Health & Policy. 
 240 
Naftalin, C., et al., 2010. A qualitative study to explore factors influencing the 
beliefs and behaviour of HIV-positive pregnant women. HIV Medicine 
Suppl., 1, pp. 1–119. 
Nduati R, John G, Mbori-Ngacha D, et al., 2000. Effect of breastfeeding and 
formula feeding on transmission of hiv-1: A randomized clinical trial. 
JAMA, 283(9), pp. 1167–1174.  
Newell, M.-L., 1998. Mechanisms and timing of mother to child transmission 
of HIV‐1. AIDS, 12(8), pp. 831–837. 
Nguyen, V.-K., et al., 2011. Remedicalizing an epidemic: from HIV treatment 
as prevention to HIV treatment is prevention. AIDS, 25(3), pp. 291–
293. 
Nicoll, A., et al., 2000. The public health applications of unlinked anonymous 
seroprevalence monitoring for HIV in the United Kingdom. International 
Journal of Epidemiology, 29(1), pp. 1–10.  
Nicoll, A., et al., 1998. Epidemiology and detection of HIV-1 among pregnant 
women in the United Kingdom: results from national surveillance 1988-
96. BMJ, 316(7127), pp. 253–258. 
Nuwagaba-Biribonwoha, P.H., et al., 2006. The impact of HIV on maternal 
quality of life in Uganda. AIDS Care, 18(6), pp. 614–620.  
O’Connell Davidson, J., 2008. If no means no, does yes mean yes? 
Consenting to research intimacies. History of the Human Sciences, 
21(4), pp. 49–67.  
Oliver, S., and Petty, J., 2012. Breast-feeding and {HIV} transmission: An 
analysis of the factors influencing {HIV} positive mothers decision to 
breast-feed – A case study approach. Journal of Neonatal Nursing, 
18(5), pp. 155–162.  
Ostrom, R.A. et al., 2006. The role of stigma in reasons for HIV disclosure and 
non-disclosure to children. AIDS Care, 18(1), pp. 60–65.  
Palella, F.J., et al., 1998. Declining morbidity and mortality among patients 
with advanced Human Immunodeficiency Virus Infection. New England 
Journal of Medicine, 338(13), pp. 853–860.  
Parisaei, M., Anderson, J., Erskine, K.J., and Gann, S., 2007. Experience of 
delivering women with HIV in an inner city London hospital 1994–2004. 
International Journal of STD & AIDS, 18(8), pp. 527–530.  
Persson, A., 2013. Non/infectious corporealities: Tensions in the biomedical 
era of “HIV normalisation”. Sociology of Health & Illness, 35(7), pp. 
1065–1079.  
Persson, A., 2010. Reflections on the Swiss consensus statement in the 
context of qualitative interviews with heterosexuals living with HIV. 
AIDS Care, 22(12), pp. 1487–1492.  
Postma, M., et al., 1999. Universal HIV screening of pregnant women in 
England: cost effectiveness analysis. BMJ, 318(7199), pp. 1656–1660.  
Psaros, C., et al., 2012. Intimacy and Sexual Decision Making: Exploring the 
Perspective of HIV Positive Women Over 50. AIDS Patient Care and 
STDs, 26(12), pp. 755–760.  
Race, K., 2001. The undetectable crisis: Changing technologies of risk. 
Sexualities, 4(2), pp. 167–189.  
Rapp, R., 2006. Reason to believe. Culture, Medicine and Psychiatry, 30(4), 
 241 
pp. 419–421.  
Reger, J., 2001. Emotions, objectivity and voice: An analysis of a “failed” 
participant observation. Women’s Studies International Forum, 24(5), 
pp. 605 – 616.  
Richter, D.L., et al., 2002. Factors affecting reproductive decisions of African 
American women oiving with HIV. Women & Health, 36(1), pp. 81–96.  
Ridge, D., Ziebland, et al. 2007. Positive prevention: Contemporary issues 
facing HIV positive people negotiating sex in the UK. Social Science & 
Medicine; 65(4), pp. 755–770.  
Rosengarten, M., 2009. HIV Interventions: Biomedicine and the traffic 
between information and flesh, in vivo: Cultural mediations of 
biomedical science. Seattle and London: University of Washington 
Press. 
Sadler, K.E., et al., 2006. Mayisha II: Pilot of a community-based survey of 
sexual attitudes and lifestyles and anonymous HIV testing within 
African communities in London. AIDS Care, 18(4), pp. 398–403.  
Safran, W., 1991. Diasporas in Modern Societies: Myths of Homeland and 
Return. Diaspora: A Journal of Transnational Studies, 1(1), pp. 83–99.  
Sanders, L.B., 2009. Sexual Behaviors and Practices of Women Living With 
{HIV} in Relation to Pregnancy. Journal of the Association of Nurses in 
{AIDS} Care, 20(1), pp. 62–68.  
Sanders, L.B., 2008. Women’s voices: The lived experience of pregnancy and 
motherhood after diagnosis with {HIV}. Journal of the Association of 
Nurses in {AIDS} Care, 19(1), pp. 47–57.  
San Francisco AIDS Foundation, 1998. Viral load testing. [Online] Available 
at: <www.thebody.com/content/art2508.html#measuring> [Accessed 
20 November 2015].  
Scheper-Hughes, N., 1993. Death without weeping. The violence of everyday 
life in Brazil. Berkeley, Los Angeles & London: University of California 
Press. 
Scheper-Hughes, N., 2004. Parts unknown: Undercover ethnography of the 
organs-trafficking underworld. Ethnography, 5(1), pp. 29–73.  
Seale, C., 2004. Generating grounded theory. In: Researching Society and 
Culture. London, Thousand Oaks and New Delhi: SAGE Publications. 
pp. 239–247. 
Siegel, K., and Lekas, H.-M., 2002. AIDS as a Chronic Illness: Psychosocial 
Implications. AIDS, 16, pp. S69–S76. 
Siegel, K., Schrimshaw, E.W., and Lekas, H.-M., 2006. Diminished sexual 
activity, interest, and feelings of attractiveness among HIV-Infected 
women in two eras of the AIDS epidemic. Archives of Sexual Behavior, 
35(4), pp. 437–449.  
Siegfried, N., et al., 2011. Antiretrovirals for reducing the risk of mother-to-
child transmission of HIV infection. Cochrane Database of Systematic 
Reviews. [Online] Available at: 
<http://dx.doi.org/10.1002/14651858.CD003510.pub3> [Accessed 10 
May 2016].  
Sinka, K., Mortimer, J., Evans, B., and Morgan, D., 2003. Impact of the HIV 
epidemic in sub-Saharan Africa on the pattern of HIV in the UK. AIDS, 
 242 
17(11), pp. 1683-1690. 
Sloma, C.R., et al., 2009. Comparison of the AbbottRealTime Human 
Immunodeficiency Virus type 1 (HIV-1) assay to the Cobas 
AmpliPrep/Cobas TaqMan HIV-1 Test: Workflow, Reliability and Direct 
Costs. Journal of Clinical Microbiology, 47(4), pp. 889–895.  
Strathern, M., 1996. Cutting the network. The journal of the royal 
Anthropological Institute, 2(3), pp. 517–535. 
Tariq, S., 2013. HIV-positive African women’s engagement with HIV care in 
the UK during and after pregnancy. Ph.D. City University London, 
London, UK. 
Tariq, S., et al., 2011a. Use of Zidovudine-Sparing HAART in Pregnant HIV-
infected women in Europe: 2000–2009. Journal of Acquired Immune 
Deficiency Syndromes (1999), 57(4), pp. 326–333. 
Tariq, S., et al., 2012b. The impact of African ethnicity and migration on 
pregnancy in women living with HIV in the UK: Design and methods. 
BMC Public Health, 12, pp. 596–596.  
Tariq, S., et al., 2016. “It pains me because as a woman you have to 
breastfeed your baby”: Decision-making about infant feeding among 
African women living with HIV in the UK. Sexually Transmitted 
Infections, 1, pp. 1-6. [Online] Available at: 
<http://sti.bmj.com/content/early/2016/01/12/sextrans-2015-
052224.full> [Accessed 17 May 2016].  
Tariq, S., Cortina-Borja, M., Elford, J., and Tookey, P.A., 2011b. Among 
migrant African women, increased duration of stay in the UK or Ireland 
reduces the risk of detectable maternal HIV viral load at delivery. 
Conference Poster: P160 [Online] Available at: 
<www.ucl.ac.uk/nshpc/documents/conference-presentations/posters-
2011-2015/2011_BHIVA_Tariq_poster.pdf> [Accessed 3 March 2016].  
Tariq, S., et al., 2012a. The association between ethnicity and late 
presentation to antenatal care among pregnant women living with HIV 
in the UK and Ireland. AIDS Care, 24(8), pp. 978–985.  
Tariq, S., Pillen, A., Elford, J., and Tookey, P.A., 2014. HIV-positive African 
women’s experiences of healthcare in the UK during pregnancy: A 
qualitative study. HIV Medicine, 15, pp. 59–59. 
Tariq, S., Woodman, J., 2010. Using mixed methods in health research. 
Journal of the Royal Society of Medicine Short Reports, 0, pp. 1–8. 
Taylor, G., et al., 2012. British HIV Association guidelines for the management 
of HIV infection in pregnant women 2012. HIV Medicine, 13(S2), pp. 
87–157.  
The National Health Service. The National Health Service (Charges to 
Overseas Visitors) Amendment Regulations 2012. [Online] Available 
at: 
<http://www.legislation.gov.uk/uksi/2012/1586/memorandum/contents> 
[Accessed 4 June 2014].  
The UK Collaborative Group for HIV and STI Surveillance, 2004. Focus on 
Prevention HIV and other Sexually Transmitted Infections in the United 
Kingdom in 2003. An update: November 2004. [Online] Health 
Protection Agency Centre for Infections, London. Available at: 
 243 
<http://webarchive.nationalarchives.gov.uk/20140714084352/http://ww
w.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1203496898848> 
[Accessed 19 November 2015].  
Tölölyan, K., 1996. Rethinking diaspora(s): Stateless power in the 
transnational moment. Diaspora: A Journal of Transnational Studies, 
5(1), pp. 3–36.  
Tookey, P.A., et al., 1998. Performance of antenatal HIV screening strategies 
in the United Kingdom. Journal of Medical Screening, 5(3), pp. 133–
136.  
Townsend, C., et al., 2014. Earlier initiation of ART and further decline in 
mother-to-child HIV transmission rates, 2000-2011. AIDS, 28(7), pp. 
1049–1057.  
Townsend, C., Cortina-Borja, M., Peckham, C., and Tookey, P., 2008. Trends 
in management and outcome of pregnancies in HIV-infected women in 
the UK and Ireland, 1990–2006. BJOG: An International Journal of 
Obstetrics & Gynaecology, 115(9), pp. 1078–1086.  
Townsend, C.L., Cliffe, S., and Tookey, P.A., 2006. Uptake of antenatal HIV 
testing in the United Kingdom: 2000–2003. Journal of Public Health, 
28(3), pp. 248–252.  
Townsend, C.L., et al., 2008. Low rates of mother-to-child transmission of HIV 
following effective pregnancy interventions in the United Kingdom and 
Ireland, 2000–2006. AIDS, 22(8), pp. 973–981.  
Treisman, K., Jones, F.W., and Shaw, E., 2014. The experiences and coping 
strategies of United Kingdom-based African women following an {HIV} 
diagnosis during pregnancy. Journal of the Association of Nurses in 
{AIDS} Care, 25(2), pp. 145–157.  
UNAIDS, 2012. Global Report: UNAIDS Report on the Global AIDS Epidemic 
2012. Joint United Nations Programme on HIV/AIDS (UNAIDS), 
Geneva, Switzerland. [Online] Available at: 
<www.unaids.org/sites/default/files/media_asset/20121120_UNAIDS_
Global_Report_2012_with_annexes_en_1.pdf> [Accessed 28 October 
2015].  
UNAIDS, 2013. Global report: UNAIDS report on the global AIDS epidemic 
2013. Joint United Nations Programme on HIV/AIDS (UNAIDS). 
University College London, National Study of HIV in Pregnancy and 
Childhood. [Online] Available at: <www.ucl.ac.uk/silva/nshpc> 
[Accessed 8 April 2016].  
Valle, M., and Levy, J., 2008. Finding meaning: African American injection 
drug users’ interpretations of testing HIV-positive. AIDS Care, 20(1), 
pp. 130–138.  
van der Zaag, A., and McKnight, U. (2017 under review). As the Subaltern 
Matters: a materialist exploration of mother-to-child transmission of 
HIV. Signs: Journal of Women in Culture and Society. 
van der Zaag, A., and McKnight, U. (forthcoming). Exploring the relational 
complexity of serodiscordance: negotiating violence, temporality and 
diaspora. In: Aggleton, P., et al. eds. (2016) Social Aspects of HIV. 
New York: Springer. 
Velimirovic, B., 1987. AIDS as a social phenomenon. Social Science & 
 244 
Medicine, 25(6), pp. 541–552. 
Vernazza, P., Hirschel, B., Bernasconi, and E., Flepp, M., 2008. Les 
personnes séropositives ne souff rant d’aucune autre MST et suivant 
un traitment antirétroviral effi cace ne transmettent pas le VIH par voie 
sexuelle. Bulletin des Médecins Suisses, 89(5), pp. 165–169. 
Vora, K., 2013. Potential, Risk, and Return in Transnational Indian Gestational 
Surrogacy. Current Anthropology, 54(S97), pp. S97–S106.  
Walby, 1996. AIDS and the body politic: Biomedicine and sexual difference. 
London and New York: Routledge. 
Walsh, D., 2004. Doing ethnography. In: C. Seale, ed. Researching Society 
and Culture. London, Thousand Oaks and New Delhi: SAGE 
Publications. pp. 225–237. 
Weait, M., 2007. Intimacy and Responsibility: The Criminalisation of HIV 
Transmission. Routledge, Oxon. 
Welsh, E., 2002. Dealing with Data: Using NVivo in the Qualitative Data 
Analysis Process. Forum Qualitative Sozialforschung/Forum: 
Qualitative Social Research, 3(2), pp. 1–6. 
West Middlesex University Hospital NHS Trust, 2014. How we fit into the 
NHS. [Online] Available at: <www.west-middlesex-hospital.nhs.uk> 
[Accessed 7 December 2015].  
Weston, H.J., 2003. Public honour, private shame and HIV: Issues affecting 
sexual health service delivery in London’s South Asian communities. 
Health & Place, 9, pp. 109–117. 
Wilson, D.P., et al., 2008. Relation between HIV viral load and infectiousness: 
a model-based analysis. The Lancet, 372(9635), pp. 314–320.  
Wilson, S., 2007. “When you have children, you’re obliged to live”: 
Motherhood, chronic illness and biographical disruption. Sociology of 
Health & Illness, 29(4), pp. 610–626.  
World Health Organization, 2010. Guidelines on HIV and infant feeding. 2010. 
Principles and recommendations for infant feeding in the context of HIV 
and a summary of evidence. (No. 9789241599535). [PDF] World 
Health Organization, Geneva. Available at: 
<http://apps.who.int/iris/bitstream/10665/44345/1/9789241599535_eng
.pdf> [Accessed 7 December 2015].  
World Health Organization, 2014. HIV Drug Resistance: Revised concept 
Notes. [Online] Available at: 
<www.who.int/hiv/topics/drugresistance/en/> [Accessed 14 October 
2015].  
Yankah, K., 2004. Narrative in times of crisis: AIDS stories in Ghana. Journal 
of Folklore Research, 41(2), pp. 181–198.  
 
 	
  
Develop your study idea 
 Guidance from NHS R&D 
 
 Is my project research? 
 
 Requirements for Ethical 
Approval 
Ensure any external funding is agreed 
in principle before submitting REC 
and R&D applications. 
Complete IRAS form and develop 
supporting documentation 
 IRAS web site 
 Participant Information Sheets 
and Consent Forms 
 
 Book in your Application 
via either the 
 Central Allocation System 
 Local Allocation Service 
Submit your application and 
supporting documentation to the 
REC allocated to review your study 
within 4 days of booking. 
 
REC coordinator validates application 
within 5 working days of receipt. 
Validation will be confirmed by letter. 
60 day clock starts from when a valid 
application is received. 
 
You will be invited to attend the REC 
meeting. 
Application reviewed by main REC and 
the decision of the REC is advised by 
letter. 
 
Provisional Opinion - further 
information requested (clock stops 
whilst awaiting further info) 
 
Submit further information for review 
as requested (clock restarts when 
further info received by REC) 
 
If your response to the REC is 
incomplete, you may be asked to 
supply a more detailed response to 
the initial request for further 
information but no new issues may 
be raised by the REC at this stage 
 
What other approval do I need as 
well or instead? 
 Contact your Trust 
 Other Approvals 
 MHRA  
All research involving NHS 
research sites requires 
permission for research for each 
site. 
NHS R&D Forum 
Applications deemed invalid may be 
modified and rebooked. 
If your application I deemed not valid 
but outstanding information appears 
relatively straightforward, the 
Coordinator may contact you and 
request outstanding information 
before it can be validated. 
 
Submit outstanding information to 
REC 
Not requiring review by NHS REC 
Modify 
application and 
resubmit 
 Appeal 
Unfavourable Opinion 
 Submit non-NHS SSI form to 
local (or specific) REC for 
review 
 
If yes complete the non-NHS SSI 
form in IRAS. 
 
For non-NHS sites only: Does your 
study require site-specific 
assessment? 
 Requirements for site-specific 
assessment 
 Guidance on SSA exemption 
 How to apply for SSA 
 
If you consider your study presents 
no material ethical issues, it may be 
eligible for review under the 
proportionate review service 
 Proportionate Review 
 
No opinion - REC 
seeks advice from a 
specialist referee. 
60 day clock does 
not stop while 
waiting for advice. 
Favourable Opinion with 
Conditions 
Favourable Opinion 
Th
e 
 R
EC
 is
 c
om
m
itt
ed
 to
 r
et
ur
ni
ng
 a
n 
op
in
io
n 
w
ith
in
 6
0 
da
ys
 o
f r
ec
ei
pt
 o
f a
 V
al
id
 a
pp
lic
at
io
n.
 
Application Process Flowchart 
  Process for obtaining ethical approval 
  Site-specific assessment for non-NHS sites 
  R&D Permission for NHS sites  
  Proportionate Review 
 
Appendix
245
